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Dissertation Abstract 
Paradoxical menstrual cycle patterns in women’s well-being (e.g., premenstrual syndrome 
[PMS] and negative experiences in the periovulatory phase) and sexual behavior (e.g., the 
periovulatory sociosexual tactic shift [PSTS]) have been found. Patterns in affect and sexuality 
may have evolved to co-occur if being “in the mood” facilitates sex. In this dissertation, the 
development of the Women’s Reproductive Experiences (REP) Questionnaire and an initial 
psychometric evaluation is presented in Part 1 of Study 1 (n = 1943 women aged 16 to 74 years). 
The Women’s REP separately measures negative and positive experiences associated with 
reproductive events across the lifespan in three domains: affective, sexual, and physical. In Part 2 
of Study 1, evidence for reliability in factor structure (e.g., seven main scales) and internal 
consistency as well as concurrent validity is provided. Women who differ in reproductive status 
(e.g., pregnant, postpartum, menopausal, menstrual cycle phase, and hormonal contraceptive 
use), including estimated conception probability and sex hormone levels, also differ on the 
Women’s REP scales. In Part 1 of Study 2 (n = 327 women of reproductive age), evidence for 
the test-retest reliability and further validity of the Women’s REP is presented. Relationships 
with another newer measure, the Proceptive and Receptive Mating Strategies Scale (PARMSS), 
were also examined (Part 1). In Part 2 of Study 2, the two measures were used to examine co-
variation in negative affective experiences (NA,) positive affective experiences (PA), and 
proceptivity across the periovulatory and premenstrual phases in naturally cycling women (n = 
41). Support was found for the hypothesis that there are two groups of women who show 
opposing patterns of change differentiated by the phase in which they experience higher NA, 
lower PA, and lower proceptivity: (1) the premenstrual phase (a premenstrual syndrome, 61%) 
and (2) the periovulatory phase (a periovulatory syndrome, 39%). In line with the PSTS, women 
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who showed what is proposed to be a periovulatory syndrome (POS) were more sociosexually 
unrestricted than women who showed a PMS pattern. Overall, the two studies provide evidence 
that reproductive events are related to various negative and positive experiences, and that not all 
women show the classic PMS pattern of menstrual cycle experiences. 
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2
Women’s Reproductive Experiences (REP) and Hormones: 
Patterns in Affective, Sexual, and Physical Well-Being 
Women’s health and functioning across the lifespan may be affected by past and present 
reproductive events, from puberty to the menopausal transition. Theories suggest that 
psychological changes associated with natural reproductive events, including premenstrual 
syndrome (PMS), may be related to evolved adaptations through sexual selection (e.g. Reiber, 
2008). As epitomized by the phrase “in the mood,” there appears to be a link between affective 
and sexual experiences in general (Brown, Calibuso, & Roedl, 2011; Warner & Bancroft, 1988). 
Patterns in affect and sexuality may have evolved to co-occur if being in a good mood facilitates 
being in the mood for sex. While mild changes in negative affect, sexual functioning, and mating 
tactics during these hormone-related events are considered to be common, there is little literature 
on positively, as opposed to negatively, valenced shifts as well as whether there are relationships 
between shifts in affect and shifts in sexual mating behaviour. Therefore, research on symptoms 
associated with reproductive events, particularly those that occur among women of reproductive 
age (i.e., menstrual cycle phase and hormonal contraceptive [HC)] use), as well as hormones and 
mating strategies will be reviewed. Following that, the results of two relevant two-part studies 
are presented. In an attempt to further the understanding of hormone-related patterns in women’s 
affective, sexual, and physical well-being, the two studies in this dissertation involved: (a) the 
development and psychometric examination of a comprehensive measure of women’s 
reproductive experiences across the lifespan, and (b) an investigation of relationships between 
affect and sexual proceptivity across the menstrual cycle in non-users. This general introduction 
represents the comprehensive literature review that was completed prior to these two studies.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
3
The rates of depression among girls and boys are nearly equal. However, epidemiological 
research suggests that there is a shift around mid-puberty to a 2:1 female to male ratio (e.g., 
Kessler et al., 1994). Furthermore, mixed episodes, bipolar II disorder, rapid cycling bipolar 
disorder, and seasonal affective disorder appear to be more common among women than men 
(Arnold, 2003). Between-sex variation in mood and affect has been hypothesized to be related, in 
part, to organizational and activational effects of steroidal sex hormones on the brain because 
such effects are largely responsible for sexual differentiation (Eckel et al., 2008; Steiner, Dunn, 
& Born, 2003).  
In some women, recurrent mood disorders or emotional instability co-occur with 
reproductive events characterized by hormonal shifts across the lifespan. In fact, psychological 
changes across the menstrual cycle have been of interest to researchers and clinicians for 
centuries. In the 5
th
 century B.C.E., Hippocrates alleged that retained menstrual flow could result 
in delusions, mania, and thoughts of suicide, among other symptoms (Dell & Svec, 2003). 
Changes in the hormonal milieu across the cycle are generally considered to underlie 
premenstrual syndrome (PMS), constellations of physical and psychological symptoms that 
appear just prior to, and remit following, the onset of menstruation
1
 (Speroff & Fritz, 2005). On 
the other hand, controversy still exists about PMS or negative mood symptoms in the 
premenstrual phase (e.g., Chrisler & Caplan, 2002; Romans, Clarkson, Einstein, Petrovic, & 
Stewart, 2012). Research on negative and beneficial side effects of HC use
2
 (i.e., suppression or 
                                                 
1
 In the present dissertation, use of the terms “PMS,” “syndrome,” “symptom,” and “side effect” denote change 
across the cycle, with HC use, or with another reproductive event and not necessarily a disorder. There are no agreed 
upon, widely used criteria for PMS. The presence of only one adverse symptom (i.e., an increase in a negative 
affective, sexual, or physical experience) in the premenstrual phase is required by the American College of 
Obstetricians and Gynecologists (2000) and the World Health Organization (1987). However, it has been 
recommended that the diagnosis of a premenstrual disorder involve at least a prospective 30% increase in symptom 
severity or clinical impairment within the two weeks before menses (O’Brien et al., 2011). 
2
 Psychological symptoms refers to both those induced by HC use overall (i.e., regardless of menstrual cycle phase) 
and those across the HC-induced cycle that may or may not be a direct result of HC use.  
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disruption of the natural menstrual cycle/fertility) has also been conducted for over 50 years 
(Kurshan & Epperson, 2006). As will be reviewed, however, “one’s woman’s low [may be] 
another’s woman’s high” (Kiesner, 2011, p. 68). That is to say, there appear to be paradoxical or 
bidirectional effects on well-being in subgroups of women, not only across the menstrual cycle, 
but also during other reproductive events, including HC use.   
Research since the 1980s has consistently suggested that a substantial proportion of 
women (i.e., 40 to 80%) report at least some premenstrual symptoms (American Psychiatric 
Association [APA], 2000; Cunningham, Yonkers, O’Brian, & Eriksson, 2009; Logue & Moos, 
1988). In 1987, a severe subtype of PMS, late luteal phase dysphoric disorder, was included in 
the Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R; APA). With the release 
of the DSM-IV (APA) in 1994, the label was changed to premenstrual dysphoric disorder 
(PMDD). It was included as a criteria set provided for further study with the suggestion that it 
should be diagnosed as a mood disorder not otherwise specified, and it has a prevalence rate of 3 
to 8% (APA, 2000; Cunningham et al., 2009). In 2013, PMDD was classified as a distinct 
depressive disorder in the DSM 5 (APA, 2013). The only other reproductive event included in 
the DSM 5 is the peripartum period, which is considered to be an onset specifier of depressive, 
manic, and mixed episodes
3
 as opposed to a distinct disorder (APA, 2013). Nonetheless, nearly 
all female reproductive hormone-related events or changes have been linked to psychological 
symptoms in subsets of women. For instance, 90% of the female population uses HCs in their 
lifetime and upwards of 40% of these women report experiencing adverse side effects, with 
emotional and sexual changes being among the primary reasons for discontinuing use (Oinonen 
                                                 
3
 This onset specifier included only the postpartum period and was not applicable to hypomanic episodes in the 
DSM-IV-TR (APA, 2000).   
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& Mazmanian, 2001a; Sanders, Graham, Bass, & Bancroft, 2001; Tilhonen, Leppäpen, 
Heikkinen, & Ahonen, 2008).  
Changes in physical and mental health, including PMS, seem to exist on a continuum of 
severity from normal or minimal to clinical and impairing (Lopez, Compton, Grant, & Breiling, 
2006; Steiner et al., 2003). In considering severity, it may be important to distinguish between 
mood and affect. Mood refers to pervasive emotional climate and is often used categorically to 
establish the presence or absence of a diagnosis. Affect reflects emotional weather or fluctuations 
over time (APA, 2000) and affords a more dimensional approach to research. The two main 
advantages of a dimensional approach are that it allows for the examination of a spectrum of 
change as well as both negatively valenced (e.g., elevated negative affect) and positively 
valenced (e.g., elevated positive affect) changes (Oinonen & Mazmanian, 2002). For example, 
some research indicates that negative affect and positive affect are independently related to 
health complaints and social activity, respectively (e.g., Watson, 1988). Even if mood and affect 
are bipolar dimensions, then both valences (e.g., negative affect and positive affect as opposed to 
just high negative affect and low negative affect) should be measured to avoid ceiling or floor 
effects (Green & Salovey, 1999) and to reduce the effects of bias in self-reports of psychological 
changes related to reproductive events (Meaden, Hartlage, & Cook-Karr, 2005).  For instance, an 
assumption that seems to underlie a focus on negative experiences is that the presence of a given 
negative experience or negatively worded item on a questionnaire is synonymous with the 
absence of a related positive experience or positively worded item (e.g., Kiesner, 2011; cf., 
Meaden et al., 2005).  
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Physiology and Endocrinology 
In order to examine how girls and women respond to hormonal changes across the 
lifespan, it is fundamental to have an understanding of the possible physiological and 
endocrinological mechanisms. Whether the effects of hormone-related events are organizational 
or activational can be ambiguous. In general, organizational changes tend to be permanent, an 
example being structural changes in the brain induced by hormone exposure. Activational 
changes refer to reversible effects that last only as long as the hormonal change is present, as 
appears to be the case with symptoms that co-occur with a reproductive event but subsequently 
remit (Phoenix, Goy, Gerall, &Young, 1959). Receptors for steroidal sex hormones exist in 
numerous tissues, including the brain. Therefore, the role of reproductive events and hormones in 
women’s functioning should not be overlooked, consistent with sex-based medicine (Hampson & 
Young, 2008). Of particular relevance to this dissertation are events that occur during the 
reproductive years of a woman’s life, namely the menstrual cycle and any HC use.  
The menstrual cycle. The menstrual cycle is an infradian biological rhythm exclusive to 
female mammals, although only a few species overtly menstruate (Strassman, 1996). It consists 
of two co-occurring cyclic processes, the ovarian cycle and the endometrial cycle, and is 
regulated by four main hormones. Follicle-stimulating hormone (FSH) and luteinizing hormone 
(LH) are gonadotropins released by the anterior pituitary gland, while estrogen and progesterone 
are steroid hormones secreted by the ovaries, the female gonads. Progesterone is also secreted by 
the corpus luteum, a temporary structure formed after ovulation. The neuroendocrine component 
of the cycle is the hypothalamic-pituitary-ovarian (HPO) axis. The hypothalamus releases a 
neurohormone, gonadotropin-releasing hormone (GnRH), stimulating the secretion of 
gonadotropins that influence ovarian function, all of which involves feedback loops (Ferin, 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
7
Jewelewicz, & Warren, 1993). GnRH and the gonadotropins are released in ultradian pulses that 
change in frequency and amplitude across the cycle, altering the sensitivity of the HPO axis 
(Rasgon, Pumphrey, et al., 2003; Schnatz, 1985). 
The ovarian cycle can be divided into three main phases: follicular, ovulatory, and luteal
4
. 
The follicular phase is considered to be days 1 to 13 of a 28-day cycle and is often described as 
containing shorter phases or sub-phases. More specifically, menstruation or menses consists of 
menstrual bleeding, days 1 to about 5, and low levels of estrogen, progesterone, LH, and 
testosterone but increasing levels of FSH. The periovulatory phase, characterized by peak levels 
of estrogen, testosterone, LH, and FSH levels, is approximately days 8 to 13 (or 21 to 16 days 
before the next onset of menstruation [-21 to -16]) (e.g., Garver-Apgar, Gangestad, & Thornhill, 
2008). There is a small increase in progesterone just prior to ovulation (Hampson & Young, 
2008). Ovulation, the release of an ovum from the fallopian tubes, typically occurs on day 14 (-
15), after which there is a drop in reproductive hormones with the exception of progesterone. 
Lastly, the luteal phase tends to be 14 days in length from days 16 to 28 (-13 to -1). Levels of 
progesterone are increasingly high and reach peak levels during the mid-luteal phase (days 18 to 
21 [-11 to -8]), estrogen levels are moderate with an increase in the mid-luteal phase, 
testosterone may increase slightly just before the estrogen rise, and FSH and LH levels are 
minimal. The premenstrual or late luteal phase can be defined as days 22 to 28 (-7 to -1), the end 
of which is marked by declining levels of both estrogen and progesterone (Speroff & Fritz, 2005; 
Stricker et al., 2006).  
                                                 
4
 It appears that the menstrual cycle can be divided/classified into between two and six meaningful phases, but that 
ovarian changes go through three main phases (Ferin et al., 1993). There is a striking lack of consistency in 
measurement across the relevant literature but most psychological studies differentiate between three or more 
general phases (menstrual, periovulatory, and luteal), even if they only examine two (e.g., Haselton & Gangestad, 
2006; Oinonen, Klemencic, & Mazmanian, 2008; Sveinsdóttir & Bäckström, 2000).    
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A woman is born with approximately 400,000 follicles with ova, most of which undergo 
atresia over the lifespan. Folliculogenesis is the process within oogenesis whereby a follicle 
matures (Speroff & Fritz, 2005). A cohort of maturing follicles is selected during each menstrual 
cycle, stimulated by a rise in FSH that can occur 1 to 2 days before the start of menstruation, but 
typically only the dominant one ovulates. FSH also triggers the aromatization process of 
androgen to estrogen in the follicles, namely estradiol (E2) that then exerts an inhibitory effect 
on FSH but stimulates LH secretion. An LH surge initiates ovulation as well as the development 
of the residual follicle into the corpus luteum. Ovulation occurs 18 hours after peak LH levels or 
36 hours after the beginning of the surge that lasts for about 48 hours in total. The corpus luteum 
produces progesterone and some estrogen. Unless the blastocyst is fertilized, the corpus luteum 
degenerates about 12 days after ovulation in a process called luteolysis. Reproductive hormones 
levels drop as the corpus luteum degenerates and the cycle begins again with menstruation (Ferin 
et al., 1993; Speroff & Fritz, 2005).  
These ovarian and hormonal changes are coupled with four stages of uterine lining 
development. In humans, approximately 75% of the upper layers of the endometrium are 
sloughed off during the menstrual phase due to arterial constriction in the ischemic phase, which 
corresponds to the late luteal phase (Ferin et al., 1993). The endometrium begins to thicken and 
enlarge when stimulated by estrogen later in the follicular phase, the proliferative phase. The 
secretory or glandular phase begins after ovulation in preparation for fertilization and 
implantation of the blastocyst (i.e., pregnancy) or until the cycle restarts (Speroff & Fritz, 2005).   
In research, reproductive events and hormonal changes are akin to naturally occurring 
experiments. By comparing phases of the menstrual cycle within women, the relative effects of 
changes in hormones on women’s functioning can be examined. In addition, fertility or 
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conception probability, as modulated by the hormonal cascade of the cycle, can be estimated. It 
is clear that fecundity is dependent on ovulation
5
. However, women are most likely to become 
pregnant after intercourse in the preovulatory phase, particularly days 12 and 13 [-17 and -16] or 
the day before ovulation, as it takes time for sperm to travel to and penetrate an ovum (Havez, 
1979; Wilcox, Dunson, Weinberg, Trussell, & Baird, 2001). The conception probability 
estimates for these two days have been found to be .084 and .086, while those of the rest of cycle 
range from < .0001 to .072 (Wilcox et al., 2001).   
Variability in the length and regularity of the cycle, the occurrence and timing of 
ovulation, as well as hormone levels and fertility exist within- and between-women (e.g., Creinin 
Keverline, & Meyn, 2004; Venners et al., 2006). Peripheral effects of hormones on physiology 
such as vaginal mucus or basal body temperature, as well as hormone estimation, detection, or 
assays can be used to monitor the cycle (Stanford, White, & Hatasaka, 2002). Nonetheless, the 
average woman’s menstrual cycles are regular such that they tend to be 24 to 35 (M = 29.5) days 
in length with a luteal phase that is consistently 13 ±1 days in length (Hampson & Young, 2008; 
Fehring, Schneider, & Raviele, 2006). In contrast, the length of the follicular phase is variable
6
. 
Thus, the first day of menstruation is considered to be day 1 of the cycle counting forward, while 
reverse or backwards counting (Jöchle, 1973) is more accurate for estimating the timing of 
phases other than the menstrual phase (see above; Hampson & Young, 2008).  
                                                 
5
 Note that women seem to spontaneously and inconspicuously ovulate in comparison to species that exhibit reflex 
ovulation (i.e., in response to a sensory trigger such as mating) or unconcealed estrus (e.g., heat and sexual 
swellings) (Jöche, 1979). 
6
 Menstrual cycles less than 25 days in length tend to have follicular phases that are too short, less than 12 days, to 
support adequate follicular development. Thus, women with such cycles are typically anovulatory. Long cycles are 
often indicative of endocrine functioning that is relatively abnormal and associated with infertility (Hampson & 
Young, 2008). Also note that very short and long follicular phases may be associated with other health outcomes, 
including breast cancer, and lifestyle factors, such as previous OC use and weight (Jukic, Weinberg, Baird, & 
Wilcox, 2007).  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
10
Menstruation appears to be a relatively recent phenomenon in the evolutionary timeline 
of humans (Finn, 1994; 1996). There are two prominent hypotheses as to why the endometrial 
cycle and menses evolved. The first suggests that cyclic bleeding is an adaptation because it 
expels sperm-borne pathogens (Profet, 1993). In 1996, Strassman essentially debunked the anti-
pathogen hypothesis as a review of the literature failed to support three basic predictions that 
follow from it, including that there should be more uterine pathogens before than after menses. 
Alternatively, evidence was provided to suggest that the endometrial cycle may be more 
physiologically efficient than continuously maintaining the uterus for pregnancy, and that 
menstrual bleeding is due to a design compromise that resulted in an inability to reabsorb all 
tissues. For instance, the metabolic rate of women tends to be 7% lower during the follicular 
phase compared to the luteal phase, which equates to a savings of about 6 days worth of food 
over four cycles (Strassman, 1996). Women’s caloric intake appears to be highest in the luteal 
phase and lowest around ovulation, possibly because women “have better things to do than eat” 
when fertile (Fessler, 2003, p. 4). Although it is unclear precisely why women menstruate, as 
opposed to reabsorb all endometrial tissues as do most other species, it appears to be a byproduct 
of phylogeny given that endometrial regression but not menstrual bleeding per se may be more 
adaptive. 
The average woman will menstruate less than 400 times (Speroff & Fritz, 2005; 
Strassman, 1997). Anthropological research suggests that modern women experience a higher 
number of menstrual cycles than did women in hunter-gatherer tribes, and possibly ancestors in 
the environment of evolutionary adaptiveness (EEA)
7
. This difference is likely due to an earlier 
age of menarche, hormonal contraceptive use, an older age at first pregnancy, a lower birthrate, 
                                                 
7
 This refers to the ancestral time in which a trait was naturally or sexually selected (i.e., spontaneous ovulation in 
this case) and therefore, the environment in which an evolved mechanism was adapted (Tooby & Cosmides, 2005).  
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and subsequently less time spent in lactational amenorrhea among Western women today 
(Strassman, 1999). A longer life expectancy and the evolution of menopause may also be 
contributing factors (see Kuhle, 2007 for a review of evolutionary hypotheses of menopause). 
However, research indicates that American women ovulate three times more frequently over a 
lifetime than women in a natural-fertility population, the Dogon of Mali tribe (Strassman, 1997). 
The incessant ovulation hypothesis (e.g., Eaton et al., 1994) has linked more frequent ovulation 
to the higher rates of reproductive cancers in Western women due the morphological effects of 
hormonal fluctuations on tissues, such as in the breast (Strassman, 1999). Although there are 
probably a number of factors involved (e.g., diet and environmental toxins), proponents of 
Darwinian medicine argue that a mismatch between the human genome, as selected in the EEA, 
and rapid cultural evolution has had a significant impact on physical and mental health. 
Moreover, some health “problems” may have adaptive origins (Eaton et al., 2002; Moalem, 
2007; Nesse & Williams, 1994), such as the body’s defenses of coughing and morning sickness 
in pregnancy (e.g., Flaxman & Sherman, 2000). Changes across the menstrual cycle, including 
PMS, may also be adaptations (or byproducts of other adaptations). Thus, HC use adds a level of 
complexity given that it alters the endogenous reproductive system through exogenous hormonal 
exposure.  
Hormonal contraception. There are over 35 different preparations or brands of HCs 
available to women in Canada (Health Canada, 2011). Combined HCs consist of a synthetic 
estrogen, typically ethinyl estradiol, and one of numerous exogenous progestogens (i.e., 
progestins). Doses have been relatively low since 1985 and are probably at a minimum for 
effectiveness. HCs alter the HPO axis such that the production of endogenous reproductive 
hormones is suppressed (Speroff & Darney, 2010) and cyclic variability is often nullified 
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(Fleischman, Navarrete, & Fessler, 2010). Indeed, combined HC users tend to have lower levels 
of endogenous estrogen, progesterone, and testosterone than nonusers (e.g., Liening, Stanton, 
Saini, & Schultheiss, 2010), which may persist after discontinuation according to Fleishman et 
al. (2010). As a result, HCs usually inhibit ovulation, disrupt ovum transfer, alter the consistency 
of cervical mucus such that sperm penetration in hindered, and affect the functional activity of 
the fallopian tubes and uterus
8
 (Speroff & Fritz, 2005). The efficacy of HCs in preventing 
pregnancy tends to be 99.7% to 99.9%, while their effectiveness ranges from 92% to 99.7% due 
to misuse (Speroff & Darney, 2010). (For detailed historical accounts of contraception for 
women, Jütte [2008)] and Marks [2001] are recommended.) 
There are five main types of HCs. Oral contraceptives (OCs) are the most commonly 
used HCs in North American (Speroff & Fritz, 2005). Monophasic OCs consist of constant 
amounts of hormones, whereas triphasic OCs were designed to mimic hormonal changes across a 
28-day menstrual cycle (Kahn & Halbreich, 2001). Most OCs combine estrogen and 
progesterone (i.e., combined OCs), but progestin-only “mini” pills are also on the market, and 
are to be taken for three weeks followed by one HC-free week in which withdrawal bleeding 
occurs. Transdermal patches and vaginal rings are combined HCs and need to be replaced every 
week or 3 weeks, respectively. Complicating matters further, combined HCs are now also 
packaged for extended cycle or continuous use (e.g., Seasonale), whereby women induce 
withdrawal bleeding at intervals of their choosing or experience amenorrhea. Finally, injections 
and hormonal intrauterine devices (IUDs) are progestin-only methods that last up to 3 months or 
5 years, respectively, and are continuous HCs (Fisher & Black, 2007). Continuous methods may 
                                                 
8
 Not all HCs exert each of these contraceptive effects. More specifically, progestin-only contraceptives do not 
necessarily inhibit ovulation. 
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involve unpredictable break-through bleeding in some women, often early in use and due to 
effects of progestins on the endometrium (Speroff & Darney, 2010).  
HCs appear to have various non-contraceptive side effects that can be both negative and 
positive. For instance, their use is associated with cardiovascular risks but reduced rates of 
endometrial and ovarian, but not cervical or breast, cancers (Speroff & Fritz, 2005). Although the 
effects of HCs on women’s long-term health are largely unknown, it has been argued that HCs 
are promising candidates in the management of menstrual cycle and gynecological disorders 
such as PMS, endometriosis, and polycystic ovary syndrome (Speroff & Darney, 2010). Based 
on the incessant ovulation hypothesis, continuous HC use and more so the use of GnRH analogs 
may be safer for women than HC induced menstrual cyclicity (Strassman, 1999), particularly 
since HPO activity may resume in the pill-free week (van Heusden & Fauser, 1999). Coutinho 
and Segal (1991) suggested that HC use without withdrawal bleeding is healthier for women than 
either artificial or natural cycling (see also Thomas & Ellertson, 2000). If this is the case, the 
incessant ovulation hypothesis should perhaps be one of menstruation or cyclicity rather than 
ovulation per se, given that most of the research conducted to date has been on HC induced 28-
day anovulatory cycles. Unfortunately, although HC formulations have various estrogenic, 
progestogenic, and androgenic effects, there is little research on the direct effects of the 
numerous exogenous hormones used in HCs as their levels are difficult to measure with available 
assays (Dickey, 2011).   
Other reproductive events. Women have the potential to experience numerous 
reproductive events across the lifespan, from menarche to menopause. In addition to the 
menstrual cycle and HC use, many other events involve precipitous hormonal changes:  puberty; 
abortion; miscarriage; pregnancy; the postpartum period; perimenopause; hormone replacement 
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therapy (HRT); and even in vitro fertilization procedures (Bloch et al., 2011). The hormonal 
changes involved in the other more common major lifetime reproductive events are outlined 
below for the purpose of comparison: puberty and menarche, pregnancy and postpartum, as well 
as perimenopause. As will become clear, symptoms or experiences during past reproductive 
events have been used as models or predictors of responses to current or succeeding reproductive 
experiences (e.g., Stone, 2011).  
Among girls, puberty or sexual development usually begins with adrenarche, an increase 
in the production of adrenal androgens. An increase in gonadotropin secretion during sleep 
begins to occur approximately two years later, when aged 9 to 10 years. Maturation of ovarian 
follicles is stimulated by FSH, which leads to follicular development and the production of 
estrogen or gonadarche (Speroff & Fritz, 2005). Menarche marks the beginning of menstrual 
cyclicity and occurs around 12.5 years, an age that had been decreasing over time but appears 
stable now (Kaminski & Palmert, 2009). Cycles are normally irregular and anovulatory, and 
steroidal levels are relatively low, in the first five gynecologic years (Speroff & Fritz, 2005). 
Pregnancy results in the development of the fetal-placental-maternal axis and the 
secretion of human chorionic gonadotropin (hCG). This hormone stimulates the corpus luteum to 
secrete increasing amounts of estrogen and progesterone until about the 10
th
 week of gestation, at 
which time the placenta is able to do so until parturition (Hendrick, Altshuler, & Suri, 1998). 
Estriol (E2) becomes the dominant estrogen, and testosterone levels are relatively high. Levels of 
hCG are lower in the second half of pregnancy (Speroff & Fritz, 2005). By the end of the third 
trimester of gestation, circulating estradiol has increased 50-fold, and circulating progesterone 
has increased 10-fold, from the maximum level across the menstrual cycle. Following delivery, 
induced by prostaglandins, these levels decrease to early follicular phase levels within one to 
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seven days (Bloch, Daly, & Rubinow, 2003). It takes about six to eight weeks for gonadotropin 
activity to resume and so the postpartum period is often characterized by hypogonadism and 
amenorrhea. Lactation can prolong these effects (Rubinow, Schmidt, Meltzer-Brody, & Harsh, 
2009).  
The perimenopausal transition begins about five years before menopause or climacteric, 
the cessation of the menstrual cycle, which has a typical age at onset of 46 to 51 years (Hampson 
& Young, 2008; Rubinow et al., 2009). One of the only objective markers of perimenopause is 
that menstrual cycles become unpredictable, and eventually anovulatory, due to atresia of ova 
across the lifespan and a lack of response to FSH by the remaining follicles. While cycle length 
and estrogen secretion may initially be long and elevated, respectively, gonadal hormone levels 
decrease substantially over time as the follicular phase shortens. There is also a switch to estrone 
(E3) as the dominant estrogen. In contrast, pituitary gonadotropin levels, particular FSH, are high 
throughout the transition and after menopause. Menopause can be surgically induced by the 
removal or ablation of both ovaries (Speroff & Fritz, 2005). Also, testosterone levels decrease 
across the lifespan, are relatively low by perimenopause, and decrease drastically with surgical 
menopause (North American Menopause Society, 2006).   
In summary, puberty (the beginning of the gynecologic years) and the perimenopausal 
period (the end of the reproductive lifespan) are characterized by an increase in estrogen 
secretion as well as irregular menstrual cyclicity, and therefore, relatively low fertility. 
Pregnancy and parturition are associated with a lack of hormonal cyclicity. However, the former 
event involves very high levels of estrogen and progesterone, while the latter event involves 
hypogonadism. After climacteric, hormone levels are relatively low and stable. 
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Overall, it is clear that change (i.e., a decrease or increase) in reproductive hormone 
levels occurs with each reproductive event. It is also important to note that major social, 
personal, and lifestyle changes can be associated with each of these events as well (Speroff & 
Fritz, 2005). Thus, it is perhaps not coincidental that all reproductive events tend to involve some 
degree of physical and psychological symptoms. Furthermore, some women seem to experience 
specific symptoms at each event and may be more sensitive to certain types of hormone-related 
symptoms than other women (Steiner et al., 2003). These findings suggest that women may not 
reach each reproductive event, including menstrual cycles, with the same risk for symptoms as at 
past events. Risk may accumulate with the experience of hormonal changes or adverse events at 
each reproductive event, beginning with hormonal exposure in utero as suggested by digit ratio 
research (Manning, 2008; Oinonen, 2009; Oinonen & Bird, 2012; Stone, 2011). Given the 
precipitous hormonal changes at each reproductive event and that only a proportion of women 
experience related symptoms, such reproductive experiences may involve (hyper)sensitivity to 
normal physiological processes. While the symptoms or side effects associated with the 
menstrual cycle and HC use will be reviewed in depth below, those of the other main 
reproductive events across the cycle will be discussed in relation to the hormonal sensitivity 
hypothesis.  
Symptoms and Side Effects 
 Symptoms or side effects associated with specific phases of the menstrual cycle or HC 
use are diverse. Over 200 adverse symptoms have been found to be associated with the cycle, 
particularly the premenstrual phase
9
 (Dennerstein, Spencer-Gardner, & Burrows, 1984; 
                                                 
9
 Given limitations of some retrospective studies of PMS (see Longue & Moos, 1988; Rubinow et al., 1986), an 
attempt was made to review prospective studies wherein the menstrual cycle may or may not have been recognized 
as part of the study by participants. However, PMS has been demonstrated among women who were unaware of the 
study purposes (e.g., Gallant, Popiel, Hoffman, Chakraborty, & Hamilton, 1992).   
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Halbreich, 1997; Halbreich, Endicott, Schacht, & Nee, 1982). Moreover, mood, anxiety, 
somatoform, substance use, and personality disorders as well as numerous physical conditions 
have been found to worsen near the end of the cycle in some women (Dell, 2004). This 
phenomenon is referred to as premenstrual exacerbation. Psychiatric admissions, suicide 
attempts, and psychotic symptoms may increase during the late luteal phase as well (Choi, Kang, 
& Joe, 2001; Dogra et al., 2007; Targum, Caputo, & Ball, 1991). The concurrent diagnosis of 
PMS or PMDD and a major psychiatric or medical disorder has been termed premenstrual 
magnification (Endicott, 1993; Steiner et al., 2003), which may represent a subtype of affective 
disorder (Endicott, Halbreich, Schacht, & Nee, 1981). In addition to being relatively common 
among Western women, PMS is found worldwide (see Reiber, 2009 for a brief review).  
One concern in the existing literature is the substantial variability across studies in what 
days constitute the premenstrual phase. While some researchers have suggested that PMS 
symptoms peak on day 26, or are highest during the last 3 days, of a standardized 28-day cycle 
(e.g., Metcalf et al., 1990), a paper by the International Society for Premenstrual Disorders 
(ISPMD) stated that symptoms occur during all or part of a two-week premenstrual phase 
(O’Brien et al., 2011). Defined in this way, the premenstrual phase and the luteal phase (which is 
typically 14 days in length after ovulation) can be interchangeable terms. For simplicity and 
consistency with past research, premenstrual phase will be used in the present dissertation in 
reference to the luteal phase (i.e., days 19 to 28). 
Physical changes. Breast swelling and tenderness, abdominal cramps, water retention, 
nausea, and headaches are the most often cited physical symptoms of the premenstrual phase 
(American College of Obstetricians and Gynecologists, 2000; Speroff & Fritz, 2005). The DSM 
includes muscle or joint pain and weight gain as other physical symptoms of PMDD (APA, 
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2000; 2013), and gastrointestinal problems (Kiesner, 2009) as well as vasomotor symptoms 
(Speroff & Fritz, 2005) may occur. The physical side effects of HCs typically include symptoms 
similar to those of PMS. However, HC side effects can also include irregular spotting and rare 
but potentially lethal (e.g., increased risk of venous thrombosis) or long-term effects (e.g., bone 
density loss during use) (Speroff & Darney, 2010). Both the premenstrual phase and HC use 
have been associated with insufficient vaginal lubrication as well as negative changes in 
complexion in some woman (Speroff & Fritz, 2005; Cerel-Suhl & Yeager, 1999; Farage, Neill, 
& MacLean, 2009). On the other hand, the periovulatory phase and some HCs have been 
associated with increased sexual behavior and improved facial complexion (Bullivant et al., 
2004; Wheeler & Malinak, 1991).  
It is interesting that some of the physical symptoms or side effects associated with the 
menstrual cycle or HC use seem to relate to sexual functioning and appearance. These changes 
may affect women psychologically and be related to changes in sexuality and person perception 
that have also been demonstrated (see section on Hormones and Sociosexuality below). Thus, it 
seems possible that there are patterns of, or associations between, hormone-related changes in 
physical, affective, and sexual well-being. 
Physical symptoms and side effects associated with reproductive events are beginning to 
be used as indicators of steroidal sensitivity in various tissues and as related to psychological 
changes (e.g., Bird & Oinonen, 2011). Physical symptoms may predict psychological 
vulnerabilities to hormonal changes (Kiesner, 2009; Kiesner & Pastore, 2010). However, it is 
important to note that menstrual cycle and HC-related affect changes also appear to be somewhat 
independent of somatic symptoms and so are unlikely to be merely indirect effects (Kiesner, 
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2009; Metcalf, Livesey, Wells, & Braiden, 1990; Oinonen & Mazmanian, 2001a). That is, there 
is evidence to suggest that hormonal changes may have direct effects on affect and mood.  
Psychological changes. Some studies suggest that highs and lows of psychological 
symptoms are random or null across the menstrual cycle, but well-controlled longitudinal studies 
and literature reviews have revealed otherwise (Halbreich, 1995). Emotional symptoms of PMS-
like change include irritability, depressed mood, tension, and nervousness, with prevalence rates 
ranging from 27 to 46% in a community sample of women (Angst, Sellaro, Stolar, Merikangas, 
& Endicott, 2001). Mood lability, anxiety, feeling overwhelmed or as though one has lost 
control, and restlessness (Dell, 2004), interpersonal sensitivity, somatization, obsessive-
compulsive symptoms (Gonda et al., 2008), as well as feelings of insecurity and low self-esteem 
(Bloch, Schmidt, & Rubinow, 1997) may also increase in the premenstrual phase. Low sexual 
drive or arousal has been found to be a symptom of PMS as well (Dickerson, Mazyck, & Hunter, 
2003; Steiner et al., 2005)
10
. Behavioural and cognitive changes tend to include impulsivity, 
aggression, crying, social withdrawal, fatigue, impaired concentration, sleep disturbance, food 
cravings, and decreased sexual activity (Dickerson et al., 2003).    
HCs are often associated with PMS-like emotional and sexual side effects overall (i.e., 
regardless of phase) as well as across the pseudo-cycle of synthetic hormones and withdrawal 
bleeding (Oinonen, 2009). Decreased sexual desire, arousal, and activity are relatively common 
side effects of OC use (see Davis & Castaño, 2004, and Schaffir, 2006 for reviews; Tilhonen et 
al., 2008), as shown in research comparing users and nonusers (e.g., Wallwiener et al., 2010) as 
well as prospective (pre-post) studies (Graham, Bancroft, Doll, Greco, & Tanner, 2007; Graham, 
Ramos, Bancroft, Maglaya, & Farley, 1995; Sanders et al., 2001; Seal, Brotto, & Gorzalka, 
                                                 
10
 Women seeking treatment for PMS have also been found to have a relatively high rate (40%) of lifetime 
psychosexual dysfunction (e.g., inhibited sexual desire or excitement) (Chandraiah, Levenson, & Collins, 1991). 
However, there is at least one published case report of premenstrual hypersexuality (Riley, 1994). 
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2005). Although this effect seems to be related to the reduction in testosterone, it is only apparent 
in about 33% of users (Graham et al., 2007). Interestingly, Graham et al. (1995) found that 
women using progestin-only OCs did not show the decline in sexual functioning that was found 
in combined OC users.  
In a systematic review, Oinonen and Mazmanian (2002) reported that all but one of 13 
prospective studies with daily ratings of affect found differences between OC-users and non-
users. However, results were largely inconsistent between the studies. The only reliable findings 
were that most OC users show less negative affect variability overall and less negative affect in 
the menstrual phase (i.e., beneficial effects), but that a subgroup of women experience adverse 
effects (see Kahn & Halbreich, 2001 and Kiesner, 2011 for similar conclusions).  
At least eight relevant studies have been conducted since Oinonen and Mazmanian’s 
(2002) review. According to Teatero, Oinonen, and Mazmanian (2015), five of these studies did 
not find differences in average levels of negative affect between the two groups. One study found 
that HC users reported more negative affect than nonusers, while another found that stable (i.e., 
long-time) OC users had lower negative affect scores than other OC users, progestin-only 
injection users, and nonusers. Two other, somewhat consistent findings were revealed. First, 
established (i.e., long-time) combined OC users appear to experience affect stability, which is in 
line with the survivor effect where early HC users who experience side effects will discontinue 
use or switch preparations, leaving a group without adverse effects (Oinonen & Mazmanian, 
2002). Second, a subgroup of women seem to experience negative OC-related side effects on 
affect, which seems particularly true for women using progestin-only HCs. That is, there appear 
to be two patterns or types of HC side effects: those that are negatively valenced and those that 
are positively valenced (Teatero et al., 2015). Unfortunately, research on the emotional and 
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sexual side effects of HCs, and specific preparations, other than combined OCs is wanting 
(Kurshan & Epperson, 2006). Given that about 20% of unintended pregnancies are associated 
with discontinuation of HC use due to side effects (Kalmuss et al., 2008), it is important that 
research on HCs and HC side effects continues to advance.  
Alternative Cyclic Patterns 
According to Moos (1991), profiles of symptoms across the menstrual cycle allow for the 
examination of cyclic differences between and within women. The vast diversity of symptoms as 
well as clusters of symptoms has lead to the conclusion that there may be different patterns or 
types of menstrual cycle syndromes (Halbreich, 1995; Halbreich et al., 1982). Early on, Abraham 
and Reid each described four types of PMS differentiated by the duration of negative symptoms 
throughout the menstrual cycle (Abraham, 1980; Abraham, 1983; Abraham & Hargrove, 1980; 
Abraham & Lubran, 1981; Reid, 1983; Reid, 1985). For example, symptoms may persist into, or 
worsen in, the first few days of the menstrual phase (APA, 2013; see review in Romans, 
Clarkson, Einstein, Petrovic, & Stewart, 2012), which has prompted some authors to use the term 
perimenstrual syndrome (e.g., Angst et al., 2001). Moreover, in some women, menstruation is 
characterized by menorrhagia, dysmenorrhea, and coagulation (Speroff & Fritz, 2005), which are 
probably related to an increase in prostaglandins in the uterus (Halbreich, 1995). That is, in 
addition to PMS and PMMD, there may be other, perhaps more atypical, presentations of 
menstrual cycle-related problems (Bancroft, 1995). According to the APA (2000; cf., 2013), 
some women with PMDD also experience adverse symptoms during the periovulatory phase. 
Thus, a subset of women may have dysphoria that occurs in more than one menstrual cycle 
phase
11
. Overall, these findings indicate that there are individual differences in symptom patterns 
                                                 
11
 Also note that there is at least one case report of dysphoric symptoms entrained to the ovulatory phase (Hsiao & 
Lui, 2007; see Teatero et al., 2013). 
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Reverse premenstrual syndrome. In 1982, Parlee identified what was later referred to 
as a reverse PMS-like pattern (Sveinsdóttir & Bäckström, 2000) among seven women. Depressed 
mood, fatigue, confusion, and hostility were lower in the premenstrual phase than the 
periovulatory phase. This alternative or atypical cyclic effect has also been labeled as pseudo-
PMS (Reiber, 2009) and a mid-cycle pattern (Kiesner, 2011). For simplicity, and to be consistent 
with research on PMS, the label periovulatory syndrome (POS) will be used in the present 
dissertation. In a review of studies with daily ratings of mood across the menstrual cycle, 
Romans et al. (2011) determined that 18 of 47 identified studies (38%) did not find evidence of 
an overall affect of the cycle on negative affect. The same proportion of studies found an 
association between negative affect and the premenstrual phase as well as another phase of the 
cycle, the menstrual phase and a non-perimenstrual phase in 25 and 13% of studies respectively. 
A PMS only pattern was reported by 15%, while a “non-premenstral” (i.e., menstrual, 
postmenstrual, or perivoluatory) phase only pattern was reported by 9%, of studies.  
Consistent with the research reviewed, Romans et al. (2012) tended to summarize results 
in terms of premenstrual versus menstrual or non-premenstrual and thus, did not delineate what 
studies may have found a POS pattern. Thus, several findings from the individual studies warrant 
mention. Data from Hardie (1997) suggests 18% of women who self-identified with PMS 
exhibited a POS pattern (i.e., adverse symptoms in the periovulatory phase) across at least one of 
two cycles, while only 19% of women showed PMS-like change. Another study found a 
premenstrual decrease from the follicular (preovulatory) phase in negative affect in 22%, a 
                                                 
12
 The majority of studies on changes across the cycle have focused on non-HC users and so, from this section 
forward it should be assumed that the results discussed are based on free-cycling women, unless stated otherwise.  
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premenstrual increase in 53%, and no change in 24% of women (Ross, Coleman, & Stojanovska, 
2003). Overall, some women, including some of those reporting PMS, may actually be 
experiencing POS and research should consider this possibility. Given the differences in findings 
between studies, Romans and colleagues (2012) concluded that PMS does not seem to exist in 
the general population. However, five studies not included in the review by Romans et al., 
discussed below, also provide evidence of different menstrual cycle patterns in negative affect, 
namely PMS and POS.  
First, one study prospectively evaluated 57 symptoms, including negative affect, in seven 
women seeking treatment for PMS, resulting in 246 symptoms that changed from the 
preovulatory (mid-follicular) to the premenstrual phase. Overall, there was enormous variability 
with 80% of such cases increasing and 20% decreasing (Sveinsdóttir & Reame, 1991). Second, 
Schnall Abrahamson, and Laird (2002; Study 1) found that 29% (n = 4) of women demonstrated 
a PMS pattern, 29% higher negative affect in a non-premenstrual phase, and 43% no change. 
Third, Reiber (2009) reported that the symptom scores of 21% women improved, while those of 
79% worsened, from the preovulatory to luteal phase. Fourth, using longitudinal multilevel 
modeling (MLM), Kiesner and Pastore (2010) reported that 46% of variance in psychological 
symptoms across cycle phases was explained by a U-shaped pattern from menstrual to luteal but 
that correlations with physical symptoms varied in strength and direction (i.e., there was also 
significant individual variability in PMS symptoms, and associations between various PMS 
symptoms, across the cycle).  
Most recently, Kiesner (2011) demonstrated that the majority of first-year female 
university students sampled showed a PMS pattern of change in depression/anxiety across two 
consecutive menstrual cycles (n = 130 of 213; 61%) but also that 13% showed the “paradoxical” 
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mid-cycle, POS pattern. Only 26% of women did not display significant cyclical change in daily 
self-ratings of symptoms. On the basis that the women who did not show a significant change 
had a higher mean depression/anxiety score than the women with the strongest PMS pattern, it 
was suggested that the latter group may experience more positive affect or well-being, 
particularly around ovulation. In other words, changes in negative versus positive affect across 
the cycle may be opposing, compensatory processes. A strength of the study was the examination 
of individual (random) longitudinal growth curve effects using MLM. However, the absence of 
negative symptoms is not necessarily the same as the presence of positive affect. Furthermore, 
Kiesner employed single items instead of scale measures with adequate psychometric properties. 
It is clear that there is between-study variability in findings regarding the effects of the 
menstrual cycle on negative affect. Between-study variability in findings may be due to (a) 
chance if there are no true effects of the cycle or (b) differences between, and perhaps even 
within, women in experiences across the menstrual cycle over time. On the basis of the studies 
reviewed above in relation to the possibility of a POS pattern of a peak of negative symptoms 
around ovulation, the latter possibility seems to better represent women’s self-reports of lived 
experiences regardless of underlying causes (e.g., genetics, hormonal changes, and sociocultural 




Although changes in positive affect across the menstrual cycle were recognized as early 
as 1937 (McCance, Luff, & Widdowson), it is clear that biases towards examining negative 
                                                 
13
 This section has been developed into a separate manuscript by Teatero, Oinonen, Mazmanian, & Streutker (2015) 
on patterns of positive affect across the menstrual cycle. Some of the studies reviewed here were subsequently not 
included in Teatero et al. (2015) because they involved samples of women diagnosed with bipolar disorder and were 
instead included in a published systematic review of research on the effects of the menstrual cycle on bipolar 
disorder by Teatero, Mazmanian, and Sharma (2014). Nonetheless, the conclusions are similar, if not the same, 
across all three papers.  
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symptoms and the premenstrual period have pervaded the literature (Meaden et al., 2005; 
Romans et al., 2012). In the present review, positive symptoms are defined as phasic changes 
that are positively valenced, such as positive affect or sexual well-being, as opposed to a lack of 
negative symptoms (Sveinsdóttir & Bäckström, 2000). Early reviews suggested that positive 
affect (e.g., feelings of vigour, elation, or well-being) is: (a) highest in the follicular phase or 
mid-cycle (Dennerstein & Burrows, 1979), (b) reported in the premenstrual phase by women 
who complain of PMS (Abplanalp, Haskett, & Rose, 1980), and (c) perimenstrually elevated 
among 5 to 15% of women (Logue & Moos, 1988). However, only one of the reviews focused 
on prospective studies and was not based on women with PMS (n = 24 studies; Dennerstein & 
Burrows, 1979).   
Parlee (1982) provided evidence suggesting that some woman may experience what was 
referred to as premenstrual elation syndrome. In 1984, Abraham called for the study of positive 
symptoms in the periovulatory phase, facetiously using the phrase postmenstrual syndrome. It 
was argued that previous research may have been somewhat misguided and that the portion of 
the menstrual cycle between menses and the premenstruum may be characterized by positive 
mood and enhanced mating effort. That is, positive affect may be associated with sexual 
proceptivity. In order to evaluate whether Abraham’s suggestion (i.e., that positive symptoms 
warrant consideration) has had an impact on subsequent research, a systematic review of the 
literature on positive mood or affect across the menstrual cycle published since the last identified 
review (Logue & Moos, 1988) was conducted and is summarized below.  
Thirty-one separate prospective studies of positive affect across the menstrual cycle were 
identified. Twenty-three of these studies involved daily self-ratings while the others included a 
testing session in each of at least two phases. Six studies did not include a periovulatory phase 
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(e.g., Davydov, Shapiro, & Goldstein, 2004; Hausman, 2005; Symonds, Gallagher, Thompson, 
& Young, 2004). Overall, nine studies (29%) did not find significant differences in mean levels 
of positive affect between phases (i.e., Abraham, Luscombe, & Soo, 2003; Almagor & Ben-
Porath, 1991; Hausman, 2005; Mansfield, Hood, & Henderson, 1989; Meuwissen & Over, 1992, 
studies 1 and 2; Natale & Albertazzi, 2006; Oinonen & Mazmanian, 2001a; Shivakumar, 
Bernstein, & Suppes, 2008), while the remaining 23 studies (74%) found one of at least two 
different patterns of cyclical change.  
For instance, one study suggested that a subgroup of women with PMDD may also 
experience positive symptoms in the premenstrual phase. In a sample of 180 participants, Rivera-
Tovar, Pilkonis, and Frank (1992) identified a cluster of women (n = 10; 6%) with increased 
positive affect (i.e., efficiency, affection, and wellbeing), typically accompanied by physical 
symptoms like pain, bloating, and headache, during the premenstrual phase across two to three 
consecutive cycles. A large group (52%) experienced mean levels of adverse affective, physical 
and agitation as well as positive symptoms. This study suggests that positive affective changes 
may occur in the premenstrual phase among some women.  
In contrast, 13 studies (42%) reported an overall peak in positive affect outside of the 
perimenstrual period (e.g., Aganoff & Boyle, 1994; Alonso, Loevinger, Muller, & Coe, 2004; 
Brown, Morrison, Larkspur, Marsh, & Nicolaisen, 2009; Boyle & Grant, 1992; Gallant, 
Hamilton, Popiel, Morokoff, & Chakraborty, 1991; Gallant et al., 1992; Graham, Janssen, & 
Sanders, 2000; Symunds et al., 2004). For example, although the sample size was only 12, 
O’Reilly, Cunningham, Lawlor, Walsh, and Rowan (2004) found that women reported being 
more composed and energetic on day 14 of the cycle (i.e., around ovulation) than during menses. 
López, Verdejo, Javier, Martin, and Gómez-Amor (2010) found that anovulation did not have an 
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effect on PMS symptoms (i.e., physical symptoms occurred regardless) but that only ovulatory 
cycles showed a peak in positive affect in the periovulatory phase. Among eight women with 
premenstrual dysphoria in another study (Eriksson et al., 2006), higher friendliness was reported 
8 to 10 days after the onset of menstruation than in the premenstrual phase. Non-significant 
trends in the same direction were reported for happiness and energy. Positive affect was also 
positively related to serotonin precursor trapping in the brain.  
Moreover, according to Metcalf and Livesey’s (1995) findings, women with PMS 
exhibited a peak in mood on day 11 but a control group did not. Similarly, a unique study by 
Meaden et al. (2005) used 12 positively worded PMDD items, such as “felt optimistic,” “liked 
myself,” and “increased sex drive.”  Ratings on these items, from “not at all” to “very severe” 
were reverse coded to be in line with the 38 negatively valenced items also used. Most 
negatively valenced symptoms (e.g., “felt hopeless,” “mood swings,” “low sex drive,” and 
“physical symptoms”) were significantly higher than average in the days leading up to 
menstruation, peaked on day 0 of the cycle (i.e., the first day of bleeding), and were lowest on 
day 11. With the exception of increased sex drive, all positively valenced symptoms were rated 
higher (i.e., more negatively due to reverse scoring) overall within each phase and across the 
cycle than negatively valenced symptoms, and they also displayed more between-subject 
variance in scores. The results of this study suggest that positively valenced symptoms tend to 
cycle with negatively valences symptoms but in the opposite direction (i.e., they may negatively 
co-vary across the cycle). It appears that, in general, positive affect may be highest around 
ovulation. Overall, the 13 studies reviewed above suggest that positive affect may tend to peak in 
the periovulatory phase, when women happen to be the most fertile. 
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Eight additional studies (26%) found phase effects but at least two patterns of change 
(e.g., Schnall et al., 2002). Among women who self-identified with PMS, Sveinsdóttir and 
Reame (1991) determined that 45% of symptom decreases between days 4 to 12 of the follicular 
phase and the luteal phase were for positive symptoms. Ratings of bursts of energy, wellbeing, 
being in control, increased activity, and increased sexual desire seemed to decrease in severity 
across the cycle but there was considerable variability in symptom patterns. Likewise, in a 
community sample of women, positive symptoms tended to show a PMS pattern, whereby 
wellbeing was higher in the follicular phase, but also increased in the luteal phase in some cases 
(Sveinsdóttir & Bäckström, 2000).   
Although Davydov et al. (2004) did not find an overall effect of phase on mean ratings of 
happiness, significant interactions with day (work-day vs. off-work day), personality, and 
arousal-related hormones were identified using MLM. Women who scored low on a measure of 
hostility were happier in the luteal phase (i.e., 5 to 10 days after the surge in LH) compared to the 
follicular phase (i.e., days 4 to 8 after the onset of the menstrual phase), but only on workdays. 
The opposite effect was observed among those high on hostility. In further analyses of data from 
the same sample, Davydov, Shapiro, Goldstein, and Chicz-DeMet (2005) found that happiness 
was highest in the luteal phase in women with high nighttime norepinephrine on non-work days, 
women with low daytime cortisol on work days, and women with high nighttime cortisol 
independent of day. In contrast, happiness was highest in the follicular phase for women in the 
opposite hormone groups, except for low nighttime cortisol. Among women with low daytime 
levels of norepinephrine and cortisol, happiness was elevated in the luteal phase (Davydov, 
Shapiro, Goldstein, & Chicz-DeMet, 2007). The authors suggested that menstrual cycle phase, 
namely changes in the level of estrogen, moderates emotional arousability depending on 
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individual differences and environmental conditions. That is, cyclic shifts may vary between and 
within women because they are context-contingent. 
Four studies that found two patterns of change included only participants with bipolar 
disorder
14
. Significant phase effects (first seven days of cycle versus last seven days) were 
reported by 32 to 65% of women but there were no apparent patterns such that there was little 
consistency within women across more than one cycle (Rasgon, Bauer, Glenn, Elman, & 
Whybrow, 2003; Rasgon, Bauer, et al., 2005; Whybrow, Grof, Gyulai, Rasgon, Glenn, & Bauer, 
2003; Leibenluft, Ashman, Feldman-Naim, & Yonkers, 1999). Group analyses in Rasgon et al. 
(2003) revealed that women’s moods were more euthymic during the premenstrual phase.  
Only one study used a measure of variance in daily ratings to examine changes in 
positive affect variability across the cycle. Oinonen and Mazmanian (2001a) found that positive, 
but not negative, affect variability was lower in the menstrual phase than the rest of the cycle. 
This finding suggests that positive affect was relatively more stable in the menstrual phase. 
Overall, it is clear that more research on possible patterns of positive affective experiences across 
the menstrual cycle is warranted.  
Hormonal contraceptive status. Nine of the studies reviewed on positive affect across 
the menstrual cycle also examined differences between and cyclic effects within nonusers and 
OC users. In one study, HC users had higher levels of positive affect overall and in most phases 
of the menstrual cycle compared to nonusers (Almagor & Ben Porath, 1991). Conversely, five 
studies did not find a mean difference between the two groups across the menstrual cycle 
(Abraham et al., 2003; Boyle & Grant, 1992; Meuwissen & Over, 1992, Study 2; Natale & 
Albertazzi, 2006; Oinonen & Mazmanian, 2001a). Abraham et al. (2003) reported that 
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 It is of interest to note that there are 15 case reports of manic symptoms entrained to the perimenstrual phases as 
well as two other reports of onset in the periovulatory phase (see Teatero et al., 2013 for a review).  
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cheerfulness and happiness changed across the cycle among OC users but not nonusers; 
unfortunately, follow-up analyses as well as mean differences do not appear to have been 
reported. Brown et al. (2009) found that happiness was highest in the ovulatory phase for 
nonusers but highest in the follicular phase for combined HC users, and that progestin-only 
contraception disrupted typical relationships between sleep, exercise, and wellbeing. Sveinsdóttir 
and Bäckström (2000) reported that the two groups did not differ in symptom severity but that 
nonusers reported recurrent change (i.e., across more than one cycle) in more symptoms. In 
another study, OC users with bipolar disorder were not found to exhibit a phase effect in positive 
affect, while non-users did show such an effect (Rasgon, Bauer, et al., 2003). However, in a 
community sample of women, neither OC users nor nonusers exhibited cyclic changes in 
positive affect (Boyle & Grant, 1992; Meuwissen & Over, 1992, Study 2; Natale & Albertazzi, 
2006). Lastly, triphasic users and first-time monophasic users had greater positive affect 
variability than monophasic users overall, and than long-time users in the menstrual phase 
(Oinonen & Mazmanian, 2001a). These results suggest that there is substantial variability in the 
experience of positive affect change across the pseudo-menstrual cycle in HC users and that 
research has not uncovered one consistent pattern.  
Three additional studies warrant mention with respect to OC use and positive affect. 
Jarva and Oinonen (2007) found evidence of positive, but not negative, affect stabilization in OC 
users compared to nonusers and men. OC users displayed the least positive affect reactivity in 
overall response to the induction of positive affect, jealousy, social ostracism, and parenting 
feelings. Moreover, current OC users and early OC users showed more positive affect 
stabilization than previous users and long-time users, respectively. There were no effects of OC 
type or menstrual cycle phase. Among adolescents, Ott, Sayegh, Shew, and Fortenberry (2005) 
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found that OC users reported less positive affect than nonusers but Ott, Shew, Ofner, Tu, and 
Fortenberry (2008) found that stable OC users experienced more positive affect overall. In a 
longitudinal study of new OC users, positive affect variability was found to be relatively high in 
the weeks before they began using OCs. In contrast, positive affect variability was greater in the 
weeks during which discontinued OC users were still using OCs (Ott et al., 2008). These results 
are in line with the research on positive affect across the menstrual cycle such that there appear 
to be individual differences in the affective side effects of OC use.  
Overall, the research reviewed thus far indicates that there is little evidence for the 
existence of only one menstrual cycle phase pattern for either negative or positive affect. It 
appears that there is substantial heterogeneity such that some free-cycling women experience no 
change, others a peak in positive or negative affect around ovulation, and still others a peak in 
positive or negative affect in the perimenstrual period. That is, there may be two phasic shifts in 
both negative and positive affect among subgroups of women. According to Pincus, Schmidt, 
Palladino, and Rubinow (2008), postmenstrual euphoric mood may be compensatory to negative 
affect in the premenstrual phase (like a rebound effect or opponent process). Unfortunately, little 
is known about what factors might differentiate women who experience different patterns in 
negative and positive affect (Davydov et al., 2004). These or similar patterns may also be seen 
among HC users given research on overall mean differences and cyclic changes in negative and 
positive affect between HC users and free-cyclers (e.g., Brown et al., 2009; Oinonen & 
Mazmanian, 2001a). However, very little research has examined why there may be different 
affect change patterns related to hormonal change.  
There are methodological issues to consider as well. First, few of the studies on affect 
change across the cycle controlled for possible response biases or sets. Almost all of them 
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employed inclusion criteria for health and “normal” menstrual cycle characteristics, which may 
inadvertently exclude a disproportionate number of women who show relatively atypical affect 
change patterns. A wide variety of phase definitions and estimation procedures were employed. 
Also, at least seven studies on positive affect averaged women’s ratings across multiple cycles 
(e.g., Mansfield et al., 1989; Metcalf & Livesey, 1995), reducing the probability of finding an 
effect if there is within-woman variability. Furthermore, some studies used bipolar visual 
analogue scales (e.g., Rasgon et al., 2005; Whybrow et al., 2003) despite recommendations that 
negative and positive affect should be measured independently (i.e., Meaden et al., 2005; 
Oinonen & Mazmanian, 2002; Watson, Clark, & Tellegen, 1988). It remains a possibility, 
however, that the conflicting results reflect a negative effect if positive affect does not truly shift 
across the menstrual cycle.  
A final point of interest is that there do not appear to be many studies that have explored 
the possibility that some positive somatic symptoms may increase at a specific cycle phase. 
Exceptions seem to include skin complexion and physiological sexual arousal, both of which 
may be enhanced in the periovulatory phase (Graham et al., 2000; Farage et al., 2009; cf. 
Meuwissen & Over, 1992) and the former with combined OC use in women with acne (Lemay & 
Poulin, 2002). For instance, Battaglia et al (2008) showed that clitoral body volume was related 
to estrogen levels, highest in the periovulatory phase, and lowest in the premenstrual phase; 
uterine and clitoral arteries also had reduced resistances in the periovulatory phase, which may 
also be related to arousability. As mentioned previously, this cyclical associations between 
positive affective, sexual, and physical is an area worth exploring in view of research suggesting 
that women tend to perceive themselves as most attractive when in the periovulatory phase (e.g., 
Röder, Brewer, & Fink, 2009), and that the likelihood of a woman orgasming (a psychosexual 
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variable) may also be dependent on context, such as the physical attractiveness of her sexual 
partner (Puts, Welling, Burriss, & Dawood, 2011). Similar to emotional changes, it is possible 
that positive physical changes associated with the menstrual cycle may facilitate mating effort, at 
certain phases of the cycle. Thus, physical symptoms that enhance attractiveness, sexual 
receptivity, or sexual proceptivity, or that decrease one’s need to spend time on other pursuits 
(reduced appetite or fatigue) may be adaptive at certain phases of the menstrual cycle.  
Proximal Mechanisms 
 The number of proposed underlying factors for menstrual cycle mood change (i.e., PMS) 
and HC side effects is vast. First of all, it is probable that some women have a genetic 
predisposition for symptoms associated with specific reproductive events (Steiner et al., 2003). 
PMS and HC-related mood change are related to a personal or familial history of either condition 
(see review in Oinonen & Mazmanian, 2002) and it has been determined that menstrual cycle 
characteristics, including PMS, are heritable beyond personality traits (e.g., Kendler, Kakowski, 
Corey, & Neale, 1998; Miller et al., 2010). For instance, polymorphisms on the estrogen receptor 
(ER) genes seem to be related to the risk of psychological changes associated with reproductive 
events, as is apparent with other hormone-related pathologies such a female reproductive cancers 
(Ancelin, Scali, & Ritchie, 2007; Westberg & Erikkson, 2008; see Miller et al., 2010 for a review 
of other candidate genetic polymorphisms). Although Richards (2006) did not find evidence that 
ER alpha, androgen receptor, or serotonin transporter genes are involved in the expression of 
mood variability in premenopausal women, a genetic predisposition for altered neurotransmitter 
or hormonal activity or sensitivity to neuroendocrine changes seems particularly likely given that 
only a portion of women experience adverse psychological effects associated with reproductive 
events such as hormonal change across the menstrual cycle (Steiner et al., 2003).  
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 Biological factors. Many of the physical symptoms associated with reproductive events 
can be linked to the physiological changes of the reproductive event, but the underlying 
mechanisms of the psychological symptoms are not as obvious. There have been no consistent 
biological abnormalities or differences associated with PMS or HC side effects. For instance, 
there do not appear to be consistent differences in estrogen, progesterone, testosterone, FSH, LH, 
or GnRH levels or oscillations across menstrual cycle phases between women with and without 
PMS (Steiner et al., 2003; see also Schmidt, Nieman, Danaceau, Adams, & Rubinow, 1998). 
Given that there have been some differences found at various phases, the follicular phase may be 
as important in the expression of PMS as the luteal phase. With respect to testosterone, different 
studies show normal, decreased, or elevated levels in women with PMS (see review in Rubinow 
et al., 2009), but it is clear that the estrogen in HCs increases the level of sex hormone-binding 
globulin and thereby, decreases the bioavailable testosterone (see Zimmerman, Eijkemans, 
Coelingh Bennink, Blankenstein, & Fauser, 2014 for a review and meta-analysis). Nonetheless, 
this finding may not be related to negative mood side effects (Young et al., 2007). Other systems 
that have been implicated in the hormonal modulation of symptoms are gamma-aminobutryic 
acid (GABA), serotonin, dopamine, and the hypothalamic-pituitary-adrenal (HPA) axis 
(Rubinow et al., 2009).  
Overall, estrogen seems to have a positive effect on mood, including positive affect 
(Bäckström et al., 1983). It is associated with an increase in neuronal excitability, including 
serotonin and noradrenaline enhancing effects (Rubinow, Schmidt, & Roca, 1998). Conversely, 
progesterone appears to exert a negative effect on mood and cortical excitability. As an example, 
progesterone and its metabolites, namely allopregnanolone, modulate the GABA system, which 
is involved in excitability (Rapkin, Biggio, & Conas, 2006). However, natural progesterone is 
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relatively low in HC users and so there may be a withdrawal effect. Also, recent research 
suggests that the concentration of allopregnanolone has a nonlinear (quadratic) relationship with 
negative affect (Andréen et al., 2009). On this basis, Kurshan and Epperson (2006) proposed that 
the luteal phase and OCs may influence mood by altering the balance between cortical excitation 
and inhibition due to the paradoxical effects of estrogen priming in the periovulatory phase and 
increasing levels of progesterone in the luteal phase. Also, the results of a recent study suggest 
levels of serotonin in the premenstrual phase are positively correlated with estrogen as well as 
inversely related to negative affect but not significantly related to positive affect (Kikuchi et al., 
2010).  
As mentioned above, there is some evidence that the menstrual cycle may attenuate or 
magnify emotional arousability depending on moderating arousal-related factors, such as 
estrogen levels and stress. Davydov et al. (2005) found that HPA or sympatho-adrenomedullary 
(SAM) stress hormone levels interacted with phase of the menstrual cycle and occupational 
stress to predict changes in mood valence. Among healthy women (n = 203), high daytime (but 
not nighttime) HPA or SAM hormone levels were associated with higher ratings of stress 
(epinephrine, norepinephrine, and cortisol) and tiredness (epinephrine and norepinephrine) as 
well as lower ratings of happiness (epinephrine and norepinephrine). Women with relatively high 
daytime cortisol levels were less happy in the luteal phase (5 to 10 days after the LH surge and 
so, approximately days  –10 to -5 in comparison to the follicular phase (approximately days 4 to 
10), but only on work days as opposed to off-work days. In contrast, high nighttime cortisol 
levels were associated with higher happiness, and lower stress ratings in the luteal versus 
follicular phase independent of work/non-work day. Also, women with high levels of 
norepinephrine were happiest (on off-work days) and less tired in the luteal phase. These results 
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suggest that environmental stress, in this case occupational stress on work-days, and stress 
hormones may be implicated in the pathogenesis of psychological changes across the menstrual 
cycle. More specifically, the authors hypothesized that differences in physiological arousal may 
underlie mood valence such that down-regulated or up-regulated arousal results in negatively 
valenced mood states while mid-level arousal results in positively valenced mood states. For 
example, it was suggested that hyperarousal would be expected when stress, stress hormone, and 
estrogen levels are high. However, estrogen levels peak around ovulation with moderate levels in 
the mid-luteal phase, yet Davydov and colleagues measured only the latter phase in the study. 
Further research on individual differences in (or two opposing patterns of) change in affective 
valence between the periovulatory and luteal phases may be informative.  
Neuroimaging studies are also promising in the search for some much-needed clarity as 
to the biological underpinnings of psychological changes associated with the menstrual cycle or 
HC use. For example, Rapkin et al. (2011) demonstrated that cerebellar activity reached a zenith 
in the premenstrual phase in women with PMDD but not healthy controls. Research has also 
shown that grey matter volumes are larger in HC users compared to nonusers in brain regions 
with a sexual dimorphism favouring women, including the prefrontal cortex (Pletzer et al., 
2010). It is unclear whether these differences in brain structure are permanent (organizational) or 
plastic (activational) as they pertain to hormonal changes, which means that researchers may 
need to differentiate between current HC users, previous users, and never users (e.g., Oinonen, 
Jarva, & Mazmanian, 2008).  
A zeitgeber theory of PMS has been proposed in that psychosocial stressors may disrupt 
biological rhythms and exacerbate emotional symptoms (e.g., Steiner, 1992). That is, there may 
be different biological vulnerabilities associated with the diversified manifestations of PMS 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
37
(Bancroft, 1995; Halbreich, 1997) that are dynamically evolving with life experiences and stress 
(Halbreich & Monacelli, 2004). These biopsychosocial models suggest that women’s 
reproductive experiences may be dependent on not only biological/hormonal mechanisms but 
also attenuating or exacerbating psychosocial factors.  
Hormonal sensitivity. Although the precise underlying biological mechanisms are not 
well understood, a consensus is emerging that hormonal sensitivity (i.e., hypersensitivity to 
normal fluctuations in reproductive hormones) underlies symptoms associated with reproductive 
events across the lifespan (Steiner et al., 2003). Many of the same physical and psychological 
symptoms occur across reproductive events (e.g., headaches, gastrointestinal problems, fatigue, 
breast tenderness, acne or skin blotches, vasomotor symptoms, changes in WHR and BMI, 
negative affect, mood lability, sexual changes, and sleep and appetite disturbances) (see review 
in Ancelin et al., 2007). As mentioned previously, the rates of depressive disorders begin to 
increase in women relative to men around menarche until menopause (Steiner et al., 2003). As an 
example of a possible relationship between symptoms at various reproductive events, some 
changes in the premenstrual phase of the menstrual cycle (e.g., PMS) are comparable to those 
associated with parturition. Both periods involve a dramatic drop in hormone levels and can 
involve different types of changes in mood or affect. The “baby blues” affect approximately 80% 
of new mothers, while a depressive episode in the postpartum period is seen in about 10 to 15% 
of women (APA, 2000). However, elation or hypomanic symptoms may occur in 10 to 18% of 
new mothers (Russell, 2009; e.g., Glover, Liddle, Taylor, Adama, & Sandler, 1994). Even mania 
and psychosis sometimes begin in the postpartum period and postpartum depression appears to 
be a recurrent disorder with an underlying bipolar diathesis (Sharma, 2005; Sharma, Smith, & 
Mazmanian, 2006). The finding that some women experience depression, while others may 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
38
experience hypomanic symptoms, following parturition seem to parallel mood symptoms in PMS 
and POS (i.e., adverse symptoms in the periovulatory phase), including among women with 
bipolar disorder (Teatero et al., 2014).  
While some of the psychological symptoms of reproductive events may be reactive to 
somatic or psychosocial stress, Bloch et al. (2000) induced depressive symptoms in 63% of 
female participants with a history of postpartum depression, but none of the control group, by 
artificially dropping their estrogen and progesterone levels. These findings suggested that some, 
but not all, women are reliably mood-sensitive to sudden decreases in these hormone levels. In 
another seminal study, PMS-like symptoms were induced in healthy women with PMS but not 
those without PMS by first suppressing the menstrual cycle (and PMS) using leuprolide, a GnRH 
agonist, and then adding estradiol or progesterone (Schmidt et al., 1998). Given the different 
changes in sex hormones between reproductive events, hypersensitivity to normal abrupt 
changes, as opposed to a hypoestrogenic state (Arpels, 1996), may underlie what has been 
referred to as reproductive mood disorder(s) (Rapkin, Mikacich, & Moatakef-Imani, 2003; 
Payne, Tietelbaum Palmer, & Joffe, 2009). However, care should be taken by researchers and 
clinicans to distinguish between reproductive experiences versus disorders to avoid 
pathologizing physical and psychological changes at reproductive events that may characterize 
being a woman (i.e., are common and to be expected to some extent).  
This hormonal sensitivity theory is supported by a growing body of literature on 
associations between negative affect or depression and reproductive events across the lifespan 
(Feld, Halbreich, & Karkun, 2005). At least five studies have examined pregnancy and the 
postpartum period in this regard. Current postpartum depression has been found to be associated 
with a history of premenstrual irritability (Sugawara et al., 1997), PMDD (Bloch, Rotenberg, 
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Koren, & Klein, 2005; 2006), adverse OC mood side effects, negative mood in the first 2 to 4 
days postpartum (Bloch et al., 2005), a positive history of postpartum depression, and negative 
mood in the third trimester (Bloch et al., 2006) (but see Gregory, Masand, & Yohai, 2000 for 
non-significant relationships). Premenstrual irritability has also been shown to be related to 
psychological distress in pregnancy (Sugawara et al., 1997). Additionally, Russell (2009) 
reported that a history of abortion was associated with negative mood in the puerperal period.  
More research has examined associations between distress during the menopausal 
transition and symptoms at past reproductive events. First, Stewart and Boydell (1993) 
determined that perimenopausal women with high distress were more likely to report a history of 
OC-related dysphoria, PMS, and postpartum depression, but not distress at pregnancy, cycle 
irregularity, or physical symptoms in general, than those with low distress. Becker, Orr, Kotlet, 
and Pines (2007), Gregory et al. (2000), Flores-Ramos, Heinze, and Silvestri-Tomassoni (2010), 
Richards, Rubinow, Daly, and Schmidt (2006), Steinberg et al. (2008), Stone (2011), and Wood 
and Mitchell (1996) reported similar results with respect to negative mood symptoms in the 
premenstrual and postpartum periods. In another study, history of PMS was a risk factor for 
vasomotor flashes, depressed mood, poor sleep, and decreased libido in the perimenopause 
period (Freeman, Sammel, Rinaudo, & Shend, 2004). Flores-Ramos et al. (2010) also found that 
earlier age at menarche, lower parity, and fewer miscarriages, but not OC side effects, were 
associated with perimenopausal depression. Conversely, two studies did not find that either PMS 
or postpartum mood change were predictive of perimenopausal depressive symptoms (Becker et 
al., 2007; Steinberg et al., 2008). These studies suggest that some women experience negative 
symptoms across various reproductive events. However, the only known study to examine past 
reproductive events as correlates of prospective menstrual cycle mood change is Haywood, 
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Slade, and King (2007). Results suggested that postpartum distress was not associated with 
subsequent premenstrual distress, with the exception of a trend for physical symptoms of PMS. 
 In contrast, only a few studies have examined associations between reproductive 
experiences with respect to positive affect. In 1982, Wood, Dery, and Most reported that age at 
menarche and negative recollections of menarche were uncorrelated with retrospective reports of 
negative affect across the most recent menstrual cycle. Contrary to expectations, positive 
recollections of menarche were correlated with negative affect in the premenstrual and menstrual 
phases. Later age at menarche was related to reports of positive affect at menarche and OC use 
was related to reports of negative affect at menarche. It is unfortunate that the study was limited 
to women’s feelings at the onset of their first menstrual period as opposed to affect change 
associated with puberty. Wieck et al. (2003) found that women with a history of perinatal bipolar 
disorder demonstrated more dopaminergic receptor sensitivity in the luteal phase than controls 
and, in an unpublished study, Russell (2009) found that positive mood change in the postpartum 
period was associated with a negative history of abortion, positive mood change at puberty, as 
well as positive mood change in the premenstrual phase. These results are consistent with what 
would be expected on the basis of the theory that some women exhibit hormonal sensitivity that 
results in responses to changes in hormone levels in unique yet predictable ways. Overall, these 
studies suggest that further research is needed on associations between symptoms, including 
those that are positively valenced, across the menstrual cycle and those at past reproductive 
events in both parous and nulliparous women. 
Although positive mood states do not seem to be particularly associated with 
perimenopause (Dennerstein, Lehert, & Guthrie, 2002), prospectively measured premenopausal 
positive affect, including a negative history of PMS, has been shown to be a significant predictor 
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of positive affect during the menopausal transition (Dennerstein, Lehert, Dudley, & Guthrie, 
2001). Also, there is some evidence that depressed mood may resolve with the menopausal 
transition (Wood & Mitchell, 1996) as well as a case report of an 85-year-old women with 
seasonal depression since menopause who developed mania in response to HRT (Young, Moline, 
& Kleyman, 1997).  
It is likely that a spectrum of hormonal sensitivity, and thus symptom severity, exists 
among women (Soares, 2010; Soares & Zitek, 2008; Stone, 2011). It has also been proposed that 
the effects of hormonal changes across the lifespan may be cumulative in those who are 
vulnerable (Ancelin et al., 2007; Deecher, Andree, Sloan, & Schechter, 2008). Women with a 
hypersensitivity to changes in reproductive hormones as well as a predisposition for various 
psychological changes (e.g., depression or bipolar disorder) may accumulate risk across the life 
span, with every reproductive event. That is, the pathogenesis of reproductive mood disorders 
may be related to electrophysiological kindling (Parry & Newton, 2001), which would have 
treatment implications such as a role for antiepileptics as suggested by a preliminary study of 
PMDD (Kayatekin, Sabo, & Halbreich, 2008).  
Kindling. Kindling refers to the recurrent and progressive, from evoked to spontaneous, 
nature of recurrent disorders (e.g., from seizures to epilepsy). Post, Rubinow, and Ballenger 
offered a kindling hypothesis of affective illnesses, specifically bipolar disorder, in 1986. The 
general premise is that sensitization to both psychosocial stressors and disorder episodes affects 
neurobiology through genetic encoding over time (see Post, 1992 for a review of evidence 
relating to transduction). Indeed, early depressive and manic episodes seem to be more reactive 
to stress than those that occur further along in the course of the disorder. With respect to episode 
sensitization, research is clear that the frequency of mood episodes increases as well (Post, 2004) 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
42
but decreasing interepisode recovery intervals seem to be limited to the initial stages of the 
disorder (Goodwin & Jamison, 2007). Kindling and sensitization also seem to be implicated in 
increasing severity of episodes overtime (Post, 2007).  
Although it does not appear that this hypothesis has been explicitly examined in PMS, 
several findings can be interpreted in a kindling context, including the associations of PMDD 
with older age at onset, lower age at menarche, symptoms at other reproductive events, and a 
history of depression (e.g., Bancroft, Rennie, & Dye, 1994). Risk of depression in general has 
been associated with earlier age at menarche, heavier menstrual flow and cycle irregularity in the 
first 5 gynecologic years, a history of abortions, and depression at other reproductive events 
(Graze, Nee, & Endicott, 1990; Harlow, Cohen, Otto, Spiegelman, & Cramer, 2004). There is 
also evidence that subgroups of women with bipolar disorders have preexisting menstrual cycle 
problems (Kenna, Jiang, & Rasgon, 2009) or mood change at two or more reproductive events 
(Gregory et al., 2000; McClure, Reich, & Wetzel, 1971; Payne et al., 2007), but it is unclear 
whether positively valenced changes kindle over time. An appropriate measure of whether 
models like kindling or incessant cyclicity are applicable to symptoms associated with hormonal 
sensitivity might be the estimated number of past reproductive events, including not only number 
of menstrual cycles (see Harlow et al., 2004 for null results) but also cumulative number of 
pregnancies and times one has switched HCs.   
Unfortunately, the mechanisms of action for adverse and beneficial changes in negative 
affect and positive affect across the cycle may vary, but research has largely focused on 
mechanisms involved in adverse effects of negative affect. It does not appear that any such 
studies have looked at the prediction of sexual complaints and positive experiences across the 
menstrual cycle in premenopausal women. Whatever the mechanisms, it is clear that there are 
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individual difference variables associated with changes in affect across the cycle and with HC 
use.  
 Individual differences. There is a small body of recent literature on personality and PMS 
(see Miller et al., 2010 for a partial review). For example, there is a link between PMS and the 
tendency to (mis)attribute bodily sensations as emotions (Schnall et al., 2002). This finding was 
demonstrated for both negative and positive affect change such that women responsive to cues 
from their bodies showed various patterns in affect across the cycle, while other women did not 
display any phase effects (Study 1). Similarly, it has been suggested that neuroticism accounts 
for PMS and reproductive mood change (e.g., van den Akker, Eve, Stein, & Murray, 1995). 
However, neuroticism, arguably a dated term, and maladaptive cognitions are also associated 
with psychopathology in general and seem to mark one’s propensity for negative affect (Ormel, 
Rosmalen, & Farmer, 2004), as opposed to being a factor that can discount the role of sensitivity 
or heritable susceptibility to physiological changes across the cycle (Miller et al., 2010). What is 
more, neuroticism was unrelated to PMS in women with other mood disorders in one study 
(Payne et al., 2009) and personality scores that relate to neuroticism have been shown to 
fluctuate across the cycle and change with OC use, including borderline personality disorder 
symptoms (DeSoto, Geary, Hoard, Sheldon, & Cooper, 2003). The extent to which personality 
variables are relevant to the expression of psychological changes across the cycle and with HC 
use requires further investigation.   
PMS or PMDD is associated with earlier age of menarche, a history of depression, 
employment outside the home, less education, and smoking (Cohen et al., 2002). It is 
understudied as to whether menstrual cycle characteristics are related to PMS (Feld et al., 2005). 
However, Soares, Cohen, Ott, and Harlow (2001) found that women with PMDD and a history 
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of depression were less educated and had less frequent marital problems than women with 
PMDD and no such history. The two groups did not differ with respect to age at menarche, cycle 
regularity, parity, or smoking. One study found that moderate exercise was a protective factor for 
PMS but not for cyclicity in positive affect (Aganoff & Boyle, 1994). Moreover, relatively high 
body mass index (BMI), a measure of body fat and thus, a crude measure of circulating estrogen, 
may have a small to medium protective effect against negative mood (Ceballos, Hooker, & 
al’Absi, 2009), even across the menstrual cycle (Oinonen & Mazmanian, 2001b). This effect 
may be limited to women within the normal range of BMI measurements (cf., Barry, Pietrzak, & 
Petry, 2008).  
Factors associated with OC-related negative affect change include a history of: 
depression, dysmenorrhea, and induced abortion (Segebladh, Borgström, Odlund, Bixo, & 
Sundström-Poromaa, 2009; Oinonen & Mazmanian, 2001a). Age of menarche does not seem to 
be as relevant (see review in Oinonen & Mazmanian, 2002). Even though HC use can alter 
women’s BMI and waist-to-hip ratio (WHR), a measure of fat distribution and crude testosterone 
levels (Singh, 1993), there appears to be little research on WHR and menstrual cycle changes in 
affect. At the extremes, BMI and WHR are related to other menstrual cycle problems such as 
irregularity and polycystic ovary syndrome or hyperandrogenism (Speroff & Fritz, 2005).  
Recent research involving sexually dimorphic proxy measures of androgen exposure or 
action suggest that there may also be preexisting hormonal differences between OC users and 
nonusers. Oinonen, Jarva, and Mazmanian (2008) found that OC users had a lower or 
masculinized second-to-fourth digit ratio (2D:4D), earlier age of menarche, a higher rate of 
hormonal disorders, greater medication and drug use, and a more unrestricted sociosexual 
orientation than never users. Conversely, BMI and WHR did not differ between groups. Overall, 
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this study suggests that OC users may have been exposed to more testosterone in utero as 2D:4D 
is a popular biomarker for prenatal exposure and its organizational effects (see Manning, 2008), 
and that this exposure may result in proclivities to OC use. Previous users had the most extreme 
traits, which may indicate that they are particularly vulnerable to OC side effects. Indeed, 
Oinonen (2009, Study 1) reported that low 2D:4D was associated with a self-reported history of 
OC-related increases in negative affect and discontinuation due to such concerns. In a second 
study, Oinonen found that 2D:4D and mid-phalangeal hair count, a putative measure of current 
androgen action or sensitivity, was associated with discontinuation due to various affect-related 
side effects. Having less mid-phalangeal hair was associated with side effects, which unlike the 
2D:4D findings, suggests that women with a relatively feminine hair count are more likely to 
experience adverse OC side effects.  
While extreme digit ratios and middle-phalangeal hair counts may be markers of 
vulnerability to changes in reproductive hormones, these variables have yet to be examined in 
relation to symptoms across the menstrual cycle. Further evidence for the plausibility of such 
associations comes from research suggesting that 2D:4D is negatively correlated with age of 
menarche (Manning & Fink, 2011; Matchock, 2008; but see Helle, 2010) and WHR (see Fink, 
Neave, & Manning, 2003), and positively related to fluctuating asymmetry (a measure of 
developmental instability and thus biological quality; Fink, Manning, Neave, & Grammer, 2004) 
in women. Among men, feminine 2D:4D has been shown to be positively associated with 
depression scores (Bailey & Hurd, 2005), fluctuating asymmetry (Fink et al., 2004), and BMI 
(Fink et al., 2003). Additionally, digit ratio has been shown to be related to a variety of estrogen- 
and androgen-related medical conditions among women, including breast cancer (Manning & 
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Leinster, 2001), cervical dysplasia (Brabin, Roberts, Farzaneh, & Fairbrother, 2008), and 
polycystic ovary syndrome (Cattrall, Vollenhoven, & Weston, 2005). 
In summary, there are few robust findings with respect to the individual differences that 
may underlie menstrual phase or HC-induced psychological changes. The potential effects of 
personality characteristics and menstrual cycle characteristics are unclear. At this time, the best 
candidates of moderating or mediating variables appear to be biologically-based traits or 
anthropometric measures, namely a history of depression, age of menarche, WHR, BMI, mid-
phalangeal hair count, and 2D:4D. It is interesting that Oinonen, Jarva, et al. (2008) reported  
links between OC use, 2D:4D, and sociosexuality given that there are several sexual selection 
theories about psychological changes associated with reproductive events, including PMS and 
reverse PMS (i.e., PMS-like symptoms in the periovulatory phase). These are discussed next.  
Evolutionary Models  
 Darwinian or evolutionary approaches to psychology, psychiatry, and medicine propose 
that diseases and disorders have about six distal, as well as many possible proximal, causes. The 
six possible distal or evolutionary explanations include defenses, pathogens, modern 
environments relative to the EEA, genetics, trade-offs in human design, and the fact that 
evolution cannot make huge leaps and therefore, leaves legacies (Eaton et al., 2002; Keller & 
Miller, 2006; Nesse & Williams, 1994). There is an abundance of theories as to the evolution of 
mental disorders. One such model has placed sexually selected fitness indicators on a continuum 
from adaptive to an unattractive extreme, with mental disorders representing breakdowns in 
mating intelligence (Shaner, Miller, & Mintz, 2007). Three distinct evolutionary models of 
symptoms associated with the menstrual cycle have been published. Generally, evolutionary 
models fall into two categories: byproduct and adaptive hypotheses.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
47
Byproduct hypotheses. According to the cyclic defense hypothesis, PMS is merely a 
byproduct of changes in immune system functioning. Doyle, Ewald, and Ewald (2007) proposed 
that symptoms in the luteal phase may often be an exacerbation of previously existing, possibly 
under-identified, infections due to a decrease in cell-mediated immunity with the rise in 
progesterone. In comparison, humoural immunity is enhanced at this time so a woman’s immune 
system is less likely to destroy an embryo. Evidence cited in support of this hypothesis included 
that control of fungi, viruses, and intercellular bacteria is less optimal in the luteal phase and that 
antibiotic treatment may be better than placebo pills for PMS. The authors also indicated that the 
hypothesis may apply to pregnancy and the postpartum period as well as when taking HCs given 
that the side effects are similar to symptoms of PMS. The latter idea is plausible if synthetic 
progestins have effects on immunity but it does not take into account the fact that HCs tend to 
suppress endogenous levels of sex hormones. Overall, the cyclic defense hypothesis suggests that 
PMS is often the misdiagnosis or exacerbation of other chronic illnesses. The extent to which it 
applies to physical versus psychological changes is unclear.   
In 2008, Rieber proposed that PMS is a byproduct of mating adaptations entrained to the 
menstrual cycle, particularly the preovulatory phase. That is, premenstrual symptoms may be a 
result of withdrawal from “positive physical and sociobehavioral states” that facilitate mating 
when a woman is more fertile earlier in the cycle (e.g., heightened self-perceived attractiveness). 
Reiber’s model suggests that changes in negative affect may be compensatory
15
 (i.e., a rebound 
effect) to changes in positive affect (recall that Kiesner, 2011 and Pincus et al., 2008 made 
similar interpretations of their findings). In support of this hypothesis, Rieber (2009) reported 
that women experience different menstrual cycle patterns of PMS-like symptoms that are 
                                                 
15
 The possibility of compensatory changes in negative and positive affect associated with reproductive hormones 
may be interpreted in the context of the opponent-process theory of emotion (Solomon & Corbit, 1974) where 
negative affect and positive affect are paired regulatory processes.     
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
48
dependent on whether their current conditions are advantageous for reproduction. For instance, a 
subgroup of women was found to experience “pseudo-PMS” (i.e., a POS pattern) in what would 
normally be the fertile phase followed by less negative states prior to menstruation. The POS 
pattern was negatively associated with age and resources as well as positively associated with 
parity, conditions considered to unfavorable for having (more) children (Reiber, 2009). Based on 
these findings, a POS pattern may be an evolved form of birth control. Also, women with PMS 
reported fewer negative symptoms in the preovulatory phase than women without PMS. Positive 
states in the premenstruum were suggested to be related to women obtaining mate retention or 
material benefits from men in order to improve their conditions before reproducing. This model 
also implies there may be within-woman variability in menstrual cycle patterns over time as 
conditions change. Rieber (2008; 2009) did not review the research on changes in positive mood 
or affect across the cycle to support this byproduct hypothesis nor were any alternative 
explanations discussed, and only negative symptoms were measured. The omission of positively 
valenced items is problematic because, as mentioned previously, the absence of negative 
symptoms is not evidence of enhanced positive affect. Finally, if positive states are adaptive at 
different phases in this model, the compensatory states (i.e., symptoms of PMS) may also be 
functional at times.  
There do not appear to be any explicit evolutionary explanations, namely byproduct 
hypotheses, of why some women have adverse HC side effects while others do not or may even 
experience beneficial side effects. However, it has been noted that HCs may disrupt 
psychological adaptations associated with the menstrual cycle (e.g., Brown et al., 2009). Not 
only do they moderate (attenuate or nullify) cyclic changes but they may impose conditions on 
the mind and body that do not correspond with women’s evolutionary legacy. For instance, HC 
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users have been found to have altered mate preferences compared to free-cycling women (see 
Alvergne & Lummaa, 2009 and Roberts, Miner, & Shackelford, 2010 for reviews), including a 
greater preference for the scent of men who are genetically similar to them in the major 
histocompatibility (MHC) region. Given that the MHC genes are involved in immune 
functioning and HC alters women’s mate preferences, HC use may affect relationship formation 
and maintenance as well as a couple’s fecundity related to genetic similarity (Roberts, Gosling, 
Carter, & Petrie, 2008). Also, in 2011, combined OCs were found to be associated with: (a) 
relationship outcomes such as women’s decreased attraction and sexual proceptivity to male 
partners met while using OCs (Roberts et al., 2012) as well as (b) reduced memory for details of 
an emotional story (Nielsen, Ertman, Lakhani, & Cahill, 2011). Overall, HC side effects might 
occur due to similar mechanisms that underlie menstrual cycle symptoms (Doyle et al., 2007) as 
well as being a byproduct of the mismatch between the EEA and advances in reproductive 
medicine, including deliberate means of suppressing endogenous hormone cyclicity.  
Adaptive hypotheses. A third evolutionary explanation for PMS symptoms, particularly 
what is referred to as late luteal phase behavioural changes (LLBCs), suggests that these cyclical 
changes co-evolved with women’s reproductive physiology insomuch as they increase 
reproductive success (Vieira, 2009). Consider, for example, the possibility that LLBCs may 
increase the likelihood of relationship dissolution among couples that have not conceived during 
the fertile phase of the menstrual cycle and are not well-matched. LLBCs may also elicit 
information about male partners’ commitment and parenting qualities. Similarly, it has been 
suggested that dysphoric symptoms in the luteal phase, during pregnancy, and in the postpartum 
period might have evolved because they keep women out of harm’s way when the survival of a 
child depends on them (Niculescu & Akiskal, 2000).  
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Abraham perhaps first articulated a hypothesis for changes in positive affect across the 
cycle in 1984 that suggested that postmenstrual elevation in mood may encourage behaviours 
that are reproductively advantageous. Although the possibility of compensatory changes in the 
preovulatory phase has been largely ignored in PMS research, Niculescu and Akiskal (2000) 
stated that “the initial euthymic phase leading to ovulation is conducive to mating. . .” (p. 1084). 
Also, it has been proposed that the genes for mania in bipolar disorder may have advantages for 
reproductive success as a result of increased sexual aggression or promiscuity as well as goal-
directed behaviour (Nesse & Williams, 1994).  
Hormones and Sociosexuality 
Given that the evolutionary theories of affect change across the menstrual cycle suggest 
that such change is related to mating effort, research on hormones and mating strategies is 
relevant and will be reviewed here. In the area of psychoendocrinology, evolutionary 
psychologists tend to focus on differences between the sexes and changes across the cycle as 
related to sexual selection
16
. Parental investment, organizational and activational effects of 
hormones, and conception probability are expected to be modulating variables. For example, the 
time and effort men must put forth in conception and childbearing is less than that of women 
based on physiology (i.e., the sizes of the gametes and internal fertilization) and therefore, men 
tend to be less invested in offspring and more apt to engage in short-term mating. In contrast, 
women tend to be “choosy” (Baker & Bellis, 1995; Trivers, 1972). This sex difference in mating 
strategy has been found to be nearly universal across cultures (Schmitt, 2003; 2005).  
Briefly, a mating strategy is a set of psychological adaptations, namely implicit decision 
rules, that organize and direct an individual’s overall sexual and as such, reproductive efforts. 
                                                 
16
 It should be assumed that the results discussed in this section are based on healthy, heterosexual, and free-cycling 
women, unless otherwise noted.  
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Mating tactics are the specific actions and perceptual preferences that serve the purpose of 
fulfilling a strategy (Buss, 1998). The term sociosexuality is often used in reference to mating 
strategies (long-term versus short-term) and simply means the degree to which one is 
comfortable with, or willing to engage in, allosexual behaviours outside of attached and 
committed relationships, as opposed to allosexual behaviours with an individual romantic partner 
and autosexual behaviours. For example, the number of different sexual partners over time, 
extra-pair sexual interests and behaviours (e.g., cheating), and attitudes toward casual sex are 
considered to be features of sociosexuality. Traditionally, it been measured as an individual 
difference variable using the Sociosexual Orientation Inventory (SOI; Simpson & Gangestad, 
1991) on a bipolar continuum from restrictiveness to unrestrictiveness. Nonetheless, the overall 
consensus is that species have evolved a repertoire of context dependent (Buss & Schmitt, 1993), 
conditional (Gross, 1996), ecologically-contingent (Gangestad & Simpson, 1990), and mixed 
(Trivers, 1972) mating strategies
17
. Reiber (2009) referred to such models as facultative when 
discussing an evolutionary hypothesis of PMS.  
Firstly, one’s health and physical attractiveness, including BMI, WHR and fluctuating 
asymmetry, influences one’s ability to attract a potential mate (i.e., the availability and quality of 
potential mates) and thus, men and women’s mating strategy (Buss & Shackelford, 2008). The 
results of Oinonen, Klemencic, et al. (2008) and Swarmi, Miller, Furnham, Penke, and Tovée 
(2008) suggest that one’s sociosexuality may influence perceptions of potential mates’ 
attractiveness, health, fertility, and even BMI. Although sociosexual orientation has not typically 
been considered a health-related variable, it has been shown to be negatively correlated with 
disease prevalence across the world (Schaller & Murray, 2008), positively correlated with high-
                                                 
17
 Although beyond the scope of present paper, it is important to note many evolved sexual mechanisms discussed 
are also supported by phylogenic research on nonhuman primates as well as vertebrates, and various evolutionary 
theories (see reviews in Thornhill & Gangestad, 2008 and Oinonen, Klemencic et al., 2008).  
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risk sexual behaviours (Seal & Agostinelli, 1994), and negatively associated with 2D:4D (e.g., 
Oinonen, Teatero, & Mazmanian, 2012). Although research on relationships between PMS-like 
cyclic changes and sociosexual strategies is very sparse, further evidence that mating strategies 
may affect or be affected by health includes the aforementioned research on sexual symptoms of 
PMS or side effects of HC use. Women with PMS may exhibit different mating strategies and 
preferences than women without PMS as suggested by Reiber’s (2009) evolutionary theory of 
PMS as well as the reviewed research on the effects of HC use on mate selection. The possibility 
that changes in sexuality and mating tactics co-occur with, or as part of, menstrual cycle patterns 
such as PMS warrants exploration. For example, a general restrictive strategy may be a symptom 
or side effect of PMS-like changes across the cycle, perhaps even beyond changes in sex drive or 
arousability and physical well-being. That is, reproductive experiences and mating strategies 
may be related. Both cycle phase and HC use, and their associated symptoms, may affect 
relationship functioning and mating strategy (Roberts et al., 2012; Slade, Haywood, & King, 
2009).  
Secondly, sexual strategies theory (SST) suggests that women engage in short-term 
mating with the intention of developing long-term relationships (Buss & Schmitt, 1993). In 
contrast, the core tenet of the strategic pluralism model (SPM) is that there is considerable 
within-sex variation in the mating strategies of women due to trades-offs between good genes 
and good provider attributes in male partners (Simpson & Lapaglia, 2007). Support for the SPM 
comes from several lines of research. Only about 16% of the variance in seeking short-term 
partners is attributed to sex (Gangestad  & Simpson, 2000); sociosexuality is associated with 
mate preferences (Simpson & Gangestad, 1992); and self-reported gender identity seems to 
account for more variance in sociosexuality and tactics like jealousy, than sex (Aylor & Dainton, 
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2004; Teatero, Mazmanian, & Oinonen, 2010a). In addition, the rate of cuckoldry may be higher 
than 10% (Diamond, 1992) and there is a body of research on changes in sexuality across the 
menstrual cycle
18
. Overall, it is clear that there is substantial within-sex variance in sociosexual 
tactics. Women do not consistently use the same sexual tactics. If hormonal mechanisms play a 
role in the likelihood of engaging in the various strategies, women using different strategies may 
differ hormonally, may differ in the likelihood of a mechanism being activated (i.e., different 
thresholds for activation), or may have different hormonal mechanisms to activate the strategies 
and tactics. 
Periovulatory tactic shifts. Evolutionary research has suggested that the preovulatory 
phase is important because it is involved in reproductive adaptations. Overall, women tend to 
report greater extra-pair desire and behaviours (Gangestad, Thornhill, & Garver, 2002; 
Gangestad, Thornhill, & Garver-Apgar, 2005), and less commitment to their long-term partners 
(Jones et al., 2005) at peak fertility in the cycle (as compared to lower fertility phases). When 
evaluating men in the context of a short-term relationship, women’s mate preferences at high 
fertility phases tend to shift towards signals of genetic quality. For example, there is a 
periovulatory peak in women’s preferences for: behavioural displays of social presence and 
direct intrasexual competition (Gangestad, Simpson, Cousins, Garver-Apgar, & Christensen, 
2004); the faces, bodies, and scent of symmetrical men (Little, Jones, Burt, & Perrett, 2007; 
Thornhill & Gangestad, 1999; Thornhill et al., 2003; cf., Oinonen & Mazmanian, 2007); and 
masculine men (Jones et al., 2005; Little, Jones, & Burriss, 2007; Penton-Voak & Perrett, 2000; 
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 Although the literature on mating strategies at other reproductive events is sparse, women may be least interested 
in short-term sexual relationships when pregnant, in the postpartum period, or when otherwise infertile (e.g., the 
premenstrual phase), which has been hypothesizes to be due to non-genetic benefits of having a stable partner (Jones 
et al., 2008).  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
54
Puts, 2005). Thus, women’s sociosexuality seems to increase when around ovulation, when sex 
is most likely to result in conception.   
In 2001, cyclical preferences for masculinity were reported to be moderated by self-
reported gender identity such that the extent of the preference shift for masculine faces increased 
as a function of self-reported masculinity (Johnston, Hagel, Franklin, Fink, & Grammer, 2001). 
Scarbrough and Johnston (2005) also found that women with low 2D:4D as well as those low in  
femininity displayed a periovulatory shift towards greater attractiveness to masculine faces. In 
contrast, women with high 2D:4D as well as those high on femininity shifted towards a 
diminished preference for masculine faces near ovulation. Another line of research suggests that 
the magnitude of cyclic within-woman changes in reproductive hormones, namely greater 
changes in estrogen levels, predicts the magnitude of preferences for faces of men characterized 
by high testosterone (Roney, Simmons, & Gray, 2011).  
Similarly, Oinonen, Klemencic, et al. (2008) reported preliminary evidence of a 
periovulatory sociosexuality tactic shift (PSTS). As measured by ratings of male faces, 
sociosexually restricted women shifted towards greater one-night stand interest during the 
periovulatory phase, the restricted PSTS pattern for simplicity. On the other hand, unrestricted 
women displayed a trend towards diminished interest in one-night stands, a shift towards 
restrictiveness at the periovulatory phase, and rated the faces as healthier than restricted women. 
This latter finding can be referred to as the unrestricted PSTS pattern. Both general patterns are 
also seen in other species such as anthropoid primates (see Oinonen, Klemencic, et al., 2008 for 
partial reviews). Evolutionary models that may support the adaptiveness of the unrestricted 
pattern include the many fathers theory (Hrdy, 1979) and best-of-N theory (e.g., Dubois, 
Wajnberg, & Cezilly, 2004). Models that may support the adaptiveness of the restricted pattern 
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include the father-at-home theory (Alexander & Noonanm, 1979) and better-options theory 
(Dubois et al., 2004). That is, unrestricted women may take advantage of sperm competition and 
“good genes,” in a different way than restricted women, such as by mating with relatively more 
men outside the fertile window in order to acquire resources or to choose the best possible mate. 
Reiber’s (2008; 2009) byproduct theory of PMS might suggest that the unrestricted PSTS pattern 
occurs under conditions unfavorable to immediate reproduction, much like reverse PMS or POS 
(i.e. adverse symptoms in the periovulatory phase). Thus, unrestricted women would be most 
interested in extra-pair or uncommitted relationships when they are unlikely to become pregnant. 
In contrast, it may be more advantageous for restricted women to partner with one man but 
engage in extra-pair relationships around ovulation. Reiber’s model might also suggest that the 
restricted PSTS pattern occurs under some conditions favourable to conception and parity.    
With respect to possible differences between the two groups of women showing opposite 
periovulatory strategy shifts, Oinonen, Klemencic, et al. (2008) reported that the unrestricted 
pattern was related to energetic efficiency such that unrestricted women had a higher body 
weight, hip size, and waist size than restricted women. In contrast, the two groups did not differ 
in BMI, WHR, or FA (i.e., mate quality), age of menarche, sex drive, rate of coitus, or 
intelligence (mental rotation scores). Given that unrestricted women have been found to have a 
lower, more masculine 2D:4D than restricted women (Clark, 2004; Oinonen, Jarva, et al., 2008), 
the two menstrual cycle patterns of preference for male facial masculinity reported by 
Scarbrough and Johnston (2005) may be related to the PSTS findings. In line with the result of 
Scarbrough and Johnston, the unrestricted PSTS pattern seemed to be associated with a 
perceptual bias (i.e., different or relaxed cues when judging male fitness) that may facilitate 
strategy enactment (Oinonen, Klemencic, et al., 2008). Moreover, the unrestricted or low 2D:4D 
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pattern may be associated with irregular menstrual cyclicity, low paternal bonding, and a “good 
genes” mate choice strategy, while the restricted or high 2D:4D pattern may be associated with 
regular menstrual cyclicity, and a “good dad” mate choice strategy (Scarbrough & Johnston, 
2005).  
The results of Oinonen, Klemencic et al. (2008) and Scarbrough and Johnston (2005) 
seem to fit with those of Davydov et al. (2004), Kiesner (2011), and Reiber (2009) with respect 
to menstrual phase effects on negative and positive affect in subgroups of women. In this sense, 
sexual unrestrictiveness in the periovulatory phase with restrictiveness in the premenstrual phase, 
the most common PSTS in the existing literature, may be similar to a PMS-like pattern (i.e., high 
positive affect or low negative affect in the periovulatory, with the opposite pattern in the 
premenstrual, phase). Restrictiveness in the periovulatory, but unrestrictiveness in the 
premenstrual, phase (the restricted PSTS pattern) may be akin a POS (periovulatory syndrome) 
pattern (i.e., low positive affect or high negative affect on the periovulatory phase). The research 
findings reviewed above suggest that psychological changes across the menstrual cycle and 
associated perceptual biases or preferences may be mediated or moderated by the organizational 
effects of sex hormones (e.g., through prenatal and pubertal hormonal exposure with measurable 
effects on sociosexual orientation, 2D:4D, and other physical features) as well as conditional on 
individual differences and context (e.g., the attractiveness of oneself relative to one’s current 
partner; Haselton & Gangestad, 2006; Pillsworth & Haselton, 2006).   
Overall, the progression of research on hormones and sociosexuality parallels that of 
research on hormones and affect. In both areas, sex differences are robust, activational effects 
have been demonstrated, and individual differences, including possible organizational effects, 
appear to be important. Changes in affect as well as sociosexuality across the menstrual cycle 
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have been reported among healthy women, but at their extremes these changes may represent 
clinical disorders (e.g., PMDD) with evolutionary origins. Examining potential associations 
between women’s health and mating tactics places findings from both fields in a larger distal 
context yet may lead to an improvement in proximate research, such as on etiology, diagnosis, 
and treatment (Reiber, 2009). As with PMS and POS, evidence is developing that phase effects 
on sociosexuality exhibit two opposing patterns in different women (i.e., unrestricted and 
restricted PSTS). An intriguing and hitherto unexplored possibility is that phasic changes in 
negative affect, positive affect, and mating tactics may be associated. That is, women who 
experience PMS (in the premenstrual phase) may also experience periovulatory peaks in positive 
affect and sociosexual unrestrictiveness; women who do not experience PMS may feel relatively 
good and be most unrestricted in the premenstrual phase and experience relatively more negative 
affect and restrictiveness in the periovulatory phase (see Kiesner, 2011; Pincus et al., 2009; 
Rieber, 2009 reviewed herein).  
To further summarize the state of research on both PMS (or menstrual cycle changes in 
symptoms) and PSTS, there are at least three explanations for the possibility of two different 
types of cyclical shifts in affect and in mating tactics. First, the majority of women (or cycles) 
may display the same shifts (i.e., PMS-like changes and restricted PSTS), while an identifiable 
subgroup of other women may exhibit the opposing shifts (i.e., POS-like changes and 
unrestricted PSTS). Each shift may be adaptive for the women who display them as suggested by 
Reiber (2008; 2009), Oinonen, Klemencic, et al. (2008), and Vieira (2009). Second, the 
relatively less researched or perhaps less common hormone-related shifts (i.e., POS-like changes 
and unrestricted PSTS) may be byproducts of other evolutionary processes (Reiber, 2008). Third, 
mixed findings between studies may suggest that these two patterns are the result of 
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methodological or statistical artifacts and that the stated changes in affect and sociosexuality do 
not co-occur. There is, of course, a chance that the findings indicative of POS and unrestricted 
PSTS shifts are a result of Type I (i.e., false positive) statistical errors. However, this seems 
unlikely given the lines of evidence reviewed here indicate that there is appreciable between- and 
within-women variability in psychological shifts across the menstrual cycle as well as other 
reproductive events. 
One area of concern in research on psychological menstrual cycle entrainments is that 
there are many methodological inconsistencies, which may introduce biases. For example, 
screening criteria (i.e., the requirement of normal cycle regularity and length; e.g., Gangestad, 
Thornhill, & Garver-Apgar, 2005; Reiber, 2009; Oinonen, Klemencic, et al., 2008) exclude a 
sub-group of women from the majority of research and it is possible that these women are those 
who (a) show alternative shifts such as POS or unrestricted PSTS patterns or (b) are particularly 
likely to experience variability across the cycle. Exemplifying this point, Kiesner (2011) found 
that 20% of women who declined participation in a menstrual cycle study did not have a regular 
menstrual cycle and Scarbrough and Johnston (2005) found that women who exhibited an 
atypical menstrual cycle pattern in the preference for male facial masculinity had more irregular 
cycles.  
It is also a possibility that previous findings may have been confounded by other 
variables. For example, it has been theorized that women exhibit two (socio)sexualities: estrus 
around ovulation for genetic benefits and extended sexuality throughout the rest of the cycle for 
material benefits (Thornhill & Gangestad, 2008). However, past research did not separate 
women’s receptive and proceptive mating strategies across the cycle, which are independent 
constructs, and the most widely used measure of sociosexuality (i.e., the SOI) was recently 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
59
revised by two independent research groups due to psychometric issues (Jackson & Kirkpatrick, 
2007; Penke & Asendorpf, 2008). One concern was that mating strategies may be 
multidimensional (e.g., long- and short-term orientations may be enacted concurrently or 
conditionally). Thus, new measures assess both long-term and short-term orientations as well as 
receptivity and proceptivity. For instance, the Proceptive and Receptive Mating Strategies Scale 
(PARMSS) was recently developed and appears to be the first measure to separately assess 
receptivity and proceptivity on a common metric. As mentioned previously, very few researchers 
have examined the possibility that there is more than one pattern of dual (socio)sexuality across 
the cycle: restricted PSTS (i.e., a periovulatory peak/premenstrual trough in 
unrestricted/proceptive behaviour) and unrestricted PSTS (i.e., a periovulatory 
trough/premenstrual peak in unrestricted/proceptive behaviour).  
Women may be relatively receptive across the cycle as male-initiated sexual activity has 
been shown to be stable (Bullivant et al., 2004). However, two studies found that women were 
most likely to agree to solicitations, such as giving out one’s number and dancing at a nightclub, 
from men when in the periovulatory phase (Gueguen, 2009a/b). These findings may, in part, 
reflect the theory that women are more receptive and more active in their mating strategies when 
fertile. For instance, women appear to be more likely to go out to socialize when in the 
periovulatory phase (Haselton & Gangestad, 2006). They also are more likely to wear revealing 
clothing (Durante, Li, Haselton, 2008; Haselton, Mortezaie, Pillsworth, Bleske-Rechek, & 
Frederick, 2007) and to initiate sexual activity (Bullivant et al., 2004; Gangestad et al., 2002; 
Van Goozen et al., 1997) at that time.  
Given that extra-dyadic proceptivity has been found to be related to sociosexuality (Seal, 
Agostinelli & Hannett, 1994) and previous research had not examined whether receptive and 
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proceptive sexual behaviour show different patterns across the cycle, (Phillips, 2015) examined 
this in a recent dissertation. It was proposed and some evidence was found for an expansion of 
the PSTS, following the development of and using the PARMSS. That is, Phillips found that 
there may be two patterns of sociosexual proceptivity across the cycle but that receptivity may 
generally peak around ovulation. 
These findings seem to fit with evidence that ovulation is not completely concealed if 
evolved male strategies are associated with cues of fertility. Schwarz and Hassebruck (2008) 
showed that men rated women in the periovulatory phase as more attractive than other women, 
which may be strengthened by familiarity (e.g., among pair-bonded couples) (Çetinkaya Dural & 
Gülbeteki, 2010). Men also tend to prefer the gait, voices, and scent of women (e.g., Pipitone & 
Gallop, 2008; Provost, Quinsey, & Troje, 2008), and may engage in more mate retention tactics
19
 
(Gangestad et al., 2002; Haselton & Gangestad, 2006; Pillsworth & Haselton, 2006), around 
ovulation than at other times in the cycle. Interestingly, Miller, Tubur, and Jordon (2007) 
demonstrated that exotic dancers reported the most tip money per hour when in “estrus.”  The 
existence of two different patterns of women’s proceptivity across the menstrual cycle may 
confuse male partners about unrestricted women’s fertility status. At this stage, it is unknown 
whether the male partners of women who exhibit reverse PSTS (i.e., increased proceptivity in the 
luteal phase) display different cyclical changes in mate retention tactics (e.g., physical features 
and behaviour) than men whose female partners exhibit the seemingly more common pattern of 
increased proceptivity in the periovulatory phase. 
A Link between Affect and Sociosexuality 
                                                 
19
 This finding is based on women’s reports of their partners’ behaviours and has yet to be verified in men.  
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As epitomized by the idiom “in the mood,” affective well-being is linked with sexual 
well-being (Warner & Bancroft, 1988). In fact, one of the symptoms of clinically elevated mood 
is increased sexual behaviour (APA, 2013), and negative affect, including depression, is often 
associated with decreased libido
20
 (Bodenmann & Ledermann, 2007). Through factor analysis, 
Sanders, Warner, Bäckström, and Bancroft (1983) demonstrated that wellbeing, consisting 
primarily of mood measures, accounted for 33% of the variance in self-reports of sexuality (i.e., 
sexual feelings and thoughts in general) and was highest in the preovulatory phase among 
women with and without PMS (for similar results see Dye, Warner, & Bancroft, 1995). In 
contrast, sexuality variance independent of mood (i.e., sexual feelings and thoughts as well as 
low energy ratings) increased in the mid-follicular phase, with non-PMS women possibly 
exhibiting another peak in the luteal phase (Bancroft, Sanders, Davidson, & Warner, 1983; see 
also Meaden et al., 2005). More recently, Brown et al. (2011) found that self-reports of libido 
and autosexual activity were highest in the preovulatory phases compared to the premenstrual 
phase in both sexually active and abstinent women. Allosexual activity demonstrated a similar 
pattern but was only significantly lower in the menstrual phase (but see Burleson, Travathan, & 
Gregory, 2002 and review in Brown et al., 2011 for opposing results with respect with auto- and 
allosexual activity). Moreover, Brown and colleagues (2011) found that sexuality variables were 
predicted by emotional factors. Positive affect variance independent of feelings of 
energy/creativity was positively associated with libido but negatively associated with autosexual 
and allosexual behaviour. When positive affect was partialled out, libido and energy/creativity 
were positively associated with autosexual behaviour, and the latter was also related to allosexual 
                                                 
20
 It is possible that the relationship between affect and sexual activity is bidirectional (Burleson, Trevathan, & 
Todd, 2007) and the latter may sometimes be used as a tactic to regulate the former. Moreover, according to the 
affective shift hypothesis, women tend to experience positive feelings following sex, specifically first-time 
intercourse, which is believed to facilitate long-term commitment (Haselton & Buss, 2001). 
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behaviour. These results are difficult to interpret since the findings pertaining to affect and 
sexuality were averaged across cycle phase (i.e., overall and not within or across phases). 
However, the authors concluded that the results support the role of at least two systems in 
women’s sexual behaviour that are condition dependent: one related to mating and one related to 
attachment or affection.  
With respect to PMS, one study reported that women with such a pattern of symptoms 
displayed an ovulatory peak in sexual interest, while women without PMS symptoms showed 
such a peak in the premenstrual phase (Van Goozen et al., 1997). Interestingly, Nowosielski, 
Drosdzol, Skrzypulec, and Plinta (2010) demonstrated that women with PMS (i.e., those with at 
least one premenstrual physical or emotional symptom that was not present around ovulation) 
reported less satisfaction from their sexual life and more sexual distress than women without 
PMS. The two groups did not differ with respect to having a regular partner, being sexually 
active, and frequency of sexual intercourse. While there were no differences in sexual 
satisfaction and distress between women with and without PMDD, the reported frequency of 
sexual intercourse was lower in women with PMDD and frequency of sexual intercourse was 
strongly correlated with satisfaction. These studies suggest that women with and without PMS 
may demonstrate opposing patterns of sexual interest across the cycle and that PMS is a risk 
factor for sexual dissatisfaction among women regardless of cycle phase.   
Two additional areas of research warrant mention. First, experimental studies suggest that 
the induction of sad mood decreases genital or psychological arousal in response to erotic 
material in sexually healthy men and women (Kuffel & Heiman, 2006; Mitchell, DiBartolo, 
Brown, & Barlow, 1998). In addition, positive mood induction has been shown to increase 
subjective but not physiological measures of sexual arousal in women (ter Kuile, Both, & van 
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Uden, 2010). Thus, it is likely that affective changes that temporarily precede or occur 
concurrently with those in sexuality are important. For instance, Fortenberry at al (2005) found 
that prior day positive affect and same-day negative affect were positive and negative predictors, 
respectively, of coitus among female adolescents, while Burleson et al. (2007) found similar 
results in middle-aged women.  
Since previous research on a mood-sex link has not differentiated between types of 
sexual interest or behaviour across the cycle (Brown et al., 2011), it remains unclear whether 
cyclic changes in mood and affect are associated with cyclic changes in mating tactics. 
Unfortunately, there also appears to be little research on relationships between sociosexual 
orientation and sexual functioning variables (e.g., drive, arousal, and orgasms). According to 
Simpson and Gangestad (1991), individual differences in SOI scores are not fully explained by 
variance in sex drive scores such that frequency of sex within committed relationships was 
uncorrelated, while frequency of sex in sexually inactive couples (i.e., extra-pair sex) was 
positively correlated, with SOI scores. However, as discussed by Penke and Asendorpf (2008), 
unrestricted sociosexual desire (in which the goal is an uncommitted relationship) is a part of 
general sexual desire that is condition-dependent and scores on the three scales of their revised 
SOI showed strong positive relationships with sex drive (cf., Ostovich & Sabini, 2004) and 
sensation seeking. Interestingly, all three of these variables tend to be sexually dimorphic with 
men scoring higher than women (e.g., Lippa, 2009; Wohlrab, Stahl, Rammsayer, & Kappeler, 
2009). It is possible that someone who is unrestricted may not have the sex drive to enact the 
behavioural component of this short-term mating strategy (e.g., one could have unrestricted 
attitudes about sex but a relatively low number of past and expected sexual partners due to a lack 
of sexual interest), However, unrestricted attitudes and unrestricted behaviour are significantly 
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associated. Taken together, these findings indicate that sexual drive, and other components of 
sexual functioning, may co-vary with changes in mating strategies and it can be postulated that 
someone who is sociosexually unrestricted is also more unrestricted or less conservative in other 
ways as well, such as religiosity, attitudes toward premarital sex and pornography, and self-
reported sexual excitability (as found by Simpson & Gangestad, 1991). Although Penke and 
Asendorpf (2008) replicated Simpson and Gangestad’s (1991) finding that frequency of sex in 
the context of a committed relationship was not associated with sociosexuality, female- and 
male-initiated sexual activity (i.e., proceptivity and receptivity) should be investigated separately 
so as to avoid confounding relationships (Brown et al., 2011), as discussed above, if they are two 
different components of overall sex drive. 
Research on jealousy, a mechanism of mate retention is another area of evolutionary 
research suggesting that affect and mating strategies co-vary (Buss, 2000). In line with findings 
on patterns of PMS and PSTS, the few studies on women’s jealousy across the menstrual cycle 
have been inconsistent as to whether there is a particular phase in which jealousy peaks (Gaulin, 
Silverman, Phillips, & Reiber, 1997; Geary, DeSoto, Hoard, Skaggs-Sheldon, & Copper, 2001; 
Krug, Finn, Pietrowsky, Fehm, & Born, 1996; Teatero, Mazmanian, & Oinonen, 2010b). Taken 
together, these studies may suggest that there at least two cyclical patterns in jealousy such that 
different groups of women show peaks at different times in the cycle, or that there is no effect of 
phase on this affect-related variable. Although Gangestad et al. (2002) reported that mood did 
not change across the cycle while women’s mating tactics did, individual items of possibly 
biased content were used (e.g., “felt happy for no good reason” [italics added]). Thus, further 
research using a variety of negative and positive affect items is needed. 
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With respect to HC use, Warner and Bancroft (1988) found that users of monophasic 
OCs were least likely to show variations in affective well-being and sexual desire compared to 
nonusers and triphasic OC users, but more likely to show peaks and troughs in well-being during 
the menstrual (i.e., non-OC) phase. Similarly, Graham and Sherwin (1993) concluded that the 
effects of triphasic OCs on mood and sexual interest are dissociated or decoupled such that co-
variation across the cycle was negligible (see also Brown et al., 2006).  Nonetheless, emotional 
and sexual side effects are the best predictors of discontinuing an HC (Sanders et al., 2001). As 
alluded to previously, HC users exhibit altered perceptual or preferential biases when rating 
potential suitors and, along with their partners, show attenuated changes in mating tactics across 
the cycle (e.g., Burriss & Little, 2006; Smith et al., 2009). Interestingly, the dose of estrogen in 
HCs seems to be positively correlated with jealousy as well as mate retention behaviours and HC 
users and their partners report a greater use of mate retention tactics than partners of nonusers 
(Cobey, Pollet, Roberts, & Buunk, 2010; Welling, Puts, Roberts, & Burriss, 2012). This research 
alludes to the possibility that HCs may disrupt or alter the relationships between negative affect, 
positive affect, and sociosexuality or mating tactics (see also Roberts et al., 2008, 2010, 2012).     
Overall, some data indicate that being in a good mood increases the likelihood of exerting 
mating effort for women. It is also possible that some women may be less likely to go out when 
they are experiencing negative affect, including feelings of insecurity, low self-esteem, and 
unattractiveness, and perhaps engage in more mate retention (or dissolution) tactics instead 
(Buss, 2000; Vieira, 2009). More generally, changes in negative and positive affect may 
facilitate mating strategies by priming women for various tactics across the cycle. Affect 
stabilization across phases of the cycle, such as through the use of HCs, may impair or alter some 
women’s sexual and relationship health by disrupting evolved mating strategies that are 
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contingent on context, such as cycle phase. Additionally, it is possible that similar relationships 
between emotional and sexual changes have evolved across other female reproductive events 
(e.g., pregnancy, the postpartum period, and menopause).  
The Present Dissertation  
 The overall purpose of this dissertation was to add to the existing literature on affective, 
sexual, and physical experiences associated with reproductive and hormonal events and 
investigate the possibility that there are co-occurring patterns of such experiences across the 
menstrual cycle. An attempt to integrate research and theories in hormonal sensitivity, 
evolutionary medicine, and paradoxical, alternative, or different menstrual cycle shifts (e.g., 
periovulatory syndrome [POS] and sociosexual tactic shifting) has been made. It is clear that 
individual differences exist with respect to the effects of sex hormones on women’s well-being. 
Given the variety of symptoms and changes that women experience, there is a striking lack of 
research on the clusters or subgroups of women who experience one of the two previously 
identified menstrual cycle patterns in either affect (but see Moos, 1991) or sociosexuality, as well 
as on compensatory, or opponent, positive and negative changes across the cycle (Pincus et al., 
2008). 
This dissertation was completed to address these gaps in the literature by examining the 
relationships between both negatively and positively valenced experiences, particularly with 
respect to affect and mating strategies. First, issues in the measurement of changes in affective, 
sexual, and physical experiences, as well as hormonal sensitivity, associated with reproductive 
events across the female lifespan led to the need for a new comprehensive measure: the 
Women’s Reproductive Experiences (REP) Questionnaire. Second, given conceptual issues in 
the measurement of mating strategies, a newly developed measure of receptive and proceptive 
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mating behaviours, the PARMSS (see Phillips, 2015). The present dissertation includes two 
studies, each with two parts. In Study 1, the development of the Women’s REP is presented and 
its initial psychometric properties assessed, namely factor structure and internal consistency 
reliability (Part 1) as well as concurrent validity (Parts 1 and 2). In Study 2, some of the findings 
of Study 1 were replicated, test-retest reliability as well as convergent and divergent validity for 
the Women’s REP and PARMSS was assessed, and relationships between women’s reproductive 
experiences and mating strategies were examined (Part 1). Subscales from the Women’s REP 
and PARMSS were then used to examine patterns of change in affect and proceptivity between 
the periovulatory and premenstrual phases (Part 2).  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
68
References 
Abplanalp, J. M., Haskett, R. F., & Rose, R. M. (1980). The premenstrual syndrome. Psychiatric 
Clinics of North America, 3, 327-347.  
Abraham, G. E. (1980). The premenstrual tension syndromes. In L. K McNall (Ed.), 
Contemporary obstetric and gynecologic nursing (pp. 170-184). Toronto: C. V. Mosby.  
Abraham, G. E. (1983). Nutritional factors in the etiology of the premenstrual tension  
syndromes. Journal of Reproductive Medicine, 28, 446-464.  
Abraham, S. (1984). Premenstrual or postmenstrual syndrome. Medical Journal of Australia, 
141, 327-328.  
Abraham, G. E., & Hargrove, J. T (1980). Effect of vitamin B-6 on premenstrual 
symptomatology. Infertility, 3, 155-165.  
Abraham, G, E., & Lubran, M. M. (1981). Serum and red cell magnesium levels in patients with 
premenstrual tension. American Journal of Clinical Nutrition, 34, 2364-2366.  
Abraham, S., Luscombe, G., & Soo, I. (2003). Oral contraception and cyclic changes in 
premenstrual and menstrual experiences. Journal of Psychosomatic Obstetrics & 
Gynecology, 24, 185-193.  
Aganoff, J. A., & Boyle, G. J. (1994). Aerobic exercise, mood states and menstrual cycle 
symptoms. Journal of Psychosomatic Research, 38, 183-192.  
Almagor, M., & Ben-Porath, Y. S. (1991). Mood changes during the menstrual cycle and their 
relation to the use of oral contraceptives. Journal of Psychosomatic Research, 35, 721 – 
728.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
69
Alonso, C., Loevinger, B. L., Muller, D., & Coe, C. L. (2004). Menstrual cycle influences on 
pain and emotion in women with fibromyalgia. Journal of Psychosomatic Research, 57, 
451-458. doi:10.1016/j.jpsychores.2004.05.003 
Alvergne, A., & Lummaa, V. (2009). Does the contraceptive pill alter mate choice in humans? 
Trends in Ecology and Evolution, 25, 171-179. 
American College of Obstetricians and Gynecologists. (2000). Premenstrual Syndrome. ACOG 
Practice Bulletin No. 15. Washington, DC: Author.  
American Psychological Association (APA). (1987). Diagnostic and statistical manual of mental 
disorders (3
rd
 edition, rev.). Washington, DC: Author.  
APA. (1994). Diagnostic and statistical manual of mental disorders (4
th
 ed.). Washington, DC: 
Author. 
APA. (2000). Diagnostic and statistical manual of mental disorders (4
th
 ed., text rev.). 
Washington, DC: Author. 
APA. (2013). Diagnostic and statistical manual of mental disorders (5
th
 ed.). Washington, DC: 
Author. 
Ancelin, M- L., Scali, J., & Ritchie, K. (2007). Hormonal therapy and depression: Are we 
overlooking an important therapeutic alternative? Journal of Psychosomatic Research, 
62, 473-485. doi: 10.1016/j.jpsychores.2006.12.019  
Andréen, L., Nyberg, S., Turkmen, S., van Wingen, G., Fernáandez, G., . . . Bäckström, T. 
(2009). Sex steroid induced negative mood may be explained by the paradoxical effect 
mediated by GABAA modulators. Psychoneuroendocrinology, 34, 1121-1132. doi: 
10.1016/j.psyneuen.2009.02.003  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
70
Angst, J., Sellaro, R., Stolar, M., Merikangas, K. R., & Endicott, J. (2001). The epidemiology of 
perimenstrual psychological symptoms. Acta Psychiatric Scandinavica, 104, 110-116.  
Arnold, L. M. (2003). Gender differences in bipolar disorder. Psychiatric Clinics of North 
American, 26, 595-620.  
Arpels, J. C. (1996). The female brain hypoestrogenic continuum from the premenstrual 
syndrome to menopause. The Journal of Reproductive Medicine, 41, 633-639.  
Aylor, B., & Dainton, M. (2004). Biological sex and psychological gender as predictors of 
routine and strategic relational maintenance. Sex Roles, 50, 689-697.  
Bäckström, T., Sanders, D., Leask, R., Davidson, D., Warner, P., & Bancroft, J. (1983). Mood, 
sexuality, hormones, and the menstrual cycle. II. Hormonal levels and their relationship 
to premenstrual symptoms. Psychosomatic Medicine, 45, 503-507.  
Bailey, A. A., & Hurd, P. L. (2005). Depression in men is associated with more feminine length 
ratios. Personality and Individual Differences, 39, 829-836. doi: 
10.1016/j.paid.2004.12.017 
Bancroft, J. (1995). The menstrual cycle and the well being of women. Social Science and 
Medicine, 6, 785-791.  
Bancroft, J., Rennie, D., & Warner, P. (1994). Vulnerability to perimenstrual mood change; The 
relevance of a past history of depressive disorder. Psychosomatic Medicine, 56, 225-231.  
Bancroft, J., Sanders, D., Davidson, D., & Warner, P. (1983). Mood, sexuality, hormones, and 
the menstrual cycle. III. Sexuality and the role of androgens. Psychosomatic Medicine, 
45, 509-517.  
Baker, R. R., & Bellis, M. A. (1995). Human sperm competition. London: Chapman & Hall. 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
71
Barry, D., Pietrzak, P. H., & Petry, N. M. (2008). Gender differences in associations between 
body mass index and DSM-IV mood and anxiety disorders: Results from the National 
Epidemiologic Survey on Alcohol and Related Conditions. Annals of Epidemiology, 18, 
458-466. doi: 10.1016/j.annepidem.2007.12.009 
Battaglia, C., Nappi, R. E., Mancini, F., Cianciosi, A., Persico, N., Busacchi, P., . . . de Aloysio, 
D. (2008). Menstrual cycle-related morphometric and vascular modification of the 
clitoris. Journal of Sex Medicine, 5, 2853-2861.  
Becker, D., Orr , A., Weizman, A., Kotler, M., & Pines, A. (2007). Depressed mood through 
women’s reproductive cycle: correlation to mood at menopause. Climacteric, 10, 56-50. 
doi: 10.1080/13697130601174374 
Bird, J. L., & Oinonen, K. A. (2011). Elevated eating disorder symptoms in women with a 
history of oral contraceptive side effects. Archives of Women’s Health, 14, 345-353.  
Bloch, M., Aharonov, I., Ben Avi, I., Schreiber, S., Amit, A., Weizman, A., & Azem, F. (2011). 
Gonadal steroids and affective symptoms during in vitro fertilization: Implication for 
reproductive mood disorders. Psychoneuroendocrinology, 36, 790-796. 
doi:10.1016/j.psyneuen.2010.10.018 
Bloch, M., Daly, R. C., & Rubinow, D. R. (2003). Endocrine factors in the etiology of 
postpartum depression. Comprehensive Psychiatry, 44, 234-246.  
Bloch, M., Rotenberg, N., Koren, D., & Klein, E. (2005). Risk factors associated with the 
development of postpartum mood disorders. Journal of Affective Disorders, 88, 9-18. 
doi:10.1016/j.jad.2005.04.007 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
72
Bloch, M., Rotenberg, N., Koren, D., & Klein, E. (2006). Risk factors for early postpartum 
depressive symptoms. General Hospital Psychiatry, 28, 3-8. 
doi:10.1016/j.genhosppsych.2005.08.006 
Bloch, M., Schmidt, P. J., Banaceau, M., Murphy, J., Niemen, L., . . . Rubinow, D. R. (2000). 
Effects of gonadal steroids in women with a history of postpartum depression.  American 
Journal of Psychiatry, 157, 924-930.  
Bloch, M., Schmidt, P. J., & Rubinow, D. R. (1997). Premenstrual syndrome: Evidence for 
symptoms stability across cycles. American Journal of Psychiatry, 154, 1741-1746.  
Bodenmann, G., & Ledermann, T. (2007). Depressed mood and sexual functioning. International 
Journal of Sexual Health, 19, 63-73. doi:10.1300/J514v19n04_07 
Boyle, G. J., & Grant, A. F. (1992). Prospective versus retrospective assessment of menstrual 
cycle symptoms and moods: Role of attitudes and beliefs. Journal of Psychopathology 
and Behavioral Assessment, 14, 307-321.  
Brabin, L., Roberts, S. A., Farzaneh, F., & Fairbrother, E. (2008). Second to fourth digit 
ratio(2D:4D0 in women with and without human papillomavirus and cervical dysplasia. 
American Journal of Human Biology, 20, 337-341. doi: 10.1002/ajhb.20731  
Brown, S. G., Calibuso, M. J., and Roedl, A. L. (2011). Women’s sexuality, well-being, and the 
menstrual cycle: Methodological issues and their interrelationships. Archives of Sexual 
Behavior, 40, 755-765. doi: 10.1007/s10508-010-9630-3 
Brown, S. G., Morrison, L. A., Larkspur, L. M., Marsh, A. L., & Nicolaisen, N. (2009). Well-
being, sleep, exercise patterns, and the menstrual cycle: A comparison of natural 
hormones, oral contraceptives and Depo-Provera. Women & Health, 47, 105-121. doi: 
10.1300/j012v47n01_06 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
73
Bullivant, S. B., Sellergren, S. A., Stern, K., Spencer, N. A., Jacob, S., Mennella, J. A., & 
McClintock, M. K. (2004). Women’s sexual experiences during the menstrual cycle: 
Identification of the sexual phase by noninvasive measurement of luteinizing hormone. 
The Journal of Sex Research, 41, 82-93.  
Burleson, M. H., Trevathan, W. R., & Gregory, W. L. (2002). Sexual behavior in lesbian and 
heterosexual women: Relations with menstrual cycle phase and partner availability. 
Psychoneuroendocrinology, 27, 489-503.  
Burleson, M. H., Trevathan, W. R., & Todd, M. (2007). In the mood for love or vice versa? 
Exploring the relations among sexual activity, physical affection, affect, and stress in the 
daily lives of mid-aged women. Archives of Sexual Behavior, 36, 357-368. doi: 
10.1007/s10508-006-9071-1 
Burriss, R. P., & Little, A. C. (2006). Effects of partner conception risk phase on male perception 
of dominance in faces. Evolution and Human Behavior, 27, 297-305. Doi: 
10.1016/j.evolhumbehav.2006.01.002 
Buss, D. M. (1998). The evolution of human intrasexual competition: Tactics of mate attraction.  
Journal of Personality and Social Psychology, 54, 616-628.  
Buss, D. M. (2000). The dangerous passion: Why jealousy is as necessary as love and sex. New  
York: The Free Press.  
Buss, D. M., & Schmitt, D. P. (1993).  Sexual strategies theory: An evolutionary perspective on  
 human mating.  Psychological Review, 100, 204-232.  
Buss, D., M., & Shackelford, T. K. (2008). Attractive women want it all: Good genes, economic 
investment, parenting proclivities, and emotional commitment. Evolutionary Psychology, 
6, 134-146.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
74
Cattrall, F. R., Vollenhoven, B. J., & Weston, G. C. (2005). Anatomical evidence for in utero 
androgen exposure in women with polycystic ovary syndrome. Fertility and Sterility, 84, 
1689-1692. doi: 10.1016/j.fertnstert.2005.05.061 
Ceballos, N. A., Hooker, S. & al’Absi, M. (2009). Sex-specific associations of body mass index 
and mood disturbance during smoking abstinence. Neurophysiology, 60, 27-43. doi: 
10.1159/000235800 
Cerel-Suhl, S. L., & Yeager, B. F. (1999). Update on oral contraceptive pills. American Family 
Physician, 1, 2073-2084.  
Çetinkaya, H., Dural, S., & Gülbetekin, E. (2010). Örtük yumurtlama hipotezinin kadinda adet 
döngüsüne bağh yüzsel simetri değişmeleri kapsaminda incelenmesi [English abstract]. 
Turk Psikoloji Dergisis, 25, 1-16.  
Chandraiah, S., Levenson, J. L., & Collins, J. B. (1991). Sexual dysfunction, social 
maladjustment, and psychiatric disorders in women seeking treatment in a premenstrual 
syndrome clinic. International Journal of Psychiatry in Medicine, 21, 189-204.  
Choi, S.H., Kang, S.B., Joe, S.H. (2001). Changes in premenstrual symptoms in women with 
schizophrenia: A prospective study. Psychosomatic Medicine, 63, 822 – 829.  
Chrisler, J. C., & Caplan, P. (2002). The strange case of Dr. Jekyll and Ms. Hyde: How PMS 
became a cultural phenomenon and a psychiatric disorder. Annual Review of Sex 
Research, 13, 274-306.  
Clark, A. P. (2004). Self-perceived attractiveness and masculinization predict women’s 
sociosexuality. Evolution and Human Behavior, 25, 113-124. doi:10.1016/S1090-
5138(03)00085-0  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
75
Cobey, K. D., Pollet, T. V., Roberts, S. C., & Buunk, A. P. (2010). Hormonal birth control use 
and relationship jealousy: Evidence for estrogen dosage effects. Personality and 
Individual Differences, 50, 315-317. doi:10.1016/j.paid.2010.09.012 
Cohen, L. S., Soares, C. N., Otto, M. W., Sweeney, B. H., Liberman, R. F., & Harlow, B. L. 
(2002). Prevalence and predictors of premenstrual dysphoric disorders (PMDD) in older 
premenopausal women: The Harvard study of mood and cycles. Journal of Affective 
Disorders, 70, 125-132.  
Coutinho, E. M.. & Segal, S. J. (1999). Is menstruation obsolete? New York: Oxford University 
Press.  
Creinin, M. D., Keverline, S., & Meyn, L. A. (2004). How regular is regular? An analysis of 
menstrual cycle regularity. Contraception, 70, 289-292. doi: 
10.1016/j.contraception.2004.04.012  
Cunningham, J., Yonkers, K. A., O’Brian, S. & Eriksson, E. (2009). Update on research and 
treatment of premenstrual dysphoric disorder. Harvard Review of Psychiatry, 17, 120-
137. doi: 10.1080/10673220902891836 
Davis, A. R., & Castaño, P. M. (2004). Oral contraceptives and libido in women. Annual Review 
of Sex Research, 15, 297-320.  
Davydov, D. M., Shapiro, D., Goldstein, I. R. (2004). Moods in everyday situations: Effects of 
menstrual cycles, work, and personality. Journal of Psychosomatic Research, 56, 27-33. 
doi: 10.1016/S0022-3999(03)00602-0 
Davydov, D. M., Shapiro, D., Goldstein, I. R., & Chicz-DeMet, A. (2005). Moods in everyday 
situations: Effects of menstrual cycle, work, and stress hormones. Journal of 
Psychosomatic Research, 58, 343-349. doi: 10/1016/jpsychores.2006.10.003 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
76
Davydov, D. M., Shapiro, D., Goldstein, I. R., & Chicz-DeMet, A. (2007). Moods in everyday 
situations: Effects of combinations of different arousal-related factors. Journal of 
Psychosomatic Research, 62, 321-329. doi: 10/1016/jpsychores.2006.10.021  
Deecher, D., Andree, T. H., Sloan, D., & Schechter, L. E. (2008). From menarche to menopause: 
Exploring the underlying biology of depression in women experiencing hormonal 
change. Psychoneuroendocrinology, 33, 3-17. doi:10.1016/j.psyneuen.2007.10.006 
Dell, D.L. (2004). Diagnostic challenges in women with premenstrual symptoms. Primary 
Psychiatry, 11, 41-46.  
Dell, D.L., & Svec, C. (2003). The PMDD phenomenon: Breakthrough treatments for 
premenstrual dysphoric disorders (PMDD) and extreme premenstrual syndrome (PMS). 
New York: McGraw-Hill.   
Dennerstein, L., & Burrows, G. D. (1979). Affect and the menstrual cycle. Journal of Affective 
Disorders, 1, 77-92.  
Dennerstein, L., Lehert, P., Dudley, E., & Guthrie, J. (2001). Factors contributing to positive 
mood during the menopause transition. Journal of Nervous and Mental Disease, 189, 84-
89.  
Dennerstein, L., Lehert, P., & Guthrie, J. (2002). The effects of the menopausal transition and 
biopsychosocial factors in well-being. Archives of Women’s Mental Health, 5, 15-22.  
Dennerstein, L., Spencer-Gardner, C., & Burrows, G. D. (1984). Mood and the menstrual cycle. 
Journal of Psychiatric Research, 18, 1-12.  
DeSoto, M. C., Geary, D. C., Hoard, M. K., Sheldon, M. S., & Cooper, L. (2003). Estrogen 
fluctuations, oral contraceptives and borderline personality disorder. 
Psychoneuroendocrinology, 28, 751-766. Doi: 10.1016/S0306-4520(02)00068-9 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
77
Diamond, J. (1992). The third chimpanzee: The evolution and future of the human animal. New 
York: Harper Collins. 
Dickerson, L. M., Mazyck, P. J., & Hunter, M. H. (2003). Premenstrual syndrome. American 
Family Physician, 15, 1743-1752.  
Dickey, R. P. (2011). Managing contraceptive pill patients (14
th
 ed.). New Orleans: EMIS.  
Dogra, T.D., Leenars, A. A., Raintji, R., Lalwani, S., Girdhar, S., Wenckstern, S., & Lester, D. 
(2007). Menstruation and suicide: An exploratory study. Psychological Reports, 101, 
430-434. doi: 10.2466/pr0.101.2.430-434 
Doyle, C., Ewald, H. A., & Ewald, P. W. (2007). Premenstrual syndrome: An evolutionary 
perspective on its causes and treatment. Perspectives in Biology and Medicine, 50, 181-
202.  
Durante, K. M., Li, N. P., & Haselton, M. G. (2008). Changes in women’s choice of dress across 
the ovulatory cycle: Naturalistic and laboratory task-based evidence. Personality and 
Social Psychology Bulletin, 34, 1451-1460. doi: 10.1177/0146167208323103 
Dye, L., Warner, P. & Bancroft, J. (1995). Food craving during the menstrual cycle and its 
relationship to stress, happiness of relationship and depression; A preliminary enquiry. 
Journal of Affective Disorders, 34, 157-164.  
Eaton, S. B., Pike, M. C., Short, R. V., Lee, N. C., Trussell, J., Hatcher, R. A., . . . Hurtado, A. 
M. (1994). Women’s reproductive cancers in evolutionary context. The Quarterly Review 
of Biology, 69, 353-367.  
Eaton, S. B., Strassman, B. I., Nesse, R. M., Neel, J. V., Ewald, P. W., Williams, G. C., . . . 
Cordain, L. (2002). Evolutionary health promotion. Preventative Medicine, 34, 109-118. 
doi: 10.1006/pmed.2001.0876 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
78
Eckel, L. A., Arnold, A. P., Hampson, E., Becker, J. B, Blaustein, J. D., & Herman, J. P. (2008). 
Research and methodological issues in the study of sex difference and hormone-behavior 
relations. In J. B Becker, K. J. Berkley, N. Geary, E. Hampson, J. P. Herman, J. P., et al. 
(Eds.), Sex differences in the brain: From genes to behavior (pp. 35-62). New York: 
Oxford.  
Endicott, J. (1993). The menstrual cycle and mood disorders. Journal of Affective Disorders, 29, 
193-200.  
Endicott, J., Halbreich, U., Schacht, S., & Nee, J. (1981). Premenstrual changes and affective 
disorders. Psychosomatic Medicine, 43, 519-529.  
Eriksson, O., Wall, A., Marteinsdottir, I., Ågren, H., Hartvig, P., Blomqvist, G., . . . Naessén, T. 
(2006). Mood changes correlate to changes in brain serotonin precursor trapping in 
women with premenstrual dysphoria. Psychiatry Research: Neuroimaging, 14, 107-116. 
doi: 10.1016/psychresns.2005.01.012 
Farage, M .A., Neill, S., & MacLean, A. B. (2009). Physiological changes associated with the 
menstrual cycle. Obstetrical and Gynecological Survey, 64, 58-72.  
Fehring, R. J., Schneider, M., & Raviele, K. (2006). Variability in the phases of the menstrual 
cycle. Journal of Obstetrics, Gynecologic, and Neonatal Nursing, 35, 376-384. doi: 
10.1111/j.1552-6909.2006.00051.x. 
Feld, J., Halbreich, U., & Karkun, S. (2005). The association of perimenopausal mood disorders 
with other reproductive-related disorders. CNS Spectrum, 10, 461-470. 
Ferin, M., Jewelewicz, R., & Warren, M. (1993). The menstrual cycle: Physiology, reproductive 
disorders, and infertility. New York: Oxford.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
79
Fessler, D. M. T. (2003). No time to eat: An adaptionist account of a periovulatory behavioral 
changes. The Quarterly Review of Biology, 78, 3-21.  
Fink, B., Manning, J. T., Neave, N., & Grammer, K. (2004). Second to fourth digit ratio and 
facial asymmetry. Evolution and Human Behaviour, 25, 125-132. doi:10.1016/S1090-
5138(03)00084-9 
Fink, B., Neave, N., & Manning, J. T. (2003). Second to fourth digit ratio, body mass index, 
waist-to-hip ratio, and waist-to-chest-ratio: Their relationships in heterosexual men and 
women. Annals of Human Biology, 30, 728-738. doi:10.1080/03014460310001620153 
Finn, C. A. (1994). The adaptive significance of menstruation. Human Reproduction, 9, 1202-
1207.  
Finn, C. A. (1996). Why do women menstruate? Historical and evolutionary review. European 
Journal of Obstetrics & Gynecology and Reproductive Biology, 70, 3-8.  
Fisher, W. A., & Black, A. (2007). Contraception in Canada: A review of method choices, 
characteristics, adherence and approaches to counseling. Canadian Medical Association 
Journal, 176, 953-961. doi:10.1503/cmaj.060851 
Flaxman, S. M., & Sherman, P. W. (2000). Morning sickness: A mechanism for protecting 
mother and embryo. Quarterly Review of Biology, 75, 113-148.  
Fleischman, D. S., Navarrete, D., & Fessler, D. M. T. (2010). Oral contraceptives suppress 




WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
80
Flores-Ramos, M., Heinze, G., Silvestri-Tomassoni, R. (2010). Association between depressive 
symptoms and reproductive variables in a group of perimenopausal women attending a 
menopause clinic in México City. Archives of Women’s Health, 12, 99-105. doi: 
10.1007/s00737-009-0101-0 
Fortenberry, J. D., Temkit, M., Tu, W., Graham, C. A., Katz, B. P., & Orr, D. P. (2005). Daily 
mood, partner support, sexual interest, and sexual activity among adolescent women. 
Health Psychology, 24, 252-257.  
Freeman, E. W., Sammel,, M. D., Rinaudo, P. J., & Sheng, L. (2004). Premenstrual syndrome as 
a predictor of menopausal symptoms. Obstetrics and Gynecology, 103, 960-966.  
Gallant, S. J., Hamilton, J. A., Popiel, D. A., Morokoff, P. J., & Chakraborty, P. K. (1991). Daily 
moods and symptoms: effects of awareness of study focus, gender, menstrual-cycle 
phase, and day of the week. Health Psychology, 10, 180-189.  
Gallant, S. J., Popiel, D. A., Hoffman, D. M., Chakraborty, P. K., & Hamilton, J. A. (1992). 
Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric 
disorder. Part 11. What makes a r “real” difference? Psychosomatic Medicine, 54, 167-
181.  
Gangestad, S. W., & Simpson, J. A. (1990). Toward an evolutionary history of female 
sociosexual variation. Journal of Personality, 58, 69-96.  
Gangestad, S. W., & Simpson, J. A. (2000). The evolution of human mating: Trade-offs and 
strategic pluralism. Behavioral and Brain Sciences, 23, 573-644.  
Gangestad, S. W., Simpson, J. A., Cousins, A. J., Garver-Apgar, C. E & Christensen, P. N. 
(2004). Women’s preferences for male behavioral displays change across the menstrual 
cycle. Psychological Science, 15, 203-207.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
81
Gangestad, S. W., Thornhill, R., & Garver, C. E. (2002). Changes in women’s sexual interests 
and their partners’ mate-retention tactics across the menstrual cycle: Evidence for shifting 
conflicts of interest. Proceedings of the Royal Society B, 269, 975-982. doi: 
10.1098/rspb.2001.1952 
Gangestad, S.W., Thornhill, R., & Garver-Apgar, C.E. (2005). Adaptations to ovulation:  
Implications for sexual and social behavior. Current Directions in Psychological Science, 
14, 312-316.  
Gaulin, S. J. C., Silverman, I., Phillips, K., & Reiber, C. (1997). Activational hormone influence  
on abilities and attitudes: Implications for evolutionary theory. Evolution and Cognition, 
3, 191-199.  
Garver-Apgar, C. E., Gangestad, S. W., & Thornhill, R. (2008). Hormonal correlates of women’s 
mid-cycle preference for the scent of symmetry. Evolution and Human Behavior, 29, 
223-232. doi: 10.1016/j.evolhumbehav.2007.12.007 
Geary D. C., DeSoto, M. C., Hoard, M. K., Skaggs Sheldon, M., & Copper, M. L. (2001).  
Estrogens and relationship jealousy. Human Nature, 12, 299-320.  
Gonda, X., Telek, T., Juhász, G., Lazary, J., Vargha, A., & Bagdy, G. (2008). Patterns of mood 
changes throughout the reproductive cycle in healthy women without premenstrual 
dysphoric disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 
32, 1781-1788. doi: 10.1016/j.pnpbp.2008.07.016 
Goodwin, F. K., & Jamison, K. R.. (2007). Manic-depressive illness: Bipolar disorders and 
recurrent depression. New York: Oxford.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
82
Glover, V., Liddle, P., Taylor, A., Adama, D., & Sandler, M. (1994). Mild hypomania (the highs) 
can be a feature of the first postpartum week. British Journal of Psychiatry, 164, 517-
521. 
Graham, C. A., Bancroft, J., Doll, H. A., Greco, T., & Tanner, A. (2007). Does oral 
contraceptive-induced reduction in free testosterone adversely affect the sexuality of 
women? Psychoneuroendocrinology, 32, 246-255. doi: 10.1016/j.psyneuen.2006.12.011 
Graham, C. A., Janssen, E., & Sanders, S. A. (2000). Effects of fragrance on female sexual 
arousal and mood across the menstrual cycle. Psychophysiology, 37, 76-84.  
Graham, C. A., Ramos, R., Bancroft, J., Maglaya, C., & Farley, T. M. (1995). The effects of  
steroidal contraceptives on the well-being and sexuality of women: A double-blind, 
placebo-controlled, two-centre study of combined and progestogen-only methods. 
Contraception, 52, 363-369. 
Graham, C.A., & Sherwin, B. B. (1993). The relationship between mood and sexuality in women 
using an oral contraceptive as a treatment for premenstrual symptoms. 
Psychoneuroendocrinology, 18, 273-281.  
Graze, K. K., Nee, J., & Endicott, J. (1990). Premenstrual depression predicts future major 
depressive disorder. Acta Psychiatrica Scandinavica, 81, 201-205.  
Green, D. P., & Salovey, P. (1999). In what sense are positive and negative affect independent? 
A reply to Tellegen, Watson, and Clark. Psychological Science, 10, 304-306.  
Gregory, R. J., Masand, P. S., & Yohai, N. H. (2000). Depression across the reproductive life 
cycle: Correlations between events. Journal of Clinical Psychiatry, 2, 127-129.  
Gross, M. R. (1996) Alternative reproductive strategies and tactics: Diversity within sexes.  
Trends in Ecology and Evolution, 11:92–98. 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
83
Gueguen, N. (2009a). The receptivity of women to courtship solicitation across the menstrual 
cycle: A field experiment. Biological Psychology, 80, 321-324. doi: 
10.1016/j.biopsycho.2008.11.004 
Gueguen, N. (2009b). Menstrual cycle phases and female receptivity to a courtship solicitation: 
An evaluation in a nightclub. Evolution and Human Behavior, 30, 351-355. doi: 
10.1016/j.evolhumbehav.2009.03.004 
Halbreich, U. (1995). Menstrually related disorders: What we do know, what we only believe 
that we know, and what we know that we know. Critical Reviews in Neurobiology, 9, 
163-175.  
Halbreich, U. (1997). Premenstrual dysphoric disorders: A diversified cluster of vulnerability 
traits to depression. Acta Psychiatrica Scandinavica, 95, 169-176.  
Halbreich, U., Endicott, J., Schacht, S., & Nee, J. (1982). The diversity of premenstrual changes 
as reflected in the Premenstrual Assessment Form. Acta Psychiatrica Scandinavica, 65, 
46-65.  
Halbreich, U., & Monacelli, E. (2004). Some clues to the etiology of premenstrual 
syndrome/premenstrual dysphoric disorder. Primary Psychiatry, 11, 33-40.  
Hampson, E., & Young, E. A. (2008). Methodological issues in the study of hormone-behavior  
 relations in humans: Understanding and monitoring the menstrual cycle. In J.B. Becker,   
 K.J. Berkley, N. Geary, E. Hampson, J.P. Herman, & E.A. Young (Eds.), Sex differences  
 in the brain: From genes to behavior (pp. 63-78). Oxford: New York.  
Hardie, E. A. (1997). Prevalence and predictors of cyclic and noncyclic affective change. 
Psychology of Women Quarterly, 21, 299-314.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
84
Harlow, B. L., Cohen, L. S., Otto, M. W., Spiegelman, D., & Cramer, D. W. (2004). Early life 
menstrual characteristics and pregnancy experiences with and without major depression: 
The Harvard study of mood and cycles. Journal of Affective Disorders, 79, 167-176. doi: 
10.1016/S0165-0327(02)00459-7 
Hausmann, M. (2005). Hemispheric asymmetry in spatial attention across the menstrual cycle. 
Neuropsychologia, 43, 1559-1567. doi:10.1016/j.neuropsychologia.2005.01.017  
Haselton, M. G., & Buss, D. M. (2001). The affective shift hypothesis: The function of 
emotional changes following intercourse. Personal Relationships, 8, 357-369.  
Haselton, M. G., & Gangestad, S. W. (2006). Conditional expression of women’s desires and 
men’s mate guarding across the ovulatory cycle. Hormones and Behaviour, 49, 509-518. 
doi: 10.1016/j.yhbeh.2005.10.006 
Haselton, M. G., Mortezaire, M., Pillworth, E. G., Bleske-Rechek, & Frederick, D. A. (2007). 
Ovulatory shifts in human female ornamentation: Near ovulation, women dress to 
impress. Hormones and Behavior, 51, 40-45. doi: 10.1016/j.yhbeh.2006.07.007 
Havez, E. S. E. (Ed.). (1979). Human ovulation: Mechanisms, prediction, detection and 
induction (vol. 3). New York, NY: North-Holland Publishing Company. 
Haywood, A., Slade, P., & King, H. (2007). Is there evidence of an association between postnatal 
distress and premenstrual symptoms? Journal of Affective Disorders, 99, 241-245. 
doi:10.1016/j.jad.2006.08.024 
Health Canada. (2011). Drug products database. Retrieved from http://www.hc-sc.gc.ca 
Hendrick, V., Altshuler, L., & Suri, R. (1998). Hormonal changes in the postpartum and 
implications for postpartum depression. Psychosomatics, 39, 93-101.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
85
Helle, S. (2010). Does second-to-fourth digit length ratio (2D:4D) predict age at menarche in 
women? American Journal of Human Biology, 22, 418-420. doi: 10.1002/ajhb.21000 
Hsiao, M., & Liu, C. (2007). Unusual manifestations of premenstrual syndrome. Psychiatry and 
Clinical Neurosciences, 61, 120-123. doi: 10.1111/j.1440-1819.2007.01620.x 
Jackson, J. J., & Kirkpatrick, L. A. (2007). The structure and measurement of human mating 
strategies: Toward a multidimensional model of sociosexuality. Evolution and Human 
Behavior, 28, 382-391. doi: 10.1016/j.evolhumbehav.2007.04.005 
Jarva, J. A., & Oinonen, K. A (2007). Do oral contraceptives act as mood stabilizers? Evidence 
of positive affect stabilization. Archives of Women’s Mental Health, 10, 225-234. doi: 
10.1007/s00737-007-0197-5 
Jöchle, W. (1973). Coitus-induced ovulation. Contraception, 7, 523-564  
Johnston, V. S., Hagel, R., Franklin, M., Fink, B., & Grammer, K. (2001). Male facial 
attractiveness: Evidence for hormone-mediated adaptive design. Evolution and Human 
Behavior, 22, 251-267.  
Jones, B. C., DeBruine, L. M., Perrett, D. L., Little, A. C., Feinberg, D. R., & Smith, M. J. L. 
(2008). Effects of menstrual cycle phase on face preferences. Archives of Sexual 
Behavior, 37, 78-84. doi: 10.1007/s10508-007-9268-y 
Jones, B. C., Little, A. C., Boothroyd, L., Feinberg, D. R., Cornwell, E., DeBruine, L. M., . . . 
Perrett, D. I. (2005). Women’s physical and psychological condition independently 
predict their preferences for apparent health in faces. Evolution and Human Behavior, 26, 
451-457. doi: 10.1016/j.evolhumbehav.2005.05.001 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
86
Jukic, A. M. Z., Weinberg, C. R., Baird, D. D., & Wilcox, A. J. (2007). Lifestyle and 
reproductive factors associated with follicular phase length. Journal of Women’s Health, 
16, 1340-1347.  
Jütte, R. (2008). Contraception: A history. Malden, MA: Polity Press.  
Kahn, L. S., & Halbreich, U. (2001). Oral contraceptives and mood. Expert Opinion on 
Pharmacotherapy, 2, 1367-1382.  
Kalmuss, D., Koenemann, S., Westhoff, C., Heartwell, S., Edwards, S, . . . Stuart, G. (2008). 
Prior pill experiences and current continuation among pill restarters. Perspectives on 
Sexual and Reproductive Health, 40, 138-143.  
Kaminski, B. A., & Palmert, M. R. (2009). Human puberty: Physiology and genetic regulation. 
In R. T. Rubin and D. W. Pfaff (Eds.), Hormone/behaviour relations of clinical 
importance: Endocrine systems interacting with brain and behavior (pp. 249-269). San 
Diego, CA: Academic Press.  
Kayatekin, Z. E., Sabo, A. N., & Halbreich, U. (2008). Levetiracetam for treatment of 
premenstrual dysphoric disorder: A pilot, open-label study. Archives of Women’s Mental 
Health, 11, 207-211. doi: 10.1007/s00737-008-0014-9 
Keller, M. C., & Miller, G. (2006). Resolving the paradox of common, harmful, heritable mental 
disorders: Which evolutionary genetic models work best? Behavioral and Brain Sciences, 
29, 385-452.  
Kendler, K. S., Kakowski, L. M., Corey, L. A., Neale, M. C. (1998). Longitudinal population-
based twin study of retrospectively reported premenstrual symptoms and lifetime major 
depression. American Journal of Psychiatry, 155, 1234-1240.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
87
Kenna, H. A., Jiang, B., & Rasgon, N. L. (2009). Reproductive and metabolic abnormalities 
associated with bipolar disorder and its treatment. Harvard Review of Psychiatry, 17, 
138-146. doi: 10.1080/10673220902899722 
Kessler, R.C., McGonagle, K.A., Nelson, C.B., Hughes, M., Swartz, M., & Blazer, D.G. (1994). 
 Sex and depression in the National Comorbidity Survey II: Cohort effects.  Journal of 
Affective Disorders, 30 (1), 15-26.  doi: 10.1016/0165-0327(94)90147-3  
Kiesner, J. (2009). Physical characteristics of the menstrual cycle and premenstrual depressive 
symptoms. Psychological Science, 20, 763-770. 
Kiesner, J. (2011). One woman’s low is another women’s high: Paradoxical effects of the 
menstrual cycle. Psychoneuroendocrinology, 36, 69-76. doi: 
10.1016/j.psyneuen.2010.06.007 
Kiesner, J., & Pastore, M. (2010). Day-to-day co-variations of psychological and physical 
symptoms of the menstrual cycle: Insights to individual differences in steroid reactivity. 
Psychoneuroendocrinology, 35, 350-363. doi: 10.1016/j.psyneuen.2009.07.011. 
Kikuchi, H., Nakatani, Y., Seki, Y., Yu, X., Sekiyama, T., Sato-Suzukim I., . . . Arita, H. (2010). 
Decreased blood serotonin in the premenstrual phase enhances negative mood in healthy 
women. Journal of Psychosomatic Obstetrics & Gynecology, 31, 83-89. doi: 
10.3109/01674821003770606 
Kuffel, S. W., & Heiman, J. R. (2006). Effects of depressive symptoms and experimentally 
adopted schemas on sexual arousal and affect in sexually healthy women. Archives of 
Sexual Behavior, 35, 163-177. doi: 10.1007/s10508-005-9015-1 
Kuhle, B. X. (2007). An evolutionary perspective on the origin and ontogeny of menopause. 
Maturitas, 57, 329-337. doi:10.1016/j.maturitas.2007.04.004 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
88
Kurshan, N. & Epperson, C. N. (2006). Oral contraceptives and mood in women with and 
without premenstrual dysphoria: A theoretical model. Archives of Women’s Mental 
Health, 9, 1-14. doi: 10.1007/s00737-005-0102-z 
Krug, R., Finn, M., Pietrowsky, R., Fehm, H., & Born, J. (1996). Jealousy, general creativity,  
and coping with social frustration during the menstrual cycle. Archives of Sexual 
Behavior, 25, 181-199.  
Leibenluft, E., Ashman, S. B., Feldman-Naim, S., & Yonkers, K. A. (1999). Lack of relationship 
between menstrual cycle phase and mood in a sample of women with rapid cycling 
bipolar disorder. Biological Psychiatry, 46, 577 – 580.  
Lemay, L .A., & Poulin, Y. (2002). Oral contraceptives as anti-androgenic treatment of acne. 
Journal of Obstetrics and Gynecology Canada, 24, 559-567.  
Liening, S. H., Stanton, S. J., Saini, E. K., & Schultheiss, O. C. (2010). Salivary testosterone, 
cortisol, and progesterone: Two-week stability, interhormone correlations, and effects of 
time of day, menstrual cycle, and oral contraceptive use on steroid hormone levels. 
Physiology and Behavior, 99, 8-16. doi: 10.1016/j.physbeh.2009.10.001 
Lippa, R. A. (2009). Sex differences in sex drive, sociosexuality, and height across 53 nations: 
Testing evolutionary and social structural theories. Archives of Sexual Behavior, 38, 631-
651. doi: 10.1007/s10508-007-9242-8 
Little, A. C., Jones, B. C., & Burriss, R. P. (2007).  Preferences for masculinity in male bodies 
change across the menstrual cycle.  Hormones and Behavior, 51, 633-639. doi: 
10.1016/j.yhbeh.2007.03.006 
Little, A. C., Jones, B. C., Burt, D. M., Perrett, D. I. (2007). Preferences for symmetry in  faces  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
89
change across the menstrual cycle. Biological Psychology, 73, 209-216. doi: 
10.1016/j.biopsycho.2007.08.003 
Logue, C. M., & Moos, R. H.  (1988). Positive premenstrual changes: Toward a new perspective 
on the menstrual cycle. Journal of Psychosomatic Research, 32, 31-40.  
López, L. E., Verdejo, E. C., Javier, F. G., Martin, J. R. O., & Gómez-Almor, J. (2010). 
Incidence of anovulatory menstrual cycle among dysmennorrheic and non-dysmenorrheic 
women: Effects on symptomatology and mood. Psicothema, 22, 654-658.  
Lopez, M. F., Compton, W. M., Grant, B. F., & Breiling, J. P. (2006). Dimensional approaches 
in diagnostic classification: A critical appraisal. International Journal of Methods in 
Psychiatric Research, 16 (S1), 6-7. doi: 10.1002/mpr.213 
Manning, J. (2008). The finger book: Sex, behaviour and disease revealed in the fingers. 
London: Faber and Faber.  
Manning, J. T. & Fink, B. (2011). Is low digit ratio linked with late menarche? Evidence from 
the BBC Internet Study. American Journal of Human Biology, 23, 527-533. doi: 
10.1002/ajhb.21186 




 digit length and age of presentation 
of breast cancer: A link with prenatal oestrogen? The Breast, 10, 355-357. doi: 
10.1054/brst.2001.0284 
Mansfield, P. K., Hood, K. E., & Henderson, J. (1989). Women and their husbands: Mood and 
arousal fluctuations across the menstrual cycle and day of the week. Psychosomatic 
Medicine, 51, 66-80.  
Matchock, R. L. (2008). Low digit ratio (2D:4D) is associated with delayed menarche. American 
Journal of Human Biology, 20, 487-489 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
90
Marks, L. V. (2001). Sexual chemistry: A history of the contraceptive pill. New Haven, CT: Yale 
University Press.  
McCance, R. A., Luff, M. C., & Widdowson, E. C. (1937). Physical and emotional periodicity in 
women. Journal of Hygiene, 37, 571-605.  
McClure, J. N., Reich, T., & Wetzel, R. D. (1971). Premenstrual symptoms as an indicator of 
bipolar affective disorder. British Journal of Psychiatry, 119, 527-528.  
Meaden, P. M., Harlage, S. A., & Corr-Karr, J. (2005). Timing and severity of symptoms 
associated with the menstrual cycle in a community-based sample in the Midwestern 
United States. Psychiatry Research, 134, 27-36. doi: 10.1016/j/psychres.2005.01.003 
Metcalf, M. G., & Livesey, J. H. (1995). Distribution of positive moods in women with the 
premenstrual syndrome and in normal women. Journal of Psychosomatic Research, 39, 
609-618.  
Metcalf, M. G., Livesey, J. H., Wells, J. E., & Braiden, V. (1990). Physical symptom cyclicity in 
women with and without the premenstrual syndrome. Journal of Psychosomatic 
Research, 34, 203-213.  
Meuwissen, I., & Over, R. (1992). Sexual arousal across phases of the human menstrual cycle. 
Archives of Sexual Behavior, 21, 101-119.  
Miller, G., Tybur, J., M., & Jordan, B. D. (2007). Ovulatory cycle effects on tip earning by lap 
dancers: Economic evidence for human estrus? Evolution and Human Behavior, 28, 375-
381. doi: 10.1016/j.evolhumbehav.2007.06.002 
Miller, A., Vo, H., Huo, L., Roca, C., Schmidt, P. J., & Rubinow, D. R. (2010). Estrogen 
receptor alpha (ER-1) association with psychological traits in women with PMDD and 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
91
controls. Journal of Psychiatric Research, 44, 788-794. doi: 
10.1016/j.jpsychires.2010.01.013 
Mitchell, W.B., DiBartolo, P. M., Brown, T.A., & Barlow, D.H. (1998). Effects of positive and 
negative mood on sexual arousal in sexually functional males. Archives of Sexual 
Behavior, 27, 197-207. doi: 10.1023/A:1018686631428 
Moalem, S. (2007). Survival of the sickest: The surprising connections between disease and 
longevity. New York: HarperCollins.  
Moos, R. H. (1991). Menstrual distress questionnaire manual. California: Western 
Psychological Services.   
Natale, V., & Albertazzi, P. (2006). Mood swings across the menstrual cycle: A comparison 
between oral contraceptive users and non-users. Biological Rhythm Research, 37, 489-
495. doi: 10.1080/09291010600772451 
Nesse, R. M., & Williams, G. C. (1994). Why we get sick: The new science of Darwinian 
medicine. New York: Vintage Books.  
North American Menopause Society (2006).  The menopause guidebook.  Retrieved  
 August 20, 2011 from  
 http://www.menopause.org/edumaterials/guidebook/guidebook.aspx 
Nowosielski, K., Drosdzol, A., Skrzypulec, V., & Plinta, R. (2010). Sexual satisfaction in 
females with premenstrual symptoms. Journal of Sex Medicine, 7, 3589-35997.  
Niculescu, A. B., & Akiskal, H. S. (2000). Sex hormones, Darwinism, and depression. Archives 
of General Psychiatry, 58, 1083-1084. 
O’Brien, P. M. S., Bäckström, T., Brown, C., Dennerstein, L., Endicott, J., Epperson, C. N., . . . 
Yonkers, K. (2011). Towards consensus on diagnostic criteria, measurement and trial 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
92
design of the premenstrual disorders The ISPMD Montreal consensus. Archives of 
Women’s Mental Health, 14, 13-21. doi: 10.1007/s00737-010-0201-3 
Oinonen, K. A. (2009). Putting a finger on potential predictors of oral contraceptive side effects: 
2D:4D and middle-phalangeal hair. Psychoneuroendocrinology, 34, 713-726.doi: 
10.1016/j.psyneuen.2008.11.009 
Oinonen, K. A. & Bird, J. L. (2012). Age at menarche and digit ratio (2D:4D): relationships with 
body dissatisfaction, drive for thinness, and bulimia symptoms in women. Body Image, 9, 
302-306. doi: 10.1016/j.bodyim.2011.12.003 
Oinonen, K. A., Jarva, J. A., & Mazmanian, D. (2008). Pre-existing hormonal differences 
between oral contraceptive users and nonusers? Evidence from digit ratio, age of 
menarche, and sociosexual orientation. In Giuseppina A. Conti (Ed.), Progress in 
biological psychology research (pp. 139-158). Hauppauge, NY: Nova Science 
Publishers, Inc. 
Oinonen, K. A., Klemencic, N., & Mazmanian, D. (2008).  The periovulatory sociosexuality 
tactic shift (PSTS): Activational hormonal mechanisms in two female sexual strategies.  
In Giuseppina A. Conti (Ed.), Progress in biological psychology research (pp. 139-158).  
Hauppauge, NY: Nova Science Publishers, Inc. 
Oinonen, K. A., & Mazmanian, D. (2001a). Effects of oral contraceptives on daily ratings of 
positive and negative affect. Journal Psychosomatic Research, 51, 647-658.  
Oinonen, K. A., & Mazmanian, D. (2001b). Does body fat protect against negative moods in 
women? Medical Hypotheses, 57, 387-388. doi: 10.1054/mehy.2001.1365 
Oinonen, K. A., & Mazmanian, D. (2002). To what extent do oral contraceptives influence mood 
and affect? Journal of Affective Disorders, 70, 229-240.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
93
Oinonen, K. A., & Mazmanian, D. (2007). Facial symmetry detection ability changes across the 
menstrual cycle. Biological Psychology, 75, 136-145. doi: 
10.1016.j.biopsych.2007.01.003  
Oinonen, K. A., Teatero, M. L., & Mazmanian, D. (2015). Sexual orientation moderates the 
relationship between 2D:4D and sociosexuality in women. Manuscript draft. Lakehead 
University, Thunder Bay, Ontario.    
O’Reilly, M. A., Cunningham, C. J., Lawlor, B. A., Walsh, C. D., & Rowan, M. J. (2004). The 
effect of the menstrual cycle on electrophysiological and behavioral measures of memory 
and mood. Psychophysiology, 41, 592-603. 
Ormel, J., Rosmalen, J., & Farmer, A. (2004). Neuroticism: A non-informative marker of 
vulnerability to psychopathology. Social Psychiatry and Psychiatric Epidemiology, 39, 
906-912. doi: 10.1007/s00127-004-0873-y 
Ott, M. A., Sayegh, M. A., Shew, M. L, & Fortenberry, J. D. (2005). Oral contraceptive 
pills and mood in adolescents [Abstract]. Journal of Adolescent Health, 36, 144. 
Ott, M. A., Shew, M. L., Ofner, S., Tu, W., & Fortenberry, J. D. (2008). The influence of 
hormonal contraception on mood and sexual interest among adolescents. Archives of 
Sexual Behavior, 37, 605-613. doi: 10.1007/s10508-007-9302-0 
Parlee, M. B. (1982). Changes in moods and activation levels during the menstrual cycle in 
experimentally naïve subjects. Psychology of Women Quarterly, 7, 119-131. doi: 
10.1111/j.1471-6402.1982.tb00824.x 
Parry, B. L., & Newton, R. P. (2001). Chronobiological basis of female-specific mood disorders. 
Neuropsychopharmacology, 25, S102-S108.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
94
Payne, J. L., Klein, S. R., Zamoiski, R. B., Zandi, P. P., Bienvenu, O. J., MacKinnon, D. F., . . . 
Potash, J. B. (2009). Premenstrual mood symptoms: Study of familiality and personality 
correlates in mood disorder pedigrees. Archives of Women’s Health, 12, 27-34.  
Payne, J. L., Roy, P. S., Murphy-Ebernz, K., Weismass, M. M., Swartz, K. L., McInnis, M. G., . . 
. Potash, J. B. (2007). Reproductive cycle-associated mood symptoms in women with 
major depression and bipolar disorder. Journal of Affective Disorders, 99, 221-229. 
doi:10.1016/j.jad.2006.08.013 
Payne, J. L., Tietelbaum Palmer, J., & Joffe, H. (2009). A reproductive subtype of depression: 
Conceptualizing models and moving toward etiology. Harvard Review of Psychiatry, 17, 
72.86. doi: 10.1080/10673220902899706 
Penke, L., & Asendorpf, J.  B.  (2008). Beyond global sociosexual orientations: A more 
differentiated look at sociosexuality and its effects on courtship and romantic 
relationships. Journal of Personality and Social Psychology, 95, 1113-1135. doi: 
10.1037/0022-3514.95.5.1113 
Penton-Voak, I. S., & Perrett, D. I. (2000). Female preferences for male faces changes cyclically 
further evidence. Evolution and Human Behavior, 21, 39-48.  
Phillips, M. (2015). Menstrual cycle phase and sociosexuality: The effect on proceptive and 
receptive mating behaviours (Doctoral dissertation). Lakehead University, Thunder Bay, 
Ontario, Canada. 
Phoenix, C. H., Goy, R. W., Gerall, A. A., & Young, W. C. (1959). Organizing action of 
prenatally administered testosterone propionate on the tissues mediating mating behavior 
in the female guinea pig. Endocrinology, 65, 369-382. doi: 10.1210/endo-65-3-369. 
 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
95
Pillsworth, E. G., & Haselton, M. G. (2006). Male sexual attractiveness predicts differential  
ovulatory shifts in female extra-pair attraction and male mate retention. Evolution and 
Human Behavior, 27, 247-258. doi: 10.1016/j.evolhumbehav.2005.10.002 
Pincus, S. M., Schmidt, P. J., Pallandino-Negro, P., & Rubinow, D. R. (2008). Differentiation of 
women with premenstrual dysphoric disorder, recurrent brief depression, and healthy 
controls by daily mood rating dynamics. Journal of Psychiatric Research, 42, 337-347. 
doi: 10.1016/j.jpsychires, 2007.01.001   
Pipitone, R. N., & Gallup, G. G. (2008). Women’s voice attractiveness varies across the 
menstrual cycle. Evolution and Human Behavior, 29, 268-274. doi: 
10.1016/j.evolhumbehav.2008.02.001 
Pletzer, B., Kronbichler, M., Aichhorn, M., Bergmann, J., Ladurner, G., & Kerschbaum, H. H. 
(2010). Menstrual cycle and hormonal contraceptive use modulate human brain structure. 
Brain Research, 1348, 55-62.  
Post, R. M. (1992). Transduction of psychosocial stress into the neurobiology or recurrent 
affective disorders. The American Journal of Psychiatry, 149, 999 – 1007.  
Post, R. M. (2004). The status of the sensitization/kindling hypothesis of bipolar disorder. 
Current Psychosis and Therapeutics Reports, 2, 125-141. doi: 10.1007/BF-2629414.  
Post, R. M. (2007). Kindling and sensitization as models for affective episode recurrence, 
cyclicity, and tolerance phenomena. Neuroscience & Biobehavioral Reviews, 31, 858-
873. doi: 10.1016/j.neubiorev.2007.04.003  
Post, R. M., Rubinow, D. R., & Ballenger, J. C. (1986). Conditioning and sensitization in the 
longitudinal course of affective illness. British Journal of Psychiatry, 149, 191-201.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
96
Profet, M. (1993). Menstruation as a defense against pathogens transported by sperm. Quarterly 
Review of Biology, 68, 335-386. 
Provost, M. P., Quinsey, V. L., & Troje, N. F. (2008). Differences in gait across the menstrual 
cycle and their attractiveness to men. Archives of Sexual Behavior, 37, 598-604.  
Puts, D. A. (2005). Mating context and menstrual cycle phase affect women’s preferences for 
male voice pitch. Evolution and Human Behavior, 26, 388-397. doi: 
10.1016/j.evolhumbehav.2005.03.001 
Puts, D. A., Welling, L. L. M., Burriss, R. P., & Dawood, K. (2011). Men’s masculinity and 
attractiveness predict their female partners’ reported orgasm frequency and timing. 
Evolution and Human Behavior, 33, 1-9. doi: 10.1016/j.evolhumbehav.2011.03.003 
Rapkin, A. J., Berman, S. M., Mandelkerm M. A., Silverman, D. H. S., Morgan, M., & London, 
E. D. (2011). Neuroimaging evidence of cerebellar involvement in premenstrual 
dysphoric disorder. Biological Psychiatry, 69, 374-380.  
Rapkin, A. J., Biggio, G., & Concas, A. (2006). Oral contraceptives and neuroactive steroids. 
Pharmacology, Biochemistry, and Behavior, 84, 628-634. doi: 
10.1016/j.pbb.2006.06.008  
Rapkin, A. J., Mikacich, J. A., & Moatakef-Imani, B. (2003 ). Reproductive mood disorders. 
Primary Psychiatry, 10, 31-40.  
Rasgon, N., Bauer, M., Glenn, T., Elman, S., & Whybrow, P.C. (2003). Menstrual cycle related 
mood changes in women with bipolar disorder. Bipolar Disorders, 5, 48 -52.  
Rasgon, N., Bauer, M., Grof, P., Gyulai, L., Elman, S., Gleen, T., et al. (2005). Sex-specific self-
reported mood changes by patients with bipolar disorder. Journal of Psychiatric 
Research, 39, 77-83. doi:10.1016/j.jpsychires.2004.05.006 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
97
Rasgon, N. L., Pumphrey, L., Prolo, P., Elman, S., Negrao, A. B., Lucinio, J., et al. (2005). 
Emergent oscillations in mathematical model of the human menstrual cycle. CNS 
Spectrum, 8, 805-814.  
Reiber, C. (2008). An evolutionary model of premenstrual syndrome. Medical Hypotheses, 70, 
1058-1065. doi: 10.1016/j.mehy.2007.08.031 
Reiber, C., (2009). Empirical support for an evolutionary model of premenstrual syndrome. 
Journal of Social, Evolutionary, and Cultural Psychology, 3, 9-28.  
Reid, R. L. (1983). Endogenous opioid activity and the premenstrual syndrome. Lancet, 322, 
786-789.  
Reid, R. L. (1985). Premenstrual syndrome. Current Problems in Obstetrics, Gynecology and 
Fertility, VIII, 4-57.   
Richards, M. A. (2006). Polymorphic regions of the estrogen receptor, androgen receptor, and 
serotonin transporter genes and their associations with mood variability in young 
women. Unpublished Master’s thesis. Lakehead University, Thunder Bay, ON.  
Richards, M., Rubinow, D. R., Daly, R., & Schmidt, P. J. (2006). Premenstrual symptoms and 
perimenopausal depression. American Journal of Psychiatry, 164, 133-137.  
Riley, A. J. (1994). Premenstrual hypersexuality. Sexual and Marital Therapy, 9, 87-93.  
Rivera-Tovar, A. D., Pilkonis, P., & Frank, E. (1992). Symptoms patterns in late luteal-phase 
dysphoric disorder. Journal of Psychopathology and Behavioral Assessment, 14, 189-
199.  
Roberts, S. C., Gosling, L. M., Carter, V., & Petrie, M. (2008). MHC-correlated odour 
preferences in humans and the use of oral contraceptives. Proceedings of the Royal 
Society B, 275, 2715-2722. doi: 10.1098/rspb.2008.0825 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
98
Roberts, S. C., Klapilova, K., Little, A. C., Burriss, R. P., Jones, B. C., DeBruine, L. M., . . . 
Havliček, J. (2012). Relationship satisfaction and outcome in women who meet their 
partner while using oral contraception. Proceedings of the Royal Society B, 279, 1430-
1436. doi: 10.1098/rspb.2011.1647  
Roberts, S. C., Miner, E. J., & Shackelford, T. K. (2010). The future of applied evolutionary 
psychology for human partnerships. Review of General Psychiatry, 14, 318-329. doi: 
10.1037/g0021253 
Romans, S., Clarkson, R., Einstein, G., Petrovic, M., & Stewart, D. (2012). Mood and the 
menstrual cycle: A review of prospective studies. Gender Medicine, 9, 361-384. doi: 
10.1016/j.genm.2012.07.003 
Roney, J. R., Simmons, Z. L., & Gray, P. B. (2011). Changes in estradiol predict within-women 
shifts in attraction to facial cues of men’s testosterone. Psychoneuroendocrinology, 36, 
742-749. doi: 10.1016/j.psyneuen.2010.10.010 
Röder, S., Brewer, G., & Fink, B. (2009). Menstrual cycle shifts in women’s self-perception and 
motivation: A daily report method. Personality and Individual Differences, 47, 616-619. 
doi:10.1016/j.paid.2009.05.019 
Ross, C., Coleman, G., & Stojanovska, C. (2003). Prospectively reported symptom change 
across the menstrual cycle in users and non-users of oral contraceptives. Journal of 
Psychosomatic Obstetrics and Gynecology, 24, 15-29.  
Rubinow, D. R. Roy-Byrne, P., Hoban, M. C., Grover, G. N., Stambler, N., & Post, R. M. 
(1986). Premenstrual mood changes: Characteristic patterns in women with and without 
premenstrual syndrome. Journal of Affective Disorders, 10, 85-90.  
 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
99
Rubinow, D. R., Schmidt, P. J., Meltzer-Brody, S., & Harsh, V. L. (2009). Hypothalamic-
pituitary-gonadal axis in women. In R. T. Rubin and D. W. Pfaff (Eds.), 
Hormone/behaviour relations of clinical importance: Endocrine systems interacting with 
brain and behavior (pp. 85-118). San Diego, CA: Academic Press. 
Rubinow, D. R., Schmidt, P. J., & Roca, C. A. (1998). Estrogen-serotonin interactions: 
Implications for affective regulation. Biological Psychiatry, 44, 839-850.  
Russell, E. (2009). Demographic, reproductive, and psychosocial predictors of mood change in 
the postpartum period. Unpublished Master’s thesis. Lakehead University, Thunder Bay, 
ON.  
Sanders, S. A., Graham, C. A., Bass, J. L., & Bancroft, J. (2001). A prospective study of the  
effects of oral contraceptives on sexuality and well-being and their relationship to 
discontinuation. Contraception, 64, 51-58. 
Sanders, D., Warner, P., Bäckström, T., & Bancroft, J. (1983). Mood, sexuality, hormones and 
the menstrual cycle. I. Changes in mood and physical state: Description of subjects and 
methods. Psychosomatic Medicine, 45, 487-501.  
Scarbrough, P. S., & Johnston, V. S. (2005). Individual differences in women’s facial 
preferences as a function of digit ratio and mental rotation ability. Evolution and Human 
Behavior, 26, 509-526. doi: 10.1016/j.evolhumbehav.2005.03.002 
Schaffir, J. (2006). Hormonal contraception and sexual desire: A critical review. Journal of Sex  
& Marital Therapy, 32, 305-314. doi: 10.1080/00926230600666311 
 
 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
100
Schaller, M., & Murray, D. R. (2008) Pathogens, personality, and culture: Disease prevalence 
predicts worldwide variability in sociosexuality, extraversion, and openness to 
experience. Journal of Personality and Social Psychology, 95, 212-221. doi: 
10.1037/0022-3514.95.1.212 
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1998). 
Differential behavioral effects of gonadal steroids in women with and in those without 
premenstrual syndrome. New England Journal of Medicine, 22, 209-216.  
Schmitt, D. P. (2003). Universal sex differences in the desire for sexual variety: Tests from 52  
nations, 6 continents, and 13 islands. Journal of Personality and Social Psychology, 85,  
85-104.  
Schmitt, D. P. (2005). Sociosexuality from Argentina to Zimbabwe: A 48-nation study of sex,  
culture, and strategies of human mating. Behavioral and Brain Sciences, 28, 247–311.  
Schnall, S., Abrahamson, A., & Laird, J. D. (2002). Premenstrual syndrome and misattribution: 
A self-perception, individual differences perspective. Basic and Applied Social 
Psychology, 24, 215-228.  
Schnatz, P. T. (1985). Neuroendocrinology and the ovarian cycle – Advances and review. 
Advances in Psychosomatic Medicine, 12, 4-24.  
Schwarz, S., & Hassebrauck, M. (2008). Self-perceived and observed variations in women’s 
attractiveness throughout the menstrual cycle—a dairy study. Evolution and Human 
Behavior, 29, 282-288. doi: 10.1016/j.evolhumbehav.2008.02.003 
Seal, D. W., & Agostinelli, G. (1994). Individual differences associated with high-risk sexual 
behavior: Implication for intervention programs. AIDS Care, 6, 393-397. doi: 
10.1080/09540129408258653 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
101
Seal, D. W., Agostinelli, G., & Hannett, C. A. (1994). Extradyadic romantic involvement: 
Moderating effects of sociosexuality and gender. Sex Roles, 31, 1-22.  
Seal, B. N., Brotto, L. A., & Gorzalka, B. B. (2005). Oral contraceptive use and female sexual 
arousal: Methodological considerations. Journal of Sex Research, 42, 249-258. 
Segebladh, B., Borgström, A., Odlind, V., Bixo, M., Sundström-Poromaa, I.. (2009). Prevalence 
of psychiatric disorders and premenstrual dysphoric symptoms in patients with 
experience of adverse mood during treatment with combined oral contraceptives. 
Contraception, 79, 50-55. doi:10.1016/j.contraception.2008.08.001 
Shaner, A., Miller, G., & Mintz, J. (2007). Mental disorders as catastrophic failures of mating 
intelligence. In G. Geher and G, Miller (Eds.), Mating intelligence: Sex, relationships, 
and the mind’s reproductive system (pp.193-223). Mahwah, NJ: Erlbaum. 
Sharma, V. (2005). Bipolar depression: The neglected realm of postpartum disorders. 
Current Psychiatry Reviews, 1, 325-329.  
Sharma, V., Smith, A., & Mazmanian, D. (2006). Olanzapine in the prevention of postpartum 
psychosis and mood episodes in bipolar disorder. Bipolar Disorders, 8, 400-404.  
Shivakumar, G., Bernstein, I.H., & Suppes, T. (2008). Are bipolar mood symptoms affected by 
the menstrual cycle? Journal of Women’s Health, 17, 473 – 478.  
Slade, P., Haywood, A., & King, H. (2009). A qualitative investigation of women’s experiences 
of the self and others in relation to their menstrual cycle. British Journal of Health 
Psychology, 14, 127-141. doi: 10.1348/135910708X304441 
 
 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
102
Smith, F. G., Jones, B. C., Little. A. C., DeBruine, L. M., Welling, L. L. M., Vukovic, J., & 
Conway, C. A. (2009). Hormonal contraceptive use and perceptions of trust modulate the 
effect of relationship context on women’s preferences for sexual dimorphism in male face 
shape. Journal of Evolutionary Psychology, 7, 195-210. doi: 10.1556/JEP.7.2009.3.1 
Simpson, J. A., & Gangestad, S. W. (1991). Individual differences in sociosexuality: Evidence 
 for convergent and discriminant validity. Journal of Personality and Social Psychology, 
 60, 870-883.  
Simpson, J. A., & Gangestad, S. W. (1992). Sociosexuality and romantic partner choice. Journal  
of Personality, 60, 32-51.  
Simpson, J. A., & Lapaglia, J. (2007). An evolutionary account of strategic pluralism in human  
mating: Changes in mate preferences across the ovulatory cycle. In J.P. Forgas, M.G. 
Haselston, W. von Hippel (Eds.). Evolution and the social mind (pp. 161-177). New 
York: Psychology Press.  
Singh, D. (1993). Adaptive significance of female physical attractiveness: role of waist-to-hip 
ratio. Journal of Personality and Social Psychology, 65, 293–307. 
Soares, C. N. (2010). DSM-V and reproductive-related psychiatric disorders: A closer look at 
windows of vulnerability. Archives of Women’s Mental Health, 13, 15-16. doi: 
10.1007/s00737-009-0116-z 
Soares, C. N., & Zitek, B. (2008). Reproductive hormone sensitivity and risk for depression 
across the female life cycle: A continuum of vulnerability? Journal of Psychiatry and 
Neuroscience, 33, 331-343.  
 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
103
Soares, C. N., Cohen, L. S., Ott, M. W., & Harlow, B. L., (2001). Characteristics of women with 
premenstrual dysphoric disorder (PMDD) who did or did not report a history of 
depression: A preliminary report from the Harvard study of moods and cycles. Journal of 
Women’s Health and Gender-Based Medicine, 10, 873-878. doi: 
10.1089/152460901753285778 
Solomon, R. L., Corbit, J. D. (1974). An opponent-process theory of motivation: I. Temporal 
dynamics of affect. Psychological Review, 81, 119-143. 
Speroff, L., & Darney, P. D. (2010). A clinical guide for contraception (5
th
 ed.). Philadelphia, 
PA: Lippincott Williams & Wilkins. 
Speroff, L., & Fritz, M. A. (2005). Clinical gynecologic endocrinology and infertility (7
th
 ed.). 
Philadelphia, PA: Lippencott Williams and Wilkins.  
Stanford, J. B., White, G. L., & Hatasaka, H. (2002). Timing intercourse to achieve pregnancy: 
Current evidence. Obstetric Gynecology, 100, 1333-1341. 
Steinberg, E. M., Rubinow, D. R., Bartko, J. J., Fortinsky, P. M., Haq, N. H., Thompson, K., & 
Schmidt, P. J. (2008). A cross sectional evaluation of perimenopausal symptoms. Journal 
of Clinical Psychiatry, 69, 973-980.  
Steiner, M. (1992). Female-specific mood disorders. Clinical Obstetrics & Gynecology, 35, 599-
611.  
Steiner, M., Dunn, E., & Born, L. (2003). Hormones and mood: From menarche to menopause 
and beyond. Journal of Affective Disorders, 74, 67-83. doi:10.1016/S0165-
0327(02)00432-9 
 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
104
Steiner, M., MacDougall, M., Berger, C., Carter, D., Reid, R., Steinberg, S.,  & Stewart, D. 
(2005). Assessment of sexual drive and desire in women with premenstrual dysphoric 
disorder who have been treated with fluoxetine. International Journal of Psychiatry in 
Clinical Practice, 9, 120-123. doi: 10.1080/13651500510029002 
Stewart, D. E., & Boydell, K. M. (1993). Psychologic distress during menopause: Associations 
across the reproductive lifecycle. International Journal of Psychiatry in Medicine, 23, 
157-162.  
Stone, S. E. (2011). Past reproductive events and finger digit ratio as predictors of symptom 
severity, psychological distress, and medical treatment-seeking during the 
perimenopausal period. Unpublished dissertation. Lakehead University, Thunder Bay, 
ON.  
Strassman, B. I. (1996). The evolution of endometrial cycles and menstruation. The Quarterly 
Review of Biology, 71, 181-220.  
Strassman, B. I. (1997). The biology of menstruation in Homo Sapiens: Total lifetime menses, 
fecundity, and nonsynchrony in a natural-fertility population. Current Anthropology, 38, 
12-129.  
Strassman, B. I. (1999). Menstrual cycling and breast cancer: An evolutionary perspective. 
Journal of Women’s Health, 8, 193-202.  
Stricker, R., Eberhart, R., Chevailler, C., Quinn, F. A., Dischol, P., & Strickler, R. (2006). 
Establishment of detailed reference values for luteinizing hormone, follicle stimulating 
hormone, estradiol, and progesterone during different phases of the menstrual cycle on 
the Abbott ARCHITECT analyzer. Clinical Chemistry and Laboratory Medicine, 44, 
883-887. doi: 10.1515/CCLM.2006.160  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
105
Sugawara, M., Todad, M. A., Shima, S., Mukai, T., Sakakura, K., & Kitamura, T. (1997). 
Premenstrual mood changes and maternal mental health in pregnancy and the postpartum 
period. Journal of Clinical Psychology, 53, 225-232.  
Sveinsdóttir, H., & Bäckström, T. (2000). Menstrual cycle symptom variation in a community 
sample of women using and not using oral contraceptives. Acta Obstetricia et 
Gynecologica Scandinavica, 70, 757-764.   
Sveinsdóttir, H., & Reame, N. (1991). Symptom patterns in women with premenstrual syndrome 
complaints: A prospective assessment using a marker for ovulation and screening for 
adequate ovarian function. Journal of Advanced Nursing, 16, 689 – 700.  
Swarmi, V., Miller, R., Furnham, A., Penke, L., & Tovée, M. J. (2008). The influence of men’s 
sexual strategies on perceptions of women’s bodily attractiveness, health, and fertility. 
Personality and Individual Differences, 44, 98-197. doi: 10.1016/j.paid.2007.07.017 
Symonds, C. S., Gallagher, P., Thompson, J. M., & Young, A. H. (2004). Effects of the 
menstrual cycle on mood, neurocognitive and neuroendocrine function in healthy 
premenopausal women. Psychological Medicine, 34, 93-102. doi: 
10.1017/S0033291703008535 
Targum, S. D., Caputo, K. P., & Ball, S. K. (1991). Menstrual cycle phases and psychiatric 
admissions. Journal of Affective Disorders, 22, 49 – 53.  
Teatero, M. L. (2009). Mating strategies across the menstrual cycle: Preferences, jealousy, and 
masculinity. Master’s thesis. Lakehead University, Thunder Bay, ON.  
Teatero, M. L., Mazmanian, D., & Oinonen, K. A. (2010a). Sex and gender identity differences 
in multidimensional jealousy [Abstract]. Canadian Psychology, 51:2a, 118. 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
106
Teatero, M. L., Mazmanian, D., & Oinonen, K. A. (2010b). Changes in behavioural jealousy 
across the menstrual cycle are related to attractiveness [Abstract]. Canadian Psychology, 
51:2a, 38-39. 
Teatero, M. L., Mazmanian, D., & Sharma, V. (2014). Effects of the menstrual cycle on bipolar 
disorder. Bipolar Disorders, 16, 22-36. doi: 10.1111/bdi.12138 
Teatero, M. L., Oinonen, K. A., & Mazmanian, D. (2015). Hormonal contraceptives and affect: 
An extensive update. Manuscript draft. Lakehead University, Thunder Bay, ON.  
Teatero, M. L., Oinonen, K., A., Mazmanian, D., & Streutker, A. M. (2015). Patterns of positive 
affect across the menstrual cycle: A systematic review. Manuscript draft. Lakehead 
University, Thunder Bay, Ontario.  
ter Kuile, M. M., Both, S., & van Uden, J. (2010). The effects of experimentally-induced sad and 
happy mood on sexual arousal in sexually healthy women. Journal of Sex Medicine, 7, 
1177-1184. doi: 10.1111/j.1743-6109.2009.01632.x 
Thomas, S. L., & Ellertson, C. (2000). Nuisance or natural and healthy: Should monthly 
menstruation be optional for women? Lancet, 255, 922-924.  
Thornhill, R. & Gangestad, S. W. (1999). The scent of symmetry: A human se pheromone that 
signals fitness? Evolution and Human Behavior, 20, 175-201.  
Thornhill, R., & Gangestad, S. W. (2008). The evolutionary biology of human female sexuality. 
New York: Oxford.  
Thornhill, R., Gangestad, S. W., Miller, R., Scheyd, G., McCollough, J. K., & Franklin, M. 
(2003). Major histocompatibility complex genes, symmetry, and body scent 
attractiveness in men and women. Behavioral Ecology, 14, 688-678. doi: 
10.1093/beheco/arg043 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
107
Tilhonen, M., Leppänen, H-M., Heikkinen, A-M., & Ahonen, R. (2008). Hormonal contraceptive 
users’ self-reported benefits, adverse reactions, and fears in 2001 and 2007. The Patient, 
1, 173-180.  
Tooby, J., & Cosmides, L. (2005). Conceptual foundations of evolutionary psychology. In D. 
Buss (Ed.), The handbook of evolutionary psychology (pp. 5 – 67). Hoboken, NJ: Wiley.  
Trivers, R. L. (1972). Parental investment and sexual selection. In B. Campbell (Ed.), Sexual 
selection and the descent of man: 1871 – 1971 (pp. 136 – 179). Chicago: Aldine. 
van den Akker, P. B. A., Eves, F. F., Stein, G. S., & Murray, R. M. (1995). Genetic and 
environmental factors in premenstrual symptom reporting and its relationship to 
depression and a general neuroticism trait. Journal of Psychosomatic Research, 19, 477-
482.  
Van Goozen, S. H. M., Wiegart, V. M., Endert, E., Helmond, F. A., & Van de Poll, N. E. (1997). 
Psychoendocrinological assessment of the menstrual cycle: The relationship between 
hormones, sexuality, and mood. Archives of Sexual Behavior, 26, 359-380.  
van Heusden, M. A., & Fauser, B. C. J. M. (1999). Activity of the pituitary-ovarian axis in the 
pill-free interval during use of low-dose combined oral contraceptives. Contraception, 5, 
237-243. doi: 10.1016/S0010-7824(99)00025-6 van  
Venners, S. A., Liu, X., Perry, M. J., Korrick, S. A., Li, Z., Yang, F., Yang, J., . . . Wang, X. 
(2006). Urinary estrogen and progesterone metabolite concentrations in menstrual cycles 
of fertile women with non-conception, early pregnancy loss, or clinical pregnancy. 
Human Reproduction, 21, 2272-2280. doi: 10.1093/humrep/del187 
Vieira, A. (2009). A theoretical proposal for late luteal phase behavioural changes in an 
evolutionary context. Psychologia, 52, 110-117.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
108
Wallwiener, M., Wallwiener, L., Seegar, H., Mück, A. O., Zipfel, F., Bitzer, J., & Wallwiener, C.  
W. (2010). Prevalence of sexual dysfunction and impact of contraception in female 
German medical students. Contraception, 82, 155-159. doi: 
10.1016/j.contraception.2009.12.022 
Warner, P., & Bancroft, J. (1988). Mood, sexuality, oral contraception and the menstrual cycle. 
Journal of Psychosomatic Research, 32, 417-427.  
Watson, D. (1988). Intraindividual and interindividual analyses of positive and negative affect: 
Their relation to health complaints, perceived stress, and daily activities. Journal of 
Personality and Social Psychology, 54, 1020-1030. doi: 10.1037/0022-3514.54.6.1020  
Watson, D., Clark, L. A., & Tellegen, A. (1988). Development and validation of brief measures 
of positive and negative affect: The PANAS scales. Journal of Personality and Social 
Psychology, 54, 1063-70.  
Wheeler, J. M., & Malinak, L. R. (1991). Complexion changes in oral contraceptive users. 
Results from a phase IV multicenter trial evaluating the safety and efficacy of ethynodiol 
diacetate, 1 mg, with ethinyl estradiol, 35 micrograms. Journal of Reproductive 
Medicine, 36, 340-344.  
Welling, L. L. M., Puts, D. A., Roberts, S. C., & Burriss, R. P. (2012). Hormonal contraceptive 
use and mate retention behaviour in women and their male partners. Hormones and 
Behavior, 61, 114-120. doi: 10.1016/j.ybeh.2011.10.01t1 
Westberg, L., & Erikkson, E. (2008). Sex steroid-related candidate genes in psychiatric 
disorders. Journal of Psychiatry and Neuroscience, 33, 319-330.  
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
109
Whybrow, P.C., Grof, P., Gyulai, L., Rasgon, N., Glenn, T., & Bauer, M. (2003). The electronic 
assessment of the longitudinal course of bipolar disorder: The ChronoRecord software. 
Pharmacotherapy, 36, 244 – 249.  
Wieck, A., Davies, R. A., Hirst, A. D., Brown, N., Papadopoulos, A., Marks, M. N., . . . 
Campbell, I. C. (2003). Menstrual cycle effects on hypothalamic dopamine receptor 
function in women with a history of puerperal bipolar disorder. Journal of 
Psychopharmacology, 17, 204-209.  
Wilcox, A. J., Dunson, D. B., Weinberg, C. R., Trussell, J., & Baird, D. D. (2001). Likelihood of 
conception with a single act of intercourse: Providing benchmark rates for assessment of 
post-coital contraceptives. Contraception, 63, 211-215.  
Wohlrab, S., Stahl, J., Rammsayer, T., & Kappeler, P. M. (2007). Differences in personality 
characteristics between body-modified and non-modified individuals: Associations with 
individual personal traits and their possible evolutionary implications. European Journal 
of Personality, 21, 931-951.  
Wood, N. F., Dery, G. K., & Most, A. (1982). Recollections of menarche, current menstrual 
attitudes, and perimenstrual symptoms. Psychosomatic Medicine, 44, 285-293.  
Wood, N. F., & Mitchell, E. S. (1996). Patterns of depressed mood in midlife women: 
Observations from the Seattle midlife women’s health study. Research in Nursing & 
Health, 19, 111-123.  
Young, E. A., Kornstein, S. G., Harvye, A. T., Wisniewski, S. R., Barkin, J., . . . Rush, A. J. 
(2007). Influences of hormone-based contraception on depressive symptoms in 
premenopausal women with major depression. Psychoneuroendocrinology, 32, 843-853. 
doi:10.1016/j.psyneuen.2007.05.013 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 
   
110
Young, R. C., Moline, M., & Kleyman, F. (1997). Hormone replacement therapy and late-life 
mania. The American Journal of Geriatric Psychiatry, 5, 179-181. 
Zimmerman, Y., Eijkemans, M.J., Coelingh Bennink, H.J., Blankenstein, M.A., & Fauser, B.C. 
(2014). The effect of combined oral contraception on testosterone levels in healthy 
women: a systematic review and meta-analysis. Human Reproduction Update, 20, 76-
105. doi: 10.1093/humupd/dmt038 
WOMEN’S REPRODUCTIVE EXPERIENCES      
 













The Women’s Reproductive Experiences (REP) Questionnaire:  












WOMEN’S REPRODUCTIVE EXPERIENCES      
 




This paper reports on the development and initial psychometric findings of the Women’s 
Reproductive Experiences (REP) Questionnaire (Part 1) as well as differences between relevant 
groups on this measure (Part 2). The Women’s REP was designed to measure both negative and 
positive experiences associated with reproductive events across the lifespan in three domains: 
affective, sexual, and physical. The impetus for its development came from research suggestive 
of a hormonal sensitivity syndrome in some women (a) at individual and (b) across reproductive 
events; (c) a dearth of research on positively valenced changes associated with such events; and 
(d) evidence of psychometric issues pertaining to measures used for individual events or 
syndromes. In Part 1, factor analysis indicated that the 134-item Women’s REP includes seven 
main scales: Negative Affective Experiences, Negative Physical Experiences, Positive Affective 
and Physical Experiences, Sexual Problems – General, Sexual Problems – Relationship, Body 
Image Quality, and Sleep Quality. Fourteen main subscales and 13 supplementary subscales 
were also identified. The Women’s REP demonstrated evidence of reliability in factor structure 
and internal consistency. Evidence of concurrent validity came from group differences in scale 
scores between women with and without self-reported current hormonal problems, hormonal 
contraceptive (HC) side effects, and premenstrual syndrome. In Part 2, women who differed in 
hormonal status (i.e., conception probability and estimated sex hormone levels; e.g., pregnant, 
postpartum, menopausal, menstrual cycle phase, and HC use) also differed in relevant ways on 
the scales. For example, pregnant women had high scores on a Progesterone-Related Experiences 
subscale. Overall, these data suggest that the Women’s REP may be of use in research and 
clinical practice for elucidating between- and within-women patterns of affective, sexual, and 
physical responses to changes across the female lifespan.   
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The Women’s Reproductive Experiences (REP) Questionnaire:  
Psychometric Findings  
An extensive history of research exists on women’s adverse experiences associated with 
reproductive events across the lifespan, from menarche to menopause. However, a gold standard 
in the measurement of these experiences over time has not yet emerged. Given the changes in 
hormone levels that occur during the various female reproductive events (Speroff & Fritz, 2005), 
it is perhaps not coincidental that all of these events are associated with psychological and 
physical changes. As examples, 49% of women who are of reproductive age report experiencing 
premenstrual syndrome (PMS; Direkvand-Moghadam, Sayehmiri, Delpisheh, & Sattat, 2014); 
about 40% of women who use hormonal contraception (HC) will experience adverse side effects 
(Oinonen, 2009; Sanders, Graham, Bass, & Bancroft, 2001; Tilhonen, Leppäpen, Heikkinen, & 
Ahonen, 2008); up to 80% of new mothers are affected by the “baby blues” (O’Hara & Wisner, 
2014); half of all peripartum depressive mood episodes begin during pregnancy (APA, 2013); 
and women in the perimenopausal period may be more vulnerable to depressed mood than 
premenopausal women (Minuzzi, Frey, & Soares, 2012). As will be reviewed, measures of 
adverse symptoms or side effects have been developed for each of these reproductive events but 
there does not appear to be a measure that can assess both negative and positive experiences 
during all such events. This kind of measure might be useful for research on what has recently 
been described as hormonal sensitivity syndrome (HSS; Pope, Oinonen, Mazmanian, & Stone, 
2015).  
In an attempt to address this gap in the literature, the present paper reports on the 
development of what appears to be the first consolidated measure of experiences, symptoms, and 
side effects reported by women during events characterized by changes in reproductive status 
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and hormones: the Women’s Reproductive Experiences (REP) Questionnaire. The two overall 
objectives for the study were to examine the (a) reliability and (b) validity of the measure. The 
initial psychometric evaluation of the Women’s REP is presented in Part 1. In Part 2, mean level 
differences on Women’s REP scores between women of various hormonal statuses were 
examined to further explore the concurrent validity of this new measure of experiences related to 
reproductive events and hormonal sensitivity.   
More specifically, the Women’s REP was designed to measure women’s reports of 
affective, sexual, and physical experiences across the menstrual cycle, with HC use, during 
pregnancy, in the postpartum period, and throughout the menopausal transition. It is non-disorder 
and non-event specific and thus, may be applicable for use with women of all ages. The goal was 
to develop a questionnaire that included both the commonalities and unique or specific 
experiences of the main reproductive events for the purpose of assessing women’s negatively 
and positively valenced responses to hormone-related changes. Many measures exist to evaluate 
some experiences associated with individual events, such as premenstrual distress, postpartum 
depression, and perimenopausal symptoms. These measures have been published or used in 
research or clinical practice (e.g., the Menstrual Distress Questionnaire [MDQ; Moos, 1991]; the 
Edinburgh Postpartum Depression Scale [EPDS; Cox, Holden, & Sagovsky, 1987]; and the 
Menopause-Specific Quality of Life Scale [MENQOL; Hilditch et al., 1996]). However, a review 
of the literature suggests there is a need for a comprehensive measurement tool for women’s 
reproductive experiences that is neither disorder- nor event-specific.  
The impetus for the development of a comprehensive questionnaire of women’s 
reproductive experiences came from five sources: (a) research suggestive of hormonal sensitivity 
at individual events for some women; (b) a growing body of literature indicating that experiences 
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at a past reproductive event may be predictive of experiences at current or succeeding events; (c) 
a dearth of research on positively valenced changes that may be associated with reproductive 
events; (d) psychometric issues pertaining to measures used for individual events; and (e) as a 
result of the previous four points, the need to develop questionnaire items to measure women’s 
experiences and symptoms at reproductive events in various Health, Hormones, & Behaviour 
Laboratory (HHAB Lab) research projects over the past 20 years (e.g., Bird, 2006, 2012; 
Oinonen, 1997, 2003; Richards, 2006, 2012; Russell, 2009; Stone, 2008, 2011; Teatero, 2009). 
These points will be discussed in more detail.    
Hormonal Sensitivity Hypothesis  
Although the precise underlying biological mechanisms are not well understood, a 
consensus is emerging that hormonal sensitivity (i.e., hypersensitivity to normal fluctuations in 
or levels of reproductive hormones) underlies the severity of symptoms and side effects 
associated with reproductive events across the lifespan (e.g., Brace & McCauley, 1997; Deecher 
et al., 2008; Oinonen, 2009; Oinonen & Mazmanian, 2002; Steiner, Dunn, & Born, 2003). While 
some of the psychological changes at these events may be reactive to somatic or psychosocial 
factors, some studies have provided strong evidence of hormonal sensitivity. For example, Bloch 
et al. (2000) induced depressive symptoms in 63% of female participants with a history of 
postpartum depression, but none of the control group, by artificially dropping their estrogen and 
progesterone levels. In another seminal study, PMS-like symptoms were induced in healthy 
women with PMS but not those without PMS by first suppressing the menstrual cycle (and PMS) 
using leuprolide, a GnRH agonist, and then adding estradiol or progesterone (Schmidt, Nieman, 
Danaceau, Adams, & Rubinow, 1998). These findings suggest that there are some women who 
are physically or affectively sensitive to changes in these hormone levels.  
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Given the hormonal changes associated with each reproductive event and that only a 
proportion of women experience affective (mood-related) symptoms or side effects, it seems that 
such experiences may involve sensitivity or hypersensitivity to normal psychophysiological 
processes among some women. Moreover, it is possible that a spectrum of hormonal sensitivity 
and thus, symptom severity, exists (Soares, 2010; Soares & Zitek, 2008). It has also been 
proposed that the effects of hormonal changes across the lifespan may be cumulative in those 
who are vulnerable (Ancelin, Scali, & Ritchie, 2007; Deecher, Andree, Sloan, & Schechter, 
2008) and underlie what has been referred to as reproductive mood disorder(s) (Rapkin, 
Mikacich, & Moatakef-Imani, 2003; Payne, Tietelbaum Palmer, & Joffe, 2009). That is, women 
may not reach each reproductive event with the same risk for symptoms as at past events in a 
way that may be akin to kindling or sensitization (Parry & Newton, 2001; Post, 1992). Risk may 
accumulate with the experience of changes or symptoms at each reproductive event, beginning 
with hormonal exposure in utero as suggested by some digit ratio research (Oinonen, 2009; 
Oinonen & Bird, 2012). Interestingly, many of the same psychological and physical symptoms 
occur across the main female reproductive events (e.g., headaches, gastrointestinal problems, 
fatigue, breast tenderness, acne or skin blotches, vasomotor symptoms, changes in waist-to-hip 
ratio and body mass index, negative affect, mood lability, negative sexual changes, and sleep and 
appetite disturbances) (see review in Ancelin et al., 2007). These common experiences across 
reproductive events and a tendency for some women to experience symptoms at individual 
events provide support for the hormonal sensitivity hypothesis.  
Past Reproductive Events  
 The hormonal sensitivity hypothesis is further supported by a growing body of literature 
on associations between symptoms, namely negative affect or depression, and reproductive 
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events across the lifespan (see Feld, Halbreich, & Karkun, 2005 for a review). These studies 
suggest that women who experience adverse affective symptoms with one event are more likely 
to experience similar symptoms at another event or other events (e.g., Flores-Ramos, Heinze, & 
Silvestri-Tomassoni, 2010; Payne et al., 2007; Stewart & Boydell, 1993; Sugawara et al., 1997; 
cf., Haywood, Slade, & King, 2007; Steinberg et al., 2008). For instance, Winkel, Einsle, 
Wittchen, and Martini (2013) found that women’s retrospective ratings of a given premenstrual 
symptom, such as irritability/anger, were associated with current ratings of the corresponding 
symptom in early pregnancy. Stone, Mazmanian, Oinonen, and Sharma (2013) also reported 
evidence that physical symptoms at past reproductive events, particularly in the premenstrual 
phase, are predictive of physical symptoms during the menopausal transition. These types of 
associations provide evidence of HSS (Pope et al., 2015).  
With increasing evidence that some women are relatively more sensitive to hormonal 
fluctuations and that experiences at one reproductive event tend to be related to those at another 
reproductive event, it may be particularly important to ensure that measurement instruments not 
only demonstrate good psychometric properties but can also be used with the majority of women 
regardless of age or current reproductive status. It may also prove beneficial to include a variety 
of reproductive experiences in such a measure given that there also appears to be heterogeneity 
in both (a) symptoms/side effects (as indicated by a review of the items on measures of 
experiences associated with individual events; see Method section) and (b) symptom associations 
(i.e., between various affective, sexual, and physical experiences) among women at individual 
events and across events (e.g., Greco, Graham, Bancroft, Tanner, & Doll, 2007; Kiesner & 
Pastore, 2010; Kiesner & Poulin, 2011; Lykins, Jannsen, & Graham, 2006; Warner & Bancroft, 
1988). This approach would allow for the examination of experiences known to be associated 
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with one event at other reproductive events with which those experiences may not be directly 
related or have yet to be examined. That is, research has largely focused on correlations between 
similar or common affective symptoms across two or more reproductive events (see reviews in 
Stone et al., 2013 and Pope et al., 2015) but experiences that are relatively unique or specific to 
one event, pain during menstruation and nausea during pregnancy as examples, may also be 
related to different affective, sexual, and physical experiences at other events. Also, a 
comprehensive measure might help clarify what past symptoms or profiles of symptoms might 
be most predictive of those that occur at later reproductive events (Winkel et al., 2013).  
Positively Valenced Experiences 
In contrast to adverse or negatively valenced experiences, there have been few studies on 
positive or positively valenced experiences during each reproductive event (see Buttner, O’Hara, 
& Watson, 2012; Dennerstein, Lehert, & Guthie, 2002; King & Ussher, 2012; Meaden, Harlage 
& Corr-Karr, 2005; Oinonen & Mazmanian, 2002). Based on a continuum perspective, such 
affective experiences could range from positive affect to elation to mania (Oinonen & 
Mazmanian, 2001; Jarva & Oinonen, 2007). This is an intriguing area of potential research in 
view of evidence that the course of bipolar disorder among subgroups of women may be affected 
by the menstrual cycle (Teatero, Mazmanian, & Sharma, 2013), pregnancy (Sharma & Pope, 
2012), and the postpartum period (Sharma et al., 2014). With respect to associations across 
reproductive events, the very few relevant findings are consistent with what would be expected 
based on the hormonal sensitivity hypothesis. Some women seem to respond to changes in 
hormone levels in unique yet predictable ways, such as by experiencing positive affect at two or 
more reproductive events (Dennerstein, Lehert, Dudley, & Guthrie, 2001; Russell, 2009). In 
contrast, an earlier study reported that positive recollections of menarche were correlated with 
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negative affect in the premenstrual and menstrual phases (Wood, Dery, & Most, 1982). Overall, 
further research is needed to examine associations between experiences, including those that are 
positively valenced, at the various reproductive events (see Warner & Bancroft, 1988 for early 
work in this area with respect to menstrual cycle phase).  
Psychometric Issues 
Most, if not all, of the studies that have examined associations among symptoms at the 
various reproductive events have used questionnaires (a) with unpublished psychometric 
properties (usually developed for the study; e.g., Flores-Ramos, Heinze, & Silvestri-Tomassoni, 
2010; Stone et al., 2013; Winkel et al., 2013) or (b) that were not designed to measure 
reproductive experiences or for use with reproductive groups of women (e.g., the Center for 
Epidemiological Studies’ Depression Scale [CES-D; Radloff, 1977]; Flores-Ramos et al., 2010; 
Freeman, Sammel, Rinaudo, & Shend, 2007). As Hunter (1992) indicated, hormonal and age-
related changes among women may be confounded when regular measures of mood and health 
are used to assess reproductive experiences. For instance, a principal components analysis of a 
measure designed to assess mid-aged (perimenopausal) women’s perceptions of emotional and 
physical symptoms, the Women’s Health Questionnaire (WHQ), revealed that depressed mood 
was somewhat independent of sleep problems and sexual difficulties, which was in contrast to 
assumptions underlying the measurement of symptoms of depressed mood in general and 
suggested that relationships among women’s reproductive experiences may differ from those of 
similar, but non-reproductive, experiences in the general population (Hunter, 1992). These 
findings indicate that questionnaires specifically designed to measure reproductive experiences 
may be more sensitive to changes as well as relationships between symptoms at an event and 
across events. In this sense, such measures may have face validity, relatively good measurement 
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validity, and sensitivity to experiences associated with hormonal changes than population-based 
measures of mood and health.       
Other existing general (i.e., non-disorder) measures of symptoms for specific 
reproductive events predominantly pertain to the premenstrual phase, vary in content, and have 
poor (or unknown) psychometric properties (Haywood, Slade, & King, 2002; see also Buttner et 
al., 2012 for a brief review of similar limitations regarding measures used in research on the 
postpartum blues). For instance, many different measures for PMS are used in the literature, 
which has made results difficult to compare or aggregate in meta-analyses (Direkvand-
Moghadam et al., 2014).  
Moreover, the items on the most commonly used published measures of experiences 
specific to a reproductive event tend to be negatively worded such that adverse experiences are 
measured to the exclusion of any positively valenced changes (Meaden et al., 2010). 
Reproductive event questionnaires that do include positively worded items consist of only a 
select few such mood-related items (e.g., MDQ; Moos, 1991) and merely involve reverse scoring 
so as to reflect negatively valenced change (e.g., WHQ; Hunter, 1992; see also Meaden et al., 
2005). However, a study on the structure of women’s mood in the early postpartum period used 
the Daily Experiences Questionnaires (DEQ), which includes items from the Positive and 
Negative Affect Schedule (PANAS; Watson, Clark, & Tellegen, 1988), and revealed two reliable 
factors: negative affect and positive affect (Buttner et al., 2012). Moreover, there is evidence 
from a brain imaging study that distinct regions of the brain are involved in negative and positive 
affective processing (Zheng, Li, and Pan, 2015). Even if affect is a bipolar dimension, then both 
valences (e.g., negative affect and positive affect as opposed to just high negative affect and low 
negative affect) should be measured to avoid ceiling or floor effects (Green & Salovey, 1999). 
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Finally, questionnaires developed based on the assumption that a given reproductive 
event is an adverse psychological and physical experience may result in data that can confirm but 
not disconfirm that assumption (Meaden et al., 2005). According to Meaden et al. (2005), 
“Further research . . . is needed to understand the apparently orthogonal differences in the 
positively and negatively worded items, and their relative accuracy and usefulness in describing 
the menstrual experience (p. 35).” In the present study, this point is applied to reproductive 
experiences more globally. Given evidence that some women report positively valenced 
reproductive experiences, existing measures may mask such phenomena by limiting and 
prescribing the range of experiences women are able to directly report (King & Ussher, 2012). 
As a result, measures of central tendency would suggest the experience of only negative changes 
or no changes at all in women. It may also be valuable to include equal numbers of negative and 
positive experiences in a questionnaire to consider response biases or sets (see O’Sullivan, 
Meyer-Bahlburg, & McKeague, 2006 for a non-reproductive/hormonal related measure of sexual 
self-concept in which negative and positive worded items were intentionally balanced).  
The Present Study 
In summary, a comprehensive measure of women’s reproductive symptoms may be more 
sensitive to changes across and associations between the various reproductive events, which may 
also help clarify patterns of hormonal sensitivity. The Women’s REP was designed to be novel in 
its assessment of: (a) three comprehensive domains of experiences (i.e., affective, sexual and 
physical), (b) both negative and positive experiences, and (c) experiences from the three domains 
that span the main reproductive events that a woman has the potential to experience across her 
lifespan. The present study details the development of the Women’s REP and its initial 
psychometric findings, including factor structure, internal consistency reliability, and concurrent 
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validity (Part 1). Concurrent validity was also assessed by examining if scores on the scales of 
the Women’s REP differ between women with and without self-reported current: hormonal 
problems, HC side effects, and PMS. In Part 2, possible relevant differences on the scales 
between women who differed in reproductive status (e.g., pregnant, postpartum, menopausal, 
menstrual cycle phase, and HC use), as well as estimated conception probability and sex 
hormones levels, were also examined.  
Method 
Participants  
Overall, 2490 women participated in at least a portion of a study on “women’s health 
experiences.” The final full sample consisted of 1,934 women between the ages of 16 and 74 
years. Demographic information for the full sample as well as a subsample of women of 
reproductive age (i.e., under the age of 44 years; e.g., World Health Organization, 2013) who 
reported that they were not pregnant, in the postpartum period, or perimenpausal (n = 1521) can 
be found in Table 2.1.  
Participants were recruited from a Canadian university and the community but 
predominantly through the Internet. Methods of recruitment included posters, word of mouth, e-
mails, and online postings and advertisements. The latter strategy was employed to increase both 
sample size and diversity. Research has suggested that web-based studies can provide valid data 
and perhaps more diverse and representative samples than specific participant pools, such as 
undergraduate students (e.g., Gosling, Vazire, Srivastava, & John, 2004; Thompson & 
O’Sullivan, 2013; 2015). University students received half of a bonus point as Psychology 
course credit for their participation and all volunteers were entered into four draws for $50 VISA 
gift cards.    
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Table 2.1  
 
Means and Frequencies of Demographic Variables for the Full Sample and Subsample of 
Reproductive Age 
 
Variable Full sample  





(n = 1521) 
 M (SD)  
Age (years) 29.32 (10.49) 26.16 (6.79) 
 n (%) 
Ethnic background 
     European (e.g., Caucasian/white) 
     African/black 
     Hispanic/Latino 
     Asian 
     Other (e.g., multi-racial) 
     Native/Aboriginal 
     East Indian 
     Unspecified 





















Continent of residence 
    North America 
    Asia 
    Europe 
    Australia  
    Unspecified 
















   In a relationship 
   Single (no primary partner) 
   Other (e.g., divorced)  













     Free-cycling (i.e., non-HC users) 
     Hormonal contraceptive (HC) use 
     Non-hormonal intrauterine device use 
     Pregnant 
     Postpartum  
















Women under the age of 44 years who were not pregnant, in the postpartum period, or 
perimenopausal. 
b
Women who reported being in more than one reproductive group were 
excluded. Thus, each group is independent. 
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Other than age (16 years or older), there were no initial inclusion or exclusion criteria in 
order to obtain a large sample of women across various stages of the lifespan with a variety of 
reproductive experiences. However, 556 women were excluded from the analyses for one or 
more of the following five reasons: (a) “other” sex (e.g., gender dysphoria) (n = 7); (b) 
unreported age (n = 25); (c) reported age was out of range or implausible (n = 5); (d) responses 
to current reproductive events were implausible (e.g., selected yes to currently being pregnant, 
postpartum, and perimenopausal) (n = 2); (e) missing more than 6 (4.8% of) the Women’s REP 
items (n = 521); and (f) response set was visually detected by the author (e.g., selected not at all 
to all Women’s REP items) (n = 5).  
Materials 
 Participants were given an electronic questionnaire that consisted of three sections: 
demographics, health background, and the Women’s REP (see Appendix A for the consent form, 
questionnaire, and debriefing form of the present study). Demographic items included age, ethnic 
background, country of residence, and relationship status. The health background section 
included items developed by the researchers pertaining to past and current reproductive events 
(i.e., pregnancy, postpartum, and perimenopause) as well as other indicators of hormonal status 
such as menstrual cycle regularity and length, date of last and expected date of next menstrual 
period, and HC use. Participants indicated whether they thought that they had ever had any of the 
following general conditions (never, past, or present): a hormonal problem or disorder, HC side 
effects, PMS, mood problems during pregnancy, and mood problems during the postpartum 
period. The questionnaire took about 15 to 30 minutes for most women to complete.   
Women’s Reproductive Experiences (REP) Questionnaire. Based on the results of 
this study, the 134-item Women’s REP consists of both negatively and positively valenced 
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experiences that constitute seven main scales, 14 main subscales, and 13 supplementary 
subscales. As will be demonstrated, the main scales include a mix of negatively and positively 
valenced items (with reverse scoring as appropriate), while the subscales tend to consist of only 
negative or positive experiences items.  
The items of the Women’s REP were generated through, or adapted from, experiences 
included in gynecological reference materials; reproductive symptoms or side effects in the 
reviewed literature; anecdotal reports from previous research participants; the criteria for PMDD, 
depression, and bipolar disorder (APA, 2000); and questionnaire items developed for past studies 
in the HHAB Lab. These latter measures included the OC Side Effects Questionnaire (OCQ; 
Oinonen & Bird, 2012), the Pregnancy Experiences Questionnaire (PEQ) (Stone et al., 2013), the 
Postpartum Physical Symptoms Questionnaire (PPSQ; Stone et al., 2013), and the Postpartum 
Elation Scale (Russell, 2009). A visual item analysis of the following existing measures, specific 
to individual reproductive events, was also completed: the MDQ (Moos, 1991), the Menstrual 
Joy Questionnaire (Chrisler, Johnston, Champagne, & Preston, 1994), the Daily Record of 
Severity of Problems (Endicott & Harrison, 1990), the EPDS (Cox et al., 1987), and the 
MENQUOL (Hilditch et al., 1996). Since changes in sexual functioning are commonly 
associated with reproductive events (e.g., Clayton, Clavet, McGarvey, Warnock, & Weiss, 
1999), items pertaining to the sexual response cycle (i.e., sexual desire or drive, arousal, and 
ability to orgasm) were generated based primarily on information about sexual dysfunctions 
(APA, 2000), Clayton and Hamilton (2010), and the OCQ (Oinonen & Bird, 2012). All of the 
measures that were reviewed are widely used or have demonstrated some satisfactory 
psychometric data.  
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The Women’s REP was developed to consist of items from three domains consistent with 
existing questionnaires and research: affective (68 items), sexual (20 items), and physical (46 
items) experiences. Each item was rated on a 5-point scale from 0 (Not at all) to 4 (Extreme) 
based on one’s experiences over the past 48 hours. An attempt was made to include a positively 
valenced item, or at least a one-dimensional opposing positively worded experience, for every 
negatively valenced item, resulting in a “negative” content scale and a “positive” content scale 
for each domain (resulting in six initial domain scales). In the physical domain, an example is 
“joint or muscle stiffness” as a negative symptom and “joint or muscle agility” as a positive 
symptom. In the affective domain, an example is “mood lability (mood swings)” and “mood 
stability (consistent mood).” In the sexual domain, an example is “disinterest in masturbation 
(alone)” and “desire/drive for masturbation (alone).” While five pairs of items, such as “breast 
size increase” and “breast size decrease” did not necessarily have an obvious negative  or 
positive valence, they were included as supplementary items descriptive of directional change. 
The 134 Women’s REP items listed by their rationally developed domain content scales can be 
found in Table 2.2.   
 Instructions provided to participants for completing the Women’s REP were as follows: 
“Below is a list of physical, emotional, and sexual experiences that can be positive or negative. 
Please indicate the extent to which you have experienced each item in the past 48 hours (i.e., 
over the past 2 days). If you have not engaged in sexual activity in the past 48 hours, please 
imagine how you would respond to the sexual items if you had engaged in sexual activity.” Note 
that no reference was made to a specific hormonal status or reproductive event. The Women’s 
REP items specific to having a current primary partner were not administered to women who 
selected that they were single. Such items were presented prior to the other items (at the end of 
WOMEN’S REPRODUCTIVE EXPERIENCES 








(k = 30) 
Positive Affective 
Experiences  
(k = 30) 
Negative Physical 
Experiences  
(k = 21) 
Positive Physical 
Experiences  
(k = 21) 
Negative Sexual 
Experiences  
(k = 10) 
Positive Sexual 
Experiences  





( k = 12) 
Loneliness 
Anxiety or worry 
Mood lability (mood 
swings) 
Crying 
Fatigue/lack of energy 




Unhappy with appetite 
Feeling down, sad, or 
depressed 
Low self-esteem 








Impairment in work or 
school 
Lack of interest or 
enjoyment in usual 
activities 
Feeling out of control 












Ease falling asleep 
Content with appetite 
Feeling happy, elated, or 
euphoric 
High self-esteem 





Sociable/desire to be 
around others 
Achievement/productivity 
in work or school 
Interest or enjoyment in 
usual activities 
Feeling in control 
Feeling like self 
 






























Joint or muscle 













Sense of physical 
wellbeing 
A strong back 
General physical 
comfort 
Strong and nimble 
legs 
Healthy digestion 















with others or the 





Difficulty having an 
orgasm with others 




















Interest in sexual 





Easy to become 
aroused with others 





Easy to have an 
orgasm with others 





















































Negative Affective Positive Affective Negative Physical Positive Physical Negative Sexual Positive Sexual Supplementary 
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Experiences 
(k = 30) 
Experiences 
(k = 30) 
Experiences 
(k = 21) 
Experiences 
(k = 21) 
Experiences 
(k = 10) 
Experiences 




( k = 12) 
Unhappy with food 
preferences 
Unhappy with food 
intake 
Negative thoughts 













Concern about body 
shape/size 
Content with food 
preferences 
Content with food intake 
Looking forward to a 




Feeling great or special 
Physical grace/motor 
coordination 
Pleased with self compared 
to other women 
Affectionate/intimate with 
others 








































Eating more than 
usual [affective] 
Eating less than 
usual [affective] 
Note. k = number of items.  
a
Items reflect sexual experiences outside of a romantic relationship regardless of relationship status, including general sexual desire and activity involving 
another person or the thought of someone for single women and sexual desire and activity involving a person other than one’s primary partner (e.g., fantasy, 
infidelity, or polyamory) for women in a relationship 
b
Items applicable to, and only administered to, participants who reported that they were in a relationship. 
c
The valences of these items are not necessarily negative or positive. Labels in square parentheses refer to purported general content domains.
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the demographics section). All items of the Women’s REP were presented in the same random 
order (i.e., the items from the various scales were intermixed) for all participants (see Appendix 
A).  
Procedure 
 The study received approval from the relevant institutional and departmental research 
ethics boards. Potential participants were directed to an Internet link for the questionnaire. All 
data were collected through a secure Internet database (www.surveymonkey.com). As an added 
precaution, optional enhanced security (Secure Sockets Layer [SSL]) was purchased to encrypt 
all responses. Identifying information for prize draws was collected through a separate link in the 
debriefing form at the end of the questionnaire to preserve anonymity.   
Data Screening  
 About 0.53% of data points (i.e., items x participants) were missing from the possible 
248,192 data points of the Women’s REP. Based on missing value analysis and examination of 
both raw and descriptive data, there were no clear patterns in the missing data and thus, the data 
were considered to be missing at random. Given that no variable or participant was missing more 
than 5% of data points, it was expected that any procedure for handling missing data would be 
equivalent. Thus, all analyses were conducted with missing data estimated by item means, a 
conservative approach (Tabachnick & Fidell, 2007). Prior to each of the main analyses, the data 
were screened for errors, missing values, univariate and multivariate outliers (± z ≥ 3.29 and p < 
.001 criterion, respectively; Tabachnick & Fidell, 2007), and the assumptions of the statistical 
tests employed. 
As sample sizes increased, some item ratings and scores on the scales of the Women’s 
REP tended to be slightly positively skewed and include several slight univariate and 
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multivariate outliers. Given these findings, all main analyses were conducted with and without 
any outlying cases. There were no substantive differences in results. Thus, the former analyses 
are presented and no transformations were conducted given that some deviation from normality 
and outliers are expected in large samples. The assumption of linearity was also met based on 
graphical checks.  
The assumptions of homogeneity of variance-covariance matrices and homogeneity of 
error variances were assessed using Box’s M test and Levene’s test for MANOVAs and 
ANOVAs, respectively. Likely due to large and unequal group sizes (Tabachnick & Fidell, 
2007), these tests were significant for some analyses. To further assess these assumptions in the 
relevant analyses, (a) random samples of relatively large groups were selected to even out group 
sizes for the MANOVAs as recommended by Tabachnick and Fidell (2007); (b) robust tests of 
equality of means (i.e., Brown-Forsythe F-tests and Games-Howell pairwise comparisons) were 
conducted; (c) non-parametric tests (i.e., Kruskal-Wallis tests and Mann-Whitney pairwise 
comparisons) were conducted; and (d) Hartley’s Fmax ratio was considered as suggested by Field 
(2009). All of these results (not presented) were consistent with those obtained with the 
presented parametric tests, there were no identifiable patterns of variances by group size, and the 
ratio of the largest group variance to the smallest group variance tended to be close to one. In 
fact, Box’s test of homogeneity of variance-covariance matrices can be disregarded if sample 
sizes are equal (Field, 2009). Thus, these findings indicate that the presented MANOVA and 
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Part 1:  
Factor Structure, Reliability, and Concurrent Validity of a New Measure: The Women’s 
Reproductive Experiences (REP) Questionnaire 
 In Part 1, the factor structure of the Women’s REP was examined and scores on the 
resulting scales and subscales were determined. It was expected that the empirically derived 
scales would correspond well to the rationally derived content domain scales that were formed in 
the development of the measure. Differences in these scores between women with and without 
self-reported current general hormonal problems, HC side effects, and PMS were then examined. 
It was expected that women who self-identified with such hormonal problems would have 
negatively valenced scores that would be high and positively valenced scores that would be low 
compared to their unaffected counterparts. Such results would provide initial evidence of 
concurrent validity for the measure.    
Data Reduction and Analysis 
Factor analyses. A series of exploratory factor analyses was conducted for the full 
sample of women (N = 1934; k [number of items] = 128) as well as the following subsamples: 
women in a relationship who responded to the relationship items of the Women’s REP (n = 
1263; k = 134), women not in a relationship (n = 658; k = 128), women of reproductive age (n = 
1621; k = 128), and women of reproductive age in a relationship (n = 976; k = 134). One woman 
who indicated that she was in a relationship did not complete the relationship items of the 
Women’s REP and was thus, excluded from the relevant subsamples. According to Streiner 
(1994), there should be at least 100 participants overall and five participants per variable for a 
factor analysis. These criteria were met for all factor analyses conducted. For each sample, a 
principal components analysis was first conducted to assess for multicollinearity, the 
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factorability of the correction matrix, and the number of factors to extract. The number of factors 
was estimated using the scree plot and eigenvalues greater than 1, as well as parallel analysis 
using syntax from O’Connor (2000). The final number of factors extracted was based on the 
rules of parsimony and interpretability (Tabachnick & Fidell, 2007). Principal axis factor 
extraction with direct oblimin rotation was then performed on the items. A pattern matrix 
coefficient cutoff of .32 for inclusion of an item in interpretation of a factor was considered 
(Tabachnick & Fidell, 2007). However, items that loaded at least .25 on a factor were also 
included in the factors, as they can be considered salient in a large sample (Kline, 1994).  
Concurrent validity analyses. Factor (scale) scores were computed for each participant 
by averaging item ratings for the purposes of examining the descriptive statistics and concurrent 
validity of the Women’s REP. A series of one-way MANOVAs and ANOVAs were conducted 
to examine group differences in Women’s REP scores. Independent variables were women’s 
reports (yes/no) of current: hormonal problems, HC side effects, and PMS (total ns = 1910, 525, 
and 335 due to missing data and inclusion criteria noted below). Twenty-four, four, and three 
women did not respond to these items, respectively.  
Results 
Factor structure. For each factor analysis detailed below, the factorability of the 
correlation matrix was determined to be adequate. There were numerous significant correlations 
above .30 among the items, most of the values in the negative anti-image correlation matrix were 
small, and Kaiser’s measure of sampling adequacy was above 0.60. While the determinants of 
the correlation matrices were less than .0001, the smallest eigenvalue was not dangerously close 
to one and the largest squared multiple correlation (SMC) between items was not dangerously 
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close to 1 (Tabachnick & Fidell, 2007). Overall, these results indicated that multicollinearity was 
not a threat. 
Full sample of women. Six factors were extracted for the 128-item version of the 
Women’s REP (i.e., excluding six items specific to being in a relationship) because any 
additional factors consisted of few loadings above .32 and items of seemingly mixed content. An 
examination of the scree plot suggested six factors, while the eigenvalue greater than one 
criterion and parallel analysis suggested 25 and 15 factors, respectively. The results of the factor 
analysis can be found in Table 2.3. Items were ordered and grouped by loading (pattern 
coefficient) size to facilitate interpretation. All of the Women’s REP items loaded on a factor 
with a minimum coefficient of .25. An interpretative label was given to each factor and can be 
found in the first row of the table. As demonstrated above the diagonal in Table 2.4, oblique 
rotation suggested that the factors were modestly correlated at most. However, the factor solution 
provided a more simple structure than when an orthogonal rotation was requested. Oblique 
rotation was used in all subsequent analyses. All factors were internally consistent such that the 
SMCs ranged from .88 to .95. The factor solution accounted for 36% of variance (similar to 
O’Sullivan et al., 2006).  
 The interpretive labels given to the factors were based on item content. Secondary 
interpretative labels were based on the direction (negative or positive) of factor loadings. The six 
factors, in order of variance explained, were Negative Affective Experiences (corresponding to 
the negative affective experiences content scale); Positive Affective and Physical Experiences (a 
combination of the positive affective experiences and physical experiences content scales); 
Sexual Experiences or Sexual Problems – General (negative and positive items from the general 
sexual experiences domain); Body Image Experiences or Body Image Quality (positive and 
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Items (and Pattern Coefficients) of the Women’s REP and Variance Explained by Factors with Proposed Interpretative Labels for the Full Sample 
 
Negative Affective 
Experiences   
(k = 16) 
Positive Affective  
and Physical Experiences  
(k = 43) 
Positive and Negative 
Sexual Experiences – 
General  
(Sexual Problems – 
General) 
(k = 14) 
Positive and Negative 
Body Image Experiences 
(Body Image Quality)  
(k = 15) 
Negative Physical  
Experiencesa 










(Sexual Problems – 
Relationship)  
(k = 6) 
Feeling down, sad, 
or depressed (.64) 
Negative thoughts 







Not feeling like self 
(.50) 
Feeling out of 
control (.48) 
Mood lability 





to be alone) (.47) 
Anxiety or worry 
(.46) 
Feeling unoriginal 
or plain (.46) 
Lack of interest or 





Poor judgment or 
irrational (.39) 
Clear-headedness (.66) 
Good judgment or rational (.66) 
Feeling capable/competent (.64) 
Excitement and enthusiasm (.64) 
Physical grace/motor coordination 
(.62) 
Feeling like self (.62) 
Feeling in control (.62) 
Smiling (.61) 
Sense of physical wellbeing (.61) 
Interest or enjoyment in usual 
activities (.60) 
Healthy digestion (.60) 
Looking forward to a bright future  
(optimism) (.59) 
Thoughtfulness (.58) 
Emotional calmness/stability (.56) 
Focused (.55) 
Calm intestinal track  (.54) 
High self-esteem (.54) 
Healthy bowel movements (.54) 
Mental relaxation/calm (.53) 
Feeling, happy, elated, or euphoric 
(.52) 
Strong and nimble legs (.52) 
Sociable (.50) 
Hydrated (.50) 
Regular bowel movements (.49) 
Connectedness/support (.49) 
A strong back (.49) 
Comfort in breast area (.49) 
Mood stability (consistent mood) (.48) 
Achievement/productivity in work or 
school (.47) 
Easy to become aroused 
for masturbation (alone) 
(-.67) 
Disinterest in masturbation 
(alone) (.65) 




masturbation (alone) (-.61) 
Easy to become aroused 
with others or the thought 




Easy to have an orgasm 
with others or the thought 




Disinterest in sexual 






aroused for masturbation 
(alone) (.51) 
Sexual desire/drive for 
others (-.50) 
Difficulty having an 
orgasm with others (.48) 
Difficulty having an 
orgasm through 
masturbation (alone) (.47) 
Unhappy with weight  
(-.75) 
Concern about body 
shape/size (-.73) 
Feeling bigger than usual 
(-.71) 
Pleased with body 
shape/size (.61) 
Content with weight 
(.60) 
Unhappy with food 
intake (-.59) 
Unhappy with appetite (-
.51) 
Eating more than usual 
(-.49) 
Food cravings (-.46) 
Content with food 
intake (.43) 
Content with appetite 
(.42) 
Increased appetite  
(-.35) 
Feeling thinner than 
usual (.35) 
Jealous of other women 
(-.30) 
Unhappy with food 
preferences (-.27) 
 
Painful or tender breasts (.49) 
Bloating/swelling  (.46) 
Abdominal cramps or 
discomfort (.45) 
Nausea or vomiting (.45) 






Leg cramps (.41) 
Heartburn or indigestion 
(.40) 
Food aversions (.40) 
Impulsivity (.40) 
Breast size increase (.39) 
Flatulence/gassy (.38) 
Diarrhea (.38) 




Impairment in work or 
school (.36) 
Acne/pimples (.35) 
Breast size decrease (.34) 
Sweating (.34) 
Pain/discomfort during 
sexual activity (.34) 
Facial skin discoloration (i.e., 
colour blotches on face) (.34) 
 
Difficulty falling 
asleep (-.69)  
Disrupted sleep (-
.69) 
Not enough sleep 
(-.68) 
Sleeping less than 
usual (-.67) 
Content with 











Easy to become 
aroused with primary 
partner (-.76) 
Difficulty becoming 
aroused with primary 
partner (.77) 
Sexual desire/drive 
for primary partner 
(-.74) 
Disinterest in sexual 
activity with primary 
partner (.67) 
Difficulty having an 
orgasm with primary 
partner (.56) 
Easy to have an 
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(k = 16) 
Positive Affective and Physical 
Experiences 
(k = 43) 
Positive and Negative 
Sexual Experiences – 
General 
(Sexual Problems – 
General)a 
(k = 14) 
Positive and Negative 
Body Image Experiences 
(Body Image Quality) 
(k = 15) 
Negative Physical 
Experiencesb 










(Sexual Problems – 
Relationship) 
(k = 6) 
 Even facial skin tone (.47) 
Content with food preferences (.46) 
Feeling great or special (.45) 
General physical comfort (.44) 
Clear complexion/skin (.44) 
Pleased with self compared to other 
women (.43) 
Energized/Active (.41) 
Affectionate/intimate with others (.41) 
Joint or muscle agility (i.e., ease of 
movement) (.40) 
Pleased with breast size (.39) 
Stomach comfort (.39) 
Physical pleasure/comfort during 
sexual activity (.35) 
Vaginal lubrication (.31) 
Physical health (.25) 
Difficulty becoming 
aroused with others or the 







Vaginal dryness (.23) 
 
 Joint or muscle stiffness (.33) 
Headaches/migraines (.32) 
Decreased appetite (.31) 
Facial hair growth (.28) 
Unhappy with breast size 
(.27) 
Decrease in facial hair (.27) 
Less breakthrough 
bleeding/spotting (.26) 
Eating less than usual (.25) 
 
  
% variance explained in the full sample (and subsample) of womenb 
17.93 (17.50) 8.74 (2.15) 3.10 (3.46) 2.61 (2.58) 2.23 (7.92) 1.76 (1.73) (1.90) 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. k = number of items. Results were based on principal axis factor analyses, oblique 
rotation with Kaiser normalization. Factors 1 through 6 were based on the full sample (N = 1934) of women. Factor 7, in addition to factors 1 through 6, was 
reflected in the subsample of women in a relationship (n = 1263). Bolded items represent items that loaded greater than .25 on two factors in the full sample (i.e., 
cross-loaded) but are listed under the factor with which they had the strongest pattern coefficient. No item cross-loaded on more than two factors. Items in square 
parentheses represent items from the factor analysis in the full sample that loaded on Factor 7 in the subsample factor analysis.  
a
Pattern coefficients for these items were negative in direction. They have been reversed in the presentation of the results for ease of interpretation. 
b
Total 
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Main Factor Correlation Matrices of the Women’s REP in the Full Sample and Subsample of Women in Relationship  
 
Factor 1  2  3. 4 5  6  7  
1. Negative Affective Experiences 1 -.09 .14 -.19 .28 -.28  
2. Positive Affective and Physical Experiences -.19 1 -.20 .20 .07 -.26  
3. Sexual Problems – General .15 -.13 1 -.07 .12 -.16  
4. Body Image Quality -.24 .14 -.05 1 -.23 .26  
5. Negative Physical Experiences .28 .15 .08 -.23 1 .29  
6. Sleep Quality -.31 .22 -.10 .25 -.24 1  
7. Sexual Problems – Relationship .22 -.25 .27 -.08 .05 -.20 1 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. Correlation coefficients for the full sample (N = 1934) are 
presented above the diagonal, while those for the subsample of women in a relationship (n = 1263) are below the diagonal. Factor 7 is 
not presented for the full sample because a subsample of women was not in a relationship and thus, six items of the Women’s REP did 
not apply to them.  
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negative items from the affective experiences and physical experiences domains); Negative 
Physical Experiences (corresponding to the negative physical experiences content scale); and 
Sleep Experiences or Sleep Quality (positive and negative items from the affective experiences 
domain). 
Seventeen (13%) of the items were complex such that they loaded above .25 on two 
factors. These items were retained on the factor with which they loaded the most or fit best with 
respect to content for the purposes of future research (bolded in Table 2.3). Six of these items 
were from the Positive Affective Experiences factor, all of which loaded to a lesser extent on 
Negative Affective Experiences, as might be expected. Eight complex items were related to 
eating or body image, all of which loaded to some extent on Body Image Experiences. One of 
these items (“Pleased with self compared to other women”) loaded higher on Positive Affective 
Experiences. Three loaded on Positive Physical Experiences, three loaded on Negative Physical 
Experiences, and one (“Unhappy with food preferences”) loaded on Sleep Experiences. Of the 
remaining complex items, “General aches and pains” also loaded on Sleep Experiences, 
“Impairment in work or school” also loaded on Negative Affective Experiences, and “Poor 
judgment or irrational” also loaded on Negative Physical Experiences. Overall, these results 
indicate that the eating- and body image-related items of the Women’s REP may cut across 
content domains. 
Relationship status subsamples. Among women in a relationship (n = 1263), seven 
factors were found to provide the optimal solution for all 134-items of the Women’s REP, which 
accounted for 37% of variance overall. The scree plot suggested six to eight factors, while the 
eigenvalue greater than one criterion and parallel analysis suggested 27 and 16 factors 
respectively. The six factors found in the above factor analysis of the full sample were 
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represented (pattern coefficients not presented). As seen in Table 2.3, the seventh factor was 
interpreted as “Sexual Experiences – Relationship” as it consisted of the six items specific to 
women with a primary partner. All factors were internally consistent such that the SMCs ranged 
from .87 to .94. As seen below the diagonal in Table 2.4, the seven factors were weakly 
correlated.  
The order of the factors Positive Affective and Physical Experiences and Negative 
Physical Experiences, in terms of variance explained, was reversed from the factor analysis in 
the full sample to the subsample of women in a relationship. The directions of the loadings were 
also reversed for Negative Physical Experiences (from negative to positive loadings) and Body 
Image Experiences (from positive to negative loadings). Seventeen items (13%) loaded on a 
different factor in the full sample than in this subsample. Eight items differed from positive 
loadings on the Positive Affective and Physical Experiences factor to negative loadings on the 
Negative Affective Experiences factor. All of these items were from the Positive Affective 
Experiences domain (e.g., “Feeling great or special”). Two items from the Body Image 
Experiences factor (e.g., “Feeling thinner than usual”), one item from the Negative Physical 
Experiences factor (“Impairment in work or school”), and one item form the Sleep Experiences 
factor (“Fatigue/lack of energy) also switched to the Negative Affective Experiences factor 
among women in a relationship. “Vaginal dryness” changed from General Sexual Experiences to 
Negative Physical Experiences and “Content with appetite” changed from Body Image 
Experiences to Positive Affective and Physical Experiences. The remaining three differences are 
parenthesized (squared) in Table 2.3.  
To examine whether women in a relationship might drive or account for the six-factor 
structure of the 128-item Women’s REP in the full sample, a factor analysis was conducted in 
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the subsample of single women (n = 658). The scree plot for this subsample suggested six to 
seven factors, while the eigenvalue criterion and parallel analysis suggested 28 and 12 factors 
respectively. Six factors were extracted. The six factors were consistent in item content with 
those found in the full sample and the subsample of women in a relationship (data not presented). 
Fifteen items (12%) loaded on different factors in the full sample than in this subsample, most of 
which were items related to either eating/body image experiences or sexual/romantic 
experiences. The former items tended to load on the Body Image Experiences factor in the full 
sample but a physical or sleep factor in this subsample (e.g., “Unhappy with food preferences”). 
Two of the sexual/romantic items without reference to a context (e.g.,  “Vaginal lubrication”) 
loaded on the Positive Affective and Physical Experiences factor in the full sample but the 
Sexual Problems – General scale in this subsample, while one other such item showed the 
opposite pattern. All factors were internally consistent (SMCs = .89 to .96). The solution 
accounted for 38% of variance.  
Subsample of reproductive age. In this subsample (n = 1521), the six factors found in the 
full sample were represented based on item loadings (data not presented), accounting for 37% of 
variance. Five items (4%) loaded on different factors in the full sample than in this subsample. 
“Vaginal dryness” moved from General Sexual Experiences to Negative Physical Experiences, 
“Impairment at work or school” changed from Negative Affective Experiences to Negative 
Physical Experiences, “Feeling thinner than usual” changed from Body Image Experiences to 
Negative Physical Experiences, “Fatigue/lack of energy” changed from Sleep Experiences to 
Negative Affective Experiences, and “Poor judgment or irrational” changed from Negative 
Affective Experiences to Negative Physical Experiences. All factors were internally consistent 
(SMCs = .87 to .96).  
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Among women of reproductive age in a relationship (n = 976), a seven-factor solution 
accounted for 38% of variance (k = 134). All seven factors from the corresponding analysis in 
the full sample of women in a relationship were represented. Seven items (5%) loaded on 
different factors in the full sample than in this subsample. Six of these items loaded on the 
Positive Affective and Physical Experiences factor in this subsample as opposed to the Negative 
Affective Experiences factor. One item changed from the Negative Affective Experiences factor 
to the Body Image Quality factor. The seven factors were internally consistent (SMCs = 0.86 to 
0.94). 
Subfactor analyses.  In order to examine the possibility of subfactors within the seven 
identified factors of the Women’s REP, a factor analysis of the items included in each main 
factor was conducted for the full sample of women or the subsample of women in a relationship. 
Among women in a relationship, the SMC of the item “Difficulty having an orgasm with primary 
partner” was suggestive of multicollinearity and thus, this item was excluded from the factor 
analysis of the Sexual Problems – Relationship items. The Negative Affective Experiences factor 
was found to be one-dimensional. All other results with interpretative labels for the subfactors 
can be found in Table 2.5. Fourteen subfactors were identified. The two subfactors of the 
Positive Affective and Physical Experiences items were labeled Positive Affective Experiences 
and Positive Physical Experiences. The four main factors that consisted of both negative and 
positive experiences (i.e., Sexual Problems – General, Body Image Quality, Sleep Quality, and 
Sexual Problems – Relationship) were found to have negative and positive subfactors. These 
were labeled: Positive Sexual Experiences – Self (consisting of positive masturbation items 
only); Positive Sexual Experiences – Others (positive sexual items involving others or the 
thought of others [not including one’s primary partner]); Negative Sexual Experiences – General 
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Positive Affective and Physical 
Experiences 
Sexual Problems – General 
 




(k = 26) 
Physical 
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(k = 3) 
Positive 
Sexual 
Experiences –  
Others  













(k = 7) 
Hormonal 
Symptoms 
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Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. k = number of items. Results were based on principal axis factor analyses, oblique 
rotation with Kaiser normalization. There was one factor (Negative Affective Experiences) that did not result in any subfactors and was thus, considered to be 
one-dimensional. Subfactors 1 through 12 were based on the full sample (N = 1934). Subfactors 13 and 14, in addition to subfactors 1 through 12, were reflected 
in the sample of women in a romantic relationship (n = 1263). Bolded items represent items that loaded greater than .25 on more than one subfactor in the full 
sample (i.e., cross-loaded) but are listed under the subfactor with which they had the strongest pattern coefficient. Item in square parenthesis was excluded from 
the factor analysis due to multicollinearity.  
a
Pattern coefficients for these items were negative in direction. They have been reversed in the presentation of the results for ease of interpretation. 
b
Total 
variance explained for each main factor is the sum of the variance explained by the relevant subfactors. 
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 % variance explainedb 
32.16 3.86 29.89 10.74 8.90 34.42 10.51 21.00 3.89 2.78 40.06 6.17 54.25 9.51 
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(negative masturbation and sexual items involving others or the thought of others [not including 
one’s primary partner]); Negative Image Experiences; Positive Body Image Experiences; 
Negative Sleep Experiences; Positive Sleep Experiences; Positive Sexual Experiences – 
Relationship; and Negative Sexual Experiences – Relationship. The Negative Physical 
Experiences items constituted three subfactors labeled Hormonal Symptoms, Decreased 
Appetite, and General Aches and Pains.  
The items of the main subfactors were further analyzed until each supplementary 
subfactor was considered one-dimensional (see Table 2.6). The Positive Affective Experiences 
main subfactor was found to further divide into a Positive Affect subfactor and an Elation 
subfactor. The items of the Positive Physical Experiences subfactor also constituted General, 
Skin, Digestion, and Breast Experiences supplementary subfactors. The items of the Sexual 
Problems – General subfactor consisted of a Negative Sexual Experiences – Others subfactor and 
Negative Sexual Experiences – Self subfactor. The Positive Body Image Experiences subfactor 
further divided into Negative Weight Experiences, Positive Appetite Experiences, and Positive 
Weight Experiences subfactors. The Hormonal Experiences items consisted of two subfactors, 
which appeared to correspond to Testosterone-Related Experiences such as “acne/pimples” and 
“facial hair growth,” and Progesterone-Related Experiences, such as “painful or tender breasts” 
and “food aversions.”    
Scoring and Internal Reliability  
 A schematic overview of the structure of the Women’s REP based on the factor analysis 
results can be found in Figure 2.1. The means, standard deviations, and internal reliability 
(Cronbach’s alphas of the standardized items) for the main factors, main subfactors, and 
supplementary subfactors, which will now be referred to as the (main) scales, (main) subscales,
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Items (and Pattern Coefficients) of the Women’s REP and Variance Explained by Supplementary Subfactors with Proposed Interpretative Labels for the Full 
Sample 
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% variance explainedb 
43.58 5.04 29.67 8.60 6.93 6.49 39.96 13.93 48.81 16.01 13.47 23.24 5.93 
Note. Women’s REP = Women’s Reproductive Experiences (REP) Questionnaire. k = number of items. Pos = Positive. Exps = Experiences. Results were based 
on principal axis factor analyses, oblique rotation with Kaiser normalization based on the full sample (N = 1934) and presented as a function of main factor (line 
1), main subfactor (line 2), and supplementary subfactor (line 3). Bolded items represent items that loaded greater than .25 on more than one subfactor (i.e., 
cross-loaded) but are listed under the subfactor with which they had the strongest pattern coefficient.  
a
Pattern coefficients for these items were negative in direction. They have been reversed in the presentation of the results for ease of interpretation. 
b
Total 
variance explained for each main subfactor is the sum of the variance explained by the relevant supplementary subfactors.  
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Figure 2.1. Schematic overview of the structure of the Women’s REP scales, subscales, and supplementary subscales. k = number of 
items. There are seven main scales, one of which is only applicable to women in a relationship. Six of these scales have subscales. 
There are 14 main subscales, two of which are only applicable to women in a relationship. Five of these subscales have supplementary 
subscales. Some scales and subscales consist of both negatively and positively worded items (e.g., Sexual Problems – General, Sexual 
Problems – Relationship, Body Image Quality, and Sleep Quality) and thus, some items are reverse scored in computing overall 
scores. 
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and supplementary subscales, can be found in Table 2.7. These data were examined for the full 
sample and four overall reproductive status groups whose experiences, symptoms, and side 
effects the questionnaire was developed to measure: women of reproductive age, pregnant 
women, women in the postpartum period, and perimenopausal women. Scores were calculated 
by first reverse scoring any items, if applicable, and taking the mean item rating for each scale or 
subscale. For example, the main scale Sexual Problems – General consists of both negatively and 
positively valanced items. The latter had negative pattern coefficients in the factor analysis 
results and were thus, reverse scored for this scale. The reliability data suggested that the scales 
and subscales of the Women’s REP demonstrate strong internal consistency in each group (i.e., > 
.70; Murphy & Davidshofter, 2005). For the main scales, the estimates ranged from 0.83 to 0.95 
in the sample and subsample with more than 100 women and 0.73 to .96 in the smaller 
subsamples (see Table 2.7).  
Concurrent Validity  
Mean scores on the Women’s REP were examined between groups of women reporting 
different current hormone-related problems: (1) hormonal problems, (2) HC side effects, and (3) 
PMS when in the premenstrual phase (all yes/no; see Tables 2.8 to 2.10). If applicable, 
participants were also asked about current mood problems while pregnant or in the postpartum 
period. Twenty-one pregnant women (84%) reported current mood problems during their 
pregnancy and seven women in the postpartum period (29%) reported current mood problems in 
the six months since the birth of their child. However, these subsample sizes were too low for 




WOMEN’S REPRODUCTIVE EXPERIENCES 




Means and Internal Consistency Estimates of the Women’s REP Scale and Subscale Scores by Full Sample and Reproductive Status Subsamples 
 
Variable Full sample  
(N = 1934) 
Subsample of 
reproductive age  
(n = 1521) 
Pregnant 
subsample  
(n = 25) 
Postpartum 
subsample  
(n = 24) 
Perimenopausal 
subsample  
(n = 109) 
 M (SD) α M (SD) α M (SD) α M (SD) α M (SD) α 
Scales 
Negative Affective Experiences (k = 16) 2.40 (0.88) 0.94 2.42 (0.88) 0.94 2.38 (0.81) 0.91 2.27 (0.96) 0.95 2.22 (0.77) 0.92 
Negative Physical Experiences (k = 31) 1.88 (0.52) 0.89 1.88 (0.52) 0.89 2.11 (0.47) 0.80 1.89 (0.41) 0.80 1.78 (0.48) 0.88 
Sexual Problems – General (k = 14) 2.71 (0.75) 0.84 2.69 (0.74) 0.83 2.53 (0.78) 0.82 2.99 (0.80) 0.85 2.95 (0.84) 0.89 
Sexual Problems – Relationship
b
 (k = 6) 2.23 (0.90) 0.85 2.20 (0.88) 0.85 1.98 (0.89) 0.89 2.34 (1.04) 0.86 2.70 (1.10) 0.89 
Positive Affective and Physical Experiences (k = 43) 2.80 (0.63) 0.95 2.80 (0.64) 0.95 2.88 (0.50) 0.90 2.78 (0.73) 0.96 2.75 (0.59) 0.95 
Body Image Quality (k = 15) 3.07 (0.75) 0.87 3.08 (0.76) 0.88 2.80 (0.60) 0.75 2.99 (0.76) 0.86 3.15 (0.75) 0.89 
Sleep Quality (k = 9) 3.09 (0.86) 0.85 3.10 (0.87) 0.85 2.74 (0.97) 0.89 2.90 (0.75) 0.73 3.01 (0.87) 0.86 
Subscales 
Hormonal Symptoms (k = 22) 1.83 (0.52) 0.84 1.84 (0.51) 0.84 2.07 (0.49) 0.74 1.79 (0.38) 0.69 1.63 (0.45) 0.84 
Decreased Appetite (k = 2)  1.72 (0.96) 0.79 1.75 (0.97) 0.79 1.32 (0.68) 0.70 1.61 (0.95) 0.86 1.61 (0.80) 0.66 
General Aches and Pains (k = 7) 2.09 (0.77) 0.78 2.04 (0.76) 0.78 2.45 (0.65) 0.56 2.29 (0.72) 0.68 2.28 (0.78) 0.78 
Negative Sexual Experiences – General (k = 8) 2.11 (0.82) 0.78 2.09 (0.80) 0.77 2.03 (0.90) 0.80 2.40 (1.01) 0.86 2.31 (0.96) 0.84 
Negative Sexual Experiences – Relationship
b
 (k = 3)  1.98 (0.95) 0.75 1.95 (0.93) 0.73 1.70 (0.81) 0.74 2.13 (1.10) 0.78 2.36 (1.18) 0.81 
Negative Body Image Experiences (k = 8)  2.33 (0.88) 0.84 2.34 (0.88) 0.84 2.90 (0.73) 0.69 2.34 (0.96) 0.85 2.14 (0.88) 0.87 
Negative Sleep Experiences (k = 6) 2.60 (0.97) 0.84 2.59 (0.97) 0.85 3.01 (1.03) 0.84 2.18 (0.66) 0.73 2.66 (1.01) 0.89 
Positive Sexual Experiences – Others (k = 3)  2.33 (1.10) 0.81 2.36 (1.11) 0.80 2.41 (1.09) 0.63 1.97 (1.06) 0.84 2.86 (1.13) 0.82 
Positive Sexual Experiences – Self (k = 3) 2.66 (1.19) 0.84 2.67 (1.20) 0.84 3.17 (1.24) 0.83 2.47 (1.17) 0.79 2.36 (1.13) 0.85 
Positive Sexual Experiences – Relationship
b
 (k = 3)  3.51 (1.00) 0.79 3.55 (0.98) 0.78 3.74 (1.04) 0.84 3.45 (1.11) 0.72 2.96 (1.18) 0.87 
Positive Affective Experiences (k = 26)  2.85 (0.72) 0.95 2.85 (0.73) 0.95 2.98 (0.59) 0.90 2.86 (0.83) 0.96 2.77 (0.67) 0.94 
Positive Physical Experiences (k = 17)  2.81 (1.07) 0.84 2.80 (1.07) 0.85 2.76 (1.08) 0.68 2.83 (1.10) 0.86 2.85 (1.10) 0.85 
Positive Body Image Experiences (k = 7)  2.39 (0.83) 0.74 2.41 (0.84) 0.82 2.46 (0.70) 0.68 2.21 (0.75) 0.76 2.33 (0.79) 0.80 
Positive Sleep Experiences (k = 3)  2.48 (0.95) 0.67 2.49 (0.98) 0.69 2.24 (1.05) 0.86 2.74 (0.89) 0.39
a
 2.37 (0.89) 0.59 
Supplementary Subscales 
Testosterone-Related Experiences (k = 13) 1.92 (0.56) 0.76 1.94 (0.56) 0.76 2.00 (0.58) 0.72 1.89 (0.46) 0.59 1.78 (0.53) 0.76 
Progesterone-Related Experiences (k = 9) 1.70 (0.58) 0.72 1.71 (0.57) 0.71 2.18 (0.59) 0.57 1.65 (0.42) 0.49 1.42 (0.43) 0.68 
Negative Sexual Experiences – Others (k = 5) 2.13 (0.85) 0.67 2.10 (0.83) 0.66 2.11 (0.87) 0.61 2.49 (1.12) 0.83 2.38 (0.99) 0.73 
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 Full sample  
(N = 1934) 
Subsample of 
reproductive age  
(n = 1521) 
Pregnant 
subsample  
(n = 25) 
Postpartum 
subsample  
(n = 24) 
Menopausal 
subsample  
(n = 109) 
 M (SD) α M (SD) α M (SD) α M (SD) α M (SD) α 
Supplementary Subscales 
Negative Weight Experiences (k = 2)  3.01 (1.32) 0.84 3.00 (1.33) 0.85 2.98 (1.48) 0.90 3.13 (1.19) 0.85 2.96 (1.25) 0.82 
Positive Affect (k = 19) 2.84 (0.75) 0.94 2.83 (0.76) 0.94 2.93 (0.62) 0.89 2.88 (0.84) 0.95 2.84 (0.71) 0.94 
Elation (k = 7) 2.87 (0.80) 0.81 2.90 (0.80) 0.81 3.13 (0.70) 0.68 2.82 (0.87) 0.85 2.58 (0.79) 0.81 
Positive Physical Experiences – General (k = 10) 2.67 (0.62) 0.76 2.67 (0.63) 0.77 2.69 (0.53) 0.51 2.59 (0.60) 0.69 2.62 (0.55) 0.70 
Positive Skin Experiences  (k = 2) 2.56 (1.05) 0.78 2.53 (1.05) 0.79 2.28 (1.16) 0.81 2.63 (0.90) 0.31 2.83 (1.00) 0.70 
Positive Digestion Experiences (k = 3) 3.02 (0.94) 0.80 3.04 (0.94) 0.80 3.09 (0.95) 0.82 2.75 (0.96) 0.78 2.84 (0.88) 0.76 
Positive Breast Experiences (k = 3)   2.81 (1.07) 0.62 2.80 (1.07) 0.63 2.76 (1.08) 0.70 2.83 (1.10) 0.73 2.86 (1.10) 0.69 
Positive Weight Experiences (k = 3) 1.97 (0.84) 0.65 2.01 (0.85) 0.67 1.78 (0.74) 0.69 3.13 (1.19) 0.57 1.77 (0.78) 0.62 
Positive Appetite Experiences  (k = 2) 2.43 (1.00) 0.77 2.43 (1.00) 0.78 2.91 (0.99) 0.55 2.26 (1.24) 0.92 2.46 (1.03) 0.82 
Note. Women’s REP = Women’s Reproductive Experiences (REP) Questionnaire. k = number of items. The subsamples are mutually exclusive.  
a
The item “Easy falling asleep” was reverse scored for the reliability analysis among women in the postpartum period due to a negative correlation between this 
item and the other items contributing to the subscale. The interitem correlations suggested that women in the postpartum period who reported being relatively 
less content with their amount of sleep as well as less uninterrupted/peaceful sleep also reported having an easier time falling asleep. These results seem to make 
sense in the context of caring for an infant. 
b
ns = 1263, 976, 22, 20, and 70 women in a relationship, respectively.  
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Summary of Means and ANOVAs for the Women’s REP Scales and Subscales by Current Hormonal Problem Group 
(Yes/No) in the Full Sample 
 







(n = 338) 
No 
(n = 1572) 
 
Scales 
Negative Affective Experiences 2.82 (0.94) 2.31 (0.84) 96.89 < .001*** .05 
Negative Physical Experiences 2.10 (0.58) 1.84 (0.50) 71.63 < .001*** .04 
Sexual Problems – General 2.86 (0.83) 2.68 (0.73) 15.94 < .001*** .01 
Sexual Problems – Relationship
a
 2.39 (0.92) 2.20 (0.89) 7.82 .005** .01 
Positive Affective and Physical Experiences 2.61 (0.54) 2.84 (0.64) 36.56 < .001*** .02 
Body Image Quality 2.82 (0.78) 3.13 (0.73) 46.88 < .001*** .02 
Sleep Quality 2.82 (0.87) 3.14 (0.84) 43.23 < .001*** .02 
Subscales 
Hormonal Symptoms  2.02 (0.56) 1.79 (0.50) 57.40 < .001*** .03 
Decreased Appetite  1.83 (1.08) 1.70 (0.93) 5.19 .023* .003 
General Aches and Pains 2.41 (0.84) 2.41 (0.84) 75.55 < .001*** .04 
Negative Sexual Experiences – General  2.33 (0.91) 2.06 (0.79) 29.66 < .001*** .02 
Negative Sexual Experiences – Relationship
a
  2.10 (0.98) 1.95 (0.94) 4.88 .027* .01 
Negative Body Image Experiences  2.57 (0.94) 2.28 (0.86) 29.85 < .001*** .02 
Negative Sleep Experiences  2.93 (0.98) 2.53 (0.95) 49.82 < .001*** .03 
Positive Sexual Experiences – Others  2.27 (1.07) 2.34 (1.11) 44.15 .358 .00 
Positive Sexual Experiences – Self  2.60 (1.21) 2.67 (1.19) 0.89 .347 .00 
Positive Sexual Experiences – Relationship
a
  3.33 (1.04) 3.55 (0.99) 8.50 .004** .004 
Positive Affective Experiences  2.62 (0.65) 2.89 (0.73) 39.56 < .001*** .02 
Positive Physical Experiences  2.65 (1.02) 2.83 (1.07) 9.32 .002** .01 
Positive Body Image Experiences  2.12 (0.80) 2.45 (0.82) 44.15 < .001*** .02 
Positive Sleep Experiences  2.32 (0.90) 2.51 (0.96) 11.46 .001** .01 
Supplementary Subscales 
Testosterone-Related Experiences 2.16 (0.61) 2.01 (0.84) 74.27 < .001*** .04 
Progesterone-Related Experiences 1.82 (0.65) 1.67 (0.56) 19.23 < .001*** .01 
Negative Sexual Experiences – Others 2.37 (0.91) 2.08 (0.83) 32.53 < .001*** .02 
Negative Sexual Experiences – Self 2.27 (1.17) 2.04 (1.06) 12.47 < .001*** .01 
Negative Weight Experiences 3.49 (1.31) 2.91 (1.30) 56.57 < .001*** .03 
Positive Affect 2.61 (0.67) 2.89 (0.76) 40.28 < .001*** .02 
Elation 2.67 (0.77) 2.91 (0.81) 24.77 < .001*** .01 
Positive Physical Experiences – General 2.57 (0.53) 2.69 (0.64) 9.78 .002** .01 
Positive Skin Experiences  2.36 (1.02) 2.60 (1.05) 13.98 < .001*** .01 
Positive Digestion Experiences 2.83 (0.99) 2.05 (0.92) 16.76 < .001*** .01 
Positive Breast Experiences  2.64 (1.02) 2.84 (1.07) 9.32 .002** .01 
Positive Weight Experiences 1.79 (0.81) 2.01 (0.84) 18.71 < .001*** .01 
Positive Appetite Experiences  2.24 (0.96) 2.47 (1.00) 15.29 < .001*** .01 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire.  
a
n = 224 and 1029 (df = 1, 1251) women in a relationship, respectively.  
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Table 2.9  
 
Summary of Means and ANOVAs for the Women’s REP Scales and Subscales by Current Hormonal Contraceptive 
(HC) Side Effects (Yes/No) among HC Users of Reproductive Age 
 







(n = 157) 
No 
(n = 368) 
   
Scales 
Negative Affective Experiences 2.61 (0.87) 2.26 (0.83) 18.63 < .001*** .03 
Negative Physical Experiences 1.97 (0.51) 1.81 (0.49) 11.36 .001** .02 
Sexual Problems –General 2.74 (0.72) 2.66 (0.73) 1.37 .242 .003 
Sexual Problems – Relationship
b
 2.25 (0.86) 2.04 (0.77) 3.40 .022* .01 
Positive Affective and Physical Experiences 2.74 (0.60) 2.89 (0.64) 6.10 .014* .01 
Body Image Quality 2.85 (0.76) 3.14 (0.74) 17.67 < .001*** .03 
Sleep Quality 3.04 (0.90) 3.16 (0.86) 2.22 .137 .004 
Subscales 
Hormonal Symptoms  1.96 (0.54) 1.77 (0.49) 15.65 < .001*** .03 
Decreased Appetite  1.68 (0.91) 1.71 (1.03) 0.09 .765 .000 
General Aches and Pains 2.09 (0.68) 1.97 (0.71) 3.31 .069
†
 .01 
Negative Sexual Experiences – General  2.16 (0.77) 2.03 (0.79) 3.07 .080
†
 .01 
Negative Sexual Experiences – Relationship
b







Negative Body Image Experiences  2.60 (0.90) 2.67 (0.86) 16.44 < .001*** .03 
Negative Sleep Experiences  2.68 (0.97) 2.52 (0.96) 2.74 .098
†
 .01 
Positive Sexual Experiences – Others  2.30 (1.14) 2.30 (1.09) 0.001 .979 .000 
Positive Sexual Experiences – Self  2.65 (1.21) 2.68 (1.21) 0.06 .813 .000 
Positive Sexual Experiences – Relationship
b
  3.57 (0.97) 3.69 (090) 1.38 .241 .004 
Positive Affective Experiences  2.77 (0.69) 2.96 (0.72) 7.86 .005** .02 
Positive Physical Experiences  2.76 (1.03) 2.90 (1.12) 1.90 .168 .004 
Positive Body Image Experiences  2.12 (0.80) 2.47 (0.84) 10.39 .001** .02 
Positive Sleep Experiences  2.48 (1.02) 2.54 (0.96) 0.52 .470 .001 
Supplementary Subscales 
Testosterone-Related Experiences 2.04 (0.57) 1.86 (0.53) 11.98 < .001*** .02 
Progesterone-Related Experiences 1.85 (0.62) 1.65 (0.54) 14.46 < .001*** .03 
Negative Sexual Experiences – Others 2.21 (0.83) 1.99 (0.78) 8.59 .004** .02 
Negative Sexual Experiences – Self 2.07 (1.03) 2.09 (1.08) 0.05 .829 .000 
Negative Weight Experiences 3.33 (1.28) 2.90 (1.34) 11.70 .001** .01 
Positive Affect 2.74 (0.72) 2.92 (0.75) 7.05 .008** .01 
Elation 2.86 (0.78) 3.06 (0.77) 7.26 .007** .01 
Positive Physical Experiences – General 2.62 (0.58) 2.70 (0.65) 2.04 .154 .004 
Positive Skin Experiences  2.57 (1.06) 2.59 (1.09) 0.06 .802 .000 
Positive Digestion Experiences 3.03 (0.90) 3.10 (0.91) 0.76 .385 .001 
Positive Breast Experiences  2.76 1.03) 2.90 (1.12) 1.90 .168 .004 
Positive Weight Experiences 1.85 (0.83) 2.05 (0.87) 6.22 .013* .01 
Positive Appetite Experiences 2.31 (1.02) 2.46 (0.99) 2.71 .100 .01 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire.  
b
n = 114 and 256 (df = 1, 367) women in a relationship, respectively.  
†





WOMEN’S REPRODUCTIVE EXPERIENCES 
   
152 
Table 2.10  
 
Summary of Means and ANOVAs for the Women’s REP Scales and Subscales by Current Premenstrual Syndrome 
(PMS) among Free-Cycling Women of Reproductive Age in the Premenstrual Phase  
  







(n = 128) 
No 
(n = 207) 
   
Scales 
Negative Affective Experiences 2.77 (0.89) 2.25 (0.82) 30.31 < .001*** .08 
Negative Physical Experiences 1.99 (0.56) 1.78 (0.47) 13.58 < .001*** .04 
Sexual Problems – General 2.73 (0.82) 2.62 (0.72) 1.59 .208 .01 
Sexual Problems – Relationship
b
 2.46 (1.01) 2.22 (0.89) 3.37 .068
†
 .02 
Positive Affective and Physical Experiences 2.65 (0.56) 2.85 (0.65) 7.66 .006** .02 
Body Image Quality 3.00 (0.77) 3.16 (0.69) 3.87 .050
†
 .01 
Sleep Quality 2.80 (0.85) 3.14 (0.79) 13.02 < .001*** .04 
Subscales 
Hormonal Symptoms  1.93 (0.54) 1.74 (0.46) 11.44 .001** .03 
Decreased Appetite  1.89 (1.09) 1.66 (0.89) 4.32 .038* .01 
General Aches and Pains 2.23 (0.85) 1.95 (0.70) 10.48 .001** .03 
Negative Sexual Experiences – General  2.19 (0.85) 2.02 (0.77) 3.54 .061
†
 .01 
Negative Sexual Experiences – Relationship
b
  2.21 (1.03) 1.97 (0.93) 2.91 .089
†
 .01 
Negative Body Image Experiences  2.42 (0.86) 2.24 (0.83) 3.63 .058
†
 .01 
Negative Sleep Experiences  2.93 (0.96) 2.51 (0.93) 15.59 < .001*** .05 
Positive Sexual Experiences – Others  2.43 (1.15) 2.47 (1.13) 0.10 .752 .000 
Positive Sexual Experiences – Self  2.66 (1.27) 2.67 (1.14) .001 .938 .000 
Positive Sexual Experiences – Relationship
b
  3.29 (1.12) 3.54 (1.01) 2.87 .092
†
 .01 
Positive Affective Experiences  2.64 (0.64) 2.91 (0.74) 11.89 .001** .03 
Positive Physical Experiences  2.63 (1.05) 2.82 (1.04) 2.69 .102 .01 
Positive Body Image Experiences  2.33 (0.88) 2.47 (0.78) 2.32 .129 .01 
Positive Sleep Experiences  2.28 (0.99) 2.44 (0.91) 2.25 .135 .01 
Supplementary Subscales 
Testosterone-Related Experiences 2.05 (0.60) 1.85 (0.53) 10.54 .001** .03 
Progesterone-Related Experiences 1.76 (0.58) 1.58 (0.48) 7.98 .005** .02 
Negative Sexual Experiences – Others 2.20 (0.91) 2.05 (0.83) 2.34 .127 .01 
Negative Sexual Experiences – Self 2.18 (1.10) 1.97 (0.98) 3.19 .075
†
 .01 
Negative Weight Experiences 3.10 (1.28) 2.85 (1.27) 2.98 .085
†
 .01 
Positive Affect 2.62 (0.65) 2.91 (0.75) 12.57 <.001*** .04 
Elation 2.71 (0.73) 2.95 (0.84) 7.09 .008** .02 
Positive Physical Experiences – General 2.65 (0.62) 2.65 (0.64) 0.00 .987 .000 
Positive Skin Experiences  2.38 (0.94) 2.60 (1.04) 3.91 .049* .01 
Positive Digestion Experiences 2.97 (0.90) 3.08 (0.95) 1.22 .270 .004 
Positive Breast Experiences  2.63 (1.05) 2.82 (1.04) 2.69 .102 .01 
Positive Weight Experiences 1.98 (0.87) 2.00 (0.76) 0.03 .872 .000 
Positive Appetite Experiences 2.29 (1.00) 2.51 (1.02) 3.55 .061
†
 .01 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire.  
b
ns = 84 and 126 (df = 1, 208) women in a relationship, respectively.  
†
p < .10. *p < .05. **p <. 01. ***p < .001. 
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Current hormonal problems. In the full sample, 338 of 1910 women (18%) reported 
having a current hormonal problem or disorder (in general). The combined six DVs (i.e., main 
scales of the Women’s REP excluding the Sexual Problems – Relationship scale) differed by 
current hormonal problem group in a MANOVA, F (6, 1927) = 2.18, p < .001, partial 
2
 = .07. A 
summary of the group means and the results of all follow-up ANOVAs can be found in Table 
2.8. ANOVAs revealed that the two groups differed on each of the seven main scales. Women 
with a current hormonal problem had relatively higher Negative Affective Experiences, Negative 
Physical Experiences, Sexual Problems - General, and Sexual Problems – Relationship scores; as 
well as lower Positive Affective and Physical Experiences, Body Image Quality, and Sleep 
Quality scores. These group differences are illustrated in Figure 2.2. 
The combined 12 main subscale scores (excluding the relationship subscales) differed by 
current hormonal problem group, F (12, 1897) = 11.20, p < .001, partial 
2
 = .06.  The combined 
13 supplementary subscale scores also differed by group, F (13, 1896) = 9.63, p < .001, partial 

2
 = .06 as did the combined two Sexual Experiences – Relationship subscale scores, F (12, 
1250) = 4.28, p = .014, partial 
2
 = .01. Using ANOVAs, the groups differed on 12 of the 14 
main subscales and all 13 individual supplementary subscales (see Table 2.8). Women with a 
current hormonal problem had significantly higher scores on all negative experiences subscales 
as well as lower scores on most positive experiences subscales. Exceptions were the Positive 
Sexual Experiences – Self and Positive Sexual Experiences – Others scores, for which 
differences were not significant but in the expected directions.  
Current HC side effects. Among women of reproductive age who reported that they were 
using an HC, 157 women (30%) reported current HC side effects. The combined six main scale 
scores significantly differed by group, F (6, 518) = 4.53, p < .001, partial 
2
 = .05. A summary of 
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Figure 2.2. Mean scores on the main scales of the Women’s Reproductive Experiences (REP) 
Questionnaire as a function of current hormonal problem group (yes/no; ns
a
 = 157 and 368, 
respectively). Error bars represent standard error of the mean.  
a
ns = 114 and 256 women in a relationship, respectively.  
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the means and follow-up ANOVA results can be found in Table 2.9. Women with HC side 
effects had higher Negative Affective Experiences and Negative Physical Experiences scores as 
well as lower Positive Affective and Physical Experiences and Body Image Quality scores than 
women without HC side effects. The women with HC side effects also had higher Sexual 
Problems – Relationship scores. Group differences were not found for Sexual Problems – 
General or Sleep Quality. These results can be seen in Figure 2.3.  
The combined 12 main (non-relationship) subscales differed as a function of HC side 
effects group, F (12, 512) = 2.57, p = .003, partial 
2
 = .06. The combined 13 supplementary 
subscale scores, F (13, 511) = 2.94, p < .001, partial 
2
 = .07, and combined two Sexual 
Experiences – Relationship subscale scores, F (2, 366) = 5.18, p = .006, partial 
2
 = .03, also 
differed by group. Using ANOVAs, the groups differed on five of the 14 main subscales and 
seven of the 13 supplementary subscales (see Table 2.9). With respect to the main subscales, 
women with HC side effects had significantly higher Hormonal Symptoms, Negative Sexual 
Experiences – Relationship and Negative Body Image Experiences scores as well lower Positive 
Affective Experiences and Positive Body Image Experiences scores than women without HC 
side effects. Mean scores did not significantly differ as a function of group on the General Aches 
and Pains, Decreased Appetite, sexual experiences, Positive Physical Experiences, or sleep 
experiences subscales.   
On the supplementary subscales, women with HC side effects had significantly higher 
Testosterone-Related Experiences, Progesterone-Related Experiences, Negative Sexual 
Experiences – Others, and Negative Weight Experiences scores as well as lower Positive Affect, 
Elation, and Positive Weight Experiences scores than their counterparts without side effects. 
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Figure 2.3. Mean scores on the main scales of the Women’s Reproductive Experiences (REP) 
Questionnaire as a function of current hormonal contraceptive (HC) sides effects (yes/no; ns
a
 = 
157 and 36, respectively) among HC users of reproductive age. Error bars represent standard 
error of the mean. 
a
ns = 114 and 256 women in a relationship, respectively.  
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There were no group differences on Negative Sexual Experiences – Self and the positive 
physical experiences supplementary subscales.  
Current PMS. Four hundred (43%) of 922 women who were of reproductive age, not 
using an HC or non-hormonal intrauterine device (IUD), and experiencing menstrual cyclicity 
reported that they currently experience PMS when in the premenstrual phase. To better assess 
group differences between women who do versus do not experience PMS, only women who 
were within the premenstrual phase of their cycle (i.e., 1 to 10 days before their next expected 
menstrual period; O’Brien et al., 2011) when they completed the Women’s REP were examined 
further. Overall, 128 women with, and 207 women without, self-reported PMS were in the 
premenstrual phase at the time of study participation. The combined six DVs representing the 
non-relationship main scales differed by group, F (6, 328) = 5.42, p < .001, partial 
2
 = .09 (see 
Table 2.10 for the means and ANOVA results). Women in the premenstrual phase who reported 
having PMS had higher Negative Affective Experiences and Negative Physical Experiences 
scores as well as lower Positive Affective and Physical Experiences and Sleep Quality scores 
than non-PMS women in the premenstrual phase (see Figure 2.4). Sleep Quality and sexual 
problems scores did not significantly differ as a function of group. 
The combined main non-relationship subscales differed by current PMS group in a 
MANOVA, F (12, 322) = 2.37, p = .006, partial 
2
 = .08, as did the combined supplementary 
subscales, F (13, 321) = 2.77, p = .001, partial 
2
 = .10. The combined two Sexual Experiences – 
Relationship subscale scores did not significantly differ between the groups, F (2, 207) = 1.68, p 
= .190, partial 
2
 = .02. ANOVAs revealed that the groups differed on five of each type of 
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Figure 2.4. Mean scores on the main scales of the Women’s Reproductive Experiences (REP) 
Questionnaire as a function of current premenstrual syndrome (PMS; yes/no; ns
a
 = 128 and 207, 
respectively) group among free-cycling women of reproductive age in the premenstrual phase. 
Error bars represent standard error of the mean. 
a
ns = 84 and 126 women in a relationship, respectively.  
†
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subscale (main and supplementary). Women in the premenstrual phase who also reported PMS 
had higher Hormonal Symptoms, Decreased Appetite, General Aches and Pains, and Negative 
Sleep Experiences scores as well as lower Positive Affective Experiences scores than those who 
did not report PMS. Positive Physical Experiences, Positive Sexual Experiences – Others, 
Positive Sexual Experiences – Self, Positive Body Image Experiences, and Positive Sleep 
Experiences scores did not differ as a function of PMS group.  
On the supplementary subscales, there were significant effects of group for Testosterone-
Related Experiences, Progesterone-Related Experiences, Positive Affect, Elation, and Positive 
Skin Experiences, such that the PMS group had higher negative and lower positive scores than 
the non-PMS group. Overall, the results were similar when strict inclusion criteria were applied 
to the cycle-related analyses (i.e., only women with regular/predictable menstrual cycles of 25 to 
35 days were included).  
Discussion 
 The purpose of Part 1 of the present paper was to examine the factor structure and initial 
psychometric properties of the Women’s REP, a new comprehensive measure of women’s 
affective, sexual, and physical experiences during reproductive events such as the menstrual 
cycle, pregnancy, the postpartum period, and the perimenopausal transition. The results indicate 
that overall the Women’s REP consists of seven scales that are internally consistent and
demonstrate some evidence of concurrent validity. These seven scales correspond well to the 
rationally derived content domain scales that emerged during the development of the measure. 
Scores on the scales and subscales of the Women’s REP differed between women who self-
reported (yes/no) current hormonal problems, HC side effects, and PMS in the present study. 
Overall, women who reported these hormone-related problems also reported some more negative 
WOMEN’S REPRODUCTIVE EXPERIENCES 
   
160 
and some less positive experiences on the measure than women currently unaffected by these 
conditions.    
 The results suggest that there may be value in measuring both negative and positive 
experiences that are relevant to reproductive events. Given that Negative Affective Experiences 
and Positive Affective and Physical Experiences were found to be orthogonal, this study is 
consistent with research suggesting that negative and positive affect should both be examined, 
even in the context of reproductive events such as the premenstrual phase (Meaden et al., 2012) 
and the postpartum period (Buttner et al., 2012). The present study extends this finding that is 
quite robust in the mood literature to other types of experiences (e.g., sexual, physical, body, and 
sleep-related). Similar findings have also been reported for a measure of sexual self-concept for 
adolescent girls such that factor analysis revealed a positively valanced sexual arousability scale 
and a negative sexual affect scale (as well as a sexual agency scale; O’Sullivan et al., 2006).  
The inclusion of positive experiences in the present study also revealed group differences 
both within and across reproductive events. For example, women who did and did not report 
current HC side effects differed on Positive Body Image Experiences and Positive Weight 
Experiences whereas women with and without PMS did not differ in these areas. The PMS 
groups differed on Positive Skin Experiences whereas the HC side effect groups did not.  It is 
also noteworthy that the Sexual Experiences – General, Body Image Quality, Sleep Quality, and 
Sexual Experiences – Relationship scales were found to have separate negative and positive 
subscales. The Women’s REP appears to be the only multidimensional measure of women’s 
reproductive symptoms that comprehensively assesses both negative and positive experiences.  
 Interestingly, mean scores on the physical and sleep-related positive experiences 
subscales, consisting primarily of positively worded items, tended to be similar (not significantly 
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different) between women with and without HC side effects or women with and without PMS. 
This finding is difficult to explain in light of the significant group differences on the 
corresponding negative experiences subscales. However, it may help to provide some support for 
the validity of self-reports of both HC side effects and PMS. It suggests that women reporting 
these experiences do not have a response bias whereby they simply present themselves more 
negatively or less positively on all items. Women who did and did not report current HC side 
effects significantly differed on Negative Sexual Experiences – Relationship, Negative Sexual 
Experiences – Others, Negative Body Image Experiences, and Negative Weight Experiences 
whereas women with and without PMS did not differ in these areas. The PMS groups differed on 
Decreased Appetite, General Aches and Pains, Negative Sleep Experiences whereas the HC side 
effect groups did not. These different patterns of experiences on the Women’s REP provide some 
evidence for the validity of the findings.   
 It is possible that women may report more extreme experiences on negatively versus 
positively worded items (but see Meaden et al., 2005), as might be suggested by the fact that the 
hormonal problems groups significantly differed on all scales and subscales except two of three 
positive sexual experiences subscales. However, the women who reported having a hormonal 
problem or disorder were likely a heterogeneous and perhaps more severe group compared those 
who reported HC side effects or PMS specifically. If so, such differences might account for the 
relatively high number of significant differences between the hormonal problem groups. That is, 
scores on the positive scales and subscales may only be low or high in extreme conditions (e.g., 
low positively valenced scores may be indicative of high severity of a woman’s condition, such 
as a hormonal disorder). 
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The subscales consisting of purely negatively or positively valenced items were 
statistically independent and so, directly opposite co-variation (i.e., low negative, high positive 
or vice versa) cannot always be assumed. On one hand, this finding may suggest that positive 
experiences are strengths, which women with and without various self-reported HC or 
premenstrual problems have to a similar extent. It is also possible that the ratio of negative to 
positive experiences is relevant. This might be the case if women interpret a lack of positive 
experiences as negative experiences or the presence of positive experiences as a lack of negative 
experiences. This possibility could be examined in future research.  
 The present study is one of the first to suggest that women’s overall affective, sexual, and 
physical experiences consist of seven distinct factors and that they can be measured at various 
points across the lifespan using the same questionnaire for each reproductive event. According to 
Tabachnick and Fidell (2007), a good factor analysis is one that makes sense. Interpretability 
seems to be a strength of the present study such that the results of the factor analyses (Tables 2.3, 
2.5, and 2.6) fit with the content domains originally developed (Table 2.2) and make sense in the 
context of experiences relevant to women. For example, although a “body image” factor was not 
hypothesized a priori (as might be the case in confirmatory factor analysis), the exploratory 
results were highly suggestive of such an internally consistent and seemingly face valid scale. 
This finding fits with what is known about the importance of appearance, weight, and dietary 
habits in women’s lives and evidence that body image may be affected by hormones and HC use 
(e.g., Bird et al., 2012; Klump et al., 2015; Racine et al., 2012).    
 A potential weakness of the Women’s REP is the complexity of the items pertaining to 
eating and body image, which tended to load on two factors. However, in the final solution, it 
would appear that the eating items, which seemed most relevant to body image and weight, 
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loaded most strongly on the Body Image Quality scale, while items pertaining to decreased 
appetite in particular formed a separate subscale of the Negative Physical Experiences scale. It 
has been suggested that complex items could be deleted in questionnaire development 
(Tabachnick & Fidell, 2007). However, the fact that these items were relevant across more than 
one domain may also suggest that they are particularly important to women’s functioning. The 
decision to continue to include such items was also related to evidence that hormones play a role 
in eating, body image, and weight (Klump, Raccine, Hildebrandt, Burt, & Neale, 2014).  
 Similarly, some differences in factor loadings from the full sample to the subsample of 
women in a relationship may suggest that items related to sexual- or romantic-experiences 
without reference to a context (e.g., “Vaginal lubrication,” “Avoidant of intimacy/affection,” and 
“Physical pleasure/comfort during sexual activity”) may be too general in content. For instance, 
the items designed for the sexual experiences domain were mostly in regards to sexual 
experiences in three contexts: “with others or the thought of others,” “through masturbation 
(alone),” or “with a primary partner.” It is possible that the former more general items should be 
presented within each context or removed in a subsequent version of the Women’s REP. Another 
potential limitation of the Women’s REP that will be considered in future iterations is the lack of 
a consistency or a response bias scale.  
This first study presents the development of the Women’s REP, a measure with potential 
value for assessing women’s reproductive experiences in both research and clinical practice. 
Given that exploratory factor analysis is one of the first steps of scale development and 
applicable to theory development, one of the next steps might be to conduct a confirmatory 
factor analysis of the Women’s REP to test the scales and subscales found here. While the 
present study included a very large number of women with a variety of reproductive experiences, 
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the ratio of the number of items to subsample size for pregnant, postpartum and perimenopausal 
women was too low for separate factor analyses. Future research should also examine whether 
the empirical structure of the Women’s REP is consistent across other samples of women in 
general, women of reproductive age, pregnant women, women in the postpartum period, and 
perimenopausal women or women mid-aged (45 to 65 years as per Hunter, 1992).  
Part 2: 
Reproductive and Hormonal Status Differences on the Women’s Reproductive Experiences 
(REP) Questionnaire 
For Part 2, the possibility that women who differ in reproductive/hormonal statuses may 
also differ on the Women’s REP was examined. Relevant reproductive and hormonal status 
differences on the Women’s REP would be further evidence for concurrent validity of the scales 
and subscales of the measure. The following types of groups were examined: (a) reproductive 
status groups (free-cycling women, copper IUD users, OC users, other HC users, pregnant 
women, postpartum women, and menopausal women); (b) cycle regularity groups in free-cycling 
women (ammenorheic, irregularly cycling, and regularly cycling women); and (c) menstrual 
phase groups (menstrual, periovulatory, and premenstrual) in each of (i) free-cycling women, (ii) 
OC users, and (iii) other HC users.  
The main goal was to explore whether the Women’s REP scores would differ between 
reproductive and hormonal status groups in relevant ways for the purposes of assessing 
concurrent validity, rather than examining specific directional group differences per se. Thus, 
given the large number of possible differences (due to the number of scales and subscales and for 
some analyses, the number of groups), some general predictions or expectations regarding group 
differences on the main scales were made for the sake of simplicity. First, pregnant, postpartum, 
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and menopausal women may have some relatively extreme scores on the Women’s REP since 
these events are associated with more extreme or eventful reproductive, hormonal, and lifestyle 
changes than free-cycling or copper IUD, OC, and HC use (Speroff & Fritz, 2005). In particular, 
it was expected that pregnant, postpartum, and menopausal women would, for the most part, 
have relatively high negative experiences scores (i.e., Neagtive Affective Experiences, Negative 
Physical Experiences, Sexual Problems – General, Sexual Problems – Relationship scale and 
subscale scores) and low positive experiences scores (i.e., Positive Affective and Physical 
Experiences, Sleep Quality, and Body Quality scale and subscale scores). It was also predicted 
that regularly cycling women and women in the periovulatory phase would have lower negative 
experiences scores and higher positive experiences scores than non-regularly cycling women and 
women in the menstrual and premenstrual phases, respectively. These predictions were based on 
research suggesting that fertility, estrogen, and testosterone tend to have positive effects, while 
progesterone generally has negative effects, on well-being and sexual behavior (see Bäckström et 
al., 1983; Rapkin, Biggio, & Concas, 2006; Roney & Simmons, 2013; Rubinow, Schmidt, & 
Roca, 1998). Menstrual cycle phase group differences were predicted to be attenuated in OC and 
HC users compared to free-cycling women (e.g., Graham & Sherwin, 1993; Oinonen & 
Mazmanian, 2002). Also, among free-cycling women, estimates of conception probability 
(Wilcox, Dunson, Weinberg, Trussell, & Baird, 2001) and reproductive hormone levels 
(estrogen, progesterone, testosterone, luteinizing hormone [LH], and follicle-stimulating 
hormone [FSH]; Puts, 2006) were examined in relation to the Women’s REP scores. It was 
predicted that negatively valenced scales would be negatively related, while positively valanced 
scales would be positively related, to conception probability, estrogen, testosterone, LH, and 
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FSH estimates. For progesterone level, estimates were expected to be positively related to 
negative experiences scales and negatively related to positive experiences scales.  
Data Reduction and Analysis  
A series of one-way MANOVAs and ANOVAs were conducted to examine differences 
in women’s experiences as a function of a number of reproductive and hormonal groups. 
Dependent variables were the Women’s REP (a) scale, (b) subscale, and (c) supplementary 
subscale scores. Significant MANOVAs were followed up with univariate ANOVAs and 
pairwise comparisons. For each of eight MANOVAs, the overall results and conclusions did not 
change substantially when Bonferroni correction was applied
21
, given that all significant analyses 
were at the level of p < .001, or when discriminant function analysis was employed to predict 
group membership from Women’s REP scores. Thus, the uncorrected results are presented.  
Reproductive status groups. For the purpose of comparing reproductive status groups, 
only women who were exclusively in one of seven naturally formed groups were included in 
analyses involving the full sample of women: free-cyclers (i.e., no non-hormonal IUD or HC 
use; final n = 1053), copper IUD users (n = 29), OC users
22
 (n = 360), other HC users
23
 (n = 
176), pregnant women (n = 25), postpartum women (n = 24), and menopausal women (n = 79). 
Thus, 58 women were excluded. Also, women who reported that they were going, or went, 
                                                 
21
 Including the MANOVAs in Part 1, Bonferroni correction involved a family-wise alpha of .05 with a significance 
level of p < .006 for each separate MANOVA. Results and conclusions also did not change substantially when the 
correction was applied for each MANOVA to the subsequent ANOVAs and to the pairwise comparisons tests, 
separately.  
22
 Women using monophasic (n = 254) and triphasic (n = 93) OC preparations did not differ on the combined six 
main scales of the Women’s REP, F (6, 340) = 0.90, p = .496, partial η
2
  = 0.02, nor did women using preparations 
containing first, second, third, and fourth generation progestins (ns = 71, 107, 135, and 34), F (18, 1020) = 0.60, p = 
.940, partial η
2
  = 0.01. Women who reported “continuous” OC use (i.e., use longer than the typical 28-day induced 
cycle length whereby withdrawal is skipped for a period of time; n = 93) did not differ on the combined scales from 
non-continuous users (n = 265), F (6, 351) = 1.57, p = .155, partial η
2
  = 0.03. Thus, these groups of women were 
combined to form an OC user group.  
23
 Women using an injected contraceptive (n = 41), a contraceptive patch (n = 16), a hormonal IUD (n = 86), or a 
vaginal ring (n = 32) did not differ on the combined six main scales of the Women’s REP, F (6, 18) = 1.23, p = .229, 
partial η
2
  = 0.04. Thus, these women were combined to form an “other” (than OC) HC user group.  
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through menopause but were less than 44 years of age (n = 18) or still experiencing menstrual 
cyclicity (n = 12) were excluded from these analyses. The purpose was to form a more 
homogenous group of women who were in the menopausal, rather than perimenopausal, period 
as defined by age (i.e., mid-aged) and a lack of menstrual cyclicity, regardless if menopause was 
induced surgically or reached naturally (Shifren & Gass, 2014). Sample sizes were too low to 
permit group analyses by stages of reproductive aging through the perimenopausal transition 
(Harlow et al., 2012).   
 Menstrual cycle regularity groups. From the full sample of women, those under the age 
of 44 years were considered to be of reproductive age and included in any subsequent analyses. 
Ninety women did not meet this criterion. Women who were pregnant, postpartum, 
perimenopausal, using HCs, or did not complete the menstrual cycle regularity item (n = 7) were 
also excluded from the analyses of regularity. This left a total of 955 free-cycling women. Of 
these, the 31 women who reported that they “never have [a] period” or “have not had [a] period 
in the past three months” were considered to be amenorrheic. Another 349 women reported that 
their periods were irregular (i.e., “I get my period and some months I don’t”) and 575 reported 
regular periods (i.e., “I usually get my period within two to three days of when I expect it” or “My 
period is like clockwork; the same number of days elapse between periods”).  
 Menstrual and pseudo- cycle phase groups. In the subsample of women of 
reproductive age, the forward and backward counts of the day of each participant’s menstrual or 
HC-induced pseudo- cycle in which she completed the questionnaire was determined (see 
Hampson & Young, 2008). These counts are made from women’s estimates of the date of the 
start of their last (most recent) and next predicted menstrual or withdrawal bleeding period. 
Given that the midcycle LH peak just prior to ovulation typically occurs 15 days prior to a free-
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cycling woman’s next menstrual period (Hampson & Young, 2008; e.g., Treloar et al., 1967), the 
distance between the dates each woman completed the study and her estimated LH peak was 
determined in days (DLH). Expected equivalents in a standardized 28-day cycle were then 
calculated as per Puts (2006). If DLH < 0, then DLH(28) = DLH [13 / (c – 15)], where c is a woman’s 
menstrual cycle length. If DLH ≥ 0, then DLH  = DLH(28). This method assumes that most 
variability in cycle length occurs in the follicular phase (i.e., from the first day of menses to the 
LH peak; Schnatz, 1985).  
 Using these standardized day of cycle estimates, women were grouped into the following 
phases: menstrual (day 1 to 7 if menstrual or withdrawal bleeding), periovulatory (day 9 to 15 if 
not bleeding), and premenstrual (day 19 to 28 if not bleeding; see O’Brien et al., 2011). These 
phases were chosen based on previous research and theory and because they maximally differ in 
the probability of conception (as recommended by Gilversleeve, Hasleton, & Fales, 2014). 
Conception probability (Wilcox et al., 2001) was estimated for each woman based on forward 
day count using actuarial data, as was the probability of being in the fertile phase around 
ovulation (Wilcox et al., 2000; values obtained from A. J. Wilcox, personal communication, 
December 11, 2012). In addition, sex hormone level estimates were assigned according to DLH(28) 
(estradiol, progesterone, testosterone, LH, and FSH; see Puts, 2006; values obtained from D. A. 
Puts, personal communication, October 23, 2014).   
Among free-cycling women, the 31 women considered to be amenorrheic were excluded 
from analyses of menstrual cycle phase. Menstrual cycle day could not be estimated for an 
additional 46 women due to a lack of, or inconsistent, self-reported menstrual cycle information. 
Of the remaining 879 women, 171 completed the study outside of the three target phases and 
were thus, excluded from the cycle phase group comparisons, but included in supplementary 
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correlational analyses. In total, 167 women were in the menstrual phase, 206 in the periovulatory 
phase, and 335 in the premenstrual phase.  
Among all types of HC users, 68 reported that they had not experienced menses for at 
least three months and were thus, also excluded from analyses of pseudo-cycle phase. Menstrual 
cycle day could not be estimated for an additional 25 OC and other HC users due to a lack of, or 
inconsistent, menstrual cycle information. Of the remaining 436 women, 97 completed the study 
outside of the three target phases. Final group sample sizes for the menstrual, periovulatory, and 
premenstrual phases were: 67, 82, 108 for OC users and 19, 25, 38 for HC users, respectively.  
Results 
Reproductive status groups. A summary of the means as well as ANOVA and pairwise 
comparison results in this section can be found in Table 2.11. The combined six main scale 
scores (Sexual Problems – Relationship examined separately) significantly differed between 
groups in a MANOVA, F (36, 10434) = 2.95, p < .001, partial η
2
  = .01. There was a significant 
main effect of group for Negative Affective Experiences, Sexual Problems – General, Sexual 
Problems – Relationship, and Sleep Quality but not Positive Affective and Physical Experiences 
scores. Negative Physical Experiences and Body Image Quality scores were not significantly 
different between the groups.  
As seen in Figure 2.5, with respect to Negative Affective Experiences, Copper IUD users 
appeared to have the highest, while the menopausal group had the lowest, scores, but the mean 
difference was not significant, p = .071. There were significant differences between other groups 
with OC users having lower scores than the free-cycling group and other HC users, ps = .013 and 
.009. The menopausal group also had the lowest Negative Physical Experiences scores in 
comparison to pregnant women, who had the highest score, p = .005. For Sexual Problems – 
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Summary of Means and ANOVAs for the Scales and Subscales of the Women’s REP by Reproductive Status Group in the Full Sample of Women  
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6.05 < .001*** .02 
Positive Physical 
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1.58 .149 .01 
Note. Women’s REP = Women’s Reproductive Experiences (REP) Questionnaire. OC = oral contraception. IUD = intrauterine device. HC = hormonal 
contraception other than oral contraception. Within rows, each subscript letter “a” through “k”
 
denotes a significant pairwise comparison at p < .05. 
l 
ns = 647, 24, 257, 118, 22, 20, and 51 (df = 6, 1132) women in a relationship, respectively.  
†
p < .10. *p < .05. **p < .01. ***p <.001.
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Figure 2.5. Mean scores of the main scales of the Women’s Reproductive Experiences (REP) 
Questionnaire as a function of reproductive status group for (a) negatively valenced scales and 
(b) positively valenced scales (ns = 1053, 29, 360, 176, 25, 24, and 79, respectively
a
). Errors bars 
represent standard error of the mean. Specific notes refer to the significance of overall ANOVAs 
for group differences.  
a
ns = 647, 24, 257, 118, 22, 20, and 51 women in a relationship.  
†
















Body Image Quality Sleep Quality
*** † 
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General, the copper IUD had significantly lower scores than the menopausal group, p < .001. 
With respect to Body Image Quality, pregnant women had the lowest mean score, significantly 
different than the highest mean score, which was found in the menopausal group, p = .044. Sleep 
Quality scores were significantly higher in the OC group than the pregnant group, p = .005. 
While the ANOVA was not significant, there was a significant pairwise comparison between 
free-cycling and OC using women on Positive Affective and Physical Experiences (free-cycling 
< OC).  
Among women in a relationship, there was a significant effect of group for mean Sexual 
Problems – Relationship scores. Menopausal women had higher scores than pregnant women as 
well as the HC, copper IUD, OC, and free-cycling groups, ps = .048 to < .001. The free-cycling 
group had higher scores than the OC and HC groups, ps = .045 and .043.  
Main subscales. The combined 12 main non-relationship subscale scores differed by 
group, F (72, 10398) = 2.84, p  < .001, partial η
2
  = .02. There was also a significant effect of 
group for 10 of all of the main subscales (see Table 2.11). There was no effect of group for 
Decreased Appetite, Positive Affective Experiences, Positive Physical Experiences, and Positive 
Body Image Experiences.  
Pairwise comparisons revealed that pregnant women had the highest Hormonal 
Symptoms scores compared to the free-cycling, OC, and menopausal groups, ps = .018 to < .001, 
while menopausal women had the lowest scores compared to the free-cycling, OC, and copper 
IUD groups, ps = .014 to < .001. General Aches and Pains scores were lower among OC users 
than any other group, ps = .036 to < .001, while pregnant women appeared to have the highest 
mean score, ps = .043 to < .001. With respect to Negative Sexual Experiences – General, the 
menopausal group had the highest mean score, significantly higher than the lowest mean score 
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(copper IUD users), p =  .004. On the Negative Body Image Experiences subscale, pregnant 
women scored higher than all of the other groups, ps = .046 to < .001. The HC group also scored 
higher than the menopausal, OC, and free-cycling groups, ps = .025 to .005. On the Negative 
Sleep Experiences scale, the OC group had the lowest score compared to the free-cycling, HC, 
pregnant, and menopausal groups, ps = .053 to < .001, while the pregnant group appeared to 
have the highest mean score, ps = .032 to .005.  
With respect to the Positive Sexual Experiences – Others subscale, copper IUD users had 
the highest mean score compared to the OC, pregnant, and menopausal groups, ps = .021 to .001. 
Menopausal women appeared to have the lowest scores, ps = .041 to .001. On the Positive 
Sexual Experiences – Self subscale, the pregnant and copper IUD groups had higher scores than 
free-cycling, OC, postpartum, and menopausal women, ps = .042 to .001, with the menopausal 
women again appearing to have the lowest scores. OC users had significantly higher Positive 
Sleep Experiences scores than all groups, ps = .053 to .002, except copper IUD users (who had 
the highest overall scores), p = .782. 
 There was also a significant effect of group on the combined two subscale scores of the 
Sexual Problems – Relationship scales, F (12, 2264) = 2.77, p = .001, partial η
2
  = .01. Both 
Negative Sexual Experiences – Relationship and Positive Sexual Experiences – Relationship 
scores differed by group. Menopausal women also had higher Negative Sexual Experiences – 
Relationship scores than pregnant, HC, copper IUD, OC, and free-cycling groups but not 
postpartum women, ps = .008 to < .001. Menopausal women had lower Positive Sexual 
Experiences – Relationship scores than the pregnant, postpartum, HC, copper IUD, OC, and free-
cycling groups, ps = .024 to < .001. Free-cycling women had lower scores than the OC and HC 
groups, ps = .034 to < .001. 
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 Supplementary subscales. The combined 13 supplementary subscale scores differed by 
group, F (78, 10392) = 2.86, p < .001, partial η
2
  = .02. There was a significant effect of group on 
Progesterone-Related Experiences and Negative Sexual Experiences – Others but not for 
Testosterone-Related Experiences and Negative Sexual Experiences – Self. Pairwise 
comparisons showed that the pregnant group had the highest Progesterone-Related Experiences 
scores compared to all other groups, ps = .002 to < .001. The menopausal group had lower scores 
than all other groups on this subscale, ps = .035 to < .001. The postpartum group and the 
perimenopausal group had higher Negative Sexual Experiences – Others scores than free-
cycling, OC, HC, and copper IUD groups, ps = .035 to < .001.  
Summary. Overall, the largest group differences across the scales and subscales tended to 
be between three groups: pregnant, menopausal, or OC using women. Pregnant women had 
comparatively high mean Negative Physical Experiences, Progesterone-Related Experiences, and 
Elation scores as well as low mean Sexual Problems – Relationship, Body Image Quality, and 
Sleep Quality scores. Menopausal women had the lowest Negative Affective Experiences, 
Negative Physical Experiences, Progesterone-Related Experiences and Elation scores but highest 
Body Image Quality scores. They had relatively high Sexual Problems – General and – 
Relationship scale and subscale scores as well. The postpartum group also had relatively high 
Sexual Problems scores and low Sleep Quality scores. OC users had the lowest Negative 
Affective Experiences scores and highest Sleep Quality scores. The scores of the remaining free-
cycling, copper IUD, HC, and women tended to be mid-range. Lastly, when differences were 
significant, OC users had better (i.e., less negative or more positive) scores than non-users and 
other HC users.  
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Menstrual cycle regularity groups. A summary of the means as well as ANOVA and 
pairwise comparison results for the amenorrheic, irregularly cycling, and regularly cycling 
groups can be found in Table 2.12. The combined six main non-relationship scale scores 
significantly differed between cycle regularity groups, F (12, 1896) = 6.58, p  < .001, partial η
2 
= 
.04. All seven individual main scales also differed as a function of group. 
As seen in Figure 2.6, amenorrheic women and irregularly cycling women generally had 
higher scores on all of the negative experiences scales and lower scores on all the positive 
experiences scales than regularly cycling women, ps = .002 to < .001 (exceptions were Sexual 
Problems – General and Sexual Problems – Relationship, for which only the differences between 
irregularly and regularly cycling women were significant, ps = .016 and .015). The amenorrhea 
group also had higher Negative Affective Experiences scores and lower Body Image Quality 
scores than irregularly cycling women, ps = .002.  
Main subscales. The combined 12 main non-relationship subscale scores significantly 
differed between cycle regularity groups, F (24, 1884) = 4.06, p < .001, partial η
2 
= .05. Positive 
Sexual Experiences – Others and Positive Sexual Experiences – Self did not significantly differ 
by group in ANOVAs. Significant overall group effects were found for 11 non-relationship and 
relationship subscales (see Table 2.12).  
Pairwise comparisons indicated that the amenorrhea and irregularly cycling groups had 
higher scores on all of the negative experiences subscales and lower scores on all of the positive 
experiences subscales than the regularly cycling group, ps = .048 to < .001. The difference 
between the amenorrhea group and the regularly cycling group was not significant for Decreased 
Appetite, p = .369. The amenorrheic group had higher Negative Body Image Experiences and 
lower Positive Body Image Experiences than the irregularly cycling group, ps = .002 and .025.  
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Summary of Means and ANOVAs for the Scales and Subscales of the Women’s REP by Menstrual Cycle Regularity Group in Women of Reproductive Age  
 






Dependent variable Amenorrhea 
(n = 31) 
Irregular 
(n = 349) 
Regular 
(n = 575) 
   
Scales 






 (0.86) 24.21 < .001*** .05 






 (0.50) 20.01 < .001*** .04 




 (0.74) 3.61 .028* .01 
Sexual Problems – Relationship
d




 (0.89) 3.30 .038* .01 






 (0.65) 16.47 < .001*** .03 





















 (0.49) 16.42 < .001*** .03 




 (0.89) 12.17 < .001*** .03 




 (0.74) 15.23 < .001*** .03 






 (0.79) 5.64 .004** .01 
Negative Sexual Experiences – Relationship
d
 2.28 (1.10) 2.07 (1.02) 1.95 (0.92) 1.74 .153 .01 






 (0.85) 12.20 < .001*** .01 




 (0.97) 10.51 < .001*** .02 






 (0.75) 14.85 < .001*** .03 






 (1.06) 11.92 < .001*** .02 
Positive Sexual Experiences – Others 2.42 (0.96) 2.31 (1.05) 2.41 (1.14) 0.93 .398 .002 
Positive Sexual Experiences – Self 2.55 (1.09) 2.64 (1.17) 2.68 (1.21) 0.30 .739 .001 
Positive Sexual Experiences – Relationship
d




 (1.00) 4.34 .015* .01 






 (0.86) 18.64 < .001*** .04 












 (0.54) 19.40 < .001*** .04 




 (0.54) 7.82 < .001*** .02 






 (0.82) 6.93 .001** .01 
Negative Sexual Experiences – Self 2.34 (1.08) 2.13 (1.05) 2.03 (1.10) 1.88 .154 .004 






 (1.30) 21.14 < .001*** .04  
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Dependent variable Amenorrhea 
(n = 31) 
Irregular 
(n = 349) 
Regular 
(n = 575) 
   
Supplementary Subscales 




 (0.78) 14.67 < .001*** .03 




 (0.82) 10.61 < .001*** .02 




 (0.66) 6.80 < .001*** .01 




 (1.06) 7.20 < .001*** .02 




 (0.95) 8.38 < .001*** .02 




 (1.06)  2.91
ab
 (1.06) 11.92 < .001*** .02 






 (0.88) 10.03 < .001*** .02 






 (1.03) 7.18 .001** .02 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. Within rows, each subscript letter “a” through “c”
 
denotes a significant pairwise 
comparison at p < .05. 
d
ns = 17, 205, 357 (df = 2, 576) women in a relationship, respectively.  
*p < .05. **p < .01. ***p < .001. 
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Figure 2.6. Mean scores as a function of cycle regularity group for (a) negatively valenced scales 
and (b) positively valenced scales (ns
a
 = 31, 349, and 575, respectively). Errors bars represent 
standard error of the mean. 
a
ns = 17, 205, and 357 women in a relationship, respectively.  
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Among women in a relationship, the combined two Sexual Problems – Relationship 
subscales scores significantly differed between the groups, F (4, 1152) = 2.52, p = .039, partial 
η
2
  = 0.01. The three cycle regularity groups did not differ on Negative Sexual Experiences – 
Relationship in an ANOVA, whereas the Positive Sexual Experiences – Relationship subscale 
did show a group effect. Pairwise comparisons revealed that the irregularly cycling group had 
lower scores than the regularly cycling group, p = .005.   
Supplementary subscales. The combined 13 subscale scores significantly differed by 
group, F (26, 1882) = 3.50, p = < .001, partial η
2
  = .05. ANOVAs did not reveal a group effect 
for Negative Sexual Experiences – Self, but the groups differed on all of the other 12 separate 
scales (see Table 2.12). Pairwise comparisons revealed that irregularly cycling women had 
higher negatively valenced scores and lower positively valenced scores than regularly cycling 
women on all subscales, ps = .001 to < .001. The ammenorheic group tended to have higher 
negative experiences scores and lower positive experiences scores compared to the regularly 
cycling group for all subscales, ps = .098 to < .001. The ammenorheic group also had a higher 
mean Negative Weight Experiences score than irregularly cycling women, p = .008.  
Summary. Results revealed that regular cycling women generally showed less negative 
and more positive symptom or experience scores across the scales and subscales than the other 
two groups, particularly irregularly cycling women.  On the Testosterone-Related Experiences 
and Progesterone-Related Experiences subscales, regularly cycling women tended to have the 
lowest scores, while irregularly cycling women had the highest score on the former scale. It is 
noteworthy that, of all the 34 scales (7 main scales, 14 subscales, and 13 supplementary 
subscales), there were only four scales on which the three menstrual cycle regularity groups did 
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not differ (i.e., Negative Sexual Experiences – Relationship, Negative Sexual Experiences – Self, 
Positive Sexual Experiences – Others, and Positive Sexual Experiences – Self subscales).  
Menstrual cycle phase groups. Preliminary reliability analyses were first conducted for 
researcher estimates of day in cycle (forward count, backward count, and phase group based on 
standardized day) as well as conception probability and hormone level estimates. In addition to 
the author, who estimated cycle day counts for all women, a research assistant did counts for a 
subset of the women (n = 234). The data suggested good inter-rater reliability (single-measures): 
forward count, rI = .88, 95% CI [.85, .91], p < .001; and backward count, rI = .90, 95% CI [.87, 
.92], p < .001. When participants were grouped by cycle phase (menstrual, perivovulatory, 
premenstrual, and outside target phases), the inter-rater reliability was found to be high as well,  
= .86, 95% CI [.81, .91], p < .001.  
The three phase groups significantly differed as would be expected in mean standardized 
day of cycle (menstrual: n = 167; M = 3.47, SD = 1.71; periovulatory: n = 206; M = 11.85, SD = 
1.87; premenstrual: n = 335; M = 23.70, SD = 2.97); as well as estimates of conception 
probability (menstrual: M = .003, SD = 0.01; periovulatory: M = 0.06, SD = 0.03; premenstrual: 
M = 0.02, SD = 0.03); estradiol levels in pg/ml (menstrual: M = 86.34, SD = 7.11; periovulatory: 
M = 197.70, SD = 46.40; premenstrual: M = 154.43, SD = 37.28); progesterone levels in ng/ml 
(menstrual: M = 0.45, SD = 0.07; periovulatory: M = 0.85, SD = 0.51; premenstrual: M = 9.37, 
SD = 3.95); testosterone levels in pg/ml (menstrual: M = 274.88, SD = 25.45; periovulatory: M = 
365.07, SD = 36.51; premenstrual: M = 287.70, SD = 38.53); LH levels in mlU/ml (menstrual: M 
= 12.03, SD = 067; periovulatory: M = 21.95, SD = 12.86; premenstrual: M = 10.92, SD = 8.95); 
and FSH levels in mlU/ml (menstrual: M = 10.39, SD = 0.61; periovulatory: M = 10.50, SD = 
4.50; premenstrual: M = 8.55, SD = 3.23); Fs (2, 705) = 147.57 to 42.03, ps < .0001, partial 
2
s = 
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.30 to .92. Estimates of the probability that a woman was in the fertile window of the 
periovulatory phase were also significantly different between phase groups (menstrual: M = 0.01, 
SD = 0.01; periovulatory: M = 0.27, SD = 0.12; premenstrual: M = 0.17, SD = 0.10), F (2, 705) = 
369.57, p < .0001, partial 
2
 = .51. Also, the estimates of conception probability and 
reproductive hormones were correlated in directions that would be expected (see Table 2.13).
These findings provide evidence of the reliability and validity of the coding/classification of 
participants’ menstrual cycle days.   
A summary of all of the univariate ANOVA results for the Women’s REP scores as a 
function of the menstrual cycle phase groups can be found in Table 2.14. The combined six non-
relationship main scale scores significantly differed between menstrual cycle phases in the 
MANOVA, F (12, 1402) = 3.37, p = < .001, partial η
2
  = .03. There was a significant main effect 
of group for four of the scales (Negative Affective Experiences, Body Image Quality, Negative 
Physical Experiences, and Sleep Quality).  
As seen in Figure 2.7, Negative Affective Experiences and Negative Physical 
Experiences scores were highest in the menstrual phase group compared to the other two groups, 
ps = .010 to < .001. Body Image Quality and Sleep Quality scores were highest in the 
periovulatory phase group compared to the other groups, ps = .070 to < .001.  
Among women in a relationship, there was no significant group effect for Sexual 
Problems – Relationship scores. However, although not significantly different, the mean score of 
women in the periovulatory phase appeared lower than that of women in the premenstrual phase, 
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Correlations between Conception Probability and Hormone Level Estimates among Free-
Cycling Women of Reproductive Age (n = 879) 
 
Variable CP E P T LH FSH 
CP 1      
E .58*** 1     
P -.13*** .37*** 1    
T .59*** .60*** -.03 1   
LH .37*** .46*** -.25*** .61*** 1  
FSH .16*** .04 -.54*** .42*** .86*** 1 
Note. CP = conception probability. E = estradiol. P = progesterone. LH = luteinizing hormone. 
FSH = follicle-stimulating hormone.  
***p < .001. 
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Summary of Means and ANOVAs for the Scales and Subscales of the Women’s REP by Menstrual Cycle Phase Group among Free-Cycling Women of 
Reproductive Age 
 






Dependent Variable Menstrual 
(n = 167) 
Periovulatory 
(n = 206) 
Premenstrual 
 (n = 335) 
   
Scales 






 (0.88) 7.86 < .001*** .02 






 (0.52) 12.68 < .001*** .04 
Sexual Problems – General 2.76 (0.68) 2.69 (0.76) 2.67 (0.76) 0.82 .440 .002 
Sexual Problems – Relationship
d
 2.24 (0.91) 2.13 (0.86) 2.31 (0.95) 1.69 .186 .01 
Positive Affective and Physical Experiences 2.72 (0.66) 2.83 (0.66) 2.77 (0.63) 1.27 .281 .004 






 (0.73) 6.50 .002** .02 












 (0.50) 18.50 < .001*** .05 
Decreased Appetite 1.82 (1.03) 1.76 (0.90) 1.75 (0.97) 0.30 .744 .001 




 (0.74) 2.06 (0.77) 3.23 .040* .01 
Negative Sexual Experiences – General 2.16 (0.79) 2.06 (0.84) 2.09 (0.81) 0.67 .510 .002 
Negative Sexual Experiences – Relationship
d
 1.97 (1.00) 1.91 (0.88) 2.07 (0.98) 1.08 .340 .01 






 (0.84) 11.27 < .001*** .03 






 (0.96) 3.57 .011* .01 




 (0.77) 2.81 (0.72) 2.50 .083
†
 .01 
Positive Physical Experiences 2.78 (1.08) 2.81 (1.02) 2.75 (1.05) 0.27 .762 .001 
Positive Sexual Experiences – Others 2.30 (1.04) 2.31 (1.11) 2.45 (1.13) 1.60 .203 .01 
Positive Sexual Experiences – Self 2.60 (1.14) 2.66 (1.21) 2.67 (1.19) 0.23 .798 .001 
Positive Sexual Experiences – Relationship
d




 (1.06) 1.99 .138 .01 
Positive Body Image Experiences 2.43 (0.92) 2.55 (0.83) 2.42 (0.82) 1.54 .216 .004 















 (0.52) 33.51 .001** .09 
Negative Sexual Experiences – Others 2.02 (0.84) 2.06 (0.92) 2.11 (0.86) 1.29 .276 .001 
Negative Sexual Experiences – Self 2.09 (1.08) 2.07 (1.15) 2.05 (1.03) 0.06 .942 .000 
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Dependent Variable Menstrual 
(n = 167) 
Periovulatory 
(n = 206) 
Premenstrual 
 (n = 335) 
   
Supplementary Subscales 





 (0.79) 2.80 (0.73) 2.45 .087
†
 .01 
Elation 2.75 (0.82) 2.91 (0.85) 2.86 (0.80) 1.98 .139 .01 
Positive Physical Experiences – General 2.67 (0.65) 2.66 (0.62) 2.65 (0.63) 0.07 .936 .000 
Positive Skin Experiences  2.43 (1.06) 2.62 (1.04) 2.51 (1.01) 1.52 .221 .004 
Positive Digestion Experiences 3.06 (0.92) 2.99 (0.94) 3.04 (0.93) 0.35 .708 .001 
Positive Breast Experiences  2.78 (1.09) 2.81 (1.02) 2.75 (1.05) 0.27 .762 .001 
Positive Weight Experiences 2.12 (0.93) 2.08 (0.86) 1.99 (0.85) 1.47 .232 .01 
Positive Appetite Experiences  2.37 (1.01) 2.57 (0.96) 2.43 (1.10) 2.14 .194 .01 
Note. Women’s REP = Women’s Reproductive Experiences (REP) Questionnaire. Within rows, each subscript letter “a” through “c”
 
denotes a significant 
pairwise comparison at p < .05. 
d
ns = 100, 128, and 210 (df = 2, 435) women in a relationship respectively. 
†
p < .10. *p < .05. **p < .01. 
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Figure 2.7. Mean scores for the main scales of the Women’s Reproductive Experiences (REP) 
Questionnaire as a function of menstrual cycle phase group for (a) negatively valenced scales 
and (b) positively valenced scales (ns
a
 = 167, 206, and 335, respectively). Errors bars represent 
standard error of the mean. 
a
ns = 100, 128, and 210 women in a relationship, respectively.  
†
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Main subscales. The combined 12 main non-relationship subscale scores differed by 
group, F (24, 1390) = 3.33, p < .001, partial η
2
  = .05. Univariate ANOVAs indicated a 
significant effect of group on four of these 12 subscales: Hormonal Symptoms, General Aches  
and Pains, Negative Body Image Experiences, and Negative Sleep Experiences (see Table 2.14). 
The group effect was not significant for Positive Affective Experiences scores.  
Pairwise comparisons indicated that Hormonal Symptoms, General Aches and Pains, and 
Negative Body Image Experiences, and Negative Sleep Experiences scores were all higher in the 
menstrual phase group than the periovulatory phase group, ps = .012 to < .001. Scores on the 
Negative Body Images Experiences and Negative Sleep Experiences were also higher among 
women in the premenstrual phase compared to the periovulatory phase, ps = .024 and .006. 
Among women in a relationship, there was no significant group effect for the combined 
Sexual Problems – Relationship subscale scores, F (4, 870) = 1.15, p = .331, partial η
2
  = .01. 
However, pairwise comparisons showed that women in the periovulatory phase had significantly 
higher Positive Sexual Experiences – Relationship scores than women in the premenstrual phase 
(see Table 2.14).  
Supplementary subscales. The combined 13 supplementary subscales differed by 
menstrual cycle phase group, F (26, 1388) = 3.79, p < .001, partial η
2
  = 0.07. There were 
significant univariate group effects for Testosterone-Related Experiences and Progesterone-
Related Experiences (see Table 2.14). Pairwise tests showed that both Testosterone-Related 
Experiences and Progesterone-Related Experiences scale scores were higher in the menstrual 
phase compared to the other two phases, ps = .001 to < .001.  
 Conception probability and hormone estimates. As seen in Table 2.15, conception 
probability was related in the directions that would be expected for all of the main scale scores. 
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Similarly, both estrogen and testosterone were positively related to the positively valenced scales 
and negatively related to the negatively valenced scales. Although not significant, correlations 
with both the Sexual Problems – General and – Relationship scores tended to be in the predicted 
directions. LH and FSH estimates were positively related to Sleep Quality scores. Progesterone 
estimates were negatively related to Sleep Quality. Relationships between all subscales and the 
conception probability as well as hormones estimates are also found in Table 2.15.  
Summary. Scores on negatively valenced scales, including Testosterone-Related and 
Progesterone-Related Experiences tend to be highest among women in the menstrual phase 
compared to periovulatory phase. They also tend to be negatively related to conception 
probability, estrogen, testosterone, LH, and FSH level estimates and positively related to 
progesterone level estimates. Means for the premenstrual phase group appeared to the middle of 
the other two groups, although differences were often not significant. In general, group 
differences on positively valenced scales were also not significant. Exceptions included Positive 
Sleep Experiences and Positive Sexual Experiences – Relationship scores, which were higher in 
the periovulatory versus premenstrual phase group. Also, positively valanced scales tended to be 
positively correlated with conception probability, estrogen, testosterone, LH, and FSH level 
estimates and negatively correlated with progesterone level estimates. Lastly, the specific 
positive physical experiences scales and sexual experiences scales (positive or negative, general 
or relationship specific) were not significantly related to estimates of conception probability and 
reproductive hormones.   
Pseudo-cycle phase groups. Among OC users, the effect of cycle phase group on the 
combined six non-relationship scales was not significant, F (12, 500) = 1.08, p = .378, partial η
2
 
= .03 (ns = 67 women in the menstrual phase, 82 in the periovulatory phase, and 18 in the 
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Correlations of the Women’s REP Scales and Subscales with Conception Probability and Hormone Level Estimates among Free-Cycling Women 
of Reproductive Age (n = 879) 
 
Variable CP E P T LH FSH 
Scales 
Negative Affective Experiences -.10** -.09** .01 -.13** -.04 -.01 
Negative Physical Experiences -.12** -.11** -.03 -.12** .01 .03 
Sexual Problems – General -.03 -.05 -.04 -.03 -.04 .03 
Sexual Problems – Relationship
a
 -.07 -.06 .04 -.05 -.05 -.05 




 .01 .10** .001 .06 
Body Image Quality .11** .11** -.02 .09* .09* .04 
Sleep Quality .07* .03 -.10** .07* .08* .08* 
Subscales 
Hormonal Symptoms -.12*** -.12** -.04 -.12*** -.04 .05 
Decreased Appetite -.01 .01 -.004 -.02 -.02 .02 
General Aches and Pains -.10** -.08* -.003 -.11** -.05 -.004 
Negative Sexual Experiences – General -.03 -.05 -.02 -.03 .02 .03 
Negative Sexual Experiences – Relationship
a
 -.06 -.04 .05 -.04 -.04 -.05 
Negative Body Image Experiences -.13*** -.11** .01 -.09** -.06
†
 -.01 
Negative Sleep Experiences -.08* -.05 .08* -.08* -.07* -.05 
Positive Affective Experiences .07* .08* .01 .11** .06 .05 
Positive Physical Experiences .01 -.003 -.02 .05 .01 .03 
Positive Sexual Experiences – Others .001 .02 .06
†
 -.02 -.03 -.05 
Positive Sexual Experiences – Self .02 .03 .04 .05 .01 -.002 
Positive Sexual Experiences – Relationship
a
 .07 .07 -.03 .05 .05 .04 






 .09** .08* 
Positive Sleep Experiences .02 -.03 -.09** .03 .07* .10** 
Supplementary Subscales 
Testosterone-Related Experiences -.08* -.06
†
 -.01 -.07* -.02 .04 
Progesterone-Related Experiences -.15*** -.17*** -.08* -.17** -.07* .05 
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Variable CP E P T LH FSH 
Supplementary Subscales 
Negative Sexual Experiences – Self -.001 -.02 -.01 -.01 .02 .02 
Negative Weight Experiences -.06
†
 -.09** .001 -.06
†
 -.07* -.01 
Positive Affect .07* .07
†
 -.003 .11** .06 .04 
Elation .06
†
 .09** .04 .09** .06 .03 
Positive Physical Experiences – General .03 .004 -.003 .05 .05 .07* 
Positive Skin Experiences  .05 .08* .01 .03 .05 .01 
Positive Digestion Experiences .002 .02 .05 .04 .02 .02 
Positive Breast Experiences  .01 -.003 -.02 .05 .01 .03 
Positive Weight Experiences .02 .04 -.04 .04 .08* .19** 
Positive Appetite Experiences  .06
†





Note. Women’s REP = Women’s Reproductive Experiences (REP) Questionnaire. CP = conception probability (based on cycle regularity). E = 
estradiol. P = progesterone. T = testosterone. LH = luteinizing hormone. FSH = follicle-stimulating hormone.  
a
n = 532 women in a relationship.  
†
p < .10 *p < .05 **p < .01. ***p < .001.  
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premenstrual phase). The effect of phase group on Sexual Problems – Relationship scores was 
not significant either, F (2, 182) = 0.28, p = .759, partial η
2
 = .003. Among other HC users, the 
combined six scores also did not significantly differ by cycle phase groups in the MANOVA, F 
(12, 150) = 1.04, p = .413, partial η
2
 = .08 (ns = 19 women in the menstrual phase, 25 in the 
periovulatory phase, and 38 in the premenstrual phase). Among HC users in a relationship, 
Sexual Problems – Relationship did not significantly differ between the three cycle phase groups, 
F (2, 52) = 1.01, p = .371, partial η
2
 = .04. Due to the non-significant MANOVA results, means 
for the pseudo-cycle phase in OC and other HC users are not presented and follow-up ANOVAs 
were not examined.  
Discussion 
The main purpose of Part 2 was to examine differences between reproductive and 
hormonal status groups on the scores of the Women’s REP as potential evidence of concurrent 
validity for the measure. Given that pregnancy, postpartum, and menopause tend to be associated 
with more extreme or eventful reproductive, hormonal, and lifestyle changes, it is perhaps njot 
surprising that women in these groups had some relatively high and low scores on the scales 
compared to free-cycling, copper IUD users, OC users, and other HC users. The largest group 
differences tended to be between pregnant and menopausal women, very distinct hormonal 
events. Pregnant women had scores indicative of adverse physical experiences, including 
Progesterone-Related Experiences, and poor sleep quality. Pregnant women also had scores 
indicative of elation and negative body image experiences as well as low negative and high 
positive sexual experiences in the contexts of a primary relationship and masturbation (alone). 
This might suggest that they were excitedly awaiting the arrival of their babies, struggling with 
the changes to their bodies that accompany pregnancy, and content with their sex lives, things 
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one might expect when expecting (Murkoff & Mazel, 2008). Women in the postpartum period 
reported negative body image experiences and poor (low positive) sleep experiences as well but 
also, negative sexual experiences, which seems to make sense in the context of having recently 
given birth (e.g., Barrett, Pendry, Peacock, Victor, Thakar, & Manyonda, 1999). In this study, 
menopause, a time of typically low and stable reproductive hormone levels, was associated with 
low scores on many negative experiences scales with the exception of scores indicative of more 
negative and less positive sexual experiences. These results are also consistent with what is 
known about the menopausal versus perimenopausal period (e.g., Burri, Hilpert, & Spector, 
2015; Hilditch et al., 1996). Lastly, OC users had better (i.e., less negative or more positive) 
scores than non-users (see Oinonen & Mazmanian, 2002; Sanders et al., 2001) and other HC 
users, who tended to have scores in the middle of the groups (as did copper IUD users). This 
study appears to be unique in its comparison of these four groups of women based on HC status. 
Overall, effect sizes of significant reproductive status group differences in the full sample were 
small, ranging from .01 to .03. 
For women of reproductive age, it was expected that regularly cycling women and 
women in the periovulatory phase would have lower negative experiences and higher positive 
experiences scores than non-regularly cycling women and women in the menstrual and 
premenstrual phases. Similarly, it was predicted that negative experiences scores would be 
negatively related, while positive experiences scores would be positively related, to conception 
probability, estrogen, testosterone, LH, and FSH estimates. Progesterone estimates were 
expected to show the opposite relationships. Some support was found for each of these 
predictions. In particular, regularly cycling women appeared to have better health and quality of 
life, both low negative and high positive experiences, than amenorrheic and irregularly cycling 
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women. In general, this finding is consistent with previous health and well-being research, 
including on polycystic ovarian syndrome (e.g., Harlow, Cohen, Otto, Spiegelman, & Cramer, 
2004; Jacobs, Boynton-Jarrett, & Harville, 2015; McCook, Bailey, Williams, Anand, & Rame, 
2015; Weller & Weller, 2002). However, it is noteworthy that of all the between-subjects 
analyses conducted in Part 2 of Study 1, the number of significant findings were, and the effect 
sizes (.01 to .05) tended to be, largest when examining the Women’s REP scales as a function of 
cycle regularity. Thus, the Women’s REP appears particularly useful in assessing the health 
benefits or sequelae of the presence or absence of cycle regularity.  
With respect to the menstrual cycle, it is first worth noting that this study appears to be 
one of the first to provide data on interrater reliability for estimates of cycle day and phase. The 
results suggested that the reliability of a given rater would be .88, providing some support for 
day and phase classifications. Overall, negative experiences tended to be high among women 
who were menstruating compared to women in the periovulatory phase, with women in the 
premenstrual phase having scores in the middle of these groups. Effects sizes ranged from .01 to 
.09. These results suggest that menses, a time of menstrual bleeding and relatively low hormone 
levels, may be associated with negative affective and physical experiences to the same or a 
greater extent than the phase that is commonly conceptualized as symptomatic or adverse, the 
premenstrual phase (see Romans et al., 2012 for a relevant review). In contrast, positive or less 
negative experiences, namely those related to positive affect, body image, and sleep, tended to be 
higher among women in periovulatory phase compared to the other two phases. It is possible that 
results would be different in a sample of women experiencing clinically significant changes 
across the cycle however.  
The results pertaining to menstrual cycle phase were specific to free-cycling women 
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given that, as expected, OC and HC users showed attenuated non-significant phase group 
differences (see also Graham & Sherwin, 1993). The latter finding may be suggestive of positive 
effects and stabilization effects of HCs on well-being, at least among those who do not 
discontinue due to adverse side effects (Jarva & Oinonen, 2007; Oinonen & Mazmanian, 2001; 
Oinonen & Mazmanian, 2002; Sanders et al., 2001).  
Correlations between the scales and both estimates of conception probability and sex 
hormones were generally as expected but small in size (|.07 to .19|). It is important to note that a 
limitation of such estimates is that they involve potential unsystematic sources of error or noise, 
which may reduce the likelihood or strength of relationships (Garver-Apgar, Gangestad, & 
Thornhill, 2008; Puts, 2006), which is a reason why both phase group (between-subjects) and 
correlational analyses were examined. It was surprising, however, that scores on the 
Testosterone-Related and Progesterone-Related Experiences subscales were negatively related to 
conception probability and hormone levels. Combined with the finding that the latter scores were 
highest in pregnant women compared to most other women, the results pertaining to menstrual 
cycle data suggest that scores on these scales likely reflect changes in testosterone or 
progesterone levels or extreme levels (low or high as opposed to just high). These findings seem 
to support the appropriateness of the labels involving the term “related” given to these two 
subscales (as opposed to just “testosterone experiences,” for example, which implies high 
hormone levels).     
Interestingly, while the negative experiences scales and subscales showed significant 
differences across all group comparisons, the positive affective, sexual, and physical scales and 
subscales tended to show fewer significant or ubiquitous findings (between groups and across 
group comparisons, respectively) and thus, perhaps specificity in results. As mentioned in Part 1, 
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it is possible that the non-significant findings represent true negative group differences. These 
findings may suggest that positive experiences are strengths that women have even when 
experiencing negative symptoms or they may be the result of sociocultural bias toward negative 
experiences (e.g., Christler et al., 1994; cf., Gallant, Hamilton, Popiel, Morokoff, & Chakraborty, 
1991). For instance, women may not notice changes in positive experiences as readily as adverse 
ones (cf., Meaden et al., 2005) and when they do notice such changes, it may suggest that the 
condition is relatively high in severity or strength. Another explanation might be that there are 
different patterns of well-being in response to reproductive events (see Bancroft, 1995; Warner 
& Bancroft, 1988; Davydov, Shapiro, & Goldstein, 2004; Kiesner, 2011; Reiber, 2009; Teatero 
et al., 2013; Teatero, Oinonen, Mazmanian, & Streutker, 2015). For example, some postpartum 
women experience low mood, some elation, and still others, no appreciable change in affective 
experiences (see reviews in Bloch et al., 2000; O’Hara & Wisner, 2014; Pope, Sharma, & 
Mazmanian, 2014). If they exist, such patterns would be masked by analyses of average 
differences or changes, which may be a weakness of cross-sectional studies in general. This 
possibility is examined in Study 2 with respect to menstrual cycle shifts. Overall, the inclusion of 
positively valenced items and scales may help identify areas of strong, normal, or particularly 
poor functioning in women who are having negative experiences. 
Similarly, the measurement of specific facets and subscales (e.g., of sexuality, including 
one’s autosexuality, socio- or allosexuality, and primary relationship) in one measure seems 
useful. For example, sexual experiences with someone other than a romantic relationship partner 
and pertaining to masturbation constituted separate factors from sexual experiences with a 
primary partner. This finding might suggest that if a woman’s score on the Sexual Problems – 
Relationship scale is indicative of sexual problems but the Sexual Problems – General score is 
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not, the negative experiences or lack of positive experiences may be due to relationship issues 
rather than biological dysfunction. In this sense, patterns of scores on this measure may be useful 
for self-help and treatment recommendations.  
Although the effect of group or association for many significant analyses was consistent 
with expectations or other research, only a small amount of variance in Women’s REP scores 
tended to be explained. This finding may be accounted for by the self-report and non-clinical 
nature of the groups, or perhaps by the facts these groups were formed naturally in the data and 
none of them were recruited according to their negative (or positive) symptoms and experiences. 
Specifically the recruitment of groups of women who are having current hormone-related 
difficulties (e.g., perimenopausal symptoms that tend to be treated with hormone-replaced 
therapy, postpartum depression, and postpartum hypomania/psychosis group) would likely result 
in the Women’s REP explaining more variance in the group differences. An examination of the 
means within the reproductive and hormonal groups suggested that scores on the Women’s REP 
tended to be in the mild to moderate range with respect to the level of negative and positive 
experiences, as would be expected in a community sample. Also related to Part 1 of this study, 
confirmation of reproductive/hormonal status or condition diagnosis as opposed to self-report 
may be important in future research given that some women who report PMS do not 
prospectively demonstrate it (e.g., Longue & Moos, 1988; Rubinow et al., 1986) and given the 
survivor effect, women using HCs in cross-sectional studies may differ from previous users who 
discontinued due to adverse side effects (Sanders et al., 2001). The latter point is actually 
consistent with OC users reporting some better reproductive experiences than non-users in the 
present study.  
It is also likely that (a) preexisting differences between women who do or do not 
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experience an elective reproductive event such as using an HC and pregnancy (e.g., Bancroft, 
Sherwin, Alexander, & Davidson, & Walker, 1991; Oinonen, Jarva, & Mazmanian, 2008) and 
(b) sociocultural expectations and lifestyle changes at the various reproductive events affect 
cross-sectional differences between hormonally relevant groups. Regardless, the group 
differences presented here provide evidence for the concurrent validity for Women’s REP. Large 
effect sizes would not be anticipated in this community study because the magnitude of the 
reproductive experiences of the women represented is low as demonstrated by the sample means.  
Overall, this study is one of the first to provide strong evidence that reproductive events 
are related to various negative and positive experiences. In taking a continuum-based 
perspective, the term “experiences” was used in the Women’s REP instead of “symptoms,” 
which tends to be used in reference to adverse rather than positive symptoms. This was done to 
use less clinical or pathologizing language that better reflects the lived experiences of women in 
the general population across their adult lives (King & Ussher, 2012). A future step in research 
on the Women’s REP might be to invite women to provide feedback regarding the reading level, 
language/labels, and user-friendliness of the measure.     
Conclusions 
This study provides some evidence of the reliability and concurrent validity of the 
Women’s REP, a questionnaire that can be used with women of all ages to examine affective, 
sexual, and physical reproductive experiences. The Women’s REP is unique in its assessment of 
not only negatively but also positively valenced experiences. It also appears to be distinct in its 
assessment of broad areas of reproductive experiences (i.e., the main scales; e.g., Negative 
Physical Experiences) to specific areas of functioning (i.e., the main and supplementary 
subscales; e.g., Decreased Appetite, General Aches and Pains, Testosterone-Related 
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Experiences, and Progesterone-Related Experiences). Based on the strengths of the Women’s 
REP, it is anticipated that it has potential for use by researchers and clinicians with non-clinical 
and clinical populations. Although it is not a disorder-specific scale, it may have utility as a 
screening measure with 134 items that can be completed in about 20 minutes and in assessing 
differences between women’s (e.g., the extent to which cycle regularity affects functioning) as 
well as change over time (e.g., across the menstrual cycle, before and after pregnancy, during the 
menopausal transition, and pre- and post- hormone use or treatment). Factor analysis revealed 
seven scales, 14 subscales, and 13 supplementary subscales that correspond reasonably well to 
rationally derived content domains and were internally consistent. Scores on these scales and 
subscales may also help lead to clarification of patterns of experiences and symptoms at a given 
reproductive event, associations among the reproductive events, and thus, HSS (hormonal 
sensitivity syndrome).  
The results of both Part 1 and Part 2 should be considered in the context of several 
limitations and strengths of the present study. Although the sample was recruited predominantly 
from the Internet community (as opposed to a random sample), the number of participants was 
large, over 1900. Also, the sample was diverse, varying widely in age, ethnicity, continent of 
residence, and reproductive experiences/events across the female lifespan, as planned. Most 
relevant studies are specific to one limited period of time in a woman’s life (e.g., Buttner et al., 
2012, postpartum period; Stone et al., 2013, perimenopause) or consist of university samples of 
relatively young women (i.e., free-cycling or HC using women of reproductive age e.g., 
Haywood et al., 2007; Kiesner, 2011; cf., Meaden et al., 2005). Limitations might include that 
the various groups and experiences examined herein were based on self-report alone (e.g., see 
O’Sullivan, 2008) and a measure of response bias or set was not used. However, women’s self-
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reports of conditions such as current hormonal disorders, HC side effects, and PMS are arguably 
important (and reflective of their lived experiences; King & Ussher, 2012). The proportions of 
women who reported reproductive/hormonal statuses or experiences are likely representative of 
women from the online community given that online studies have been found to provide valid 
data (e.g., Gosling et al., 2004). In addition, participants who appeared to exhibit a response set 
(based on a thorough examination of the raw data by the author) were excluded and in general, 
the study results were not consistent with a negative or positive response bias to the items of the 
Women’s REP.  
Overall, women who differed in current hormonal problems, HC side effects, PMS, 
reproductive status, cycle regularity, cycle phase, conception probability estimates, and sex 
hormone estimates differed on relevant scales of the Women’s REP. Further study and 
refinement of the measure is warranted. The test-retest reliability, further evidence of concurrent 
validity, construct validity, and menstrual cycle-related change of the Women’s REP will be 
assessed in a separate longitudinal study (see Study 2 of this dissertation). The results reported 
herein are important in that they provide evidence of the usefulness of such a comprehensive 
measure as well as of the scales that may represent women’s reproductively related or 
hormonally mediated experiences across the adult lifespan.
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Not in the Mood Tonight?  






















Research and theory suggest that there may be paradoxical menstrual cycle patterns in both 
women’s affective well-being (e.g., premenstrual syndrome [PMS] and negative symptoms 
around ovulation) and mating tactics (e.g., the ovulatory shift and the periovulatory sociosexual 
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tactic shift [PSTS] hypotheses). Patterns in affect and sexuality may have evolved to co-occur if 
being in a good mood facilitates being “in the mood” for sex. There is a dearth of evolutionary 
and prospective research on this possibility, particularly that which includes all of negative affect 
(NA), positive affective (PA), and sexual experiences. Part 1 of this paper reports on the 
psychometric properties as well as between- and within-women relationships between two new 
measures: The Women’s Reproductive Experiences (REP) Questionnaire and the Prospective 
and Receptive Mating Strategies Scale (PARMSS). Both questionnaires demonstrated good test-
rest reliability and evidence of concurrent, convergent, and divergent validity (Part 1; n = 327). 
In Part 2, within-women patterns of NA, PA, and sexual proceptivity across the periovulatory 
and premenstrual phases among naturally cycling women (n = 41) were examined. Support was 
found for the existence of two groups who show opposing patterns of change differentiated by 
the phase in which they experience higher NA, lower PA, and lower proceptivity: (1) a PMS 
pattern in 61% of women and (2) what is proposed to be a periovulatory syndrome (POS) 
trajectory among 39% of women. Consistent with the PSTS theory and accumulating evidence 
(e.g., three other studies), women who showed the POS pattern were more unrestricted than 
women who showed a PMS pattern. Future research should continue to examine the possibility 
of at least two phenotypes of psychosexual change across the menstrual cycle. A focus on  
diversity in women’s reproductive experiences may help prevent pathologization of normal 
female experiences.  
Not in the Mood Tonight? 
Patterns in Menstrual Cycle-Related Affective and Sexual Proceptivity  
In health research, an emerging theme with respect to reproductive and hormonal 
experiences is variability between women. From menarche to menopause, different women seem 
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to have different affective, sexual, and physical responses (i.e., symptoms, side effects, and 
experiences) to the same reproductive events (Kiesner & Poulin, 2012). These differences have 
been found for both the strength and valence (positive or negative) of women’s experiences 
(Bancroft & Graham, 2011; Kiesner, 2011). Unfortunately, negative experiences and among 
women of reproductive age, the premenstrual phase are often the focus of this type of research, 
to the neglect of positive experiences and the periovulatory phase (Meaden, Hartlage, & Cook-
Karr, 2005). What appears to be the only measure of women’s negative and positive experiences 
designed for use across the adult lifespan, the Women’s Reproductive Experiences Questionnaire 
(Women’s REP), was shown to have good psychometric properties (Study 1 herein) and thus, 
may have potential for delineating patterns of experiences across the menstrual cycle.  
Interestingly, in evolutionary research, there is some evidence of differences between 
women as well as within-women plasticity in mating strategies (e.g., paradoxical menstrual cycle 
shifts among different women). As an example of the latter phenomenon, one study found that 
two groups of women shifted away from their primary restricted or unrestricted sociosexual 
orientation around ovulation (Oinonen, Klemencic, & Mazmanian, 2008). In this type of 
research, the focus (i.e., the independent variable) is generally women’s naturally cycling 
fertility
24
, which is maximal around ovulation, and sexuality (as the dependent variable) rather 
than health and well-being per se. A recently developed measure, the Proceptive and Receptive 
Mating Strategies Scales (PARMSS; Phillips, 2015), appears to be the only comprehensive 
measure of both receptive and proceptive sexuality using a common metric and was designed 
from an evolutionary perspective. Receptivity and proceptivity seem to be separate constructs 
                                                 
24
 It should be noted that the majority of the research reviewed on changes across the menstrual cycle in affective, 
sexual, and physical experiences was conducted with women not using hormonal contraception (HC) given that HCs 
suppress fertility and are also associated with different patterms of experiences among women (see Bancroft & 
Graham, 2011 for a review).   
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and may have confounded previous findings on mating strategies and tactic changes. Overall, the 
PARMSS has shown some evidence of reliability and validity in a single study (n = 63; Phillips, 
2015; Study 1) and has been used in examining relevant patterns of menstrual cycle shifts (n = 
23; Phillips, 2015; Study 2). One of the goals of the present study was to address the need for 
additional psychometric and menstrual cycle data for the PARMSS.  
 In an effort to combine, and address gaps in, the areas of health and evolutionary 
research, the present paper further examines the psychometric properties, namely test-retest 
reliability, construct validity, and interrelationships of these two new measures (Part 1). Also in 
Part 1 of the present study, analyses involving differences between women of various 
reproductive and hormonal status groups from Study 1 of this dissertation were replicated to 
further examine the concurrent validity of the Women’s REP and explore differences between 
the groups on the PARMSS. In Part 2, the possibility of different within-women menstrual cycle 
patterns in negative affective experiences, positive affective experiences, and proceptivity was 
investigated. Overall, as will be detailed below, the rationale for conducting this study came 
from fairly discrete areas of research indicating various menstrual-cycle related patterns of: (a) 
negative reproductive experiences; (b) positive reproductive experiences; and (c) mating tactics; 
as well as (d) co-variation of, or links between, affective and sexual experiences.  
 
 
Negative Reproductive Experiences  
 Over 200 different adverse symptoms associated with the menstrual cycle, particularly 
the premenstrual phase, have been identified since the 5
th
 century B.C.E. (see Dell & Svec, 2003; 
Halbreich, 1997). Research since the 1980s has consistently suggested that a substantial 
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proportion of women worldwide (i.e., 40 to 80%) report at least some mild premenstrual 
symptoms (Cunningham, Yonkers, O’Brian, & Eriksson, 2009; Reiber, 2009; but see Romans et 
al., 2012). Premenstrual syndrome (PMS involves at least one adverse physical or psychological 
experience that appears in the two weeks prior to, and remits following, the onset of 
menstruation (American College of Obstetricians and Gynecologists, 2000; O’Brien et al., 2011). 
Examples of such psychological and physical experiences include mood lability, low mood, and 
low sex drive as well as breast swelling and tenderness, abdominal cramps, and headaches 
(Speroff & Fritz, 2005). These findings suggest that the relatively high levels of progesterone in 
the premenstrual phase may be related to an increase in negative affective, sexual, and physical 
experiences. While no one specific hormone or hormonal profile has been consistently associated 
with PMS symptoms (see Andréen et al, 2009), there is evidence that changes in the hormonal 
milieu across the menstrual cycle may have direct effects on psychological experiences even 
though psychological and physical symptoms tend to be associated (e.g., Kiesner, 2009). Overall, 
the term PMS is often controversially used in reference to non-clinical experiences (Chrisler & 
Caplan, 2002; Romans et al., 2012).  
 Given that women become more at risk for depressive disorders around menarche until 
menopause, one factor proposed to underlie negative experiences associated with the menstrual 
cycle as well as other reproductive events across the lifespan is hormonal sensitivity. It is 
generally agreed that some women are more psychologically or physically sensitive to changes 
in, or levels of, sex hormones such that they experience an increase or decrease in adverse 
experiences (see Bloch et al., 2000 and Schmidt, Nieman, Danaceau, Adams, & Rubinow, 1998 
for seminal studies). Given that negative experiences at the various reproductive events tend to 
be associated, it has also been proposed that the effects of hormonal changes across the lifespan 
WOMEN’S REPRODUCTIVE EXPERIENCES 
   
222 
may underlie what has been referred to as reproductive mood disorder(s) (e.g., Payne, 
Tietelbaum Palmer, & Joffe, 2009) and hormonal sensitivity syndrome (HSS; Pope, Oinonen, 
Mazmanian, & Stone, 2015). For some women, symptoms may go through a process of kindling 
or sensitization across reproductive events (Parry & Newton, 2001), beginning with prenatal 
exposure in utero as suggested by digit ratio research (Oinonen, 2009; Oinonen & Bird, 2012). 
That is, reproductive experiences may depend on organizational (permanent) and activational 
(acute) effects of hormones. A likely explanation for these findings is genetic predisposition for 
altered neurotransmitter activity or sensitivity to neuroendocrine changes given that only a 
portion of women experience some adverse effects associated with reproductive events such the 
premenstrual phase (Steiner, Dunn, & Born, 2003; Gillings, 2014).  
 In fact, with respect to proximal differences between women with and without PMS, 
there have been few, if any, robust findings (see Miller et al., 2010). For instance, there have 
been no consistent biological markers identified (Steiner et al., 2003). Some studies have found 
that PMS or premenstrual dysphoric disorder is associated with earlier age at menarche (AAM), 
less education, working outside the home, being married or cohabitating, less frequent marital 
problems, and parity whereas others have not found such significant differences between women 
with and without these problems (e.g., Cohen et al., 2002; Reiber, 2009; Sanders, Warner, 
Bäckström, & Bancroft, 1983; Soares, Cohen, Ott, & Harlow, 2001; Warner & Bancroft, 1988). 
Overall, more research is needed on individual differences and cyclic shifts in negative 
experiences, particularly with respect to quantifying hormonal sensitivity along a continuum of 
severity.  
 It is intriguing that while health research has largely focused on PMS, other cyclic 
patterns of negative experiences have also been reported in the literature since the 1980s (e.g., 
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Abraham, 1980). This fact has led some researchers and clinicians to suggest that there are 
menstrual cycle syndromes (Halbreich, 1995) and a variety of menstrual cycle-related problems 
(Bancroft, 1995). Essentially, there has also been notable variability in results between and 
within retrospective, between-subjects, qualitative, and prospective reports on negative 
experiences and the cycle (Warner & Bancroft, 1988; Teatero, Mazmanian, & Sharma, 2014; 
Romans, Clarkson, Einstein, Petrovic, & Stewart, 2012). In particular, it has been suggested that, 
“one’s woman’s low is another’s woman’s high” (Kiesner, 2011, p. 68). The results of at least 
ten prospective studies have suggested that some negative experiences may peak around 
ovulation for some women (Hardie, 1997; Kiesner & Poulin, 2012; Kiesner & Pastore, 2010; 
Parlee, 1982; Ross, Coleman, & Stojanovska, 2003; Sveinsdóttir & Reame, 1991; Van Goozen, 
Wiegant, Endert, Helmond, & Van de Poll, 1997), which has been referred to as a reverse PMS 
(Sveinsdóttir & Bäckström, 2000), pseudo-PMS (Reiber, 2009), and a mid-cycle (Kiesner, 2011) 
pattern.  
 For example, Kiesner (2011) demonstrated that the majority of first-year female 
university students sampled showed a PMS pattern of change in depression/anxiety across two 
consecutive menstrual cycles (n = 130 of 213) but also that 13% showed a paradoxical peak in 
the periovulatory phase. Only 26% of women did not display significant change in daily self-
ratings of symptoms. On the basis that the women who did not show a significant change had a 
higher mean depression/anxiety score than the women with the strongest PMS pattern, it was 
suggested that the latter group may experience more positive affect or well-being, particularly 
around ovulation. In other words, changes in negative versus positive affect across the cycle may 
be opposing compensatory processes.  
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Similarly, while it has commonly been shown that headaches increase in the menstrual 
phase in some women, there are a few studies indicative of a mid-cycle (periovulatory) pattern of 
headaches. In fact, 51% and 16% of women in Kiesner and Martin (2013) showed menstrual and 
mid-cycle headache patterns, respectively. These patterns were significantly associated with the 
patterns of depression/anxiety previously identified by Kiesner (2011) such that 54% of women 
who exhibited the menstrual or mid-cycle patterns of headaches also exhibited the premenstrual 
or mid-cycle patterns, respectively, of depression/anxiety. In a third report, Kiesner (2013) found 
that the PMS group from the 2011 study retrospectively reported more hard alcohol use and less 
negative affective and sleep responses to alcohol use compared to the paradoxical mid-cycle 
group.  
As outlined by Kiesner and Martin (2013), sampling and measurement bias in previous 
research has tended to preclude the identification of patterns of symptom changes across the 
menstrual cycle by: (a) excluding women who do not report PMS; (b) using perimenstrual-
specific measures; and (c) only considering one average pattern in a sample of women thereby 
overlooking individual differences. A strength of Kiesner (2011) was the examination of 
individual (random) longitudinal growth curve effects using multilevel level modeling (MLM). 
However, the absence of negative affect is not necessarily the same as the presence of positive 
affect (Watson, 1988). Furthermore, single items of depression/anxiety, instead of scale 
measures with adequate psychometric properties, were employed. Thus, further examination of 
negative and positive experiences across the cycle seems warranted.  
Positive Reproductive Experiences  
 Although changes in positive affect across the menstrual cycle were recognized as early 
as 1937 (McCance, Luff, & Widdowson), it is clear that biases towards a focus on changes in 
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negative experiences and the premenstrual period have pervaded the literature (Meaden et al., 
2005). Early reviews of research on positive changes across the cycle suggested that well-being 
tends to be highest around ovulation (e.g., Dennerstein & Burrows, 1979; cf., Abplanalp, 
Haskett, & Rose, 1980). In 1982, Parlee showed that some woman may experience what was 
referred to as premenstrual elation syndrome and in 1984, Abraham called for the study of 
positive symptoms in the periovulatory phase, facetiously using the phrase postmenstrual 
syndrome.  
A recent review of 26 prospective studies of positive affective experiences across the 
cycle (Teatero, Oinonen, Mazmanian, & Streutker, 2015) indicated that eight of these studies 
(31%) did not find significant differences in mean levels of positive affect between phases (e.g., 
Abraham Luscombe, & Soo, 2003). Twelve studies (46%) reported a peak in positive 
experiences outside of the premenstrual phase, typically around ovulation (e.g., López, Verdejo, 
Javier, Martin, & Gómez-Amor, 2010). The results within each of the remaining six studies 
(23%) revealed more than one pattern of change, namely paradoxical shifts among different 
women or cycles. Unfortunately, the one study that was able to identify different groups of 
women who exhibited specific patterns of experiences across the cycle only included women 
with PMDD (Rivera-Tovar, Pilkonis, & Frank, 1992).  
However, in a series of reports using MLM, Davydov and colleagues (2004; 2005; 2007) 
found that personality (anger expression, anxiety, and hostility), stress hormone levels, and 
work- versus non-work day moderated changes in affect valence (i.e., happiness, sadness, 
anxiety, stress, or tiredness) across the cycle. The authors proposed that down-regulated or up-
regulated physiological arousal might result in negative affective experiences, while mid-level 
arousal results in positive affective experiences. Relatedly, women with high emotional 
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sensitivity to bodily cues showed paradoxical patterns in negative and positive affect across the 
cycle, while other women did not display any phase effects (Schnall, Abrahamson, & Laird, 
2002, Study 1) and biopsychosocial theories of PMS suggest that psychosocial stressors may 
disrupt biological rhythms and alter affective experiences (e.g., Steiner, 1992). These reports 
indicate that there may be different biological vulnerabilities associated with the diverse 
manifestations of experiences, both negative and positive, across the cycle (Bancroft, 1995) that 
are dynamically evolving with life experiences and stress (Halbreich & Monacelli, 2004). That 
is, cyclic shifts in experiences may vary between- and within-women (between-cycles) because 
they are dependent on genetics and current biological, psychological, and social conditions. 
Overall, the psychoendocrinological research reviewed thus far indicates that there is 
evidence for more than one menstrual cycle pattern of reproductive experiences (see Teatero, 
Mazmanian, & Sharma, 2014 for a review with similar conclusions on the effects of the cycle on 
bipolar disorder). That is, there may be two phasic shifts in both negative and positive affect 
among subgroups of women. According to Pincus, Schmidt, Palladino, and Rubinow (2008), 
postmenstrual (periovulatory) euphoric mood may be compensatory to negative affect in the 
premenstrual phase like a rebound effect or opponent process. Thus, the hormonal sensitivity 
hypothesis may apply to both the strength/magnitude and the direction/valence of women’s 
reproductive experiences (Kiesner, 2011). That is, some women may show increased negative 
experiences or decreased positive experiences, other women may show decreased negative 
experiences or increased positive experiences, and still others no changes related to the same 
hormonal event (e.g., menarche, HC use, pregnancy, the postpartum period, and perimenopause). 
In fact, while estrogen generally seems to have a positive effect on women’s emotional well-
being, estrogen, progesterone, and testosterone have all been found to have paradoxical effects 
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on different women (Andréen et al., 2009; Graham, Bancroft, Doll, Greco, & Tanner, 2007; 
Schmidt et al., 1998). These findings also suggest that researchers and clinicans should 
distinguish between reproductive experiences versus disorders to avoid pathologizing affective, 
sexual, and particularly physical changes at reproductive events that may be normal responses 
among all women to some extent.  
In consideration of methodological issues, however, it is clear that most of the studies 
reviewed on negative and positive affect change across the cycle did not control for possible 
response biases or sets. Almost all of them employed inclusion criteria for health and “normal” 
menstrual cycle characteristics, but a wide variety of phase definitions and estimation procedures 
as well as measures or individual ratings were employed (see also Romans et al., 2012). For 
example, some studies on positive affect averaged women’s reports across multiple cycles, 
reducing the probability of finding an effect if there is within-woman variability. It is a 
possibility, of course, that conflicting results between- and within- studies reflect a null or 
negative effect. Use of a new psychometric test designed to comprehensively measure women’s 
negative and positive reproductive, including not only affective but also sexual (including 
relationship) and physical experiences, the Women’s REP, may help clarify patterns of phasic 
change across the cycle and associated hormonal sensitivity.  
It is noteworthy that there do not appear to be many studies in this area of research that 
examine the possibility that some positive, rather than only negative, physical experiences or 
changes take place across the cycle. Exceptions seem to include skin complexion and 
physiological sexual arousal, both of which may be enhanced in the periovulatory phase (e.g., 
Graham, Janssen, & Sanders, 2000; Farage, Neill, & MacLean, 2009). This is an area worth 
exploring in view of research on mating strategies reviewed next. Both positive and negative 
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changes in affective, sexual, and physical symptoms may influence attractiveness, sexuality, and 
time spent on other pursuits (e.g., eating and sleeping) across the cycle, which may be adaptive 
from an evolutionary perspective (Fessler, 2003).  
Sociosexuality  
In evolutionary psychology, a focus of psychoendocrinological research tends to be 
changes across the menstrual cycle, often referred to as the ovulatory cycle instead, as related to 
sexual selection. Importantly, a mating strategy, typically called one’s sociosexual orientation or 
sociosexuality, is considered to be a set of implicit psychological mechanisms that manage an 
individual’s overall sexual and reproductive efforts (Belsky, Steinberg, & Draper, 1991). On 
average, men tend to be more apt to engage in more unrestrictive (short-term) sexual pursuits and 
to initiate sexual activity than women, who tend to be more sociosexually restrictive, preferring 
sex in the context of long-term relationships (Schmitt, 2005; Vanier & O’Sullivan, 2011). These 
psychological differences may ultimately have evolved in relation to differences in parental 
investment due to sex differences in physiology (Trivers, 1972) for example but may also be 
related to or maintained in modern society by proximal biological, psychological, and social 
factors, such as sexual scripts (see O’Sullivan & Vannier, 2013; Thompson & O’Sullivan, 2012). 
However, it is also generally agreed that most species have evolved conditional mixed mating 
strategies, across and within the sexes. In fact, flexibility in this regard appears to be more 
advantageous than fixedness (Gowaty, 2013; Milich, Bahr, Stumpf, & Chapman, 2014). 
Recent research is suggestive of opposing within-sex mating strategy phenotypes 
(Wlodarski & Dunbar, 2015; Wlodarski, Manning, & Dunbar, 2015). Based on three samples, 
both sociosexual orientation and second-to-forth digit ratio (2D:4D) appeared to be bimodally 
distributed in each sex, as opposed to normally distributed continuums (Wlodarski & Dunbar, 
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2015). That is, on average, men tend to be more sociosexually unrestricted and have higher 
2D:4Ds than women (about 58 versus 47%) but both sexes show two phenotypes in these traits: 
(a) short-term (i.e., unrestricted or high prenatal androgen exposure) and (b) long-term (i.e., 
restricted or low prenatal androgen exposure) mating orientations (see also Jackson & 
Kirkpatrick, 2007). According to Wlodarski and Dunbar (2015), these two competing strategies 
may have evolved due to frequency-dependent selection such that the value of each strategy is 
inversely related to its frequency in the population and the extent that it is pursued is dependent 
on the fitness benefits for an individual. 
The fact that significant differences have been found between individuals low and high in 
sociosexuality (and in 2D:4D) supports the notion of two mating strategy phenotypes. For 
instance, sociosexuality has been shown to be correlated with attractiveness, gender role or 
identity (self-perceived masculinity), alcohol expenditure, and mate preferences such as for 
attractiveness and social visibility (Clark, 2004; Teatero, 2009). One’s mating strategy may not 
only depend on genetics and personal characteristics but also environmental context (e.g., 
disease prevalence; Schaller & Murray, 2008) and organizational and activational effects of 
hormones (e.g., prenatal testosterone exposure and reproductive events across the lifespan; see 
Gangestad, Thornhill, & Garver-Apgar, 2005). Moreover, there appears to be more variance in 
mating strategies within than between the sexes (Gangestad & Simpson, 2000). According to this 
strategic pluralism model as well as the dual mating hypothesis, women have developed a 
repertoire of tactics: (a) estrus around ovulation to obtain good genes through short-term sexual 
relationships (including with others than their primary partners) when fertile and (b) extended 
sexuality during the rest of the cycle to maintain good fathers and resources for their children 
through long-term romantic relationships (Pillsworth & Haselton, 2006). Given that mating 
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strategies seem to be multidimensional (e.g., long- and short-term orientations may be enacted 
concurrently or conditionally), measures have been developed to assess both long-term and 
short-term orientations as well as receptivity and proceptivity. 
Overall, in opposition to health research, evolutionary research has tended to focus on the 
positive or increased experiences in the periovulatory phase. Some research has supported the 
ovulatory shift hypothesis that women are more attracted to indicators of genetic quality in men, 
particularly masculinity, in the periovulatory phase (see Gildersleeve, Haselton, & Fales, 2014 
for a meta-analysis). Interestingly, women’s attractiveness and sexual motivation (e.g., desire for 
men other than their partners and proceptivity) have also been found to be enhanced around 
ovulation (see review in Haselton & Gildersleeve, 2015).  
However, in general, there have been inconsistent results between prospective studies on 
cyclic changes in women’s mating tactics (Pillsworth, Haselton, & Buss, 2004; see Wood, 
Kressel, Joshi, & Louie, 2014 for a meta-analysis that did not find evidence of a significant 
effect of cycle phase on mate preferences). In fact, in both meta-analyses cited, there was 
statistically significant variability in the effect sizes of phasic shifts in mate preferences (i.e., 
Gildersleeve et al., 2014; Wood et al., 204) and, according to Wood and Carden (2014), over 
30% of the effects were in directions opposite to the ovulatory shift hypothesis. Moreover, both 
the strength and direction of between-women and within-women effects of menstrual cycle phase 
on sexuality and mate preferences have been shown to be moderated by biological, personal, and 
contextual variables. Some of these moderating variables include the magnitude of cyclic within-
women changes in estrogen (Roney, Simmons, & Gray, 2011), attractiveness (Haselton & 
Gangestad, 2006); masculinity (Johnston, Hagel, Franklin, Fink, & Grammer, 2001); as well as 
partner attractiveness and relationship satisfaction (Larson, Pillsworth, & Haselton, 2012; 
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Pillsworth, Haselton, & Buss, 2004). For example, Pillsworth et al. (2004) found that estimates 
of conception probability were positively related to general sexual desire but only among women 
in a relationship. Also among these women, the relationship between conception probability and 
desire for someone other than one’s current partner strengthened as a function of relationship 
length. Among single women, the relationship between conception probability and sexual desire 
was not significant but appeared negative in direction.  
There has also been some conflicting evidence with respect to direct hormonal predictors 
of women’s sexual motivation. While testosterone has generally been thought to be positively 
related to sociosexuality (see Edelstein, Chopik, & Kean, 2011 for a partial review), levels of this 
hormone do not appear to be related to within-cycle changes in sexual desire and behaviour and 
while estrogen appears to be positively related to sexual behaviour, progesterone appears to 
inhibit desire and proceptivity across the cycle (Roney & Simmons, 2013). Interestingly, 
progesterone has also long been known to facilitate sexual behavior, particularly after estrogen 
priming, in some species, such as rats (Nelson, 2005) and different women have been shown to 
have decreased or increased sexual interest to the same hormonal changes across various 
reproductive events (e.g., Schmidt et al., 1998; Graham et al., 2007). Thus, although rarely 
considered in past research (but see Oinonen, Klemencic, et al., 2008), it is possible that different 
women show paradoxical hormone-related shifts in sociosexuality.  
For example, Scarbrough and Johnston (2005) found that women with low (masculine) 
2D:4Ds as well as those low in femininity displayed a periovulatory shift towards greater 
attractiveness to masculine faces. In contrast, women with high 2D:4Ds as well as those high on 
femininity shifted towards a diminished preference for masculine faces. This finding is relevant 
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in view of the fact that low 2D:4D has been shown to be related unrestrictiveness (e.g., Clark, 
2004).  
However, only two known studies have identified specific groups of women who exhibit 
different menstrual cycle patterns of sociosexuality. In 2008, Oinonen, Klemencic, et al. (2008) 
found preliminary evidence of two patterns of the ovulatory shift (i.e., two context-dependent 
phenotypes of mating strategy tactics): the periovulatory sociosexual tactic shift (PSTS). As 
measured by ratings of male faces, restricted women shifted towards greater one-night stand 
interest during the periovulatory phase. Unrestricted women displayed a trend towards 
diminished interest in one-night stands, a shift towards restrictiveness at the periovulatory phase, 
and generally rated the male faces as healthier than restricted women. In 2015, Phillips replicated 
the PSTS in her dissertation such that women high and low in sociosexuality exhibited different 
patterns of self-reported proceptivity (i.e., likelihood of initiating sexual activity rather than 
merely being receptive to it). This effect was strongest in women who were exclusively 
heterosexual (i.e., reported that they had no degree of same-sex attraction). Phillips used a newly 
developed psychometric test unique in its measurement of both proceptivity and receptivity 
separately, the PARMSS, which may help clarify patterns of phasic change in sexuality across 
the cycle. As suggested by Wallen (1990), due to extended receptivity across the cycle (i.e., the 
continuous possibility of receptivity), sexual initiation may be the best indicator of women’s 
sexual motivation.  
With respect to evolution, the restricted PSTS pattern may have emerged more recently 
than the unrestricted pattern given that unrestrictiveness appears to have been a relatively 
common strategy of our ancestors. Both general patterns are also seen in other species such as 
anthropoid primates (Oinonen, Klemencic, et al., 2008). Evolutionary models that may support 
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the adaptiveness of the unrestricted pattern include the many fathers theory and best-of-N theory. 
Models that may support the adaptiveness of the restricted pattern include the father-at-home 
theory and better-options theory (see Oinonen, Klemencic, et al., 2008 for partial reviews). That 
is, unrestricted women may take advantage of sperm competition and “good genes” by mating 
with relatively more men outside the fertile window in order to acquire resources or to choose 
the best possible mate. In contrast, it may be more advantageous for restricted women to partner 
with one man but engage in other sexual relationships around ovulation with “good genes” men.  
Overall, it seems plausible that if there are two phenotypes (i.e., overall strategies) among 
women that they would involve paradoxical menstrual cycle shifts in mating tactics. If this were 
the case, unrestricted and restricted women would be expected to show two different cyclic 
patterns of sociosexuality, as demonstrated by Oinonen, Klemencic et al. (2008). For instance, 
evolutionary researchers have generally agreed that women tend to be more restrictive than men 
but exhibit a shift towards indicators of unrestrictiveness around ovulation, indicators that 
unrestricted women prefer more overall than restricted women. This means that women low and 
high in short-term mating orientation appear to be pursuing different strategies and thus, may 
show different tactics, such as in proceptive attitudes and behaviours, across the menstrual cycle 
(Phillips, 2015). Further study of the PSTS is needed. 
 
 
Affective Experiences and Sexuality  
 In clinical research, there is a robust link between mood disorder and sexual dysfunction. 
One of the symptoms of clinically elevated mood is increased sexual behavior (APA, 2013) and 
depression is often associated with decreased sexual functioning (Bodenmann & Ledermann, 
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2007). Given the idioms “in the mood” and “not in the mood tonight” in reference to proceptive 
and receptivity sexual behaviour, respectively, a review of the literature suggests that 
surprisingly little research has been conducted on non-clinical affective experiences and 
sexuality (see Warner & Bancroft, 1988 for an early study). In general, negative affect seems to 
be related to decreased, and positive affect to increased, sexuality. This has been demonstrated 
through cross-sectional (e.g., Brown, Calibuso, & Roedl, 2011; Wiebe, Brotto, & MacKay, 
2011); experimental (e.g., mood induction; see also Verhaeghe & Enzlin 2013); and prospective 
(e.g., menstrual cycle; Meaden et al., 2005; Sanders et al., 1983, cf., Graham & Sherwin, 1993) 
studies. However, a few studies have shown some women (10 to 23%) report a paradoxical 
increase in sexual functioning with low mood (Lykins, Janssen, & Graham, 2006; Graham, 
Sanders, Milhausen, & McBride, 2004). Such a positive correlation between negative affective 
experiences and sex may be particularly strong among individuals with sexual addiction 
(Bancroft & Vukadinovic, 2004). Thus, the relationship between negative affect and sexual 
behaviour may be bidirectional (Burleson, Trevathan, & Todd, 2007).  
 Overall, affective experiences seem to involve two independent but at times, co-varying 
valences (i.e., negative and positive; e.g., Study 1). Similarly, sexuality appears to be driven by a 
number of dual processes (e.g., restrictiveness and unrestrictiveness, receptivity and proceptivity, 
sex/mating and attachment/affection, and sexual excitation and inhibition (e.g., Bancroft, 
Graham, Janssen, & Sanders, 2009; Brown et al., 2011). Research on menstrual cycle 
fluctuations in affect and sexuality does not always make these distinctions when examining 
between- and within-women differences (Brown et al., 2011) and such research is either 
associated with a health or evolutionary perspective as opposed to both. However, according to 
the affective shift hypothesis in evolutionary psychology, women’s positive affect tends to 
WOMEN’S REPRODUCTIVE EXPERIENCES 
   
235 
increase following sex to perhaps facilitate long-term commitment (Haselton & Buss, 2001). 
Also, the results of the few studies on jealousy, an affective experience and a tactic of mate 
retention (Buss, 2000), across the menstrual cycle have been inconsistent (Teatero, 2009). 
Despite these findings, studies on changes in women’s mating tactics across the cycle have not 
attempted to account for possible changes in affect (cf., Gangestad et al., 2002). Further research 
is needed on affect and sex across the cycle, particularly from a combined health and 
evolutionary lens.   
 However, evolutionary models of PMS as adaptive or as a byproduct of adaptive changes 
in positive experiences across the cycle have been put forth (see Gillings, 2014 for a brief 
review). Vieira (2009) hypothesized that negative premenstrual experiences co-evolved with 
women’s reproductive physiology because they increase reproductive success. For instance, it is 
possible that PMS may: increase the likelihood of relationship dissolution among couples that 
have not conceived during the fertile phase of the menstrual cycle and are not well matched; help 
women assess their partners’ commitment and parenting qualities; or increase male ardour during 
his partner’s next fertile phase (Gillings, 2014). Similarly, it has been suggested that symptoms 
during the premenstrual phase, during pregnancy, and in the postpartum period may have 
evolved because they keep women out of harm’s way when the survival of a fertilized embryo or 
child depends on them (Niculescu & Akiskal, 2000). The empirical support for these hypotheses 
seem minimal and weak (Gillings, 2014). 
Another model suggests that PMS is a byproduct of adaptions around ovulation, such as 
increased well-being and sexual proceptivity, around ovulation that facilitate mating and 
fertilization (cf., the cyclic defense hypothesis; Doyle, Ewald, & Ewald, 2007). That is, after the 
fertile periovulatory phase of a woman’s cycle, she may experience lowered positive affect and 
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sexuality as a negative state (Reiber, 2008). In support of this model, Reiber (2009) reported 
evidence that women experience different menstrual cycle patterns of PMS that are dependent on 
whether their current conditions are advantageous for reproduction. Some women (21%) had 
higher scores on a measure of PMS in the periovulatory phase, while all others had higher scores 
in the premenstrual phase. Symptom scores in the periovulatory phase were negatively 
associated with age and resources (income) as well as positively associated with parity, 
conditions considered to be unfavorable for having (more) children. Premenstrual positive states 
were suggested to be related to women obtaining mate retention or material benefits from men in 
order to improve their conditions before reproducing. Consistent with this model, it has been 
found that women with PMS show a periovulatory peak in sexual interest (while women without 
PMS show a peak in the premenstrual phase; Van Goozen et al., 1997) and women with PMDD 
report a lower frequency of intercourse and less sexual satisfaction overall compared to other 
women (Nowosielski, Drosdzol, Skrzypulec, & Plinta, 2010). Women with a PMS pattern may 
be sociosexually restricted overall but further research is needed as no results were found when 
the key terms “premenstrual syndrome,” “premenstrual symptoms,” “sociosexuality,” and 
“mating strategy” were entered into PsychINFO. 
It is worth noting that, based on group comparisons (as opposed to symptom load 
correlations), Reiber (2009) found that women with PMS tended to have more children than 
women who had relatively high symptom scores around ovulation. However, positive 
experiences were not examined. The omission of positively valenced changes is problematic 
because, as mentioned previously, the absence of negative experiences is not necessary evidence 
of enhanced positive affect. Thus, if positive states are adaptive at different phases of the cycle, it 
is possible that the compensatory states (i.e., negative experiences) might also be functional at 
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times (Viera, 2009). Clearly, additional study of different patterns in cyclical affect and sexuality 
change is needed. 
The Present Study  
 To summarize, there are numerous reasons to consider the possibility that (a) negative 
affective experiences, positive affective experiences, and sexuality co-vary in predictable ways 
in general and that (b) there may be more than one pattern of relationships between negative 
affective experiences, positive affective experiences, and sociosexual unrestrictiveness or 
proceptivity across the menstrual cycle (see Table 3.1 for an overview of related evidence and 
theories related to [b]). Thus far, researchers have tended to separately examine these variables 
and to report which menstrual cycle phase on average each of these three variables is highest or 
lowest. As originally posed by Reiber (2009), perhaps the question should be at what phase of a 
woman’s cycle will well-being (i.e., low bad mood, high good mood, or proceptivity for sex) be 
evolutionarily advantageous? For some or seemingly most women, optimal well-being in the 
periovulatory phase may be part of the enactment of a typically restricted mating strategy or 
related to being in conditions favourable to reproduction and raising viable offspring. Good 
mood in the most fertile phase of the cycle may be conductive to mating, the likelihood of sex, 
and thus, fertilization. For other women, it may be more adaptive to be feeling one’s best in the 
premenstrual phase, when one is not menstruating nor particularly fertile, as a tactic that is part 




Evidence and Theories Related to Paradoxical Menstrual Cycle Shifts in Affective Experiences and Sociosexuality  
 
Evidence Relevant Theories 
Negative Affective Experiences 
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1. Various retrospective, between-subjects, and qualitative reports of 
menstrual cycle shifts among women (Halbreich, 1995; Warner & 
Bancroft, 1988; Teatero et al., 2014) 
 
2. Paradoxical experiences between women at other reproductive events (e.g., 
increased versus decreased negative affect as a side effect of hormonal 
contraceptive use; see Kiesner, 2011)  
 
3. Inconsistent cyclic peaks in phases between different prospective studies 
(see Romans et al., 2012 for a review) 
 
4. Moderators of the strength/direction of cyclic shifts within studies (Kiesner 
& Pastore, 2010; e.g., emotional sensitivity to bodily cues; Schnall et al., 
2002) 
 
5. Identification of groups of women who exhibit different/paradoxical shifts 
across the cycle (within studies; e.g., Kiesner, 2011; Reiber, 2009) 
 Hormonal sensitivity 
hypothesis (Steiner et al., 
2003)  
 
 Biopsychosocial theories (e.g., 
Bancroft, 1995; Halbreich, 
1997) 
 
 Byproduct model (Reiber, 
2009) 
Positive Affective Experiences  
1. Various retrospective, between-subjects, and qualitative reports of 
menstrual cycle shifts among women (e.g., King & Ussher, 2013; Warner 
& Bancroft, 1988)  
 
2. Paradoxical experiences between women at other reproductive events (e.g., 
postpartum depression versus elation; Sharma et al., 2006) 
 
3. Inconsistent cyclic peaks in phases between different prospective studies 
(see Teatero, et al., 2014 and Teatero et al., 2015 for reviews) 
 
4. Moderators of the strength/direction of cyclic shifts within studies (e.g., 
personality and stress hormones; Davydov et al., 2007) 
 
5. Identification of groups of women who exhibit different/paradoxical shifts 
across the cycle (Rivera-Tovar et al., 1992) 
 Hormonal sensitivity 
hypothesis as applied to 
strength and valence (Kiesner, 
2011) 
 




1. Two within-sex phenotypes of mating strategies based on sociosexuality 
and digit ratio: restricted and unrestricted (Wlodarski et al., 2015). 
 
 Frequency-dependent selection 
(see Wlodarski & Dunbar, 
2015) 
2. Mean differences between women low and high in sociosexuality (e.g., 
attractiveness; Clark, 2004), suggesting two different overall strategies in 
the population.   
 
3. Qualitative reports of various menstrual cycle shifts by different women 
(e.g., King & Ussher, 2013) 
  Strategic pluralism model and 
dual mating hypothesis 
(Simpson & Gangestad, 2000; 








Evidence Relevant Theories 
Sociosexuality 
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4. Inconsistent phase differences and cyclic shifts across both between-
subjects and prospective studies (e.g., Woods et al., 2014)  
 
5. Significant variability in the meta-analytic effect sizes of cyclic shifts in 
mate preferences (Haselton et al., 2014; Woods et al., 2014), suggesting 
one trajectory of change may not adequately describe the effects of the 
menstrual cycle   
 
6. Moderators of the strength/direction of phase differences and cyclic shifts 
within studies (e.g., self- and partner attractiveness; Haselton & Gangestad, 
2006) 
 
7. Identification of groups of women who exhibit different/paradoxical 
patterns across the cycle: Periovulatory sociosexual tactic shift (PSTS; 
Oinonen, Klemencic, et al., 2008; Phillips, 2015) 
 Restricted women shifts towards unrestrictivness/proceptivity  
 Unrestricted women shift towards restrictiveness/proceptivity 
 Restricted pattern: father-at-
home theory of concealed 
ovulation; good genes sexual 
section; sperm competition 
theory (see Oinonen, 
Klemencic, et al., 2008) 
 
 Unrestricted pattern: Sexual 
strategies theory; many-fathers 
theory of concealed ovulation 
















and rearing. Good mood and sex in the premenstrual phase might have been conducive to mate 
retention and resource acquisition without as much risk of pregnancy in the environment of 
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evolutionary adaptiveness (i.e., among our ancestors; Reiber, 2009; Oinonen, Klemencic, et al., 
2008).  
In Part 1 of the present study, an examination of the psychometric properties and 
relationships between the scales of two new measures relevant to the intersection of women’s 
health and reproduction/mating is presented: the Women’s REP and the PARMSS. An attempt 
was also made to replicate evidence of the validity of the Women’s REP from a study of its 
initial psychometric properties (Study 1) by examining scores on this measure as a function of: 
self-reported current hormonal problems in general, HC use, HC side effects, and PMS. In Part 2, 
prospective patterns of menstrual cycle shifts in negative affective experiences, positive affective 




As detailed below, the Time 1 sample for Part 1 of this study consisted of 327 women of 
reproductive age who met inclusion criteria. Demographic information for the Time 1 sample as 
well a subsample of free cycling women who met criteria for menstrual cycle phase analyses for 
Part 2 of the study can be found in Table 3.2. In total, 629 women between the ages of 16 and 71 
years (M = 23.95, SD = 7.78) participated in the screening portion of the study. These women 
resided in eight different countries but predominantly North America (96.8%).  
Volunteers were recruited from a university campus, the local community, and the 
Internet community to participate in a study of “hormones and sociosexuality.” Some students 
Table 3.2 
 
Means and Frequencies of Demographic Variables for the Full Time 1 Sample and Menstrual 
Cycle-Related Subsample 
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Variable Full sample  
(N = 327) 
Subsample  
(n = 42) 
 M (SD)  
Age (years) 22.73 (5.26) 22.92 (5.43) 
 Frequencies (%) 
Ethnic background 
     European (e.g., Caucasian/white) 
     Native/Aboriginal 
     African/black 
     Asian 
     East Indian 
     Other (e.g., multi-racial) 
     Middle Eastern 
     Hispanic/Latino 





















Country of Residence 
    Canada 
    United States  










    Yes 








    In a relationship 
    Single (no primary partner) 












      
Hormonal contraceptive (HC) use
 
    Free-cycling (i.e., non-HC users) 
    Status changed
c
 













Reported relationship status changed from Screening to Time 1 or Time 1 to Time 2 (i.e., 
switched from single to in a relationship, vice versa, or from one partner to another). 
b
Only free-cycling women were included in the menstrual cycle-related subsample. 
c
Reported 
reproductive status changed across Screening to Time 1 or Time 1 to Time 2 (i.e., switched from 




were eligible to receive bonus points for participation towards their final grade in an applicable 
course. Other participants (i.e., those not eligible for bonus points) were offered nominal 
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remuneration as modest incentive to participate. All participants were entered into a prize draw 
for each stage of the study in which they took part. A variety of recruitment methods were used: 
posters and brochures; in-class announcements; e-mails and word of mouth; booths at local 
community events; as well as multi-media (i.e., newspaper and Internet) advertisements. Internet 
recruitment included social media, free participant pools, and other relevant websites. This 
strategy was used to maximize both sample size and diversity (see Gosling, Vazire, Srivastava, 
& John, 2004; Study 1 of the present dissertation). All volunteers were eligible to participate in 
Stage 1 in order to assess whether they met criteria for Stages 2 and 3, which involved a 
prospective menstrual cycle design. 
Materials 
 All questionnaires and forms for this study referred to below can be found in Appendix 
B. 
 Screening Questionnaire (SQ). At Stage 1, volunteers completed an initial online 
questionnaire through the Internet to assess whether they met criteria for the prospective portion 
of the study and to gather information on participants’ current health. Overall, the SQ had four 
main sections: demographics (e.g., age, education, and occupational status), health background 
(e.g., personal and familial history of medical and psychiatric conditions), relationships and 
sexuality (e.g., romantic and sexual history), as well as past and present reproductive experiences 
(including menarche/puberty [e.g., age at menarche in years], the menstrual cycle, HC use, 
pregnancy [e.g., number of times pregnant], the postpartum period, and the menopausal 
transition). General items and ratings were developed by the Health, Hormones, and Behaviour 
Laboratory (HHAB Lab; particularly Oinonen, 1997; Oinonen, 2003; Phillips, 2015; Stone, 
2011; and Teatero, 2009) or for the purposes of the larger project. Dependent on a woman’s 
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reproductive experiences across the lifespan, this questionnaire took most women about 40 
minutes to complete.  
 Similar to Study 1, participants indicated whether they had ever been diagnosed or treated 
for any of following general conditions (never, past, or present): a hormonal problem or 
disorder, HC side effects, and PMS. Also of relevance to the present study, women provided 
ratings (starting at 1) of: (a) how often they drink alcohol on a 5-point scale from never or rarely 
to almost everyday; (b) sensitivity to hormone changes and to alcohol on a 5-point scale from 
very slightly or not at all to extremely; (c) current physical health, emotional health, and sexual 
functioning separately on a 9-point scale from very unhealthy to very healthy; (d) frequency of 
masturbation on a 9-point scale from never to at least once a day; and likelihood (percentage 
change) of having sex with someone for the first time without using a condom on an 11-point 
scale from 0% to 100%; and (e) rate of pubertal development compared to others their age on a 
5-point scales from much younger to much older.  
The SQ also consisted of the following specific scales that were used to examine 
response biases and help establish the validity of the Women’s REP and PARMSS in the present 
study: the Kinsey Scale (Kinsey, Pomeroy, & Martin, 1948); the Sociosexual Orientation 
Inventory-Revised (SOI-R; Penke & Asendorpf, 2008); the Brief Reproductive Experiences 
Scale (B-REP) for past and present reproductive events (developed as an ultra brief complement 
to the Women’s REP below); and the Infrequency (INF) as well as Negative Impression 
Management (NIM) and Positive Impression Management (PIM) scales of the Personality 
Assessment Inventory (PAI) (Morey, 2007). The Neuroticism scale of the short-form Eysenck 
Personality Questionnaire-Revised (EPQ-R; Eysneck, Eysneck, & Barrett, 1985) was also 
included in the SQ. All of these measures are described in more detail below. 
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Kinsey Scale. The Kinsey Scale is a widely used 6-point continuum of self-reported 
sexual orientation from 1 (exclusively heterosexual) to 6 (exclusively homosexual) (Kinsey et al., 
1948) and the option of X (asexual). The option of Other (please describe) was added to the 
scale for the present project due to anecdotal reports from previous participants (Teatero, 2009). 
There is evidence that sexual orientation measured in this way, as opposed to with three 
categories (heterosexual, bisexual, homosexual), may moderate associations such as between 
2D:4D and sexual orientation (Grimbos, Daywood, Burriss, Zucker, & Puts, 2010) as well as 
2D:4D, sociosexual orientation (Oinonen, Teatero, & Mazmanian, 2011), and shifts in sexuality 
across the menstrual cycle (Phillips, 2015).  
Sociosexual Orientation Inventory-Revised (SOI-R). In 2008, Penke and Asendorpf 
revised the original SOI (Simpson & Gangestad, 1991) to consist of three 3-item sociosexual 
subscales: behaviour, attitude, and desire. The items were chosen based on a series of pilot 
studies and are all rated on 9-point scales. The behavioural estimates range from 0 to 20 or more 
partners. The response format (from 1 to 9) for the attitude subscale ranges from strongly 
disagree to strongly agree, while that for the desire subscale is from never to at least once a day. 
Higher scores on the full scale and each aggregated subscale reflect more sexual 
unrestrictiveness versus restrictiveness. Internal consistencies have been shown to range from .85 
to .87. A sex difference has been most apparent in the desire subscale and least apparent in the 
behaviour subscale, and all scales seem to have predictive validity (Penke & Asendorpf, 2008). 
Brief Reproductive Experiences (B-REP) Ratings. The B-REP is a 6-item scale created 
for the present study to very briefly measure the overall experiences of women in regards to 
events characterized by changes in sex hormones. It was designed based on and as a complement 
to the Women’s REP. Participants first indicated whether or not they had experienced a given 
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reproductive event. Ratings of the effects of each applicable reproductive event (in general) are 
then requested for four domains (i.e., physical health, mood, sexual functioning, and relationship 
interests), ranging from 1 (not at all) to 5 (extremely). Each item was phrased negatively (e.g., 
“negative effects on my mood”) as well as positively (e.g., “positive effects on my mood”) to 
assess both negative and positive experiences. Four additional items pertain to possible changes 
in relationship interests (i.e., an increase and decrease in short-term and long-term relationship 
interest). This retrospective/cross-sectional measure was included for the following reproductive 
events: puberty (excluding the items pertaining to sexual functioning and relationships), the 
premenstrual phase, HC use, pregnancy, and the postpartum period. The sets of single-item 
ratings that were used in the present study to help validate the Women’s REP and/or further 
examine the possibility of groups of women who show different menstrual cycle patterns in 
affect and sexuality were the B-REP – HC Ratings and B-REP – Premenstrual Phase Ratings.  
Personality Assessment Inventory (PAI). Although self-report data is often necessary in 
studies that involve internal thoughts, attitudes, and emotions, it can sometimes be affected by 
response biases or styles. The INF, NIM, and PIM scales of the PAI were included to appraise 
the validity of participants’ responses (Morey, 2007). Items are rated on a four-point scale from 
false, not at all true (a score of zero) to very true (a score of three). The INF scale consists of 
four items that are implausible and therefore, extremely unlikely to be endorsed (i.e., infrequent) 
and four items that should have extremely high endorsement rates. Total scores on this scale can 
range from 0 to 24, with a score of 9 or above indicative of non-purposeful (e.g., careless or 
random) responding.  NIM and PIM are each made up of nine items that are associated with an 
unfavourable/negative or favourable/positive response style, respectively. Scores on each of 
these scales can range from 0 to 27.  People who score high on NIM (i.e., a score of 13 or above) 
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may be attempting to present themselves negatively or malinger. People who score high on PIM 
(i.e., 23 or above) may be attempting to present themselves positivity or in a socially desirable 
manner. While the NIM and PIM scales have been shown to have moderate internal consistency 
estimates and high test-retest reliability estimates, the INF scale has expectedly demonstrated 
low internal consistency estimates and moderate test-retest reliability due to the nature of the 
items. All three scales appear to have good construct validity (Morey, 2007).  
Neuroticism. The Neuroticism scale of the short-form ESQ-R consists of 12 true/false 
items (e.g., “Does your mood often go up and down?”) with an internal consistency of .80 among 
women (Eysenck et al., 1985). According to Eysneck et al. (1985), neuroticism (i.e., higher 
scores) reflects overall emotionality and, like many other traits, has strong genetic as well as 
biological components (e.g., sympathetic nervous system reactivity). 
 Phase Questionnaire (PQ). There were two identical online PQs that were administered 
via the Internet (e-mail) across the equivalent of one menstrual cycle. This questionnaire had two 
sections: current health (e.g., reproductive status updates and experiences) as well as 
relationships and sexuality (e.g., relationship updates, sexual activity, and mating strategies). 
General health, sexuality, and perception items were developed by the HHAB Lab for the present 
study or for the purposes of the larger project. Participants were asked (or scheduled) to complete 
each PQ at roughly the same time (i.e., morning, afternoon, or evening) either in the lab or online 
in a location of their choosing. Participants were instructed to reflect on the past 48 hours when 
responding to the items in the PQ so as to better capture experiences during the targeted phases. 
On average, the PQ took approximately 40 minutes to complete.  
The PQ consisted of the following specific scales (described below): the Women’s 
Reproductive Experiences Questionnaire (Women’s REP; developed in Study 1); the 
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Multidimensional SOI (M-SOI; Jackson & Kirkpatrick, 2007); the Proceptive and Receptive 
Mating Strategies Scale (PARMSS) (adapted from Phillips, 2015); and the INF (infrequency) 
scale of the PAI (Morey, 2007). Eight other variables that were used as validity measures (for the 
Women’s REP or PARMSS) or included as part of a larger program of research were: 
neuroticism (Eysneck et al., 1985; see Screening Questionnaire section
25
); the Positive and 
Negative Affect Schedule (PANAS; Watson et al.1988); the Multidimensional Jealousy Scale 
(MJS; Pfeiffer & Wong, 1989); the Pinney Sexual Satisfaction Inventory (Pinney, Gerrard, & 
Denney, 1987); and the Perceived Relationship Quality Components Inventory; PRQC; Fletcher, 
Simpson, & Thomas, 2000) as well as perceived partner mate retention tactics (Pillsworth & 
Haselton, 2006); the Mating Intelligence (IQ) Scale (O’Brien et al., 2009); and the brief 
Empathizing Quotient (EQ) and Systemizing Quotient (SQ) scales (Manning, Baron-Cohen, 
Wheelwright, & Fink, 2010). In addition, women were asked to rate both themselves and their if 
applicable, partners (starting at 1) on traits such as attractiveness, masculinity, and femininity 
from not at all to extremely, self-attractiveness relative to their partner (if applicable) from less 
attractive to more attractive, as well as to indicate how many times they had initiated, a partner 
had initiated, or they had both equally had initiated sexual activity. The latter set of items was 
measured twice, once for sexual activity with anyone (other than a current romantic relationship 
partner) and once for sexual activity with one’s romantic relationship partner (if applicable). 
Similar to Roney and Simmons (2013) and Vannier and O’Sullivan (2011), these estimates were 
used to derive receptivity (number of times initiated by partner) and proceptivity (number of 
times initiated by self or both self and partner) scores.  
                                                 
25
In the PQ, the Neuroticism scale was presented in Likert-type scale format from 0 (not at all true) to 6 (extremely 
true), as opposed to true/false format, in order to maximally capture potential variance in scores over time. 
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Women’s Reproductive Experiences (REP) Questionnaire. The Women’s REP was 
developed in Study 1 to consolidate the measurement of the various symptoms or side effects of 
events characterized by changes in sex hormones. More specifically, this measure was designed 
to measure both negative and positive experiences women may have across the menstrual cycle, 
with HC use, during pregnancy, in the postpartum period, and the perimenopausal transition. In 
Study 1, the measure demonstrated good internal consistency among women of reproductive age, 
pregnant women, postpartum women, and menopausal women (.73 to .95 for the main scales) 
and evidence of concurrent validity (i.e., women of different reproductive and hormonal status 
also differed in expected ways on relevant scales). Goals of the present study were to reexamine 
the internal consistency and concurrent validity as well as examine the test-retest reliability, 
construct validity, as well as any menstrual cyclicity in scores on the Women’s REP.   
The Women’s REP was designed to consist of items from three domains: affective (68 
items), sexual (18 items), and physical (48 items). Experiences are rated on a 5-point scale from 
0 (not at all) to (extreme). It includes a positively valenced item, or at least a one-dimensional 
opposing positive symptom, for every negatively valenced item. In Study 1, factor analysis 
revealed seven scales, 14 subscales, and 13 supplementary subscales that were consistent with 
the rationally derived domains and modestly intercorrelated. An overview of the scales and 
subscales of the Women’s REP can be found in Table 3.3. One scale and two subscales consist 
of items only applicable to women in a relationship, while all other sexuality items reflect 
experiences with others (including merely the thought of others) or masturbation (alone). Scores
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 Table 3.3 
 
Structure of the Women’s Reproductive Experiences (REP) Questionnaire Scales and Subscales  
 
Scales Subscales Supplementary Subscales 
Negative Affective Experiences   
Negative Physical Experiences Hormonal Symptoms 
 
Decreased Appetite 
General Aches and Pains 
Testosterone-Related Experiences 
Progesterone-Related Experiences 
Sexual Problems – General Negative Sexual Experiences – General 
 
Positive Sexual Experiences – Others
a 
Positive Sexual Experiences – Self 
Negative Sexual Experiences – Others
a 
Negative Sexual Experiences – Self 
 
Sexual Problems – Relationship
b 
Negative Sexual Experiences – Relationship
b 
Positive Sexual Experiences – Relationship
b 
 
Positive Affective and Physical 
Experiences 
Positive Affective Experiences 
 
Positive Physical Experiences  
Positive Affect 
Elation 
Positive Physical Experiences – General  
Good Skin 
Healthy Digestion 
Comfort with Breasts  
Body Image Quality Negative Body Image Experiences 
Positive Body Image Experiences 
 
Negative Weight Experiences 
Positive Weight Experiences 
Positive Appetite Experiences 
Sleep Quality Negative Sleep Experiences 
Positive Sleep Experiences 
 
Note. Some scales and subscales consist of both negatively and positively worded items (e.g., Sexual Problems – General, Sexual Problems – Relationship, Body Image Quality, 
Positive Body Image Experiences, and Sleep Quality) and thus, some items are reverse scored in computing overall scores. 
aSexual experiences outside the context of a romantic relationship regardless of relationship status, including general sexual desire and activity involving another person or the 
thought of someone for single women and sexual desire and activity involving a person other than one’s primary partner (e.g., fantasy, infidelity, or polyamory) for women in a 
relationship.bApplies to women in a relationship only. 
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are obtained by reverse scoring items as necessary and summing across (sub)scale items. Higher 
scores indicate more negative or positive experiences in the past two days.  
Multidimensional Sociosexual Orientation Inventory (M-SOI). Jackson and Kirkpatrick 
(2007) created the M-SOI based on Simpson and Gangestad’s (1991) SOI. It includes three 
scales: short-term mating orientation (STMO; 10 items), long-term mating orientation (LTMO; 
seven items), and previous sexual behaviour (PSB; three items). Internal consistency was shown 
to be .95, .88, and .83, respectively (Jackson & Kirkpatrick, 2007; see also Phillips, 2015). In the 
present study, the 9-point rating scales from the SOI-R were used for all items (Penke & 
Asendorpf, 2008; see Screening Questionnaire section), as opposed to 7-point scales and 
numerical estimates (Jackson & Kirkpatrick, 2007). The M-SOI and SOI-R overlap in content 
such that five of the nine items of the latter are included in the former. The three additional 
sociosexual desire items from the SOI-R were also included in the PQ. While the SOI-R is 
purported to measure the classical construct of sociosexuality, from restricted to unrestricted, the 
M-SOI involves separate scales for long-term (restricted) and short-term (unrestricted) mating 
strategies.  
Higher scores on LTMO and STMO reflect a greater propensity for that particular 
strategy. The PSB items are specific to how many partners of the opposite sex the respondent has 
had, which Jackson and Kirkpatrick (2007) converted to z-scores prior to aggregation. For the 
present study, reference to the opposite sex was removed from these items to be inclusive and 
consistent with previous SOI research (Simpson & Gangestad, 1991; Penke & Asendorpf, 2008) 
and z-scores were not used for calculating scores due to the repeated-measures design. Although 
Jackson and Kirkpatrick (2007) found that the scales were moderately correlated among men, the 
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expected sex difference in STMO scores was observed (i.e., men > women) and men’s mate 
preferences were related to the STMO and LTMO scales. These findings suggest that the scale 
emonstrated some validity. The M-SOI was included in the present study as the subscales are 
theoretically meaningful and showed further evidence of validity in distinguishing between 
restricted and unrestricted women in a recent HHAB Lab study (Phillips, 2015).  
Proceptive and Receptive Mating Strategies Scale (PARMSS). The PARMSS was 
developed in Phillips (2015) to measure proceptive and receptive sexual behaviours in imaginary 
situations: potential long- and short-term relationships as well when evaluating photographs of 
potential mates. The PARMSS appears to be the first comprehensive measure of both proceptive 
and receptive behaviours using a common metric (i.e., items that are similar but reflective of 
proceptivity or receptivity in the same scenario). Although Phillips used three specific vignettes 
in addition to picture ratings, participants in the present study were provided with a definition of 
a short- and then a long-term relationship adapted from Little and colleagues (e.g., Little, Jones, 
& Burriss, 2007) and the asked to respond to 16 items adapted from the PARMSS for both 
relationship types. The items were posed in a proceptive (e.g., “Ask this a person for their phone 
number”) and receptive (e.g., “Give this person your phone number if asked”) manner, all 
following the phrase phrase “how likely are you to . . .” (presented once at the beginning). 
Participants responded on a 9-point scale from 1 (not likely at all) to 9 (extremely likely). Two 
scores were calculated by aggregating the eight items for each of the following four subscales: 
Receptivity – Long-Term (LT), Proceptivity – LT, Receptivity – Short-Term (ST), and 
Proceptivity – ST.  
Also, a picture-rating task was adapted from Oinonen (2003) and Phillips (2015). 
Participants were presented with four photographs of the opposite sex one at a time and rated 
WOMEN’S REPRODUCTIVE EXPERIENCES 
   
252 
each of the photos using the PARMSS items. These photos were selected from a pool of 35 
photos of men, from previous research in the HHAB lab and sources on the Internet, that women 
had previously rated as being relatively high on social visibility (i.e., attractiveness and social 
status; Phillips, 2015). Photos were similar in frame to passport photos and of men with a neutral 
or smiling expression. Photos of only attractive men were used to reduce the possibility of floor 
effects in the PARMSS item ratings (such as might be the case if male photos were perceived as 
undesirable in terms of mating-relevant attributes like masculinity; e.g., Thompson & 
O’Sullivan, 2013). Each photo was accompanied by the same brief instructions for participants 
to imagine that the person in the photo is now their age and the 16 items of the PARMSS as well 
as several other trait ratings on the same 9-point scale, including attraction to the person as a 
long-term and as short-term partner. Scores were calculated by averaging the applicable picture 
ratings across photos for two subscales: Receptivity – Picture Ratings (PR) and Proceptivity – 
PR. Thus, overall, six scores were used from the PARMSS, two from the picture ratings and four 
from the vignette ST/LT ratings.  
Higher scores on the six subscales reflect greater propensity for that particular mating 
behaviour. In Phillips (2015), the items or scores of the PARMSS demonstrated good internal 
consistency (.70 to. 92) and test-retest reliability (.76 to .88) as well as evidence of convergent 
and divergent validity (e.g., scores were correlated with the STMO scale of the M-SOI). This 
measure was included in the present study primarily to examine changes in proceptivity across 
the menstrual cycle in relation to changes in the Women’s REP and to further assess its 
psychometric properties.  
Positive and Negative Affect Schedule (PANAS). The PANAS is a 20-item measure of 
both positive and negative affect (Watson et al., 1988). It consists of adjectives that are rated on a 
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scale from 1 (very slightly or not at all) to 5 (extremely) based on the extent to which the 
respondent has felt that way in the past 48 hours (i.e., over the past two days). The two scales 
have been shown to be weakly negatively correlated, ranging from -.12 to -.23, with internal 
consistency of .90 for positive affect and .87 for negative affect (Watson et al., 1988). It has been 
found to have adequate validity and is one of the most widely used measures of its kind (e.g., 
Oinonen & Mazmanian, 2001).  
Multidimensional Jealousy Scale (MJS). Pfeiffer and Wong’s (1989) MJS is a self-
report measure consisting of three eight-item scales: cognitive, emotional, and behavioural 
romantic jealousy. Respondents are instructed to think of a person (referred to as “X”) with 
whom they are having, or have recently had, a relationship while responding to the items. The 
cognitive items are statements that reflect suspicions of threat to a partnership, particularly those 
involving a rival. The emotional items are hypothetical jealousy-evoking situations to which one 
indicates how she would feel on a scale from 1 (very pleased) to 7 (very upset). However, it has 
been noted that asking whether one is very pleased that his or her partner is engaging in 
behaviour that could be construed as infidelity may result in a ceiling effect (Teatero, 2009) and 
so the anchors were changed to not at all upset and extremely upset for the present study. The 
behavioural scale consists of detective and protective behaviours. On the cognitive and 
behavioural scales, respondents are asked to rate how often they engage in each item on a scale 
from 1 (never) to 7 (all the time). Overall, higher scores reflect more pathological jealousy.  
According to Pfeiffer and Wong (1989) the three scales of the MJS are orthogonal, albeit 
modestly correlated. The one- to two-month test-retest reliability was reported to be .75 for the 
cognitive, .82 for the emotional, and .34 for the behavioural scale. Evidence for concurrent 
validity comes from a positive relationship between the MJS and a one-dimensional measure of 
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relationship jealousy. Moreover, the MJS is related to jealousy of sexual infidelity, love, liking, 
and happiness in theoretically consistent ways, showing convergent and discriminant validity 
(Pfeiffer & Wong, 1989). Internal consistencies of the scales have been found to range from .88 
(behavioural) to .94 (emotional) among women (Teatero, 2009). The MJS was included in the 
present study as a validity measure that represents an affect-related variable specific to 
relationship health (Buss, 2000).  
Pinney Sexual Satisfaction Inventory (PSSI). General sexual satisfaction as well as 
sexual satisfaction with one’s current partner (if applicable) were assessed by the PSSI (Pinney et 
al., 1987). This measure consists of 14 and 10 items, respectively. All items are rated on a 7-
point scale from strongly disagree (score of 1) to strongly agree (score of 7). Items include “I am 
satisfied with the frequency with which I have sexual intercourse” and “I wish my partner were 
more romantic when we make love.” The ratings are summed across the applicable subscale. 
Total scores can range from 14 to 98 with higher scores indicative of sexual satisfaction. 
According to Pinney and colleagues, the PSSI appears to have high internally consistency with a 
Cronbach’s alpha of .92 as well as concurrent validity. This scale was included as a validity 
measure for the sexual subscales of the Women’s REP.  
Perceived Relationship Quality Components (PRQC) Inventory. The PRQC Inventory is 
an 18-item measure of six components of a romantic relationship: relationship satisfaction, 
commitment, intimacy, trust, passion, and love (Fletcher et al., 2000). Each item (e.g., How 
satisfied are you with your relationship?) is rated on a seven-point scale from not at all to 
extremely. Internal consistency estimates ranged from .74 (trust) to .96 (committment) across 
two studies. Confirmatory factor analysis indicated that the six first-order subscale model was 
appropriate as well as one second-order factor (i.e., relationship quality). This measure appears 
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to have face validity and was used to assess the relationships between relationship quality and 
each of: affective, sexual, and physical reproductive experiences; receptivity; and proceptivity. 
The items from the passion and love scales were inadvertently excluded from the questionnaire.  
Other self-report measures. Several other measures were included for the purposes of a 
larger program of research. These included seven items assessing perceived partner mate 
retention tactics from Pillsworth and Haselton (2006) that constitute two scales (solicitousness [α 
= .92] and jealousy [α = .85]); 11 items from Gangestad et al. (2002) that measure in-pair and 
extra-pair desire and behaviour (both α = .85; Teatero, 2009); the Mating IQ Scale (O’Brien et 
al., 2009); The Mating IQ Scale; and the brief EQ and SQ (Manning et al., 2010). The Mating IQ 
scale, a measure of intelligence as it pertains to mating success, was first published by Geher and 
Kaufman (2007). The second version of the scale consists of 20 items for women (and 20 similar 
but different items for men; O’Brien et al., 2009). The concept of mating IQ is relatively new and 
more empirical studies are needed but it refers to the extent to which one enacts an overall 
mating strategy that is adaptive for one’s sex based on evolutionary theory. Full scale scores 
range from 0 to 100, with higher scores reflecting greater mating IQ. Among undergraduate 
students, O’Brien et al. (2009) found that the 5-point Likert scale format had moderate internal 
consistency (α = .57 for women) but that total scores were associated with more lifetime sexual 
partner in men and an earlier age of first sexual intercourse in women, variables that may 
represent (within-sex) decisions from an evolutionary perspective.   
Finally, the brief EQ and SQ measure the extent to which one possesses empathizing 
abilities (the desire to understand others, much like theory of mind; women > men) and 
systemizing abilities (the drive to understand systems; men > women), respectively. Both scales 
consist of the 10 most sexually dimorphic items from the full-scale measures (Manning et al., 
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2010). Ratings from 0 (definitely agree) to 4 (definitely disagree) are summed across each scale 
with higher scores reflecting the ability to systemize or empathize. Differences in these abilities 
seem to be related to prenatal androgen exposure as well as endogenous reproductive hormone 
levels (Teatero & Netley, 2012).   
Body measurements. The following health-related body measurements were obtained in 
Stages 2 and 3 during laboratory sessions (if applicable) after completion of the PQ: digit 
lengths, mid-phalangeal hair counts, grip strength, height, weight, as well as waist and hip 
circumference. Mitutoyo Electronic Digital Calipers (Model MIT-500-171) were used to directly 
measure the lengths of the digits, from tip to basal crease to .01 mm, on the left and right hands. 
The ventral surfaces of participants’ hands were also scanned onto a secure desktop computer 
using a Hewlett Packard (HP) Scanjet. Mid-phalangeal hairs on each digit were counted by sight 
using a 5X aspheric 2” medical magnifying lens at the most appropriate angle according to hair 
colour and length as per Oinonen (2009). A digital scale was used to measure weight in 
kilograms. A Dynatron Hydraulic Hand Dynamometer was used to assess grip strength in kgs 
force, while all additional measurements were taken using a measuring tape in meters. A random 
subset of participants had their measurements taken by a second research associate to assess 
interrater reliability. Direct digit lengths, mid-phalangeal hair counts, height and weight, and 
waist and hip circumference were used in the present study to calculate digit ratios, mid-
phalangeal hair count, BMI, and WHR, respectively. The other measurements will be used as 
part of a larger program of research. 
Digit ratio (the ratio of the second finger to the fourth finger [2D:4D] as per Manning et 
al., 1998; see also Oinonen, 2009 and Teatero, 2009) and total number of mid-phalangeal hairs 
(MPH; as per Westlund, Oinonen, Mazmanian, &, Bird, 2015) for both the left and right hands 
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were calculated 2D:4D and MPH count are sexually dimorphic proxy measures of prenatal 
androgen exposure and current androgen action or sensitivity, respectively. BMI, a crude 
estimate of body fat and possibly circulating estrogen levels (see Oinonen & Mazmanian, 
2001b), was calculated based on height and weight (kg/m
2
) and WHR, an estimate of body fat 
distribution and crude circulating testosterone levels, was determined by dividing waist by hip 
circumference (Singh, 1993). The repeatability estimates of these measures in the present study 
were adequate and significant at p < .001: right 2D:4D, rI (94) = .86, 95% CI [.79, .90]; left 
2D4D, rI (94) = .77, 95% CI [.67, .84]; mean 2D:4D, r (94) = .88, 95% CI [.83, 92]; right mid-
phalangeal hair count, r (94) = .85, 95% CI [.78, .90]; left mid-phalangeal hair count, r (94) = 
.95, 95% CI [.92, .97]; mean mid-phalangeal hair count, r (94) = .94, 95% CI [.91, .96]; BMI, rI 
= .82, 95% CI [.74, .88]; WHR, r (92) = .84, 95% CI [.77, .89]. The intraclass correlation 
between BMI based on self-report height and weight and measured BMI was rI (113) = .88, 95% 
CI [.79, .93], p < .001. The inter-rater reliability estimates were also assessed to be good: right 
2D:4D, rI (9) = .76, 95% CI [.27, .94], p = .002; left 2D4D, rI (9) = .83, 95% CI [43, .95], p = 
.001; mean 2D:4D, rI (9) = .89, 95% CI [.65, .97], p < .0001; right mid-phalangeal hair count, rI 
(9) = 1.00, 95% CI [.99, 1.00], p < .001; left mid-phalangeal hair count, rI (9) = .94, 95% CI [.78, 
.98], p < .0001; mean mid-phalangeal hair count, rI  (9) = .98, 95% CI [.93, 1.00], p < .001; BMI, 
rI (9) = .98, 95% CI [.92, 1.00], p < .0001; WHR, rI (9) = .95, 95% CI [.81, .99], p < .001.  
Daily Questionnaire (DQ). A DQ consisting of the PANAS (see Phase Questionnaire 
section) as well as eight other items designed to briefly measure health status (e.g., whether a 
respondent was menstruating and whether a respondent had obtained a luteinizing hormone (LH) 
surge detection test result [if applicable]) as well as relationship and sexual behaviour (e.g., 
whether the respondent engaged in any sexual activity in the past 24 hours). As part of a larger 
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study, the DQs will allow for the calculation of variance in mood (i.e., mood stability) across the 
cycle (e.g., Oinonen & Mazmanian, 2002), which can then be compared with women’s reports of 
mood swings or affective sensitivity, and for the prediction of next day responses based on 
previous day responses (e.g., Burleson et al., 2007). In the present study, health status items from 
the DQ were used as measures of menstrual cycle phase.  
Measures of menstrual cycle phase. From the SQ, the following items were initially 
used to to schedule testing dates and to categorize data into phases: reported average menstrual 
cycle length, cycle regularity, day of the last menstrual period (LMP), the expected date of next 
menstrual period (NMP), and LH detection test results (if applicable). The following information 
was later used to verify whether participants were scheduled precisely into the target phases: (a) 
the questions “Are you menstruating today?” and “If yes, for how many days have you been 
menstruating?” from the PQs and DQs; (b) e-mail follow-up with participants regarding the 
actual date of their predicted NMP; (c) LH detection test results (if applicable); and (d) hormonal 
assays (if applicable). Free-cycling women who participated in lab sessions used urinary LH 
surge detection strips. The strips were professional grade with sensitivity of about 25 mlU/ml 
and specificity greater than 98%. According to Stanford, White, and Hatasaka (2002), LH strips 
measure the rise in LH that tends to occurs 24 hours prior to, and thus are an accurate 
prospective marker of, ovulation. Participants were not initially told which hormone the strips 
were intended to test. Volunteers began testing 18 days prior to the reported start of their NMP 
and they tested daily for about 5 days or until a positive result (i.e., two coloured bands present 
on a strip; see Procedure for further details). The DQ included two items pertaining to the test 
results. If and when a positive test result was obtained (yes or no item), participants were asked 
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to provide a confidence rating from 0 (0% confident) to 8 (100% confident). Hormonal assays 
were also completed among a subset of women. 
Hormonal assays. Saliva samples were collected from free-cycling women during the 
PQ administrations for the subset of participants who completed the PQs in the lab. This was 
done using the saliva sample package provided to them at each lab session. Participants were 
asked to refrain from eating, smoking, exercising, brushing their teeth, wearing chapstick or 
lipstick, and drinking anything but water for one hour prior to attending a lab session. 
Participants were asked to rinse their months with chilled bottled water, which was provided, 
prior to beginning the PQ. A test tube was to be filled with about 2 mL of saliva over the course 
of completing the PQ. Verbal instructions were provided. The samples were collected in 10 mL 
polypropylene tubes. They were stored in a laboratory freezer at no less than -34 degrees Celsius 
until they were shipped to a Salimetrics laboratory at Penn State University for immunoassay. 
Once there, a technician assayed concentrations of estradiol, progesterone, testosterone, and 
cortisol at sensitivities of 0.1, 5, and 1 pg/nL and < 0.007 ug/dL, respectively. 
Procedure 
 The study received approval from relevant institutional and departmental research ethic 
boards. Biosafety approval was also obtained for all procedures involving saliva collection. For 
each participant, the study took place over approximately one month: Stage 1: Recruitment and 
screening; Stages 2 and 3: Prospective menstrual cycle phase design; and Stage 4: Debriefing 
and follow-up. Data were collected online through a secure Internet database 
(www.surveymonkey.com). As an added precaution, optional enhanced security (Secure Sockets 
Layer [SSL]) for the online surveys were used to encrypt all responses. See Figure 3.1 for a 
diagram of participant flow through the four stages of the study. 
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Figure 3.1. Participation flow through the four stages of the study.  
a 
Thirty-three and 19 women provided some data at Time 1 and Time 2, respectively but were 
missing more than 5% of items from the Women’s Reproductive Experiences (REP) scale. Four 
additional participants were excluded post hoc. The final samples were, therefore, n = 327 for 
Time 1 and n = 278 for Time1-Time2. 
b 
Follow-up and non-follow-participants were included in 
the final sample and subsamples.   
Stage 1: 
Screening Questionnaire (SQ) 
N = 629 
Stage 2: 
Time 1 









Debriefing and follow-up 
n = 249
b 
Ineligible for study 
participation 
n = 120 
Eligible for study 
participation 
n = 509 
Eligible non-participants 
n = 146 
Non-completers 
n = 53 
Non-follow-up participants 
n = 61 
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 Stage 1: Recruitment and screening. Potential participants were directed to an Internet 
link for Stage 1, which involved completion of the SQ outside of the laboratory (i.e., at their 
convenience online). At this time, they were first presented with a printable cover Letter 
following by Consent Form A. Each volunteer was required to complete Consent Form A to 
participate in the research. The participants were then given the SQ followed by Debriefing Form 
A with details about the next stages of the study (see Appendix B for all letters and forms).  
Stages 2 and 3: Prospective menstrual cycle phase design.  Based on the measures of 
menstrual cycle phase from the SQ, participants who meet study criteria were sent the brief 
online DQ each day and scheduled for two PQs across the equivalent of one cycle. All DQs were 
sent to participants via email and completed online (outside of the lab for many participants) 
with the request that participants complete them at roughly the same time each day. Local 
volunteers came to the university campus to complete the two PQs online during separate lab 
sessions with the researcher or research associate. Lab sessions were scheduled for between 8:30 
and 10:30 AM if possible to help control for diurnal fluctuation of hormones. At the beginning of 
the first DQ as well as at each PQ administration, participants were presented with and 
completed Consent Form B.  
For women who experience menstrual or withdrawal bleeding, testing dates were 
determined by the backward or reverse counting method (Jöchle’s, 1973) to coincide with two 
menstrual cycle phases: the periovulatory phase (days 9 to 15 of a 28-day cycle or 20 to 14 days 
prior to menses [days -20 to -14]), and the premenstrual phase (days 19 to 28 or -10 to -1). The 
backward counting method is frequently used in the literature and is considered to be valid (e.g., 
Brown et al., 2010). These phases were chosen because they differ in the probability of 
conception as well as relative hormone levels (i.e., estrogen, progesterone, FSH, and LH) and 
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have been implicated in the patterns in women’s affective, sexual, and physical functioning that 
are under investigation. Participants were given optimal dates on which to complete the 
questionnaires that corresponded with days 12 (-17) for the periovulatory phase (i.e., the 
estimated highest fertility day) and 22 (-7) or 26 (-3) for the premenstrual phase of their 
estimated menstrual cycles. Two target days were chosen for the premenstrual phase to capture 
the middle of both the early and late premenstrual phase. Women who did not experience menses 
or whose phases could not be estimated were scheduled for testing periods that were yoked with 
other participants. Based on the next proximate menstrual cycle phase and scheduling 
availability, all participants were scheduled for one of two natural testing orders: periovulatory-
premenstrual (PO-PM) or premenstrual-periovulatory (PM-PO). Thus, the study was a pseudo-
randomized counterbalanced controlled crossover design with respect to menstrual cyclicity. 
However, the data was first organized by time in the form of Time 1-Time 2.   
Given that one of the two online PQ or laboratory sessions was scheduled to occur 
around ovulation, LH test results were used to prospectively and retrospectively determine this 
phase for free-cycling women who completed the study in the lab. Participants were instructed as 
to when to begin using the testing strips based on their menstrual cycle information 
(approximately 18 days prior to the expected date of one’s NMP). An attempt to schedule 
participants within two days before the LH surge and within three days after the LH surge (i.e., -
2 to +3 when 0 represents the day of the positive LH test) was made with the goal of scheduling 
the session on days 0 or +1. Free-cycling volunteers (who reported that they experience 
menstruation) were provided with a kit of at least five LH strips and an Instructions Sheet. If they 
obtained a positive result more than two days before their previously scheduled periovulatory 
laboratory session, their appointment was changed to occur within two days of the positive 
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results. If they obtained a positive result more than three days after the laboratory session, the 
participant had been inadvertently tested outside of the targeted periovulatory phase (see also 
Phillips, 2015). 
Stage 4: Debriefing and follow-up. Following completion of, or withdrawal from, the 
study, participants received Debriefing Form B. In this form, it was requested that female 
participants who experience natural or HC-induced menstrual cycles inform the researcher of the 
date of their NMP by email or telephone and that the researcher would be following up with 
them to provide reminders. This information was used to further check the accuracy of the 
assigned phases and to re-categorize cycle phase if the prediction of a participant’s menstrual 
cycle phases was initially imprecise.  
General Data Screening  
Several screening criteria were applied in order to obtain a sample of women in the 
typically fertile period of the lifespan and thus, to control for obvious non-fertile or infertile 
hormonal states. Based on information provided at Stage 1 (N = 609), 19% of women did not 
meet criteria for inclusion in the study for one or more the following reasons: (a) not within 
typical reproductive age range (i.e., 16 to 44 years; n = 24); (b) less than three months since 
having an abortion or miscarriage (n = 4); (c) less than three months since using high dose 
emergency contraception such as Plan B (n = 20); (d) pregnant (n = 9); (e) postpartum (i.e., less 
than six months since giving birth; n = 6); (f) lactating (n = 19); (g) menopausal (n = 14); and (h) 
no attraction to the opposite sex (i.e., exclusively homosexual in sexual orientation, which 
corresponds to a rating of 6 on the Kinsey scale; or asexuality, a lack of attraction to either sex (n 
= 11). Criterion (h) was applied primarily because male picture stimuli were used in the present 
study but for the purposes of generalizability, women with any orientation towards men were 
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included in the study. Women whose eligibility was undeterminable due to missing data were not 
included in the study (n = 39).  
Overall, the data were screened for errors at data entry and missing values. About 0.34% 
of data points (i.e., items x participants) were missing from the possible 41,8456 data points of 
the Women’s REP in the final Time 1 sample, and 0.35% of 35,456 possible data points at Time 
2 for the Time 1-Time 2 sample. For the PARMSS, 0.25% of data points were missing from the 
possible 30,624 data points in the Time 1 sample and 0.20% of 25,248 possible data points at 
Time 2.  Based on missing data analysis as well as examination of both raw and descriptive data, 
there were no clear patterns in the missing data and thus, they were considered to be missing at 
random. It was expected that any procedure for handling missing data would be acceptable given 
that no variable or case was missing more than 5% of data points and the generalizability of the 
subsamples were to be assessed by comparing participants and non-participants in Part 1 (see 
below). All analyses were conducted after replacing missing data from the Women’s REP and 
the PARMSS with item means. 
The Infrequency (INF), Negative Impression Management (NIM), and Positive 
Impression Management (PIM) scales of the PAI were also examined as potential screening 
variables in the Time 1 sample. It was found that between six and 15 participants scored above 
the empirical cut-off or were missing data on the INF at one of the three measurement points (33 
in total). High scorers just met or exceeded the cut-off by no more than four points. For the NIM 
and PIM scales, which were only included in the SQ, three and four participants scored above the 
cut-offs, respectively, and nine and three participants were missing up to two of the items on 
each scale, respectively. However, based on visual examinations of all of these participants’ data, 
there were no indications of extremely biased or careless responding. As a result, no participants 
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were removed from the analyses on the basis of these three measures but NIM and PIM scores 
were examined as potential correlates of the Women’s REP and the PARMSS in Part 1. Within 
normal limits, NIM and PIM scores may accurately reflect respondents’ cognitions and 
perceptions related to unfavourable or favourable views about themselves (Morey, 2007). 
Prior to each main analysis, the data were screened for the assumptions of the statistical 
tests employed. These included univariate and multivariate outliers (± z ≥ 3.29 and p < .001 
criterion, respectively), normality, linearity, homogeneity of variance-covariance (Box’s M test, 
p < .05), homogeneity of variance (Levene’s test, p < .05), and sphericity (Mauchly’s test, p < 
.05) (Tabachnick & Fidell, 2001). The assumption of linearity was met based on graphical 
checks. The Women’s REP and PARMSS scores tended to be positively skewed, particularly the 
negative experiences and proceptivity scales, and include some slight outliers. In some group 
analyses, the Box’s M and Levene’s test were significant. With large samples (n > 100), some 
deviation from both normal distribution and homogeneity is common (Field, 2009; Tabachnick 
& Fidell, 2001). For all main analyses, results were nearly identical when outliers were removed 
and when robust and non-parametric analyses were examined. Thus, no changes or 
transformations were made to the data and the results of the parametric statistics are presented.   
Part 1:  
The Women’s Reproductive Experiences (REP) Questionnaire: Reliability, Validity, and 
Associations with Mating Strategies 
 The purposes of Part 1 were to examine the psychometric properties of, and relationships 
between, the two newly developed primary measures used in Part 2: the Women’s REP and the 
PARMSS. A related goal was to assess the replicability of, and extend, the reliability and validity 
results of the Women’s REP from Study 1 (Parts 1 and 2). This part of the present study involved 
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three sets of predictions. Based on the results on Study 1, the first set of predictions was that 
women with current (1) hormonal problems, (2) HC side effects, (3) cycle irregularity, and (4) 
PMS, and would have some relatively higher negative experiences scores and some lower 
positive experiences scores on the Women’s REP than their unaffected counterparts (i.e., women 
without such hormone-related experiences). Also, (5) OC users were expected to have lower 
negative and higher positive experiences scores than other HC users and nonusers. The construct 
validity of the both the Women’s REP and the PARMSS was explored based on patterns of 
correlations with 30 other health-, sexuality-, and relationship-relevant variables. It was predicted 
that (6) the scales of the two measures would be (a) most strongly related to variables measuring 
similar constructs (in terms of area: health, sexuality, or relationship and valance: negative or 
positive) and (b) weakly or unrelated to dissimilar variables. Finally, research and theory suggest 
that women’s reproductive experiences (not only hormonal changes but also the physical, 
psychological, and sexual changes associated with them) may facilitate adaptive mating strategy 
enactment (e.g., Oinonen et al., 2008; Reiber, 2009). That is, being in  “a good mood” might put 
women “in the mood” for sex. Thus, in the third set of predictions, it was hypothesized that, 
regardless of current hormonal status, (7) positive reproductive experiences (affective, sexual, 
and physical) would be positively related to unrestricted mating tactics and aspects of sexuality, 
namely proceptivity. In contrast, (b) negative reproductive experiences were expected to be 
inversely related to sociosexuality as well as both receptivity and proceptivity (Phillips, 2015).  
Data Reduction and Analysis 
Of the 509 women who completed the SQ and were eligible for inclusion in the study, 
363 (71%) provided at least some data at Time 1 and 310 (61%) at both Time 1 and Time 2 
(Stages 2 and 3). Some of these women were missing more than 5% (i.e., 6) of the main items on 
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the Women’s REP at Time 1 (n = 33) and were therefore, excluded from all analyses. Women 
missing this amount of data at Time 2 (n = 19) were only excluded from time-related or 
repeated-measures analyses (e.g., test-retest reliability). An additional eight women were missing 
more than 5% (i.e., 5) of the items from the PARMSS in the Time 1 sample, and 14 such women 
in the Time 1-Time 2 sample, were excluded from the relevant analyses only. Lastly, participants 
whose reproductive status changed to pregnant at Time 1 or Time 2 (n = 2) or who endorsed 
“maybe” being pregnant at Time 2 and did not respond to attempts to follow-up (n = 2) were 
excluded from the analyses. Thus, the final full (Time 1) sample consisted of 327 women and the 
Time 1-Time 2 subsample consisted of 277 women (see Figure 3.1).  
To examine the internal consistency of the Women’s REP and PARMSS scales, 
Cronbach’s alpha coefficients of the standardized items were computed in the full sample. Test-
retest reliability was assessed using Pearson product-moment correlation coefficients between 
Time 1 and Time 1 and the effect of time was explored using repeated measures ANOVAs. 
Relationships within and between the scales of Women’s REP, PARMSS, and other measures 
were assessed using Pearson correlations in the full sample. 
A series of one-way MANOVAs and ANOVAs were conducted to examine differences 
in women’s reproductive experiences, as measured by the Women’s REP, as a function of a 
variety of reproductive or hormonal status groups. Group differences in proceptivity and 
receptivity scores were also examined for exploratory purposes. Independent variables included 
women’s reports of current hormonal problems (yes/no) and reproductive status (i.e., non-users, 
OC users, and other HC users) in the full sample; current HC side effects (yes/no and B-REP – 
Current HC Ratings) among HC users; and cycle regularity (regular and irregular) as well as 
current PMS (yes/no and B-REP – Premenstrual Phase Ratings) among non-users. Dependent 
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variables were the Women’s REP scale, subscale, and supplementary subscale scores as well as 
PARMSS scores. Significant MANOVAs were followed up with univariate ANOVAs and 
pairwise comparison tests.  
Given that only one woman was using a non-hormonal IUD, this type of contraceptive 
was not included in the analyses involving reproductive status and in the subsample of HC users. 
In determining reproductive (HC use or nonuse) status, exclusion criteria included: (a) change in 
status (e.g., to or from HC use, another HC, or nonuse) less than three months prior to study 
participation (n = 28) or (b) change in status from the SQ to the PQ at Time 1 (n = 17). One 
additional free-cycling woman reported that she was amenorrheic and thus, she was not included 
in the cycle regularity and PMS analyses. Thus, the final ns for the reproductive status, HC users, 
and non-users subsamples were 286, 159, and 127, respectively. Lastly, women who changed 
their relationship status from the SQ to Time 1 or from Time 1 to Time 2 were excluded (n = 39) 
from analyses involving only women in a relationship.    
Results 
Data screening. To help assess generalizability, women who participated at Time 1 and 
completed the Women’s REP (i.e., the Time 1 sample) were compared to women who were 
eligible to participate after Screening but did not (n = 175). As seen in Table C1 of Appendix C, 
twenty variables from the SQ were examined, five of which were significantly different between 
the two groups. The Time 1 participants reported a higher level of education, higher frequency of 
masturbation (alone), and older age at menarche than non-participants. They were also more 
likely to report being a full-time post-secondary school student as well as using an HC. It seems 
particularly plausible that the women who completed Time 1 were more likely to be full-time 
university students. Comparisons were also made between the sample of women who 
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participated in and completed the Women’s REP at Times 1 and 2 (n = 277) and women who did 
not complete the full study (n = 50) (see Tables C2 and C3 of Appendix C). The only significant 
difference was that women who completed both PQs were more likely to be from the local 
community then those that only completed Time 1.    
Reliability analyses.  
Internal consistency reliability. Cronbach’s alpha coefficients for all scales and 
subscales of the Women’s REP can be found in Table 3.4. The main scales of the Women’s REP 
demonstrated good internal consistency estimates (i.e., > .70; Murphy & Davidshofter, 2005). 
Estimates ranged from .85 to .95 (Sexual Problems – General and Positive Affective and 
Physical Experiences, respectively). The main subscales had internal consistency estimates that 
ranged from .69 (Positive Sleep Experiences) to .95 (Positive Affective Experiences). The 
supplementary subscales had Cronbach’s alphas that ranged between .61 (Positive Breast 
Experiences) and .94 (Positive Affect).  
Cronbach’s alpha coefficients for the PARMSS scores are presented in Table 3.5. The 
mean item scores across the four photographs were used for the Receptivity-PR and 
Proceptivity-PR scales. All scales showed good internal consistencies with estimates ranging 
from .92 to .95.  
Test-retest reliability. The average number of days between Time 1 and Time 2 was 
22.30 days (SD = 41.49). The test-retest reliability estimates for the Women’s REP scales and 
subscales as well as the PARMSS subsales can be found in Tables 3.6 and 3.7 (all significant at p 
< .001). The scales of the Women’s REP were found to have low but significant test-retest 
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Internal Consistency Estimates of the Scales and Subscales of the Women’s REP in the Full Time 1 Sample (n = 
327) 
 
Variable Cronbach’s   
Scales 
Negative Affective Experiences (k = 16) .93 
Negative Physical Experiences (k = 31) .85 
Sexual Problems – General (k = 14) .85 
Sexual Problems – Relationshipa (k = 6) .87 
Positive Affective and Physical Experiences (k = 43) .95 
Body Image Quality (k =15) .90 
Sleep Quality (k = 9) .86 
Subscales 
Hormonal Symptoms (k = 22) .80 
Decreased Appetite (k = 2) .86 
General Aches and Pains (k = 7) .71 
Negative Sexual Experiences – General (k = 8) .78 
Negative Sexual Experiences – Relationshipa (k = 3) .76 
Negative Body Image Experiences (k = 8) .85 
Negative Sleep Experiences (k = 6) .83 
Positive Sexual Experiences – Others (k = 6) .81 
Positive Sexual Experiences – Self (k = 3) .83 
Positive Sexual Experiences - Relationshipa (k = 3) .81 
Positive Affective Experiences (k = 26) .95 
Positive Physical Experiences (k = 17) .84 
Positive Body Image Experiences (k = 7) .86 
Positive Sleep Experiences (k = 3) .69 
Supplementary Subscales 
Testosterone-Related Experiences (k = 13) .73 
Progesterone-Related Experiences (k = 9) .65 
Negative Sexual Experiences – Others (k = 5) .63 
Negative Sexual Experiences – Self (k = 3) .75 
Negative Weight Experiences (k = 2) .86 
Positive Affect (k = 19) .94 
Elation (k = 7) .79 
Positive Physical Experiences – General (k = 10) .77 
Positive Skin Experiences (k = 2) .78 
Positive Digestion Experiences (k = 3) .81 
Positive Breast Experiences (k = 3) .61 
Positive Weight Experiences (k = 2) .73 
Positive Appetite Experiences (k = 2) .80 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. k = number of items.  
a
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Internal Consistency Estimates for the Proceptive and Receptive Mating Strategies Scale 
(PARMSS) in the Full Time 1 Sample (n = 319) 
 





















Note. Number of items for each scale was eight.  
a
Based on responses to a vignette of an imaginary scenario involving a potential long-term or 
short-term relationship. 
b
Based on responses to photographs of four potential male partners. 
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Means, Test-Retest Reliability (Correlation) Coefficients, and Repeated Measures ANOVAs for the Scales and 
Subscales of the Women’s REP in the Time 1-Time 2 Subsample (n = 277) 
 






 Time 1 Time 2     
Main Scales 
Negative Affective Experiences 2.09 (0.74) 2.08 (0.72) .60*** 0.07 .786 .000 
Negative Physical Experiences 1.73 (0.41) 1.72 (0.39) .68*** 0.42 .515 .002 
Sexual Problems – General 2.72 (0.70) 2.77 (0.70) .64*** 1.53 .217 .006 
Sexual Problems – Relationship
a
 2.19 (0.93) 2.19 (0.99) .71*** 0.005 .942 .000 
Positive Affective and Physical 
Experiences 
2.84 (0.56) 2.80 (0.52) .66*** 2.51 .114 .009 
Body Image Quality 3.20 (0.71) 3.19 (0.72) .71*** 0.05 .816 .000 
Sleep Quality 3.19 (0.81) 3.18 (0.83) .59*** 0.07 .789 .000 
Subscales 
Hormonal Symptoms 1.68 (0.41) 1.68 (0.39) .66*** 0.10 .751 .000 
Decreased Appetite 1.71 (0.98) 1.61 (0.84) .45*** 3.09 .080 .01 
General Aches and Pains 1.88 (0.61) 1.87 (0.62) .60*** 0.03 .854 .000 
Negative Sexual Experiences – General 2.00 (0.75) 2.03 (0.79) .61*** 1.29 .258 .01 




1.86 (0.94) 1.88 (1.03) .64*** 0.20 .657 .001 
Negative Body Image Experiences 2.19 (0.79) 2.20 (0.84) .61*** 0.06 .813 .000 
Negative Sleep Experiences 2.48 (0.88) 2.49 (0.90) .58*** 0.06 .804 .000 
Positive Sexual Experiences – Others 2.20 (0.97) 2.18 (0.95) .61*** 0.09 .760 .000 
Positive Sexual Experiences – Self 2.40 (1.05) 2.33 (1.00) .63*** 1.58 .211 .01 




3.48 (1.05) 3.51 (1.11) .68*** 0.10 .590 .001 
Positive Affective Experiences 2.89 (0.64) 2.84 (0.60) .60*** 2.17 .142 .01 
Positive Physical Experiences 2.77 (0.52) 2.74 (0.50) .70*** 1.77 .184 .01 
Positive Body Image Experiences 2.50 (0.79) 2.50 (0.76) .77*** 0.02 .880 .000 
Positive Sleep Experiences 2.54 (0.89) 2.53 (0.90) .49*** 0.05 .829 .000 
Supplementary Subscales 
Testosterone-Related Experiences 1.77 (0.45) 1.76 (0.43) .69*** 0.48 .489 .002 
Progesterone-Related Experiences 1.56 (0.48) 1.56 (0.46) .48*** 0.04 .851 .000 
Negative Sexual Experiences – Others 1.93 (0.73) 1.96 (0.78) .55***  0.42 .519 .002 
Negative Sexual Experiences – Self 2.08 (1.02) 2.16 (1.08) .63*** 1.99 .159 .01 
Negative Weight Experiences 2.81 (1.18) 2.72 (1.18) .74*** 3.32 .069
†
 .01 
Positive Affect 2.88 (0.66) 2.84 (0.62) .61*** 1.43 .233 .01 
Elation  2.89 (0.71) 2.82 (0.66) .45*** 2.86 .092
†
 .01 
Positive General Physical Experiences  2.69 (0.55) 2.67 (0.51) .67*** 0.41 .525 .001 
Positive Skin Experiences  2.54 (0.97) 2.54 (0.93) .57*** 0.00 .991 .000 
Positive Digestion Experiences 3.02 (0.80) 2.98 (0.79) .61*** 0.69 .408 .002 
Positive Breast Experiences  3.02 (0.98) 2.88 (0.97) .63*** 7.19 .008* .03 
Positive Weight Experiences 2.06 (0.82) 2.03 (0.76) .72*** 0.53 .466 .002 
Positive Appetite Experiences  2.50 (0.86) 2.43 (0.84) .53*** 2.07 .151 .01 
Note. Test-retest interval: M = 22.30 days (SD = 41.49). 
a
n = 155 (df = 1, 154) women in a relationship.  
†
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Means, Test-Retest Reliability (Correlation) Coefficients, and Repeated Measures ANOVAS of 
the PARMSS in the Time 1-Time 2 Subsample (n = 263) 
 













3.96 (2.13) 3.69 (2.12) .81*** 11.80 .001** .04 
Long-Term (LT)
 
4.90 (2.53) 4.42 (2.37) .80*** 25.00 .000*** .09 
Picture Ratings (PR)
 




2.75 (1.74) 2.47 (1.67) .76*** 15.03 .000*** .05 
LT
 
3.80 (2.37) 3.21 (2.12) .77*** 36.78 .000*** .12 
PR
 
2.65 (1.67) 2.47 (1.60) .78*** 7.21 .008** .03 
Note. PARMSS = Proceptive and Receptive Mating Strategies Scale. Test-retest interval: M = 
22.30 days (SD = 41.49). 
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Body Image Quality). The main subscales had estimates that ranged from .49 (Positive Sleep 
Experiences) to .77 (Positive Body Image Experiences). The test-retest estimates of the 
supplementary subscales ranged from .48 (Progesterone-Related Experiences) to .74 (Negative 
Weight Experiences). As expected for state- as opposed to trait-like scales that may be sensitive 
to subtle day-to-day changes, the within-woman stability of the Women’s REP scales tended to 
be modest. However, as a group, women did not demonstrate significant change in scores from 
Time 1 to Time 2 (as indicated by the ANOVAs) on 34 of the 35 scales and subscales. The 
exception was the Positive Breast Experiences supplementary scale. 
The PARMSS demonstrated acceptable test-retest reliability estimates (i.e., > .70; 
Murphy & Davidshofter, 2005). They ranged from .80 to .83 for the receptivity scales and .76 to 
.78 for the proceptivity scales. Although the within-woman stability of PARMSS scores was 
high, as a group, women’s scores significantly decreased from Time 1 to Time 2 for all scales, ps 
= .008 to < .001. These results were consistent with a carryover effect or an effect of familiarity 
to the items or photos of the PARMSS.  
Intercorrelations. Scores on the main scales of the Women’s REP were moderately 
correlated with one another (see Table 3.8). Scores on the negatively valenced scales were 
related to lower scores on the positively valenced scales, rs = -.23 to -.57, ps < .01 to .001. For 
example, the Negative Affective Experiences scale was inversely correlated with the Positive 
Affective and Physical Experiences scale. For each type of scale (negatively or positively 
valenced), all relationships were positive in direction, rs = .23 to .65, ps < .001. For example, the 
Negative Affective Experiences scale was correlated with the Negative Physical Experiences 
scale. These results indicate that the scales of the Women’s REP are independent (i.e., the 
strongest correlation did not exceed the conventional cut-off of .80 for a strong effect size) as
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Correlations between the Main Scales of the Women’s REP in the Full Time 1 Sample (n = 327)  
 




5  6  7 
1. Negative Affective Experiences 1       
2. Negative Physical Experiences .65*** 1      
3. Sexual Problems – General .30*** .23*** 1     
4. Sexual Problems – Relationship
a 
.42*** .27*** .27*** 1    
5. Positive Affective and Physical Experiences -.54*** -.25*** -.32*** -.42*** 1   
6. Body Image Quality -.54*** -.44*** -.23*** -.31*** .41*** 1  
7. Sleep Quality -.57*** -.45*** -.28*** -.23** .41*** .32*** 1 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire.  
a
n = 194 women in a relationship.  
*p < .01. **p < .001. 
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well as related to one another in the expected directions. As seen in Appendix D (Tables D1 and 
D2), the subscales of the Women’s REP showed the same patterns of intercorrelations.  
 Similarly, as demonstrated in Table 3.9, PARMSS scores were moderately to strongly 
correlated with one another, rs = .71 to .75 among the receptivity scales; rs = .70 to .73 among 
the proceptivity scales; and rs = .62 to .90 between the two types of scales, all ps < .001. The 
strongest correlation was between Receptivity – ST and Proceptivity – ST. The weakest 
correlations were between Receptivity –LT and Receptivity – ST as well as Receptivity – PR and 
Proceptivity – LT, providing some evidence that such contexts should be examined seperately.  
Validity analyses.    
Current hormonal problems. Eight women (2.4%) reported being diagnosed with or 
treated for a current hormonal problem or disorder. The problems listed by these participants 
primarily involved thyroid and reproductive hormones. The eight women with a current 
hormonal problem were compared to the other 319 women. A summary of all MANOVA and 
ANOVA results in this section can be found in Table 3.10. The combined six DVs from the main 
scales (excluding the relationship scale) of the Women’s REP did not significantly differ by 
current hormonal problem group, F (6, 320) = 1.31, p = .250, partial 
2
 = .02. However, the 
follow-up ANOVA for Positive Affective and Physical Experiences was significant and thus this 
scale was explored further. The mean score for the comparison group was higher than that of the 
hormonal problem group.  
The two subscales of the Positive Affective and Physical Experiences scale were 
examined. The univariate effects of group on both Positive Affective Experiences and Positive 
Physical Experiences scores were significant. When the six supplementary subscales of these 
two main subscales were examined, there were also significant group differences for Positive  
WOMEN’S REPRODUCTIVE EXPERIENCES 




Correlations between the Subscales of the PARMSS in the Full Time 1 Sample (n = 319)  
 
Scale 1  2 3  4 5  6   
Receptivity 
1. Short-Term (ST) 1      
2. Long-Term (LT)
 
.72*** 1     
3. Picture Ratings (PR) .75*** .71*** 1    
Proceptivity 
4. ST .86*** .62*** .65*** 1   
5.  LT .64*** .90*** .62*** .71*** 1  
6.  PR .64*** .63*** .87*** .73*** .70*** 1 
Note. PARMSS = Proceptive and Receptive Mating Strategies Scale.  
***p < .001.
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Affect, Elation, and Positive Physical Experiences – General. The means on all of these scales 
were higher in the comparison group than the hormonal problem group. 
Five women in a relationship reported being currently diagnosed with or treated for a 
hormonal problem. There was a significant group difference for Sexual Problems – Relationship, 
F (1, 192) = 9.73, p = .002, partial 
2
 = .05. Univariate ANOVAs were also significant for both 
Negative Sexual Experiences – Relationship and Positive Sexual Experiences – Relationship. 
The mean for the former subscale was higher for the hormonal problem group than the 
comparison group. The mean for the positively valenced subscale was lower for the hormonal 
problem group than the rest of the subsample. 
Exploratory analyses revealed that the combined six scores of PARMSS also did not 
significantly differ between the groups among the full Time 1 sample, F (6, 302) = 1.79, p = 
.100, partial 
2
 = .03. However, as seen in Table 3.10, the means for the Receptivity – LT and 
Proceptivity – LT scores, appeared low in the hormonal problem group. 
Reproductive status groups. Overall, 127 non-users (43%), 129 OC users (43%), and 30 
other HC users (10%) were included in these analyses. The three groups did not significantly 
differ on either the combined non-relationship Women’s REP scales in a MANOVA, F (12, 558) 
= 1.17, p = .302, partial 
2
  = .03. However, as seen in Table 3.11, pairwise comparisons 
suggested that OC users had higher Positive Affective and Physical Experiences scores than non-
users, p = .027. When the relevant subscales were examined, the effect of group was significant 
for Elation. Pairwise comparisons also indicated that OC users had significantly higher scores on 
these subscales than non-users, ps = .033 and .021. Although the ANOVA for the Positive  
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Summary of Means and ANOVAs for the Scales of the Women’s REP and the PARMSS by Current Hormonal Problem Group (Yes/No) in the Full Time 1 Sample  
 
Dependent variable M (SD) F  (1, 325) p Partial η
2
 
 Yes (n = 8) No (n = 319)    
Women’s REP 
Negative Affective Experiences 2.30 (0.97) 2.09 (0.75) 0.57 .450 .002 
Negative Physical Experiences 1.82 (0.42) 1.73 (0.41) 0.41 .523 .001 
Sexual Problems – General 2.97 (1.13) 2.70 (0.69) 1.18 .277
 
.04 
Sexual Problems – Relationship
a 
     Negative Sexual Experiences – Relationship 
     Positive Sexual Experiences – Relationship 















Positive Affective and Physical Experiences 
     Positive Affective Experiences 
          Positive Affect 
          Elation 
     Positive Physical Experiences 
          Positive Physical Experiences – General 
          Positive Skin Experiences 
          Positive Digestion Experiences 















































Body Image Quality 3.30 (0.60) 3.20 (0.72) 0.15 .700 .000 
Sleep Quality 2.09 (0.65) 3.22 (0.80) 0.19 .664 .001 
PARMSS
b 
Receptivity       
     Short-Term (ST)  3.75 (2.61) 3.99 (2.12) 0.06 .807 .000 
     Long-Term (LT) 3.47 (2.56) 4.95 (2.49) 2.78 .097
†
 .01 
     Picture Ratings (PR) 3.08 (1.74) 3.73 (1.95) 0.89 .347 .003 
Proceptivity       
     ST  2.28(1.68) 2.79 (1.77) 0.07 .786 .000 
     LT  2.20 (1.80) 3.87 (2.39) 3.50 .062
†
 .01 
     PR  1.74 (0.61) 2.70 (1.67) 2.63 .11 .01 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = Proceptive and Receptive Mating Strategies Scale. For the Women’s REP, subscales are 
indented under their respective main scales. Only the subscales of significant or near significant (i.e., p < .10) main scales or subscales are presented.  
ans = 5 and 189 (df = 1, 192) women in a relationship, respectively bn = 8 for Yes and n = 311 for No (df = 1, 317).  
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Summary Means and ANOVAs for the Scales of the Women’s REP and PARMSS by Reproductive Status Group in the Full Time 1 Sample 
 
Dependent variable Nonusers 
(n = 127) 
OC users 
(n = 129) 
HC users 
 (n = 33) 
F  





Negative Affective Experiences 2.20 (0.79) 2.56 (0.75) 2.02 (0.73) 1.43 .241 .01 
Negative Physical Experiences 1.73 (0.44) 1.70 (0.40) 1.74 (0.38) 0.19 .827 .001 
Sexual Problems – General 2.67 (0.72) 2.74 (0.67) 2.74 (0.82) 0.30 .741 .002 
Sexual Problems – Relationship
a 
        
Negative Sexual Experiences – Relationship
b
 























Positive Affective and Physical Experiences 
     Positive Affective Experiences  
          Positive Affect 
          Elation  



















































Body Image Quality 3.16 (0.73) 3.19 (0.72) 3.35 (0.78) 0.86 .426 .01 
Sleep Quality 3.12 (0.77) 3.30 (0.80) 3.12 (0.78) 1.87 .156 .01 
PARMSS
c 
Receptivity        




 (2.34) 2.25 .107 .02 




 (2.55) 5.13 (2.14) 2.76 .065
†
 .02 
  Picture Ratings (PR) 3.85 (1.86) 3.64 (2.04) 4.17 (1.82) 1.03 .360 .01 
Proceptivity        




 (2.26) 2.17 .116 .02 




 (2.41) 4.07 (2.17) 3.18 .043* .02 
  PR  2.82 (1.67) 2.64 (1.70) 3.00 (1.79) 0.67 .511 .01 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = Proceptive and Receptive Mating Strategies Scale. OC = oral 
contraceptive. HC = other hormonal contraceptive. For the Women’s REP, subscales are indented under their respective main scales. Only the subscales of 
significant or near significant (i.e., p < .10) scales or subscales are presented. 
a
Significant pairwise comparison at p < .05. 
b
ns = 57, 89, and 23 (df = 2, 166). 
women in a relationship, respectively. 
b
ns = 125, 126, and 329 (df = 2, 296), respectively 
 
†
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Physical Experiences subscale was not significant, post hoc tests revealed that the mean score 
was higher for OC users compared to non-users, p = .049.  
Among women in a relationship, 57 were non-users, 89 were OC-users, and 23 were 
other HC-users. While mean differences tended to be in expected directions, they were not 
significant.   
The exploratory examination of a reproductive status group difference on the combined 
PARMSS scales using MANOVA was not significant, F (12, 546) = 1.21, p = .274, partial 
2
  = 
.03. Nonetheless, ANOVAs revealed significant group differences for Proceptivity – Long-Term 
and a non-significant trend for Receptivity – Long-Term. Pairwise comparisons indicated that 
the mean scores on these scales were higher in nonusers than OC users, ps = .021 and .013, 
suggesting that nonusers report a greater willingness than OC users to engage in both receptive 
and proceptive mating behaviours with potential long-term partners. Post hoc tests also showed 
that other HC users had higher Receptivity – ST and Proceptivity – ST scores than OC users, ps 
= .038 and .043.  
Current HC side effects. In the combined OC and other HC reproductive status groups, 
two women (1.3%) reported that they were currently diagnosed with or being treated for HC side 
effects and therefore, group analyses were not conducted. As seen in Table 3.12 (and Appendix 
E for the Women’s REP subscales), however, many of the Women’s REP and the PARMSS 
scores were correlated in expected directions with the ten Women’s B-REP – Current HC 
Ratings (i.e., current HC users ratings of negative and positive [or increased and decreased] 
effects of their HCs on emotional health, physical health, sexual functioning, and relationship 
interests), providing some evidence of concurrent validity. The effect sizes were modest but in 
the appropriate directions when statistically significant. As examples, high scores on the  
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Correlations of the Main Scales of the Women’s REP and the PARMSS with the Women’s Brief Reproductive Experiences (B-REP) – Current Hormonal 




Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = Proceptive and Receptive Mating Strategies Scale. STRs = short-term 
relationships. LTRs = long-term relationships. The B-REP measures current HC users ratings of the negative and positive or increased and decreased side effects 
of their HCs on their emotional health, physical health, and sexual functioning (one item for each valance for a total of 10 ratings) from 1 (not at all) to 5 
(extremely). High ratings reflect greater side effects, negative or positive.   
a
Actual ns = 151 to 159 due to missing data. 
b
ns = 110 to 111 women in a relationship.  
†










































 .21** .18* .05     .05 .05 -.15
†
 .12 .09 .19* 
Negative Physical 
Experiences 





Sexual Problems – 
General 
.01 -.04 .004 -.09    -.11 -.04 -.11 .01 -.18* .03 




-.09 .09 .01 .18
†
     .15 .03 -.06 .02 .19* -.09 
Positive Affective and 
Physical Experiences 
.04 -.08 -.03 .13     .15
†
 .12 .28*** .07 -.003 .09 
Body Image Quality -.13
†
 -.30*** -.07 -.01     .05 .05 .17* -.07 -.07 .01 




Receptivity           
   Short-Term (ST) -.02 .04 -.04 .11     .09 .06 -.08 .14
†
 .28** -.002 
   Long-Term (LT) -.10 -.05 -.06 .12     .05 -.01 -.11 .11 .15
†
 -.02 
   Picture Ratings (PR) .05 .08 .01 .19*     .15
†
 .10 .03 .16
†
 .31*** .04 
Proceptivity           
   ST -.05 .04 -.04 .17*    .16* .10 -.04 .15
†
 .24** .03 
   LT -.08 -.03 -.02 .12    .04 -.02 -.08 .14
†
 .13 .03 
   PR .02 .06 .06 .25**    .21** .13 .09 .19* .27** .08 
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Negative Affective Experiences scale were related to high ratings of negative HC side effects on 
emotional health (non-significant trend), physical health, and sexual functioning as well as 
decreased interest in short-term relationships, rs = .13 to .21, ps = .076 to .008; and high 
Negative Physical Experiences scores were related to high ratings of negative HC side effects on 
emotional and physical health, both rs = .19, ps = .016 and .018. These findings provide some 
concurrent validity for these scales. Positively valanced scale scores on the Women’s REP were 
generally not significantly related to ratings of negative or positive side effects of HCs, with the 
exception of Body Image Quality (see Table 3.12). However, women who reported high scores 
on this scale tended to also report increased interest in long-term relationships as a side effect of 
their HC, r = .28, p < .001. While the Sexual Problems – General and Sexual Problems – 
Relationships scores were not significantly correlated with the ratings of HC sexual functioning 
side effects, the former scale was negatively, while the latter was positively, correlated with 
increased interest in short-term relationships, rs = -.18 and .19, ps = .026 and .041.  
With respect to the PARMSS, women with high receptivity and proceptivity scores also 
tended to have high ratings of: positive side effects ratings for emotional health and physical 
health, rs = .16 to .25, ps = .039 to .002; decreased interest in long-term relationships, rs = .14 to 
.19, ps = .094 to .020; and increased interest in short-term relationships, rs = .27 to .31, ps = .003 
to .001. Overall, women who reported that their HC has (a) positive effects on their health, (b) 
decreased their long-term relationship interest, and (c) increased their short-term relationship 
interest were more receptive and proceptive.  
To explore the proportion of women reporting various effects of their HCs on the B-REP, 
ratings of mild to extreme (as opposed to not at all) were combined. Overall, on the Women’s B-
REP – Current HC Ratings, 42 (27%) of women reported mild to extreme negative effects of 
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their current HC on their physical health and 66 (42%) reported positive effects. Forty-four 
(28%) women reported negative, and 47 (30%) reported positive, effects on their emotional 
health. With respect to sexual functioning, 35 (45%) reported negative effects and 46 (29%) 
reported positive effects. Increased interest in short-term relationships associated with their 
current HC was reported by 19 (12%) of women. Nineteen women (12%) also reported 
decreased interest in short-term relationships. Increased interest in long-term relationships was 
reported by 29 (19%), and decreased interest by 12 (8%), of women.  
Menstrual cycle regularity groups. Among the subsample of free-cyclers, 35 women 
(28%) rated their cycles as irregular (i.e., “Some months I get my period and some months I 
don’t”), while 92 women reported regular cycles (i.e., “I usually get my period within two to 
three days of when I expect it” or “My period is like clockwork; the same number of days elapse 
between periods”). The combined effect of the main scales of the Women’s REP (excluding the 
relationship scale) approached significance with a MANOVA, F (6, 120) = 1.90, p = .087, partial 

2
 = .09. As seen in Table 3.13, univariate ANOVAs revealed that women with irregular cycles 
scored higher than those with regular cycles on the Sexual Problems – General scale. Also, the 
irregularly cycling group reported significantly lower Body Image Quality and Sleep Quality 
scores than women with regular cycles. 
When the subscales of the main scales that showed evidence of group differences were 
examined, ANOVAs indicated that the mean Negative Sexual Experiences – General and 
Negative Sleep Experiences scores were higher in the irregular than regular cycling group (see 
Table 3.13). With the supplementary subscales, the irregular group reported higher symptoms on 
the Negative Sexual Experiences – Others and Negative Sexual Experiences – Self scales. 
Among women in a relationship, 10 women reported irregular cycles and 47 reported regular 
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Summary of Means and ANOVAs for the Scales of the Women’s REP and PARMSS by Cycle Regularity Group among Free-Cycling Women  
 
Dependent variable Irregular 
(n = 35) 
Regular 
(n = 92) 
F (1, 125) p Partial η2 
Women’s REP 
Negative Affective Experiences 2.46 (0.867 2.10 (0.73) 5.46 .021* .04 
Negative Physical Experiences 
     Hormonal Symptoms 
          Testosterone-Related Experiences 
          Progesterone-Related Experiences 
     Decreased Appetite 































Sexual Problems – General 
    Negative Sexual Experiences – General 
          Negative Sexual Experiences – Others 
          Negative Sexual Experiences – Self 
     Positive Sexual Experiences – Others 































Sexual Problems – Relationshipa 2.78 (1.30) 2.22 (1.01) 2.26 .138 .04 
Positive Affective and Physical Experiences 2.67 (0.67) 2.75 (0.53) 0.54 .466 .004 
Body Image Quality 3.11 (0.82) 3.18 (0.70) 0.23 .630 .002 
Sleep Quality 
     Negative Sleep Experiences 

















Receptivity       
     Short-Term (ST) 4.26 (2.02) 4.07 (2.23) 0.19 .664 .002 
     Long-Term (LT) 5.68 (2.23) 5.22 (2.56) 0.84 .260 .01 
     Picture Ratings (PR) 4.18 (1.64) 3.73 (1.93) 1.42 .235 .01 
Proceptivity       
     ST  2.52 (1.48) 3.04 (1.96) 1.98 .162 .02 
     LT  4.01 (2.20) 4.37 (2.51) 0.54 .463 .004 
     PR  2.71 (1.48) 2.86 (1.75) 0.20 .657 .002 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = Proceptive and Receptive Mating Strategies Scale. For the Women’s REP, subscales are 
indented under their respective main scale. Only the subscales of significant or near significant (i.e., p < .10) main scales or subscales are presented.    
ans = 10 and 47 (df = 1, 56) women in a relationship, respectively. bns = 34 and 91 (df =1, 123), respectively.  
†p < .10. *p < .05., **p < .01. ***p < .001.
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cycles. There was no difference between the groups in mean Sexual Problems – Relationship 
score.   
When scores on the PARMSS scales were explored, the groups differed on the combined 
scales in the MANOVA, F (6, 118) = 2.48, p = .027, partial 
2
 = .11, but follow-up ANOVAs 
were not significant. However, all of the receptivity means appeared higher among the 
irregularly cycling group, while all of the proceptivity means appeared higher among the 
regularly cycling group. 
Current PMS. Among free-cyclers, 14 women (11%) reported that were currently 
diagnosed with or being treated for PMS and 113 women did not. Only women who were within 
the premenstrual phase of their cycle (i.e., one to 10 days before the self-reported date of NMP 
[next menstrual period]) when they participated in Time 1 were examined further. Due to small 
sample sizes of women in the premenstrual phase at Time 1 (2 women with, and 28 women 
without, self-reported PMS), group analyses were not conducted. Instead, correlations of the 
Women’s REP and PARMSS with ratings of PMS symptoms (on the Women’s B-REP – 
Premenstrual Phase Ratings) were examined among the 30 women in the premenstrual phase. As 
seen in Table 3.14 (and Appendix F for the Women’s REP subscales), some of the Women’s 
REP and PARMSS scales were correlated with Women’s B-REP – Premenstrual Phase Ratings 
and the correlations tended to be in the expected directions when significant, with one exception 
noted below. 
Overall, for most negatively valenced Women’s REP scales, women with high scores 
also tended to have high PMS ratings indicating negative effects of the premenstrual phase on 
emotional, sexual, and physical health or functioning, rs = .37 to .74, ps = .044 to < .001, as well 
as decreased relationship interests, rs = .37 to .66, ps = .046 to < .001. The correlations for the 
WOMEN’S REPRODUCTIVE EXPERIENCES 




Correlations of the Main Scales of the Women’s REP and the PARMSS with the Women’s Brief Reproductive Experiences (B-REP) – Premenstrual Phase 















































 .20 .40* .38
*





.59** .64*** .39* .14 .13 .17 .24 .47** .02 .66*** 
Sexual Problems – 
General 
.29 .27 .37* -.31
†
 -.09 -.03 -.01 .23 -.13 .41* 
Sexual Problems – R
b





Positive Affective and 
Physical Experiences 
-.25 -.16 -.30 .17 -.01 .29 .16 -.05 .23 -.23 
Body Image Quality -.28 -.12 .13 -.09 -.25 -.29 .01 .22 -.09 .20 
Sleep Quality .08 .23 .01 .44* .42* .42* .23 .08 .47** -.16 
PARMSS 
Receptivity            
   Short-Term (ST) -.30 -.19 -.08 .18 .06 -.20 -.09 -.16 -.03 -.14 
   Long-Term (LT) -.20 -.06 .02 .12 -.05 -.26 -.24 -.06 -.06 -.09 
   Picture Ratings (PR) -.22 -.09 .10 .31
†
 .01 -.07 .11 -.06 .14 -.02 
Proceptivity           
   ST -.42* -.35
†
 -.08 .01 -.02 -.26 .01 -.25 -.01 -.18 
   LT -.30 -.18 -.08 -.03 -.11 -.31 -.15 -.18 -.04 -.19 
   PR -.43* -.33
†
 .11 .04 -.08 -.21 .08 -.20 .08 -.19 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = Proceptive and Receptive Mating Strategies Scale. STRs = short-term relationships. LTRs 
= long-term. Relationships. R = Relationship. The B-REP measures women’s reports of the negative and positive or increased and decreased effects of the premenstrual phase (in 
general) on their emotional health, physical health, and sexual functioning (one item for each valance for a total of 10 ratings) from 1 (not at all) to 5 (extremely). High ratings 
reflect greater side effects, negative or positive.   
aActual ns = 29 to 30 due to missing data. bns = 14 to 15 women in a relationship.  
†p < .10.  *p < .05. **p < .01. ***p < .001.  
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Negative Affective Experiences scale were relatively strong. However, contrary to expectations, 
Negative Affective Experiences scores also showed small positive correlations with the three 
positive PMS ratings, rs = .38 to .40, ps = .45 to .28, while Negative Affective Experiences, 
Sexual Problems – General, and Sexual Problems – Relationship scores not significantly related 
to these ratings. The positively valenced scale scores of the Women’s REP tended to be non-
significant in these analyses. The exception was Sleep Quality, which was positively related to 
positive effects of the premenstrual phase on emotional health, physical health, and sexual 
functioning as well as increased interest in short-term relationships, rs = .42 to .47, ps = .020 to 
.009. Proceptivity scores on the PARMSS were negatively correlated with the negative effects of 
the premenstrual phase on physical health and emotional health, rs =  -.42 to -.43, ps = .023 to 
.019, but not with ratings of the effects on relationship interests.  
To explore the proportions of women in the full subsample of freecycling women (not 
just those in premenstrual phase) reporting various effects of the premenstrual phase on the B-
REP, ratings of mild to extreme (as opposed to not at all) were combined. On the Women’s B-
REP – Premenstrual Phase Ratings, 70 (55%) women reported that the premenstrual phase has 
negative effects, while 31 (25%) reported positive effects, on their physical health. Ninety-three 
(74%) reported negative effects, while 33 (26%) reported positive effects, on their emotional 
health. With respect to sexual functioning, 74 (59%) of women reported that the premenstrual 
phase has negative effects, while 74 (59%) reported that it has positive effects. Thirty-five (28%) 
of women reported that their interest in short-term relationships increases in the premenstrual 
phase, and 18 (14%) reported that it decreases. Increased interest in long-term relationships was 
reported by 51 (40%), and decreased interest by 17 (13%), of women. 
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Correlations with other relevant measures. Correlations for scores on the Women’s REP 
and the PARMSS with 30 other health-, sexuality- or relationship-relevant variables from the SQ 
or the Time 1 PQ were computed. As seen in Tables 2.15, 2.16, and 2.17 (and Appendix G, H, I 
for the Women’s REP subscales), both the negatively valenced and positively valenced scales of 
the Women’s REP tended to be related to these variables in expected directions. Within each 
valance (i.e., negative or positive), the scales tended to be related to the same variables, 
particularly those of the same valence. For example, the negative experiences scales, such as 
Negative Affective Experiences, were positively correlated with Negative Impression 
Management, Neuroticism, hormonal sensitivity rating, and Negative Affect (PANAS), rs = .14 
to .75, ps = .046 to < .001, as well as negatively correlated with Positive Affect (PANAS), 
physical health rating, emotional health rating, sexual functioning rating, sexual satisfaction in 
general (PSSI – General), and LTMO (Long-Term Mating Orientation) scores, rs = -.13 to -.53,  
ps = .016 to < .001. The positive experiences scales showed the opposite relationships with these 
variables (see Tables 2.15 and 2.16). Similarly, among women in a relationship, negative 
experiences scores tended to be negatively correlated with sexual satisfaction (PSSI – Partner), 
relationship quality scores (e.g., commitment to partner), and proceptive behaviour in the past 48 
hours, rs = -.16 to -.47, ps = .029 to < .001, as well as positively correlated with jealousy (not 
including Sexual Problems scores), rs = .15 to .29, ps = .040 to < .001. Positive experiences 
scores showed the opposite relationships (see Table 3.17). These findings provide evidence of 
convergent validity.  
Correlations between affective and sexual Women’s REP scale scores were also 
relatively strong with other affective and sexual variables, respectively, providing some evidence 
of divergent validity. It was also revealed that Sexual Problems – General scores were negatively
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Table 3.15  
 
Correlations of the Main Scales of the Women’s REP and the PARMSS with Other Health-Relevant Variables in the Full Time 1 




Scale NIM PIM N HS NA PA EH PH SF 
Women’s REP 
Negative Affective Experiences .36*** -.32*** .46*** .19** .75*** -.49*** -.41*** -.15** -.23*** 
Negative Physical Experiences .35*** -.31*** .37*** .23*** .50*** -.21*** -.29*** -.10
†
 -.09 
Sexual Problems – General .19** -.15** .17** .03 .19** -.23*** -.19** -.05 -.35*** 
Sexual Problems – Relationship
b
 .25** -.19** .22** .14* .36*** -.37*** -.17* -.19** -.53*** 
Positive Affective and Physical 
Experiences 
-.25*** .18** -.34*** -.06 -.40*** .75*** .39*** .33*** .30*** 
Body Image Quality -.17** .27*** -.34*** -.15** -.39*** .30*** .29*** .21*** .17** 
Sleep Quality -.25*** .24*** -.32*** -.03 -.46*** .39*** .27*** .22*** .22*** 
PARMSS
 
Receptivity           
     Short-Term (ST) .06 -.04 -.003 -.11
†
 .16** .03 -.06 .004 -.02 
     Long-Term (LT) .02 -.07 .04 -.07 .16** .05 -.004 .08 -.03 
     Picture Ratings (PR) .04 -.02 .02 -.07 .12* .09 .04 .09 .01 
Proceptivity           
     ST .05 -.03 -.02 -.12* .16** .05 -.03 .02 -.01 
     LT .01 -.06 .03 -.10† .12* .06 .02 .07 .002 
     PR .02 -.03 -.02 -.06 .08 .13* .07 .09 .04 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = Proceptive and Receptive Mating Strategies 
Scale. NIM = Negative Impression Management. PIM = Positive Impression Management. N = Neuroticism. HS = Hormonal 
Sensitivity Rating. NA = Negative Affect (Positive and Negative Affect Schedule [PANAS]). PA = Positive Affect (PANAS). EH = 








189 to 194 women in a relationship.  
†
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Scale SO PSSI MF A – LT A – ST SOI LTMO STMO PSB R P 
Women’s REP 
Negative Affective Experiences .19** -.34*** .10
†
 .07 .09 .08 -.15** .09
†
 .06 .002 .003 
Negative Physical Experiences .10
†
 -.19*** .08 .11* .13* .04 -.13* .08 .01 -.03 -.001 
Sexual Problems – General -.07 -.18** -.32*** -.08 -.18** -.28*** .02 -.25*** -.12* -.05 -.14* 













Positive Affective and Physical 
Experiences 
-.18** .39*** .01 .03 .04 -.04 .20*** -.07 -.07 .003 -.03 
Body Image Quality -.03 .22*** .01 -.08 -.01 -.05 .05 -.03 -.10
†
 .01 .09 




 .05 .05 .03 .05 
PARMSS 
Receptivity subscales            
     Short-Term (ST) .09 -.25*** .07 .36*** .54*** .39*** -.29*** .49*** .15** .07 .11
†
 
     Long-Term (LT) .01 -.24*** -.05 .52*** .40*** .17** -.11* .23*** .000 .04 .03 
     Picture Ratings (PR) -.02 -.24*** .06 .72*** .69*** .24*** -.24*** .33*** .03 .05 .01 
Proceptivity subscales            
     ST .09 -.18** .01 .28*** .48*** .31*** -.28*** .41*** .14** .08 .14* 
     LT .02 -.15** -.07 .42*** .36*** .16** -.10
†
 .20*** .03 .06 .08 
     PR -.04 -.16** .002 .60*** .60*** .14* -.24*** .23*** -.02 .06 .03 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = Proceptive and Receptive Mating Strategies Scale. SO = Kinsey Sexual 
Orientation Scale. PSSI = Pinney Sexual Satisfaction Inventory – General (total score). MF = Masturbation Frequency Rating. A – LT = Attraction for a Long-
Term Relationship – Picture Ratings. ST = Attraction for a Short-Term Relationship – Picture Ratings. SOI = Sociosexual Orientation Inventory – Revised (total 
score). LTMO = Long-Term Mating Orientation. STMO = Short-Term Mating Orientation. PSB = Past Sexual Behaviour. R = Number of Times Receptive to 
Sexual Activity with Others (excluding primary partner) in the past two days (48 hours). P (Proceptive) = Number of Times Sexual Activity with Others Initiated 
by Self or Both Self and Partner (excluding primary partner) in the past two days (48 hours). 
a
ns = 311 to 327 due to missing data. 
b
ns = 189 to 194 women in a relationship.  
†
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-.19** -.24** -.16* -.20** -.25*** .24** .15* .23*** .08 -.05 






 -.16* .02 .02 .02 -.002 -.17* 





 -.47*** -.25*** .12
†
 -.10 .04 -.12
†
 -.30*** 
Positive Affective and 
Physical Experiences 
.27*** .40*** .15* .39*** .34*** -.17* -.14
†
 -.10 -.03 .16* 
Body Image Quality .15* .23** .02 .20** .16* -.20** -.14
†
 -.19** -.08 .08 
Sleep Quality .10 .21** .01 .14* .15* -.12
†
 -.05 -.09 -.03 .07 
PARMSS 
Receptivity            
     Short-Term (ST) -.16* -.29*** -.40*** -.26*** -.22** .14
†
 .02 .17* .14* -.08 
     Long-Term (LT) -.07 -.26*** -.33*** -.28*** -.28*** .21** -.02 .14
†
 .04 -.02 
     Picture Ratings (PR) -.17* -.24** -.25*** -.22** -.24** .10 .001 .18* .10 -.02 
Proceptivity            
     ST -.11 -.17* -.32*** -.17* -.18* .09 .06 .21** .23** -.02 
     LT -.04 -.17* -.26*** -.18* -.29*** .21** .01 .18* .04 -.14
†
 
     PR -.15* -.17* -.16* -.16* -.26*** .07 .04 .24** .18* -.05 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = Proceptive and Receptive Mating Strategies Scale. PSSI = Pinney Sexual 
Satisfaction Inventory – Partner (total score). S = Relationship Satisfaction. C = Commitment to Partner. I = Intimacy with Partner. T = Trust in Partner. CJ = 
Cognitive Jealousy. EJ = Emotional Jealousy. BJ = Behavioural Jealousy. R = Number of Times Receptive to Sexual Activity with Partner in the past two days 
(48 hours). P (Proceptive) = Number of Times Sexual Activity with Partner Initiated by Self or Both Self and Partner in the past two days (48 hours).  
a
ns = 188 to 194 due to missing data.  
†
p < .10. *p < .05. **p < .01. ***p < .001.
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related to masturbation frequency and indicators of sociosexual unrestrictiveness (e.g., SOI and 
STMO [Short-Term Mating Orientation], rs = -.18 to -.32, ps = .003 to < .001, while Sexual 
Problems – Relationship scores were unrelated to masturbation frequency and negatively related 
to sociosexual variables, rs = .16 to .23, ps = .029 to .001.  
Scales of the PARMSS were unrelated to the impression management, Neuroticism, and 
Positive Affect scales as well as health ratings. Receptivity and proceptivity scores tended to be 
negatively correlated with sexual satisfaction in general (PSSI - General) and in a relationship 
(PSSI – partner), relationship quality among women in a relationship, and LTMO, rs = -11 to -
.40, ps = .043 to < .001. They were also positively correlated with picture ratings of attraction for 
long-term and short-term relationships and indicators of unrestrictiveness (e.g., SOI, LTMO, and 
Past Sexual Behaviour) as well as cognitive and behavioural jealousy and receptive behaviour 
among women in a relationship, rs = .14 to .72, ps = .014 to < .001. These findings provide 
evidence of convergent and divergent validity for PARMSS. The only health-relevant variable in 
Table 3.15 with which the PARMSS scores were significantly related was Negative Affect 
(PANAS), rs = .12 to .16, ps = .040 to .004. Women higher in receptivity and proceptivity 
reported higher negative affect.  
Correlations between the Women’s REP and the PARMSS. Correlations between the 
scales and subscales of the Women’s REP and the PARMSS are presented in Table 2.18. Both 
Negative Affective Experiences and Negative Physical Experiences scores were positively 
related to the receptivity scores, rs = .10 to .13, ps = .078 to .023, particularly the imaginary 
vignette short-term relationship scale (Receptivity – ST). These associations suggest that women 
with higher emotional and physical reproductive symptoms reported more receptivity. Sexual 
Problems – General was negatively related to all PARMSS scales (except Proceptivity – PR), rs 
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Correlations between the Scales and Subscales of the Women’s REP and the PARMSS in the Full Time 1 Sample (n = 319) 
 







ST LT PR 
Scales 




 .06 .03 .03 





Sexual Problems – General -.18** -.14* -.14* -.20*** -.17** -.13 
Sexual Problems – Relationship
a
 .18* .14* .17* .10 .09 .08 
Positive Affective and Physical Experiences -.03 -.03 .05 -.02 -.02 .07 
Body Image Quality -.03 -.03 -.03 .03 .03 .02 
Sleep Quality -.04 -.10
†
 -.05 -.04 -.07 -.02 
Subscales 







Decreased Appetite .15* .13* .15* .13* .14* .12* 
General Aches and Pains .02 .02 .02 -.01 -.03 -.02 
Negative Sexual Experiences – General -.07 -.10
†
 -.05 -.14* -.16* -.07 






 .07 .03 .04 
Negative Body Image Experiences .05 .07 .07 -.003 .02 .02 
Negative Sleep Experiences .06 .13* .08 .04 .08 .05 
Positive Sexual Experiences – Others .38*** .27** .32*** .31*** .25*** .25*** 
Positive Sexual Experiences – Self .07 -.01 .06 .05 -.01 .03 
Positive Sexual Experiences – Relationship
a
 -.19** -.19** -.18** -.12 -.13
†
 -.10 
Positive Affective Experiences -.03 -.02 .03 -.02 -.01 .05 
Positive Physical Experiences -.01 -.03 .07 -.02 -.04 .07 
Positive Body Image Experiences -.01 .02 -.02 .04 .07 .06 
Positive Sleep Experiences .01 -.03 .03 -.01 -.03 .02 
Supplementary Subscales 
Testosterone-Related Experiences .15** .15** .12* .12* .12* .08 
Progesterone-Related Experiences .03 .10
†
 .06 .06 .13* .07 
Negative Sexual Experiences – Others -.11
†
 -.13* -.09 -.17* -.19** -.11* 
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ST LT PR 
Supplementary Subscales 
Negative Weight Experiences .07 .03 .06 -.01 -.04 .01 
Positive Affect -.02 .01 .05 -.01 .01 .08 
Elation -.06 -.09 -.02 -.03 -.05 .03 
Positive General Physical Experiences -.003 -.03 .07 -.002 -.02 .08 
Positive Skin Experiences .01 .04 .08 -.004 -.004 .09 
Positive Digestion Experiences .02 .04 .06 -.004 .03 .05 
Positive Breast Experiences -.09 -.13* -.05 -.09 -.14* -.04 
Positive Weight Experiences .01 .04 .05 .04 .07 .08 
Positive Appetite Experiences .06 .06 .07 .08 .08 .11
†
 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = Proceptive and Receptive Mating Strategies Scale.  
a
n = 191 women in a relationship.  
†
p < .10. *p < .05. **p < .01. ***p < .001.  
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= -.14 to -.18, ps = .021 to < .001, suggesting that women with general sexual problems are less 
receptive and less proceptive. However, Sexual Problems – Relationship scores were positively 
related to Receptivity – ST scores, rs = .14 to .18, ps = .047 to .015, suggesting that women 
having more sexual problems in their relationship are more receptive to potential short-term 
partners. The other main scales of the Women’s REP (Positive Affective and Physical 
Experiences, Body Image Quality, and Sleep Quality) were not significantly correlated with the 
PARMSS scores.  
 Examination of correlations between the Women’s REP subscales and the PARMSS 
indicated that both receptivity and proceptivity were moderately positively related to Positive 
Sexual Experiences – Others scores, rs = .25 to .38, ps < .001, and weakly positively related to 
Decreased Appetite and Testosterone-Related Experiences scores, rs = .12 to .15, ps = .036 to 
0.10. Women who reported greater decreased appetite and testosterone-related reproductive 
symptoms tend to report higher receptivity and proceptivity. Receptivity scores were also 
negatively related to Positive Sexual Experiences – Relationship scores, rs = -.18 to -.19, ps = 
.013 to .008, while proceptivity scores were negatively related to Negative Sexual Experiences – 
General, rs = -.14 and -.16, ps = .011 and .005.  
Discussion 
 The main purposes of this report (Part 1 of Study 2) were to examine the psychometric 
properties and relationships between the scales of Women’s REP and the PARMSS, two new 
measures relevant to the intersection of women’s health and reproduction/mating. An attempt 
was made to replicate evidence of internal consistency and concurrent validity of the Women’s 
REP from Study 1. The development and initial psychometric evaluation of the PARMSS was 
presented in Phillips (2015). Thus, another goal of the present study was to address the need for 
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further examination of the psychometric properties of this unique measure of both receptivity 
and proceptivity. The test-retest and construct validity of the Women’s REP and the PARMSS 
were also explored.  
As in Study 1, the Women’s REP scales and subscales tended to show good internal 
consistency reliability and low to moderate intercorrelations, ranging from .61 to .95 (M = .82) 
and |.01| to |.68| (M = .36), respectively. These findings provide further evidence that the scales 
are measuring independent constructs. Building on Study 1, the test-retest reliability of the 
Women’s REP scores was examined in the present study. Results revealed that the test-retest 
reliability was low, ranging from .59 to .72 (M = .62) for the main scales, but appropriate for at 
least two reasons. First, reproductive experiences related to fertile times in the female lifespan 
would be expected to be brief and somewhat fleeting, such as across phases of the menstrual 
cycle with changes in hormone levels. Thus, it is likely that the test-retest reliability estimates 
would be higher if both testing sessions occurred during the same phase of consecutive menstrual 
cycles. Also, the Women’s REP is purported to be a measure of experiences that are more state- 
than trait-like and thus, its scores would not be expected to be highly stable. Nonetheless, with 
respect to the possibility of effects of time, the Women’s REP scores did not exhibit any 
significant changes between Times 1 and 2. This suggests that the scale scores are reasonably 
stable across a 22-day (SD = 41.49) period where substantial reproductive status changes are 
unlikely to have occurred. These findings replicate those of Study 1 with respect to internal 
consistency and indicate that Women’s REP demonstrates good reliability. 
 The PARMSS scales demonstrated good internal consistency reliability, an average of 
.93, and acceptable test-retest reliability (ranging from .76 to .83; M = .79) for a trait-like 
measure. However, an effect of time consistent with a carryover effect or an effect of familiarity 
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with the items or photos of the PARMSS was found such that scores tended to uniformly 
decrease from Time 1 to Time 2. Phillips (2015) also found such an effect. An explanation may 
be that the vignettes and photo stimuli are no longer novel with repeated administration and thus, 
less activating for women at Time 2 with respect to mating strategy enactment. Unsurprisingly, 
the scales of the PARMSS were also moderately to strongly intercorrelated, suggesting that 
women who endorse receptivity also tend to endorse proceptivity. Results also revealed that 
within the type of scale, receptivity or proceptivity, the three scores demonstrated somewhat 
lower correlations with one another (M = .72) than between context (i.e., vignette; e.g., the 
correlation between Receptivity – LT and Proceptivity – LT was .90) and between picture ratings 
(r = .87). Therefore, similar to the mate preferences literature (e.g., Gildersleeve et al., 2014; 
Thompson & O’Sullivan, 2013), it seems valuable to separately assess receptive and proceptive 
sexuality under various circumstances.   
 In five areas, the results of the present study partially replicated findings from Study 1 
suggesting group differences on the Women’s REP with respect to presence/absence of: a 
hormonal problem, a specific reproductive status (HC use), HC side effects, cycle regularity, and 
PMS. In Study 1, women who reported being diagnosed or treated with a hormonal problem 
differed from women without a hormonal problem on all main scales of the women’s REP such 
that they reported greater negative and lower positive reproductive experiences. Consistent with 
these results, the hormonal problems group in the present study, despite a low sample size, had 
relatively high Negative Sexual Experiences – Relationship scores and relatively low positive 
sexual, affective, and physical experiences scores. In spite of low power, these findings indicate 
that, as expected, scores on the Women’s REP seem to capture hormone-related experiences.      
 With respect to the examination of differences between reproductive status groups, non-
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significant mean differences suggested that OC users had lower Negative Sexual Experiences – 
Relationship and higher positive affective and physical experiences (with significantly higher 
Elation) scores than non-users. These findings were also in line with expectations based on the 
results of Study 1. However, in Study 1, OC users had lower negative affective and sexual 
experiences scores than both non-users and other HC users as well as higher Body Image Quality 
scores than other HC users and higher Sleep Quality scores than other HC users and nonusers. 
These findings mean that across Studies 1 and 2, all of the main scales were significantly 
different in convergent ways for OC users compared to other women and are consistent with 
some research indicating that OCs can have positive effects on the affective and physical health 
of some women (Oinonen & Mazmanian, 2002; Sanders et al., 2001).    
Among all HC users (i.e., OCs and other HCs), 1.3% reported currently being diagnosed 
or treated for HC side effects in general. Examination of the B-REP – Current HC Ratings in the 
full sample of HC users revealed that one-quarter to one-half of the users reported mild to 
extreme negative effects of their current HC on their emotional (27%), sexual (45%), and 
physical (28%) health. These findings are consistent with those of Sanders et al. (2001) with 
respect to OC discontinuation. Interestingly, 42, 30, and 29% of women reported positive effects 
on their emotional, physical, and sexual health, respectively (see Graham et al., 2007; Greco et 
al., 2007 for similar findings). Relatively fewer women indicated that their HC had effects on 
their relationship interests (8 to 19%). Ratings of the negative effects of one’s current HC on 
physical health had small positive relationships with Negative Affective Experiences and 
Negative Physical Experiences scores as well as a moderate negative relationship with Body 
Image Quality scores. Contrary to what would be expected, sexual and positive affective and 
physical experiences scores on the Women’s REP were not significantly correlated with any 
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ratings of the effects of one’s current HC. Keeping in mind that women who are most likely to 
experience negative effects of HC use on their health may not be represented in the HC groups 
reported on here due to the possibility of discontinuation of use (and thus, the survivor effect) 
(e.g., Sanders et al., 2001), the finding that some scales are associated with HC side effect 
experiences provides further evidence of concurrent validity of the Women’s REP.  
 In Study 1, free-cycling women with irregular versus regular menstrual cycles 
significantly differed on the main scales of the Women’s REP. In the present study, irregularly 
cycling women were found to have higher Negative Affective Experiences, Negative Physical 
Experiences (non-significant trend), and Sexual Problems – General scores as well as lower 
Sleep Quality scores than regularly cycling women. These findings were consistent with the 
general pattern of results in Study 1 but differed slightly such that differences in Positive 
Affective and Physical Experience and Body Image Quality scores were not significant. Overall, 
however, the results of both studies are consistent with research suggesting that regularly cycling 
women have a higher quality of life or well-being than women with irregular cycles (e.g., Jacobs, 
Boynton-Jarrett, & Harville, 2015; McCook, Bailey, Williams, Anand, & Rame, 2015) and 
appear to the first to suggest that these groups differ in specific areas such as sleep.  
 Eleven percent of free-cycling women reported being currently being diagnosed or 
treated for PMS in general. Among all free-cycling women in the premenstrual phase, 
examination of the B-REP – Premenstrual Phase Ratings indicated that the majority, 55, 59, and 
74%, of women reported mild to extreme negative effects of the premenstrual phase on their 
emotional, sexual, and physical health, respectively. Also, 25, 59, and 26% endorsed positive 
effects of the premenstrual phase on their emotional, sexual, and physical health. These findings 
are consistent with those of Warner and Bancroft (1988) and Kiesner (2011). Interestingly, 28 
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and 40% of women reported increased, and 14 and 13% reported decreased, interest in short- and 
long-term relationships in the premenstrual phase. Women who completed the study while in the 
premenstrual phase and reported greater negative effects of the premenstrual phase on their 
emotional and physical, and sexual health indeed reported more negative reproductive 
experiences on the Women’s REP (i.e., Negative Affective Experiences, Negative Physical 
Experiences, and Sexual Problems). Combined with the results of Study 1 regarding group 
differences between women in the premenstrual phase with and without PMS, the finding that 
some scales are related to PMS symptomatology provides further evidence of the concurrent 
validity of the Women’s REP. Also, it is interesting to note that women who reported positive 
effects of the premenstrual phase on physical, emotional, or sexual health, also had higher scores 
on the Women’s REP Sleep Quality scale (despite also having higher scores on the Negative 
Affective Experiences scale).  
 Overall, the findings from Study 1 regarding the concurrent validity of the Women’s REP 
based on differences between women of various reproductive/hormonal statuses were partially 
replicated. That is, the results of the two studies were consistent. While there were not as many 
significant findings in the present study, the total sample size in Study 1 was 83% larger than that 
of Study 2. Also, while in Study 1 women were asked whether they thought that they currently 
had hormonal problems, HC side effects, and PMS, women in Study 2 were asked whether they 
were currently diagnosed or being treated for such experiences. Thus, Study 1 had more power 
to detect any effects. Also, it is possible that the group differences and relationships found in 
Study 2 may have diagnostic utility or be particularly important given that some of the problem 
groups were arguably subclinical (i.e. “diagnosed or treated”) as opposed to non-clinical as in 
Study 1. Supporting the rationale of including both negative and positive scales in the Women’s 
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REP, both types of scales showed significant as well as non-significant findings. A third 
difference between the studies is that the sample in the present study was relatively young in age 
(predominantly university students) and thus, likely restricted in lifespan reproductive 
experiences. However, this was a result of intentional inclusion/exclusion criteria to examine 
women of reproductive age.  
 Some findings pertaining to exploratory analyses involving reproductive/hormonal status 
and the PARMSS are worth noting given the possibility that reproductive experiences and 
mating strategies may be related. Women with hormonal problems and OC users appeared to 
have lower scores on the PARMSS overall but particularly on Proceptivity – LT than women 
without hormonal problems and non-users/other HC users, respectively. There were no 
significant differences in PARMSS scores between the cycle regularity groups. The difference 
between hormonal problem groups is consistent with the hypothesis that negative reproductive 
experiences are negatively related to unrestricted mating strategies and tactics. In contrast, it is 
somewhat surprising that OC users were less proceptive in terms of long-term relationships than 
nonusers in the present study given that Bancroft, Sherwin, Alexander, Davidson, and Walker 
(1991) and Oinonen, Jarva, and Mazmanian (2008) found that OC users were more unrestricted 
than nonusers. However, sociosexuality and proceptivity seem to be independent constructs 
(based on correlations herein and Phillips, 2015) and so, it is possible that OC users are less 
proceptive in the context of long-term relationships than non-users. This finding should be 
replicated before conclusions are drawn.   
 Correlations between the PARMSS scores and B-REP Ratings indicated that receptivity 
and proceptivity are: (a) higher in women who report more positive emotional and physical 
health effects as well as decreased interest in long-term relationships, and increased interest in 
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short-term relationships associated with their current HCs; and (b) lower in women who report 
more negative effects of the premenstrual phase on their emotional health. Moreover, negative 
experiences scores on the Women’s REP tended to be related to B-REP ratings of decreased 
relationship interests, while positive experiences scores showed the opposite correlations. These 
findings provide further evidence that positive reproductive experiences may facilitate sexual 
behaviour (or vice versa). While some of the data presented herein may also provide some 
evidence of validity for the B-REP, further research could examine the psychometric properties 
and potential uses of this short-form complement to the Women’s REP.  
Lastly, unique to this study, correlations between the Women’s REP, PARMSS, and 
other health-, sexuality-, and relationship-relevant variables provide data on (1) the validity of 
the Women’s REP and PARMSS as well as (2) relationships between affect and mating 
strategies. Evidence for the convergent validity of both measures comes from the findings that 
their scores were related to scores of similar or related variables in appropriate directions. As 
examples, negative reproductive experiences tended to be moderately and positively related to 
other negatively valenced variables, such as neuroticism, negative affect, hormonal sensitivity, 
and jealousy. Positive reproductive experiences showed the opposite relationships. These 
findings may help account for the significant correlations between the Women’s REP and 
negative impression management (positive) and positive impression management (negative), 
given that the impression management were in the normal range and have also been shown to 
moderately correlated with a variety of self-report measures, including depressive symptoms, in 
non-clinical samples (Morey, 2007). That is, it appears that women who have relatively higher 
negative, and lower positive, reproductive experiences may be biologically (hyper)sensitive or 
reactive (Eysneck et al., 1985; Steiner et al., 2003).  
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Some PARMSS scores were negatively related to sexual satisfaction and long-term 
mating orientation and positively related to short-term mating orientation, numerical reports of 
receptive sexual behaviour with a primary partner, and proceptive sexual behaviour with 
someone other than a primary partner. Evidence for divergent validity comes from non-
significant, modest, or relatively fewer correlations with dissimilar variables. For example, scales 
of the women’s REP were most strongly related to other health-related as opposed to relationship 
variables, while the PARMSS scores were strongly related to other mating strategy variables 
(e.g., sociosexuality) and largely unrelated to health-related variables and masturbation 
frequency (autosexuality) (similar to the results of Phillips, 2015). Contrary to expectations, 
however, there were several indicators that receptivity and proceptivity are positively related to 
negative experiences (i.e., negative affect, jealousy, and negative affective, relationship, and 
physical reproductive experiences) but not positive experiences (e.g., positive affect in general as 
measured by the PANAS and positive reproductive experiences). However, other findings 
discussed herein suggested that receptivity or proceptivity scores were low among women with a 
hormonal problem and OC users, positively related to ratings of positive side effects of HCs, 
negatively related to ratings of negative effects of the premenstrual phase. Taken together, these 
results may suggest that negative well-being is related to increased sexuality among some 
women in general (e.g., Lykins et al., 2006; cf., Fortenberry et al., 2005), whereas increases (i.e., 
changes) in negative and positive reproductive experiences are related to decreased and 
increased mating behaviour respectively (e.g., Graham & Sherwin, 1993; Graham et al., 2007; 
Sanders et al., 1983; cf., Greco et al., 2007).   
Overall, two main conclusions can be drawn from Part 1 of this study. First, the 
psychometric properties of both the Women’s REP and the PARMSS provide evidence of 
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reliability and validity. Thus, further use and examination of these measures in research is 
warranted. Second, relationships between negative reproductive experiences, positive 
reproductive experience, and mating strategies necessitate further examination for clarification of 
possible theoretical and practical implications. These relationships are the focus of Part 2 of this 
study. A prospective menstrual cycle design and scales from the Women’s REP and the 
PARMSS are used to examine patterns of phasic shifts in negative affect, positive affect, and 
sexual proceptivity.   
Part 2:  
 Periovulatory Syndrome? 
Patterns of Negative and Positive Affective Experiences and Sexual Proceptivity across the 
Menstrual Cycle 
 The overall purpose of Part 2 of the present study was to examine menstrual cycle phase 
shifts in the Women’s REP and the PARMSS as two newly developed measures purported to be 
sensitive to hormonal changes (Study 1 and Phillips, 2015). A specific goal was to investigate 
the possibility of paradoxical patterns of co-variation in negative affective experiences, positive 
affective experiences, and mating tactics across the cycle in subgroups of women. In order to do 
so, the method of cluster analysis of scores based on two menstrual cycle phases was used 
instead of: (a) imposing a moderating or grouping variable on the data (e.g., Davydov et al., 
2007; Oinonen, Klemencic, et al., 2008; Phillips, 2015) or (b) using MLM for daily 
questionnaire data to obtain and cluster analyze effect sizes of change across the menstrual cycle 
(Kiesner, 2011).  
These previously used methods, while seemingly ideal, pose several problems for 
researchers interested in whether or not there are patterns rather than a single average trajectory 
WOMEN’S REPRODUCTIVE EXPERIENCES 
   
306 
of menstrual cyclicity in a variable thought to be hormonally mediated (Graham & Bancroft, 
2013; Moskowitz & Herschberger, 2002). First, the most appropriate moderating or grouping 
variables are not clear or well researched at this point. While different menstrual cycle-related 
patterns of both affective experiences and sociosexuality have been found in the literature, few 
studies have intentionally investigated this possibility or how these subgroups of women may 
ultimately or even proximately differ (Reiber, 2009). Second, method (b) above does not seem 
feasible for some researchers given the very high level of expertise required for repeated 
measures MLM, researcher expense, and participant time. Cluster analysis of menstrual phase 
difference scores may be an efficient way of identifying patterns of menstrual cycle phase shifts 
(Reiber, 2009; Rivera-Tovar et al., 1992). Cluster analysis has previously been used to identify 
patterns of: (1) change in symptoms between two phases among women diagnosed with late 
luteal phase dysphoric disorder (Rivera-Tovar et al., 1992) as well as in a non-clinical university 
sample of women (Kiesner, 2011); (2) menstrual bleeding (Gerlinger, Endrikat, Kallischnigg, & 
Wessel, 2007); and (3) hormonal symptoms and sensitivity across reproductive events (Pope et 
al., 2015).  
Dependent Variables and Pattern Acronyms 
One concern about the existing literature is that there is a lack of consistency in 
describing or labeling different patterns of psychological and physical change across the 
menstrual cycle. Phasic shifts in negative affect that differ from a PMS pattern (i.e., symptoms in 
the periovulatory phase versus symptoms in the perimenstrual phases) have been referred to as 
“reverse,” “mid-cycle,” and “pseudo” PMS patterns. These terms do not seem to adequately 
reflect the observed phenomena, particularly since PMS means premenstrual syndrome. In the 
evolutionary literature, the atypical or less familiar pattern across the cycle has been referred to 
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as an unrestricted (versus restricted) pattern based on the fact that these women were grouped 
based on their sociosexual orientation. For simplicity, the main variables and proposed cyclic 
effects in the present study have been given descriptive terms. The Negative Affective 
Experiences scale and Positive Affective Experiences subscale of the Women’s REP will be 
referred to as NA and PA, respectively, as these acronyms are well-known in the health and well-
being literature. Patterns of change will be differentiated by the phase in which women are 
expected to experience higher NA, lower PA, and lower proceptivity: (1) the premenstrual phase 
(a premenstrual syndrome [PMS] pattern) and (2) the periovulatory phase (a periovulatory 
syndrome [POS] pattern).  
 The Proceptivity – PR scale of the PARMSS was used as the main measure of 
proceptivity for two main reasons. First, two patterns of menstrual cycle change between women 
high and low in measures of sociosexuality, namely short-term mating orientation, using this 
scale were recently identified (Phillips, 2015). Second, a recent meta-analysis of women’s mate 
preferences across the cycle determined that effects tend to be stronger when picture stimuli of 
real men are used as opposed to self-reports of one’s general or specific preferences without an 
accompanying male stimulus (Gildersleeve et al., 2014; see also Phillips, 2015). Also, photos 
provide more ecological validity. That is, sexual desire or imagional responses to stimuli may be 
a better or purer measure of internal regulatory motivation than actual behavior, which can be 
constrained by culture and opportunity (Haselton et al., 2006).    
Hypotheses 
Three main data-driven and theory-based hypotheses have been developed by comparing 
two bodies of seemingly disparate literature on changes across the menstrual cycle: negative and 
positive experiences (i.e., health and well-being) and sociosexuality (i.e., mating strategies). The 
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overarching theory is that there are two patterns of menstrual cycle change in affective 
experiences and sexual motivation that may have coevolved through sexual selection and if so, 
are context-dependent. The implication may be that women’s mating strategy enactment, such as 
through changes in proceptivity, is facilitated by changes in their NA or PA (Reiber, 2009; 
Vieira, 2009), all of which are purported to be calibrated by hormones.  
Hypothesis 1: Menstrual cycle patterns in NA, PA, and proceptivity. (a) The majority 
of free-cycling women will exhibit a PMS pattern whereby NA scores are higher, PA scores are 
lower, and proceptivity scores are lower in the premenstrual phase than the periovulatory phase 
(i.e., the standard or typical changes examined in relevant literature). (b) A second identifiable 
subgroup of women will exhibit the opposite POS pattern of lower NA, higher PA, and higher 
proceptivity scores in the premenstrual phase compared to the periovulatory phase. This 
hypothesis is based on research suggesting that there are two patterns of change in reproductive 
experiences, particularly NA and PA, across the menstrual cycle (e.g., Davydov et al., 2007; 
Kiesner, 2010; Reiber, 2009; Rivera-Tovar et al, 1992) and two opposing periovulatory 
sociosexual tactic shifts (i.e., PSTS; e.g., Oinonen, Klemencic, et al., 2008; Phillips, 2015; 
Scarbrough & Johnson, 2005).  
 Hypothesis 2: Differences between the PMS and POS groups. The above two groups 
of women who differ in their main patterns of phasic change in affect and proceptivity will also 
differ in: (a) cross-sectional reports of premenstrual experiences as measures by the B-REP – 
Premenstrual Ratings and (b) overall sociosexual orientation. Specifically, it is expected that the 
PMS pattern group will report more negative effects of the premenstrual phase on their 
emotional health, sexual functioning, and interest in short-term relationships than the POS 
pattern group, who will report more positive effects. Also, the original PSTS study involved first 
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dividing women into two groups: those who were sociosexually unrestricted and those who were 
more restricted (Oinonen, Klemencic, et al., 2008). Therefore, it is predicted that the PMS 
pattern group will be more restricted/less unrestricted, particularly with respect to short-term 
mating, than the POS pattern group (Phillips, 2015).  
Review of the relevant research also suggests that the groups might differ in the 
following areas given links with mating strategy phenotypes or patterns of affect or sexuality 
across the menstrual cycle (see Table 3.1): (c) demographics (age, education level, AAM/rate of 
pubertal development, and parity; Manning & Fink, 2011; Reiber, 2009); (d) relationships 
(status, length, satisfaction, and partner attractiveness; Pillsworth et al., 2004; Haselton & 
Gangestad, 2006); self-perceptions (attractiveness, femininity, and masculinity; Clark, 2004; 
Haselton & Gangestad, 2006; Scarbrough & Johnston, 2005); alcohol use (frequency of use, 
sensitivity to its effects, and number of drinks in the past 48 hours; Clark, 2004; Kiesner & 
Martin, 2013); personality/impression management (neuroticism and negative and positive 
impression management; van den Akker, Eves, Stein, & Murray, 1995); and anthropometric 
body measurements (2D:4D, mid-phalangeal hair count, BMI, and WHR; Oinonen, 2009; 
Scarbrough & Johnston, 2005; Wlodarski & Dunbar, 2015). However, examination of these 
potential differences was exploratory and thus, specific predictions were not made.  
 Hypothesis 3: Phasic shifts on other scales of the Women’s REP and PARMSS. The 
PMS and POS groups will also display opposing menstrual cycle changes in (a) negative and 
positive sexual experiences scores on the Women’s REP and (b) other scores on the PARMSS. 
The rationale for this hypothesis comes from research suggesting that PMS can include sexual 
symptoms (Dickerson et al., 2003; Van Goozen et al., 1997) and that it is important to examine 
both negatively and positively valenced changes (e.g., Meaden et al., 2005). The two pattern 
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groups may also differ in negative physical experiences, positive physical experiences, body 
image quality, and sleep quality scores on the Women’s REP but no specific predictions were 
made. In general, the PMS pattern group would be expected to show high negative experiences 
scores, and low positive experiences scores, in the premenstrual phase compared to the 
periovulatory phase, while the POS pattern group would be expected to show the opposite shifts.  
Data Reduction and Analysis 
 Women from the Time 1-Time 2 sample (n = 277) in Part 1 provided additional data for 
Part 2 of the study. The final menstrual cycle related sample consisted of 42 free-cycling women 
(i.e., not using HCs; see Table 3.2). In Part 2, participants were tested at two different menstrual 
cycle phases among free-cycling women. Upon completion of the study, forward and backward 
counts of cycle day were estimated for each completed session (Times 1 and 2) using menstrual 
cycle information provided by participants in the SQ, PQs, and DQs as well as follow-up by e-
mail for LMP (last menstrual period) (Hampson & Young, 2008). Similar to Study 1 Part 2, 
these counts were used to determine estimates of standardized day in a 28-day menstrual cycle, 
conception probability, and levels of reproductive hormones (Puts, 2006; Wilcox et al., 2001) 
based on actual/current, instead of average, cycle length. Data was restructured from Time 1-
Time 2 to highest fertility day-lowest fertility day (i.e., for women tested in the target phases, 
periovulatory phase-premenstrual phase), regardless of testing order. Data from participants who 
met exclusion criteria noted below were not included in the analyses in order to examine a 
subsample of women who provided data over the equivalent of one cycle, as per testing order, 
and to control for exogenous effects on hormones, as is common in similar 
psychoendocrinological research. 
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 Of the 277 women from the Time 1-Time 2 subsample of Part 1, 235 were ineligible for 
inclusion in this part of the study for one or more of the following nine reasons: (a) a lack of 
menstrual bleeding reported across all stages of the study (e.g., amenorrhea; n = 13); (b) unclear 
or inconsistent menstrual cycle information such that phases could not be estimated (n = 4); (c) 
nonconsecutive phases (i.e., provided data over the equivalent of more than one cycle; n = 13); 
(d) current use of any hormone-related medication (e.g., insulin, hormone replacement, or 
thyroid medications; n = 9); (e) current use of a non-hormonal IUD contraceptive (n = 1); (f) 
change in hormonal contraceptive status (i.e., HC use or non-use) less than three months prior to 
study participation (n = 20); and (g) change in reproductive status or HC type during study 
participation (n = 22). An additional 121 were not included in the present study as they were (h) 
using an HC and thus, pseudo- or induced- rather than naturally-cycling
26
. While 87 free-cycling 
women met these criteria and provided data at two cycle-related times points, 45 of them were 
not included in repeated measures analyses because (i) at least one of Times 1 and 2 was 
completed outside of the target menstrual cycle phases. 
 Prior to the analyses of the three hypotheses, data on the measures of hormonal status 
used to schedule and confirm menstrual cycle phases were examined and the generalizability of 
the final subsample was assessed using between-subjects ANOVAs. General menstrual cycle 
shifts in scores on the Women’s REP and PARMSS were then explored using repeated measures 
MANOVAs and follow-up ANOVAs. In order to examine whether there were at least two 
groups based on pattern of change between the two target phases (Hypothesis 1), the difference 
scores (i.e., for symptoms or experiences) was calculated for each of NA, PA, and proceptivity 
                                                 
26
 Women using HCs were excluded from the present report because HCs have been found to have paradoxical 
effects on mood and sexuality overall and across the menstrual cycle in subgroups of women (Graham & Bancroft 
2013a) and have been hypothesized to disrupt psychological mating adaptations in general and across the menstrual 
cycle (Roberts, Miner, & Shackelford, 2010).  
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and used in subsequent analyses. Use of Time 2 minus Time 1 (Time 2 – Time 1) scores seems 
common in psychoendocrinological research (e.g., Graham et al., 2007; Greco et al., 2007; 
Sanders et al., 2001; Oinonen & Mazmanian, 2007; van Anders, Hamilton, Schmidt, & Watson, 
2007). To find potential groups, a single Ward’s method hierarchical cluster analysis on the 
standardized difference scores was used. This was chosen because it is one of the only 
methodologies that permit the possibility of different patterns, rather than an average trajectory, 
of menstrual cyclicity (Reiber, 2009). Rieber (2009) used similar methodology but grouped 
women based on having higher or lower scores in one phase versus the other. Repeated measured 
ANOVAs and Pearson product-moment correlations were also used to examine all hypotheses.  
Results 
Measures of hormonal status. Of the 87 free-cycling women who provided data at two 
cycle-related time points, 80 (92%) provided follow-up information regarding the actual date of 
their NMP after study participation. Using all available information for each participant, 52 
women were determined to have completed a PQ in the periovulatory phase (i.e., not bleeding 
and on standardized days 9 to 15 or LH days -2 to +3). The remaining women completed their 
highest fertility PQ on days 4 to 8 or 16 to 27. Fifty-seven women completed a PQ in the 
premenstrual phase (i.e., on standardized days 19 to 28 and not bleeding). The remaining women 
completed their lowest fertility PQ on days 1 to 7 (with 17 women in the menstrual phase) or 
days 11 to 18.  
In total, 33 of the 87 free-cycling women opted to complete at least one PQ during a lab 
session (n = 30 for both PQs) and thus, were eligible to provide saliva samples and complete LH 
testing. Thirty-two of these women provided a saliva sample in at least one phase (27 at both 
phases but testosterone could not be assayed for one of these women because the quantity of 
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saliva was not sufficient [qns]). The intra-assay coefficients of variation were 3.4% for estradiol, 
4.6% for progesterone, and 2.0% for testosterone. There were no outliers or unexpected values in 
the hormone data by phase. Correlations between conception probability, hormone estimates, and 
assayed hormone levels on average (i.e., regardless of phase) and using low fertility minus high 
fertility phase change scores can be found in Appendix J. Within and between the estimates and 
assays, the hormones were generally correlated in directions that would be expected
27
.  
Ten of the women who completed a lab session, half of whom completed a PQ in both 
target phases, did not complete LH testing (e.g., either LH kits were not yet available in the 
study, appropriate testing dates could not be determined initially, or they did not use the kit after 
it was provided). Ten women, eight who completed a PQ in both target phases, reported a 
positive test result indicative of a surge in LH and pending ovulation. Positive LH test results 
were found on standardized days 8, 12, 13, 14, 17, and 19; up to six days before and five days 




Thirteen women, five who completed a PQ in both target phases, failed to report a 
positive LH result. Negative results could be due to kit malfunction, improper testing, or a lack 
of an LH surge such as due to anovulation. The latter possibility is unlikely in normally cycling 
women (Schnatz, 1985). In these cases, the LH testing dates of 10 women were inaccurately 
                                                 
27
 These results were similar to those of Study 1 (Table 2.13) as well as Roney and Simmons (2013; Table 1) and 
provide some evidence of the reliability and validity of the menstrual cycle-related data. 
28
 The backwards count days of the positive results were -25, -18, -17, -16, -15, -12, and -10; up to five days before 
and 10 days after the estimate of LH day (day -15); with 30% occurring on day -15 and 70% during the target 
periovulatory days. It is of note that categorizing phase based on standardized day in cycle was, as expected, the 
same for the premenstrual phase but included 17 different women as in the periovulatory phase compared to the 
backwards method because it accounts for both cycle length and variability in follicular phase length. The 
standardized method was used to categorize phase data in the present study for three main reasons: (1) to be 
consistent with Study 1; (2) the hormone estimates used are based on this method (see also Apgar-Garver et al., 
2008); and (3) it allowed for inclusion of more women, including those with relatively long or irregular cycles, for a 
sample potentially more representative of women in general. 
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scheduled (i.e., testing did not take place in the periovulatory phase); two women did not follow 
kit instructions (e.g., did not test on all five days consecutively); and one woman did not provide 
follow-up confirmation of the actual date of her NMP after study participation. Given that these 
women met all other criteria, five of these women as well as five of the women that did not 
complete any LH testing were included in the final subsample, a procedure that is supported by 
the findings of Brown et al. (2011) and Gangestad et al. (2015).  
Overall, 42 women provided data in both target phases. Thus, the data from about 48% of 
eligible participants did not fall into the appropriate cycle phases despite scheduling sessions 
based on self-reported LMP, NMP, cycle regularity, and average cycle length at the screening 
stage of the study as well as adjustments made to scheduling as more cycle information became 
available from participants over time. The two cycle phases in the final subsample significantly 
differed as expected in mean day of cycle (periovulatory: M = 11.69, SD = 1.91; premenstrual: M 
=23.69, SD = 2.64); as well as estimates of conception probability (periovulatory: M = 0.06, SD 
= 0.03; premenstrual: M = 0.01, SD = 0.01); estimates of estradiol levels in pg/ml (periovulatory: 
M = 195.20, SD = 47.69; premenstrual: M = 160.60, SD = 31.56); estimates of progesterone 
levels in ng/ml (periovulatory: M = 0.83, SD = 0.64; premenstrual: M = 9.85, SD = 3.47); 
estimates of testosterone levels in pg/ml (periovulatory: M = 356.25, SD = 32.61; premenstrual: 
M = 292.86, SD = 32.27); estimates of LH levels in mlU/ml (periovulatory: M = 19.10, SD = 
11.26; premenstrual: M = 10.66, SD = 1.12); and estimates of FSH levels in mlU/ml 
(periovulatory: M = 9.60, SD = 3.61; premenstrual: M = 6.17, SD = 089); Fs (1, 41) = 13.39 to 
751.42, ps = .001 to < .0001, partial 
2
s = .25 to .95. Estimates of the probability that a woman 
was in the fertile window of the periovulatory phase were also higher in the periovulatory versus 
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premenstrual phase (Ms = 0.42 and 0.08, SDs = 0.16 and 0.05, respectively), F (1, 41) = 133.92, 
p < .0001, partial 
2
 = .77.  
All 18 women in the final subsample who completed a PQ during a lab session did so for 
both PQs. The two phases significantly differed as above (data not presented). Fifteen of these 
women provided saliva samples at both sessions. The two phases did not significantly differ in 
assayed levels (pg/ml) of estradiol (periovulatory: M = 2.21, SD = 0.65; premenstrual: M = 2.09, 
SD = 0.73); progesterone (periovulatory: M = 113.87, SD = 53.70; premenstrual: M = 161.53, SD 
= 95.82); or testosterone (periovulatory: M = 77.55, SD = 22.07; premenstrual: M = 65.46, SD = 
18.62), Fs (1, 13 to 1, 14) = 0.34 to 4.66, ps = .571 to .05, partial 
2
s = .02 to .26. However, the 
relative pattern of the means (i.e., periovulatory having higher estradiol and testosterone and 
lower progesterone than premenstrual) is consistent with expectations. Taken together, the data 
from estimates and assays provided some evidence of validity that women in the final subsample 
were in the target phases.   
Data screening. To help assess generalizability, comparisons were made between the 
final subsample of women included in Part 2 and participants who were excluded on the basis of 
criteria (a) to (h) above (n = 190, ineligible participants) as well as participants whose PQs were 
not completed in both target phases [criterion (i); n = 45, imprecisely scheduled participants]. As 
seen in Appendix K, 19 variables from the SQ were examined. Three differences were 
significant across the two sets of comparisons. Ineligible participants had a higher (more 
unrestricted) mean sociosexual orientation score and were more likely to be single than the final 
subsample of women. This is consistent with research suggesting that HC users, who consisted 
of a large portion of ineligible participants, tend to be more unrestricted than non-users (e.g., 
Oinonen, Jarva, et al., 2008). Imprecisely scheduled participants reported a higher frequency of 
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masturbation than the final subsample. Thus, the final subsample of free-cycling women may be 
more restricted than the general population of women but this difference seems to be 
representative of the population of free-cycling women.   
General menstrual cycle phase effects. Means, standard deviations, and univariate 
results can be found in Table 3.19 for the Women’s REP and Table 3.20 for the PARMSS. There 
was no effect of periovulatory versus premenstrual phase on the combined main scales of the 
Women’s REP (excluding the relationship scale) in a MANOVA, F (6, 35) = 1.66, p = .160, 
partial 
2
 = .22. Univariate analyses also did not reveal any significant effects of phase. Among 
women in a relationship, the effect of phase on Sexual Problems – Relationship was not 
significant.  
When the subscales of the Women’s REP were explored, the effect of phase on the 
combined main subscales approached significance, F (12, 30) = 2.09, p = .050, partial 
2
 = .46, 
but was not significant for the supplementary subscales, F (13, 29) = 0.74, p = .716, partial 
2
 = 
.25. The univariate effect of phase on Decreased Appetite was significant such that the mean 
score (reflecting more decreased appetite) was higher in the periovulatory versus premenstrual 
phase.  
 The multivariate effect of cycle phase on the combined six PARMSS scales was not 
significant, F (6, 35) = 1.47, p = .216, partial 
2
  = .22. Based on univariate analyses, however, 
Receptivity – ST scores were significantly higher in the periovulatory than premenstrual phase. 
An overall examination of the means revealed that all PARMSS scores appeared higher in the 
periovulatory than the premenstrual phase. 
Hypothesis 1: Menstrual cycle patterns of NA, PA, and proceptivity. For reference 
and ease of interpretation, means and standard deviations for all scores used in this section are
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Table 3.19  
 
Summary of Means and Repeated Measures Analyses of Variance of the Scales and Subscales of the Women’s REP by Periovulatory 
and Premenstrual Phase in Free-Cycling Women (n = 42) 
 






 Periovulatory phase Premenstrual phase    
Scales 
Negative Affective Experiences 2.11 (0.68) 2.10 (0.69) 0.17 .686 .004 
Negative Physical Experiences 1.71 (0.42) 1.66 (0.38) 1.17 .286 .03 
Sexual Problems - General 2.92 (0.69) 2.86 (0.55) 1.06 .309 .03 
Sexual Problems – Relationship
a
 1.99 (1.10) 2.14 (1.00) 0.82 .379 .05 
Positive Affective and Physical Experiences 2.81 (0.56) 2.80 (0.62) 0.36 .552 .01 
Body Image Quality 3.22 (0.65) 3.09 (0.71) 2.01 .164 .05 
Sleep Quality 3.16 (0.81) 3.13 (0.74) 0.14 .710 .003 
Subscales 
Hormonal Symptoms 1.64 (0.42) 1.62 (0.36) 0.21 .651 .01 
Decreased Appetite 1.88 (0.97) 1.85 (0.60) 10.89 .002** .21 
General Aches and Pains 1.85 (0.60) 1.85 (0.64) 0.004 .953 .000 
Negative Sexual Experiences – General 2.09 (0.84) 2.02 (0.72) 0.44 .509 .01 
Negative Sexual Experiences – Relationship
a
 1.69 (1.15) 1.78 (1.00) 0.25 .626 .01 
Negative Body Image Experiences 2.14 (0.72) 2.32 (0.79) 2.56 .118 .06 
Negative Sleep Experiences 2.54 (0.93) 2.55 (0.79) 0.20 .892 .000 
Positive Sexual Experiences – Others 1.96 (0.92) 1.89 (0.80) 0.23 .633 .01 
Positive Sexual Experiences – Self 2.01 (0.90) 2.16 (0.92) 1.25 .270 .03 
Positive Sexual Experiences - Relationship
a
 3.70 (1.12) 3.48 (1.10) 1.51 .236 .08 
Positive Affective Experiences 2.84 (0.63) 2.84 (0.71) 0.001 .982 .000 
Positive Physical Experiences 2.77 (0.55) 2.73 (0.56) 0.28 .599 .01 
Positive Body Image Experiences 2.49 (0.68) 2.42 (0.82) 0.91 .345 .02 
Positive Sleep Experiences 2.56 (0.84) 2.49 (0.91) 0.34 .564 .01 
Supplementary Subscales 
Testosterone-Related Experiences 1.73 (0.47) 1.69 (0.46) 0.46 .501 .01 
Progesterone-Related Experiences 1.51 (0.42) 1.51 (0.42) 0.001 .979 .000 
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 Periovulatory phase Premenstrual phase    
Supplementary Subscales 
Negative Sexual Experiences – Self 2.16 (1.05) 2.16 (0.81) 0.92 .344 .02 
Negative Weight Experiences 2.02 (0.84) 2.76 (1.11) 0.57 .456 .01 
Positive Affect 2.84 (0.65) 2.85 (0.73) 0.02 .891 .000 
Elation  2.85 (0.73) 2.82 (0.78) 0.06 .810 .001 
Positive General Physical Experiences  2.70 (0.58) 2.70 (0.57) 0.003 .958 .000 
Positive Skin Experiences  2.55 (0.84) 2.49 (1.02) 0.19 .665 .01 
Positive Digestion Experiences 2.96 (0.85) 2.90 (0.79) 0.32 .574 .01 
Positive Breast Experiences  3.01 (1.08) 2.87 (1.01) 1.06 .309 .03 
Positive Weight Experiences 2.06 (0.75) 2.06 (0.88) 0.000       1.00 .000 
Positive Appetite Experiences  2.42 (0.80) 2.26 0.92) 1.41 .242 .03 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire.  
a
n = 18 (df = 1, 17) women in a relationship.  
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Summary of Means and Repeated Measures ANOVAs of the Subscales of the PARMSS by Periovulatory and Premenstrual Phase in 
Free-Cycling Women (n = 41) 
 
Scale M (SD) 
 
F 





 Periovulatory phase Premenstrual phase    
Receptivity 
Short-Term (ST) 3.82 (2.09) 3.45 (1.97) 4.30 .045* .10 
Long-Term (LT) 4.82 (2.30) 3.50 (2.33) 3.10 .086
†
 .07 
Picture Ratings (PR) 3.77 (1.69) 3.68 (1.72) 0.41 .840 .001 
Proceptivity 
ST 2.34 (1.39) 2.32 (1.60) 0.02 .902 .00 
LT 3.33 (1.84) 3.21 (2.00) 0.20 .654 .01 
PR 2.52 (1.33) 2.54 (1.45) 0.34 .564 .01 
Note.
 
PARMSS = Proceptive and Receptive Mating Strategies Scale.
 
†
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presented in Table 3.21. As seen in Table 3.22, premenstrual minus (-) periovulatory phase NA 
scores (i.e., NA change scores) were negatively correlated with PA change scores, r = -.57, p < 
.0001, but neither mean NA phase scores nor the NA change scores were correlated with 
proceptivity, rs = .01 to -.11, ps = .958 to .488. PA change scores were positively correlated with 
proceptivity change scores, r = .39, p = .013. However, the relationship between mean levels of 
PA and proceptivity was not significant within either phase, rs = .11 and .16, ps = .494 and .394.  
When standardized change scores for NA, PA, and proceptivity were entered into a single 
hierarchical cluster analysis, the dendogram suggested two clusters of cases. This was predicted 
and thus, two cluster groups were extracted. It is important to note that positive change scores 
represent higher scores in the premenstrual versus periovulatory phase, while negative change 
scores represent higher scores in the periovulatory versus premenstrual phase. As seen in Figure 
3.2, one cluster had scores indicative of increased NA, decreased PA, and decreased proceptivity 
scores in the periovulatory phase relative to the premenstrual phase (i.e., a negative mean NA 
change score and positive mean PA and proceptivity change scores). This group (n = 16) was 
consistent with a POS pattern of scores across the menstrual cycle (i.e., a menstrual cycle pattern 
in NA, PA, and proceptivity). The second cluster had scores indicative of the opposite, a PMS 
pattern (n = 25) of change scores with increased NA, decreased PA, and decreased proceptivity 
scores in the premenstrual versus periovulatory phase (i.e., a positive mean NA change score and 
negative mean PA and proceptivity change scores). Univariate ANOVAs confirmed that the two 
groups significantly differed on all three change scores, Fs (1, 39) = 6.14 to 47.10, ps = .018 to < 
.001, partial 
2
s = .42 to .55 (see Table 3.21 for raw data).   
Phase scores (as opposed to change scores) were entered into a repeated measures 
MANOVA with cluster group as an IV to examine the interaction between cluster group and
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Summary of Means for Negative Affective Experiences, Positive Affective Experiences, and Proceptivity – Picture Ratings Scores 
Relevant to Hypothesis 1 
 
Variable Premenstrual phase Periovulatory phase Premenstrual minus  
(-) periovulatory 








Full Subsample (N = 41) 
Negative Affective Experiences (NA) 2.11 (0.69) 2.11 (0.69) -0.008 (0.65) 0.00 (1.00) 
Positive Affective Experiences (PA) 2.82 (0.70) 2.82 (0.53) -0.005 (0.60) 0.00 (1.00) 
Proceptivity – Picture Ratings (PR) 2.54 (1.49) 2.52 (1.33) 0.026 (0.81) 0.00 (1.00) 
POS pattern group (n = 16) 
Negative Affective Experiences (NA) 1.80 (0.47) 2.10 (0.70) -0.31 (0.46) -0.46 (0.71) 
Positive Affective Experiences (PA) 3.17 (0.74) 2.63 (0.58) 0.54 (0.51) 0.91 (0.86) 
Proceptivity – Picture Ratings (PR) 2.92 (1.19) 2.51 (0.95) 0.41 (0.78) 0.47 (0.96) 
PMS pattern group (n = 25) 
Negative Affective Experiences (NA) 2.30 (0.75) 2.12 (0.69) 0.18 (0.69) 0.29 (1.06) 
Positive Affective Experiences (PA) 2.59 (0.59) 2.95 (0.64) -0.35 (0.32) -0.58 (0.54) 
Proceptivity – Picture Ratings (PR) 2.30 (1.57) 2.52 (1.54) -0.22 (0.75) -0.30 (0.92) 
Note. POS = periovulatory syndrome. PMS = premenstrual syndrome.  
a
Positive premenstrual minus periovulatory change scores reflect higher scores in the premenstrual versus periovulatory phase. 
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Correlations between Negative Affective Experiences, Positive Affective Experiences, and Proceptivity – Picture Ratings Scores for 
the Premenstrual Phase, Periovulatory Phase, and Premenstrual Minus (-) Periovulatory Phase (n = 41)  
 
 1 2 3 4 5 6  7  8 9 
Premenstrual phase 
     1. Negative Affective Experiences 1         
     2. Positive Affective Experiences -.42* 1        
     3. Proceptivity – Picture Ratings -.10 .16 1       
Periovulatory phase 
     4. Negative Affective Experiences .56*** -.32* -.01 1      
     5. Positive Affective Experiences -.13 .60** .07 -.52*** 1     
     6. Proceptivity – Picture Ratings -.03 .001 .83*** .01 .11 1    
Premenstrual minus (-) periovulatory phase
a
 
     7. Negative Affective Experiences .47*** -.12 -.10 .-.47*** .41** -.04 1   
     8. Positive Affective Experiences -.36* .54** .11 .18 -.35* -.11 -.57*** 1  
     9. Proceptivity – Picture Ratings -.13 .27
†
 .42** -.02 -.06 -.15 -.11 .39* 1 
a 
Premenstrual minus (-) periovulatory phase change scores: Positive scores reflect higher scores in the premenstrual versus periovulatory phase. Negative scores 
reflect higher scores in the periovulatory versus premenstrual phase. Thus, positive correlations indicate that a variable was related to higher scores, and negative 
correlations indicate that a variable was related to lower scores, in the premenstrual versus periovulatory phase.  
†
p < .10. *p < .05. **p < .01. ***p < .001. 
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Figure 3.2.  A cluster analysis of standardized premenstrual minus (-) periovulatory Negative 
Affective Experiences (NA), Positive Affective Experiences (PA) and Proceptivity – Picture 
Ratings change scores revealed two menstrual cycle pattern groups: periovulatory syndrome 
(POS) and premenstrual syndrome (PMS). Positive values represent mean phase scores represent 
NA, PA, or proceptivity scores that were higher in the premenstrual versus periovulatory phase. 
Negative values represent mean phase scores that were higher in the periovulatory versus 











































POS Pattern Group 
(n = 16) 
PMS Pattern Group 
(n = 25) 
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phase (i.e., 2 between [group: POS cluster, PMS cluster] x 2 within [phase: periovulatory, 
premenstrual] MANOVA; see Table 3.21 and Figure 3.3). The overall group x phase interaction 
was significant, F (3, 37) = 15.73, p = < .001, partial 
2
 = .56, as well as the interactions for all 
three DVs in follow-up ANOVAs, F (1, 39) = 6.14 to 47.10, ps = .08 to < .001, partial 
2
s  = .14 
to .55. The POS pattern group showed significant phase effects for both NA and PA, Fs (1, 15) = 
7.03 and 17.78, ps = .018 to < .001, partial 
2
s = .32 and .54, respectively, with proceptivity 
showing a trend, F (1, 15) = 4.43, p = .053, partial 
2
s = .23. The PMS pattern group showed a 
significant phase effect for PA, Fs (1, 24) = 29.87, p < .001, partial 
2
s = .55, but not for either 
NA, F (1, 24) = 1.73, p = .201, partial 
2
s = .07, or proceptivity, F (1, 24) = 2.14, p = .156, 
partial 
2
 = .08. However, the means were in the expected directions.  
Group equivalency was examined based on 18 demographic and hormonal status 
variables (data presented in Appendix L). The two pattern groups did not differ in mean standard 
testing day in the periovulatory and premenstrual phases; menstrual cycle length; cycle 
regularity; sexual orientation; mean NA, PA, or proceptivity scores; or in change scores for 
conception probability estimates, hormone estimates, and assayed hormone levels. They also did 
not differ in previous HC use.  
 For exploratory purposes, standardized change scores for each of the three main variables 
were entered into separate cluster analyses. All dendograms suggested two clusters, which were 
extracted. Cluster membership based on NA change scores (Cluster 1: n = 20, M = -0.78, SD = 
0.55; Cluster 2: n = 21, M = 0.74, SD = 0.72) was significantly related to cluster membership 
based on PA change scores (Cluster 1: n = 27, M = 0.51, SD = 0.83; Cluster 2: n = 14, M =  -
0.99, SD = 0.31), χ
2 
 (1, n = 41) = 6.37, p = .012, ϕ = .39. However, NA change score cluster 
membership was not related to proceptivity cluster membership (Cluster 1: n = 12, M = 1.06, SD 
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Figure 3.3. Mean Negative Affective Experiences, Positive Affective Experiences, and Proceptivity – 
Picture Ratings scores as a function of menstrual cycle phase as well as menstrual cycle pattern group 
based on cluster analysis of standardized change scores. POS = periovulatory syndrome. PMS = 
premenstrual syndrome. Error bars represent standard error of the mean.  
†
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= 0.0.55; Cluster 2: n = 29, M = -0.44, SD = 0.79), χ
2 
 (1, n = 41) = 0.01, p = .920, ϕ = .02. The 
overlap between opposing NA and PA patterns (i.e., the frequency of PMS and POS patterns in 
affect combined) was 68%, while that between NA and proceptivity was 51%. The PA and 
proceptivity clusters were also not significantly related, χ
2 
 (1, n = 41) = 2.31, p = .129, ϕ = .24, 
but there was 54% overlap between corresponding patterns (i.e., PMS and POS patterns for each 
variable). Moreover, the two PA cluster groups showed non-significant trends for phase effects 
on proceptivity scores, Fs (1, 13 and 1, 26) = 3.02 and 3.47, ps = .106 and .074, partial 
2
s = .19 
and .12, whereas the proceptivity clusters did not show differences in PA scores between phases, 
Fs (1, 11 and 1, 28) = 1.46 and 0.99, ps = .252 and .329, partial 
2
s = .12 and .03. That is, there 
was a trend for proceptivity to increase with increases in PA in each of the PA cluster groups, but 
no evidence that PA increased with increases in proceptivity in the two proceptivity cluster 
groups. Combined with the change score correlations in the bottom section of Table 3.22 (i.e., a 
correlation of .39 between changes in PA and proceptivity but only -.11 between changes in NA 
and proceptivity), these findings suggest that changes in PA are more strongly linked with 
changes in proceptivity than are changes in NA. 
Hypothesis 2: Differences between the PMS and POS groups. In order to examine the 
validity of the two PMS and POS groups, group differences on the B-REP – Premenstrual Phase 
Ratings were examined. These ratings of the extent to which respondents endorse experiencing 
negative and positive effects of the premenstrual phase on affective, physical, and sexual health 
or functioning, had been completed during the screening phase prior to either of the 
periovulatory or premenstrual sessions. As demonstrated in Table 3.23, the two groups from 
Hypothesis 1 significantly differed on the B-REP – Premenstrual Phase Ratings of the positive, 
but not negative, effects on physical health and sexual functioning. The POS pattern group 
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Summary of Comparisons between Menstrual Cycle Pattern Groups on the Women’s Brief Reproductive Experiences (B-REP) – 
Premenstrual Phase Ratings  
 
 M (SD) t (39) p Cohen’s 
d 
Rating POS pattern group (n =16) PMS pattern group (n = 25)    
Negative effects on emotional health 2.50 (1.32) 2.44 (1.36) 0.14 .890 0.05 
Negative effects on physical health 1.81 (0.98) 2.20 (1.26) -1.04 .303 -0.33 
Negative effects on sexual functioning 1.19 (0.54) 1.32 (0.63) -0.69 .492 -0.22 
Positive effects on emotional health 1.19 (0.40) 1.12 (0.33) 0.58 .562 0.19 
Positive effects on physical health
a
 1.44 (0.63) 1.08 (0.28) 2.50  .045* 1.15 
Positive effects on sexual functioning 2.75 (1.39) 1.92 (1.18) 2.04 .048* 0.65 
Increased interest in ST relationships
a
  1.56 (1.26) 1.36 (0.64) 0.60  .559 0.27 
Decreased interest in ST relationships 1.19 (0.75) 1.08 (0.28) 0.65 .517 0.21 
Increased interest in LT relationships
a 
2.00 (1.59) 1.80 (1.08) 0.48  .634 0.20 
Decreased interest in LT relationships 1.19 (0.75) 1.08 (0.28) 0.65 .517 0.21 
Note. POS = periovulatory syndrome. PMS = premenstrual syndrome. ST  = Short-term. LT = Long-term.  
a
df = 18.77 to 23.85 because equal variances between groups could not be assumed.  
*p < .05.  
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reported more positive effects in the premenstrual phase than the PMS pattern group. That is, the 
group who were prospectively found to have lower NA and higher PA scores in the premenstrual 
than periovulatory phase also previously reported experiencing more general positive effects of 
the premenstrual phase at the screening stage of the study than the group that had prospectively 
had higher NA and lower PA scores in the premenstrual phase. Thus, it appears that “feeling 
good” during the premenstrual phase may differentiate these two clusters of women more so than 
levels of negative symptoms at this time.      
Also as hypothesized, the menstrual cycle pattern groups significantly differed in 
measures of sociosexuality (see Table 3.24). As seen in Figure 3.4, the POS pattern group had 
higher, more unrestricted, total scores on the SOI-R and on the STMO scale of the M-SOI than 
the PMS pattern group. These differences were found for sociosexual attitudes and behaviour, 
including a non-significant trend for lifetime number of sexual partners, but not desire.  
With respect to other relevant variables, the groups did not differ in mean age; 
relationship length and satisfaction; self-perceptions; alcohol use; personality/impression 
management; or body measurements (see Table 3.24). However, differences in education level, 
partner attractiveness, and BMI approached significance. Education level and partner 
attractiveness appeared lower, while BMI appeared higher, in the PMS versus POS pattern 
group. When relationship status was examined, the two groups did not differ in likelihood of 
being in a relationship, single, or having switched status during the study, χ
2 
 (2, n = 41) = 3.37, p 
= .186, Cramer’s V = .29 (uncorrected for expected counts less than 5) or of being in a 
relationship versus single only, χ
2 
 (1, n = 41) = 1.17, p = .279, ϕ = -.18. In the PMS group, 31% 
of women were in a relationship, 44% were single, and 25% switched status during the study. In 
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Differences between Menstrual Cycle Pattern Groups on Relevant Variables   
 
Variable M (SD) t (39) p Cohen’s d 
 POS pattern group  
(n =16) 
PMS pattern group  
(n = 25) 
   
Demographic variables 
Age (years)  24.39 (5.82) 22.13 (5.13) 1.30 .202 0.42 
Education
a 
 7.06 (0.57) 6.52 (1.39) 1.48 .091
†
 0.50 
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Variable M (SD) t (39) p Cohen’s d 
 POS pattern group  
(n =16) 
PMS pattern group  
(n = 25) 
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Note. SOI-R = Sociosexual Orientation Inventory – Revised. M-SOI = Multidimensional Sociosexual Orientation Inventory. STMO = Short-Term Mating 
Orientation. LTMO = Long-Term Mating Orientation. 2D:4D = ratio of the lengths of the second digit (finger) to the fourth digit. BMI = body mass index. WHR 
= waist to hip ratio. 
a 
df  = 4.31 to 35.58 because equal variances between groups could not be assumed. 
b
From 1 (some elementary school) to 9 (completed a university degree). 
c
 ns 
= 5 and 14 women in a relationship. df = 17. 
c
From 1 (much younger) to 5 (much older) compared to other people of the same sex and age. 
d
As measured by the 
Perceived Relationship Quality Component (PRQC) Inventory. 
e
From 1 (partner less attractive) to 7 (partner much more attractive) relative to self. 
f
From 1 (not 
at all) to 9 (extremely). 
g
Lifetime number of sexual intercourse partners. 
h
Rating of percentage likelihood from 1 (0%) to 11 (100%) that one would have sex with 
someone for the first time without using a condom. 
i
n = 16 and 24 due to missing data. df = 38. 
j
From 1 (never or rarely) to 5 (almost every day). 
k
From 1 (very 
slightly or not at all) to 5 (extremely). n = 15 due to missing data. df = 13. 
l
As measured by the short-form Eysenck Personality Questionnaire-Revised (EPQ-R).
 
m
As measured by the Personality Assessment Inventory (PAI).
 n
ns = 8 and 10 women who participated in laboratory sessions. df = 16.  
†
p < .10. *p < .05. **p < .01 
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Figure 3.4. Mean sociosexuality variable scores as a function of menstrual cycle pattern group. 
Across all variables, the POS Pattern group had a more unrestricted sociosexual orientation than 
the PMS Pattern group. POS = periovulatory syndrome. PMS = premenstrual syndrome. SOI-R 
= Sociosexual Orientation Inventory – Revised. STMO = Short-Term Mating Orientation scale. 
M-SOI = Multidimensional Sociosexual Orientation Inventory. PSB = Past Sexual Behaviour 
scale. Error bars represent standard error of the mean. 
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the POS group, 56% of women were in a relationship, 36% were single, and 8% switched status. 
The groups also did not differ in ever having been pregnant (yes/no), χ
2
 (1, n = 41 = 0.36, p = 
.662, Fisher’s exact test, ɸ = -.09. Nineteen percent of the PMS pattern group has ever been 
pregnant compared to 12% of the POS pattern group.  
 As exploratory analyses, correlations were computed between separate NA, PA, and 
proceptivity change scores and the other relevant variables to identify correlates of cyclical 
change in these three variables (see Tables 3.25 and 3.26). Increases in NA scores (i.e., higher 
scores in the premenstrual versus periovulatory phase) were positively related to the rating of 
negative effects of the premenstrual phase on physical health, r = .32, p = .045. There was also a 
near-significant negative relationship with the rating of positive effects of the premenstrual phase 
on physical health, r = -.27, p = .086. Increases in PA scores (i.e., higher scores in the 
premenstrual versus periovulatory phase) were positively correlated with ratings of positive 
effects on sexual functioning, increased interest in short-term relationships, and increased 
interest in long-term relationships in the premenstrual phase, rs = .32 to .34, ps = .041 to .031. 
These findings were consistent with expectations.  
 Increases in NA scores from the periovulatory to the premenstrual phase were also 
significantly positively correlated with partner attractiveness (relative to self), r = .50, p = .030, 
and negatively correlated at trend levels with total SOI-R score, SOI-R attitudes, and sensitivity 
to the affects of alcohol, rs = -.27 to -.29, ps = .085 to .063. Relationships for changes in both PA 
and proceptivity with education level approached significance, ps = .071 and .082, such that 
relatively higher scores in the premenstrual phase were correlated with having more education. 
As expected, increases in PA scores from the periovulatory to the premenstrual phase were 
significantly positively related to total SOI-R scores, SOI-R attitudes, and STMO scores (i.e., 
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Correlations between Premenstrual Minus Periovulatory Phase Change Scores
a
 in Negative Affective Experiences, Positive Affective 
Experiences, and Proceptivity – Picture Ratings and the Women’s B-REP – Premenstrual Phase Ratings (n = 41) 
 






Proceptivity – Picture 
Ratings
 
Negative effects on emotional health .19 .08 .10 
Negative effects on physical health .32* -.10 .06 
Negative effects on sexual functioning -.17 .04 .04 
Positive effects on emotional health -.06 .10 .01 
Positive effects on physical health -.27
†
 .25 .07 
Positive effects on sexual functioning .12 .34* .15 
Increased interest in ST relationships -.03 .34* .02 
Decreased interest in ST relationships -.12 .05 .14 
Increased interest in LT relationships -.10 .32* .02 
Decreased interest in LT relationships -.17 .12 .12 
Note. B-REP = Brief Reproductive Experiences. ST = Short-term. LT = Long-term.  
a
Premenstrual minus periovulatory phase change scores. High scores reflect higher scores in the premenstrual versus periovulatory 
phase. Thus, positive correlations indicate that a rating was related to higher scores, and negative correlations indicate that a rating 
was related to lower scores, in the premenstrual versus periovulatory phase.  
†
p < .10. *p < .05.  
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Correlations between Premenstrual Minus Periovulatory Phase Change Scores
a
 in Negative Affective Experiences, 
Positive Affective Experiences, and Proceptivity – Picture Ratings and Relevant Variables (n = 41)  
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Note. SOI-R = Sociosexual Orientation Inventory-Revised. M-SOI = Multidimensional Sociosexual Orientation 
Inventory. 2D:4D = ratio of the lengths of the second digit (finger) to the fourth digit. BMI = body mass index. 
WHR = waist to hip ratio.  
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a
Premenstrual minus periovulatory phase change scores. High scores reflect higher scores in the premenstrual versus 
periovulatory phase. Thus, positive correlations indicate that a rating was related to higher scores, and negative 
correlations indicate that a rating was related to lower scores, in the premenstrual versus periovulatory phase. 
b
From 
1 (some elementary school) to 9 (completed a university degree). 
c
From 1 (much younger) to 5 (much older) 
compared to other people of the same sex and age. 
d
n = 19 women in a relationship. 
e
As measured by the Perceived 
Relationship Quality Component (PRQC) Inventory. 
f
From 1 (partner less attractive) to 7 (partner much more 
attractive) relative to self. 
g
From 1 (not at all) to 9 (extremely). 
h
Lifetime number of sexual intercourse partners. 
i
Rating of percentage likelihood from 1 (0%) to 11 (100%) that one would have sex with someone for the first time 
without using a condom. 
j
n = 40 due to missing data. 
k
From 1 (never or rarely) to 5 (almost every day). 
l
From 1 
(very slightly or not at all) to 5 (extremely). 
m
As measured by the short-form Eysenck Personality Questionnaire-
Revised (EPQ-R).
 n
As measured by the Personality Assessment Inventory (PAI). 
o
n = 18 women who participated in 
laboratory sessions.  
†
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sociosexual unrestrictiveness), rs = .24 to .40, ps = .022 to .010, as well as middle-phalangeal 
hair counts, rs = .43 to .51 ps = .076 to .029. Lastly, increases in proceptivity across the cycle 
(i.e., relatively higher proceptivity scores in the premenstrual phase) were positively related to 
education level (trend), older AAM (trend) and slower rate of development, rs = .28 to .39, ps = 
.011 to .068, as well as more higher or more feminine 2D:4D, rs = .41 to .53, ps = .088 to .022.  
Hypothesis 3: Phasic shifts on other scales of the Women’s REP and PARMSS. 
Means, standard deviations, and univariate results as a function of menstrual pattern group can 
be found in Table 3.27 for the Women’s REP and Table 3.28 for the PARMSS. Phase scores on 
the other Women’s REP scales, main subscales, and supplementary subscales as well the 
PARMSS scales were entered into separate repeated measures MANOVAs as DVs with 
menstrual cycle pattern group as an IV to examine the interaction between group and phase (i.e., 
2 between [group: POS, PMS] x 2 within [phase: periovulatory, premenstrual] MANOVAs)
29
. 
The NA and PA scales, the subscales of the PA scale, and the Proceptivity – PR scale were 
excluded from these analyses as the two groups were formed using these scales. Significant 
effects (bolded in the tables) were followed-up with univariate ANOVAs.  
On the combined four non-relationship scales of the Women’s REP, there was no main 
effect for group, F (4, 36) = 0.43, p = .789, partial 
2
 = .045, nor an interaction effect for group x 
phase, F (4, 36) = 1.91, p = .130, partial 
2
 = .18. Univariate analyses also did not reveal group 
or interaction effects for Negative Physical Experiences and Body Image Quality scores, Fs (1, 
39) = 0.01 and 0.81, ps = .971 and .373, partial 
2
s = .000 and .020. However, exploratory 
analyses revealed that there was a significant interaction effects for Sexual Problems – General, 
F (1, 39) = 6.17, p = .017, partial 
2
 = .14. Follow-up univariate analyses showed a non- 
                                                 
29
 The overall effects of menstrual cycle phase were reported in the general menstrual cycle phase effects section 
above (see Tables 3.19 and 3.20).   
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Summary of Means and Repeated Measures ANOVAs of the Scales and Subscales of the Women’s REP by Menstrual Cycle Pattern Group 
 
 POS pattern group  
(n =16) 
PMS pattern group 
(n = 25) 













1.64 (0.43) 1.59 (0.30) 0.39 .542 .03 1.75 (0.43) 1.70 (0.43) 0.35 .560 .01 
Sexual Problems - General 2.98 (0.72) 2.62 (0.35) 4.31 .055
†
 .22 2.91 (0.68) 2.99 (0.62) 0.89 .355 .04 




2.58 (0.99) 2.20 (1.04) 1.29 .340 .30 1.82 (1.10) 2.11 (1.02) 1.99 .182 .13 
Body Image Quality 3.16 (0.72) 3.20 (0.84) 0.25 .624 .02 3.26 (0.63) 3.00 (0.62) 4.54 .044* .16 
Sleep Quality  3.16 (0.87) 3.15 (0.70) 0.01 .942 .000 3.14 (0.80) 3.08 (0.75) 0.22 .643 .01 
Subscales
a 
Hormonal Symptoms 1.56 (0.44) 1.57 (0.29) 0.01 .921 .01 1.69 (0.42) 1.65 (0.41) 0.35 .559 .01 
Decreased Appetite 2.03 (1.07) 1.47 (0.78) 7.64 .014* .34 1.78 (0.93) 1.48 (0.85) 3.27 .083
†
 .12 
General Aches and Pains 1.78 (0.53) 1.72 (0.54) 0.27 .612 .02 1.90 (0.66) 1.92 (0.71) 0.31 .854 .001 
Negative Sexual 
Experiences – General 
2.17 (0.89) 1.82 (0.52) 3.93 .066
†






2.08 (1.10) 1.83 (1.04) 1.00 .391 .25 1.57 (1.17) 1.76 (1.02) 0.71 .414 .05 
Negative Body Image 
Experiences 
2.14 (0.85) 2.26 (0.89) 1.17 .297 .07 2.14 (0.66) 2.37 (0.76) 1.80  .192 .07 
Negative Sleep 
Experiences 
2.48 (0.93) 2.59 (0.72) 0.58 .460 .04 2.59 (0.95) 2.55 (0.84) 0.04 .847 .002 
Positive Sexual 
Experiences – Others 
1.88 (0.83) 2.08 (0.63) 0.77 .394 .05 1.95 (0.97) 1.77 (0.90) 1.45 .241 .06 
Positive Sexual 
Experiences – Self 
2.02 (0.90) 2.54 (0.76) 4.38 .054
†
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 POS pattern group 
(n =16) 
PMS pattern group 
(n = 25) 

























2.62 (0.47) 2.89 (.61) 7.88 .013* .34 2.84 (0.58) 2.61 (0.51) 8.17 .009** .25 
Positive Body Image 
Experiences 
2.37 (0.71) 2.59 (1.00) 4.28 .056
†
 .22 2.56 (0.66) 2.28 (0.67) 9.33 .005** .28 






1.68 (0.52) 1.69 (0.45) 0.01 .909 .001 1.75 (0.46) 1.68 (0.49) 0.67 .419 .03 
Progesterone-Related 
Experiences 
1.38 (0.43) 1.38 (0.24) 0.003 .959 .000 1.61 (0.40) 1.60 (0.42) 0.02 .902 .001 
Negative Sexual 
Experiences – Others 
2.09 (0.84) 1.80 (0.53) 2.32 .148 .13 2.03 (0.87) 2.14 (0.96) 0.58 .454 .02 
Negative Sexual 
Experiences – Self 
2.29 (1.13) 1.85 (0.72) 4.33 .055
†
 .22 2.09 (1.02) 2.11 (0.91) 0.01 .943 .000 
Negative Weight 
Experiences 
2.66 (1.17) 2.75 (1.29) 0.26 .617 .02 2.84 (1.12) 3.00 (1.11) 0.91 .349 .04 
Positive Physical 
Experiences – General 
2.62 (0.50) 2.88 (0.62) 5.41 .034* .27 2.73 (0.64) 2.56 (0.51) 4.69 .041* .16 
Positive Skin Experiences  2.25 (0.80) 2.56 (1.14) 2.05 .173 .12 2.74 (0.84) 2.40 (0.95) 4.52 .044* .16 
Positive Digestion 
Experiences 
2.81 (0.84) 3.08 (0.93) 3.57 .078
†
 .19 3.03 (0.87) 2.79 (0.69) 2.61 .119 .10 
Positive Breast 
Experiences  
2.69 (1.08) 2.94 (1.09) 0.97 .341 .06 3.16 (1.04) 2.78 (0.97) 6.35 .019* .21 
Positive Weight 
Experiences 
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Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. POS = periovulatory syndrome. PMS = premenstrual syndrome. PO = periovulatory 
phase. PM = premenstrual phase. Bolded subscales represent significant group x phase interactions in an ANOVA that followed a significant interaction in a 
MANOVA (p < .05; see text for statistics).
 
a
The Negative Affective Experiences scale, Positive Affective and Physical Experiences scale, and Positive Affective Experiences subscale are excluded as the 
two groups were formed using these scales. 
b
n = 5 and 14 (df = 1, 4 and 1, 13) women in a relationship, respectively.  
†
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Summary of Means and Repeated Measures ANOVAs of the Subscales of the PARMSS by Menstrual Cycle Pattern Group 
 
 POS pattern group 
(n =16) 
PMS pattern group 
 (n = 25) 












 PO PM    PO PM    
Receptivity  
Short-Term (ST) 3.82 (1.71) 3.91 (1.96) 0.11 .751 .01 3.82 (2.34) 3.16 (1.97) 8.92 .006** .27 
Long-Term (LT) 5.00 (1.66) 4.98 (2.06) 0.002 .962 .000 4.71 (2.66) 4.18 (2.48) 6.42 .018* .21 
Picture Ratings (PR) 4.07 (0.97) 4.27 (1.13) 0.60 .452 .04 3.58 (2.02) 3.31 (1.94) 2.02 .169 .08 
Proceptivity
a 
ST 2.25 (0.95) 2.70 (1.98) 1.52 .237 .09 2.40 (1.63) 2.08 (1.30) 5.16 .032* .18 
LT 3.24 (1.36) 3.57 (2.08) 0.45 .513 .03 3.39 (2.12) 2.98 (1.96) 1.78 .195 .07 
Note.
 
PARMSS = Proceptive and Receptive Mating Strategies Scale. POS = periovulatory syndrome. PMS = premenstrual syndrome. 
PO = periovulatory phase. PM = premenstrual phase. Bolded scales represent significant univariate group x phase interactions 
following a near-significant interaction for the combined five scales in a MANOVA (p = .099; see text for statistics). 
 
a
The subscale Proceptivity – Picture Ratings (PR) is excluded as the two clusters were formed using this subscale.  
*p < .05. **p < .01.  
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significant trend for an effect of phase on Sexual Problems – General among women in the POS 
pattern group, such that scores were relatively high in the periovulatory phase. 
The main effect of group was not significant for the combined 11 main scales of the 
Women’s REP (excluding the relationships scales) in a MANOVA, F (11, 29) = 0.46, p = .912, 
partial 
2
 = .15. The group x phase interaction effect was significant, F (11, 29) = 2.34, p = .033, 
partial 
2
 = .47. Univariate analyses revealed significant group x phase effects for Positive 
Sexual Experiences –Self, Positive Physical Experiences, and Positive Body Image Experiences, 
Fs (1, 39) = 2.35, p = .032, partial 
2
 = .147, as well as non-significant trends for Negative 
Sexual Experiences – General and Positive Sleep Experiences, Fs (1, 39) = .372 and 3.82, ps = 
.061 to .058, partial 
2
s= .09. The interaction effects were not significant for the other scales, Fs 
(1, 39) = 0.17 to 2.13, ps = .680 to .152, partial 
2
s = .004 to .05. Follow-up ANOVAs indicated 
that Positive Sexual Experiences – Self scores were higher in the premenstrual versus 
periovulatory phase among the POS group (trend) with no significant effect for the PMS group. 
Positive Physical Experiences – General scores were significantly higher in the premenstrual 
phase for the POS group but higher in the periovulatory phase for the PMS group. The groups 
also showed opposite significant menstrual cycle shifts in Positive Body Image Experiences 
scores (see Table 3.27).  
Among women in a relationship, a univariate group x phase interaction effect for Sexual 
Problems – Relationship scores was not significant, F (1, 17) = 2.00, p = .176, partial 
2
 = .11. 
However, there were only four women in a relationship in the POS pattern group who completed 
this scale during both target phases. The effect of phase was not significant in either group, Fs 
(1,4 and 1, 13) = 1.28 and 1.99, ps = .340 and .182, partial 
2
s = .30 and .13, respectively.  
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For the combined 11 supplementary subscales of the Women’s REP, effect of group was 
not significant in a MANOVA, F (11, 29) = 0.89, p = .561, partial 
2
 = .25, while the group x 
phase interaction was significant, F (11, 29) = 2.35, p = .032, partial 
2
 = .47. Univariate 
analyses revealed significant group x phase effects for all positive physical experiences scales 
(i.e., general, skin, digestion, breast, weight, and appetite), Fs (1, 39) = 5.18 to 13.92, ps = .025 
to .003, partial 
2
s = .12 to .21. Follow-up ANOVAs indicated that positive scales scores tended 
to be significantly higher in the periovulatory phase than the premenstrual phase in the PMS 
group with POS group showing the opposite patterns (see Table 3.26). The interaction effects 
were not significant for the other four scales, Fs (1, 39) = 0.10 to 2.86, ps = .906 to .099, partial 

2
s = .000 to .07.  
 The combined PARMSS scales exhibited a non-significant trend for a phase x group 
interaction in a MANOVA, F (5, 35) = 2.03, p = .099, partial 
2
 = .23, which was followed-up 
with ANOVAs. There were no significant interaction effects for the separate Receptivity – LT, 
Receptivity – PR, and Proceptivity – LT scales, Fs (1, 39) = 1.81 to 2.22, ps = .186 to .144, 
partial 
2
s = .04 to .05. The effect of phase x group was significant for Receptivity – ST and 
Proceptivity – ST, Fs (1, 39) = 4.57 and 5.16, p = .039 and .029, partial 
2
 = .11 and .12. Within 
the groups, the effects of phase were not significant for the POS pattern group, while the PMS 
pattern group demonstrated significantly higher scores in the periovulatory versus premenstrual 
phase. All findings in this section were consistent with expectations.  
Discussion  
 The main purpose of this report (Part 2 of Study 2) was to examine prospective patterns 
of menstrual cycle shifts in NA, PA, and sexual proceptivity. Specifically, the previously 
unexplored possibility of two paradoxical shifts in this set of experiences across the cycle was 
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examined and supported (as outlined below). Previous research has linked well-being with 
sexuality. However, only separate average trajectories of NA, PA, and sexuality have tended to 
be examined and researchers typically focused on determining the menstrual cycle phase in 
which each variable peaked or troughed. The present study appears to be the first to 
comprehensively differentiate between and assess: (a) negative and (b) positive affective, sexual, 
and physical experiences associated with reproductive events and hormonal sensitivity; as well 
as (c) proceptive and receptive mating psychology. Overall, combining both the PMS/POS 
(present study and e.g., Kiesner, 2011) and PSTS (Oinonen, Klemencic, et al., 2008) hypotheses, 
two groups of women were identified who show opposing patters of affect change and 
proceptivity across the cycle with respect to (1) the phase in which they experienced higher NA, 
lower PA, and proceptivity and (2) their overall sociosexual orientation.    
Hypothesis 1: Two menstrual cycle pattern shifts in NA, PA, and proceptivity. It was 
hypothesized that the majority of free-cycling women would exhibit a PMS pattern whereby NA 
scores are higher, PA scores are lower, and proceptivity scores are lower in the premenstrual 
versus periovulatory phase (i.e., the standard trajectories separately examined in the relevant 
literature), while a second group of women would exhibit the opposite POS pattern (i.e., lower 
NA, higher PA, and higher proceptivity scores in the premenstrual phase). This hypothesis was 
supported. As seen in Figures 3.2 and 3.3, two groups were revealed in a cluster analysis used to 
group women in patterns of change scores in the three DVs. As expected, the majority of women 
(61%) displayed a PMS pattern, while 39% of women exhibited a POS pattern.  
Additional analyses revealed that NA and PA were not significantly correlated with 
proceptivity scores in each phase separately (rs = -.10 to .01 for NA and .11 to .16 for PA). 
However, despite a strong inverse relationship between both mean levels and change in both NA 
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and PA (rs = -.42 to -.57), change in PA across the cycle was positively related to change in 
proceptivity (r = .39) but change in NA was not significantly related to change in proceptivity. 
When two cluster groups were derived for each DV separately, there was a 54% overlap in 
corresponding groups for PA and proceptivity. Thus, the results of the present study are 
comparable to a past finding suggesting that 61% and 13% of women demonstrate premenstrual 
and mid-cycle patterns of depression/anxiety (Kiesner, 2011), respectively, and 51% and 16% of 
women demonstrate menstrual and mid-cycle headache patterns (Kiesner & Martin, 2013). In 
fact, Kiesner and Martin (2013) found that these two sets of menstrual cycle changes were 
significantly associated as 54% of women who exhibited a menstrual or mid-cycle pattern of 
headaches also exhibited the corresponding premenstrual or mid-cycle pattern of 
depression/anxiety.  
In the present study, there was a trend for proceptivity to increase with increases in PA 
across the menstrual cycle in each of the PA cluster groups, but no evidence that PA increased 
with increases in proceptivity in the proceptivity cluster groups, and the sizes of phase x group 
effects for affect, particularly PA, were larger than those for proceptivity. Thus, while 
directionality or causation cannot be determined in the current study, there seems to be more 
evidence that changes in PA drive changes in proceptivity (as opposed to NA affecting 
proceptivity or proceptivity affecting PA or NA). While not hypothesized, this finding appears to 
be consistent with Reiber’s (2009) model of PMS (i.e., high NA and low mating effort) as a 
suboptimal state that is a byproduct of positive adaptive states (i.e., high PA and proceptivity) in 
the periovulatory phase. However, it remains a plausible that there are times when NA may be 
evolutionary advantageous and more strongly predict mating effort (Viera, 2009). 
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It is also worth noting that only 1 of 34 Women’s REP scales and subscales and 1 of 6 
PARMSS scales demonstrated a main effect of menstrual phase (i.e., a general cyclic shift in the 
overall subsample). Consistent with research on women’s dietary behaviour (see Fessler, 2003 
for a review), reports of decreased appetite were highest (i.e., women’s appetite was lowest) in 
the periovulatory phase. The size of this effect was moderate. Thus, hormonal changes across the 
cycle may reduce a woman’s set point for satiety or hunger around ovulation, which appears to 
be a robust finding. Between Study 1 and Study 2, it is clear that eating experiences can be 
reproductive and hormone related (see also Klump et al., 2014). Reduced caloric intake and 
metabolic rate when fertile has been hypothesized to be adaptive possibly because women “have 
better things to do than eat” when fertile (Fessler, 2003, p. 4). That is, during the periovulatory 
phase, energy and effort normally expended to seek out food may instead be focused on 
increasing one’s attractivity in order to seek out a mate.  
When examined all together, the women in the present study also reported greater 
receptivity, but not proceptivity, when fertile compared to when in the premenstrual phase (i.e., a 
general phase effect for receptivity). This finding was of a small effect size but seems consistent 
with the dual mating hypothesis of estrus and extended sexuality (e.g., Pillsworth & Haselton, 
2006) given that women have the ability to engage in sexual behaviour when relatively infertile, 
at any time, which is not the case in some other species (Nelson, 2005). There is compelling 
evidence that estrus sexuality still exists in humans (which in human? evolutionary theory, is 
associated with sex with attractive men when fertile to obtain “good genes” for one’s offspring; 
see Haselton & Gildersleeve, 2015 and Gangestad & Haselton, 2015 for reviews). While little 
research has explicitly examined women’s receptive versus proceptive behaviours across the 
cycle (Phillips, 2015; but see Bullivant et al., 2004 and Gueguen, 2009), women seem to engage 
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in behaviours that might be proceptive but could also be indicators of increased receptivity in the 
periovulatory phase (e.g., socializing more with men and dressing more provocatively; Haselton 
& Gildersleeve, 2015). The present findings suggest that women’s receptivity may be 
particularly responsive to increases in estrogen (see Roney & Simmons, 2013) or estrogen 
priming as has been demonstrated in some animal research (Nelson, 2005). Proceptivity did not 
demonstrate a general phase effect across the cycle in the present study but the peak in 
proceptivity around ovulation in the PMS pattern group might have contributed to a phase effect 
for receptivity. These results, a main effect for an ovulatory shift in receptivity and two opposing 
patterns of proceptivity herein, are nearly identical to those of Phillips (2015) and consistent with 
the PSTS theory (Oinonen, Klemencic, et al., 2008).    
Overall, similar to the findings of Wlodarski and Dunbar (2015) regarding two overall 
mating strategy phenotypes as opposed to a continuum of sociosexuality, the majority of the data 
presented here do not seem to be best represented by one average trajectory of menstrual cycle 
change. With respect to NA, headaches, and symptom associations, Kiesner and colleagues 
(2009; 2010; 2011; 2013) have also concluded that statistically (based on MLM) there are 
differences between women in the magnitude and direction, namely patterns, of cyclic shifts or 
symptom co-variation (as opposed to merely average/overall shifts or relationships in the female 
population). This also appears to be the case for PA and sociosexual tactics (e.g., Davydov et al., 
2007 and Phillips, 2015, respectively). The biological, evolutionary, and psychosocial bases of 
these different menstrual cycle patterns in women’s experiences should be the focus of future 
research, as has also been recommended for the two overall within-sex mating strategy 
phenotypes (Wlodarsk et al., 2015). For instance, even if the only alternative pattern to the more 
common PMS pattern of change (or ovulatory shift in short-term mating preferences) is one of 
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attenuated or no change, an important question then becomes examining why some free-cycling 
women fail to experience cyclic shifts that might be advantageous for them, even if it is opposite 
to that of other women.   
Hypothesis 2: Group differences between the PMS and POS groups. Some evidence 
for the validity of the PMS and POS groups comes from the finding that they differed in their B-
REP – Premenstrual Phase Ratings, which were completed prior to the two prospective cycle 
phase testing sessions. Women in the PMS group reported significantly less positive effects of 
the premenstrual phase on their physical health and sexual functioning compared to the POS 
group. These group differences were moderate to large in effect size. In addition, examination of 
premenstrual minus (-) periovulatory change scores indicated that women with higher NA scores 
in the premenstrual relative to the periovulatory phase also endorsed higher ratings of negative 
effects of the premenstrual phase on their physical health. Such correlations also revealed that 
relatively high PA scores in the premenstrual phase were positively related to ratings of 
increased interest in both long- and short-term relationships in the premenstrual phase (all rs 
discussed in this section = .32 to .34). These results provide some evidence of validity for the 
cluster analysis results. That is, the group found to have lower NA, higher PA, and higher 
proceptivity scores in the premenstrual than periovulatory phase (POS pattern) based on repeated 
measures reported more positive effects of the premenstrual phase in general at the earlier 
screening stage of the study than the group that had prospectively had high NA and low PA 
scores in the premenstrual phase (PMS pattern).      
Based on evidence for, and evolutionary theories related to, the original PSTS hypothesis 
(Oinonen, Klemencic, et al., 2008; summarized in the third panel of Table 3.1), it was predicted 
that the POS pattern group, with high proceptivity in the premenstrual phase, would have a more 
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unrestricted overall mating strategy (i.e., exhibit one of two between- and within-sex phenotypes 
of sociosexuality previously identified in the relevant literature). Indeed, strong support was 
found for this hypothesis. Women who showed the POS pattern reported having had more sexual 
partners in their lifetime, higher total sociosexuality scores, more unrestricted attitudes and 
behaviour, and higher short-term mating orientation scores. The groups did not differ in general 
sexual desire or long-term mating orientation. The finding that sociosexuality differs between 
two groups of women showing opposing cyclical patterns of affect and proceptivity fits with the 
initial findings associated with the PSTS theory (Oinonen et al., 2008) and with those of Phillips 
(2015). Overall, support was found for both the notion that affective experiences may facilitate 
mating strategy enactment (or vice versa) and the PSTS theory given that the two groups 
identified for cyclical shifts in NA, PA, and proceptivity differed based on sociosexuality. That 
is, if there are PMS and POS patterns among women, they may represent distinct mating strategy 
phenotypes (see Wlodarski & Dunbar, 2015): unrestricted and unrestricted, respectively. Thus, it 
may be unlikely that PMS (and POS) is a merely a byproduct of withdrawal from positive states 
between menstrual cycle phases (see Reiber, 2009) but rather the result of an interaction between 
a woman’s overall sociosexual orientation and hormone-related changes across the cycle.  
It is noteworthy that the PMS and POS groups did not significantly differ on any other 
variables in the areas of demographics, relationships, alcohol use, personality/impression 
management, and body measurements. They also did not differ in mean levels of NA, PA, and 
proceptivity. Thus, sociosexuality appears to a particularly important indicator of patterns in 
women’s menstrual cycle-related mating tactics. However, non-significant trends were found for 
group differences in education level, partner attractiveness related to self, and BMI. The POS 
group (with high proceptivity around ovulation) reported slightly higher education (though both 
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groups tended to be in the range of having completed some university), reported lower relative 
partner attractiveness, and had lower BMIs. Partner attractiveness was also correlated with 
premenstrual minus (-) periovulatory change scores in NA. The two findings for partner 
attractiveness are consistent with research on partner-related moderators of women’s cyclic 
sexual desire (Haselton & Gangestad, 2006; cf., Phillips, 2015). An association with BMI seems 
to make sense in the context that women with relatively high BMIs have higher circulating 
estrogen levels, which in the normal range has been hypothesized to protect against changes in 
mood (Oinonen & Mazmanian, 2001) but high BMI is also associated with various menstrual 
cycle problems, including PMS (Speroff & Fritz, 2005).   
Some other trends in the data warrant mention for future research. Premenstrual minus (-) 
periovulatory change scores also indicated that both slower rate of pubertal development and 
later AAM were correlated with higher proceptivity in the premenstrual phase (a POS pattern), 
while sensitivity to the effects of alcohol was related to lower NA scores in the premenstrual 
phase (also a POS pattern) (most a non-significant trend level). AAM and sociosexuality have 
been found to be inversely related (Manning & Fink, 2011) and later AAM would thus, be 
expected to be associated with a PMS and not a POS pattern (see Cohen et al., 2002; Reiber, 
2009). Interestingly, early and late AAM have been found to be associated with greater alcohol 
use in adolescence and adulthood (Richards & Oinonen, 2011), respectively, and alcohol use has 
found to be positively related to sociosexuality (Clark, 2004). The result pertaining to alcohol in 
the present study is similar to that of Kiesner (2012) in which women with a PMS pattern of NA 
reported less negative affective and sleep responses associated with alcohol use than women with 
a mid-cycle (POS) pattern. Combined, the findings described here indicate that both AAM and 
patterns of alcohol use or reactivity may be implicated in mating strategy enactment and patterns 
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of affect and proceptivity across the cycle. However, further research is needed to clarify the 
nature of the relationships.  
Lastly, premenstrual minus (-) periovulatory change scores indicative of high PA in the 
premenstrual phase (a POS pattern) and high proceptivity in the premenstrual phase (also a POS 
pattern) were related to high (more feminine) 2D:4D and high (more masculine) mid-phalangeal 
hair count, respectively. Taken together, these findings seem to have some relationship to those 
of Oinonen (2009) regarding HC side effects. Oinonen found that low digit ratio and low mid-
phalangeal hair count were both associated with a history of HC side effects (i.e., more 
masculine 2D:4D and more feminine MPH). The differential associations for these two 
measurements (i.e., more masculine 2D:4D and more feminine MPH in women showing aspects 
of the PMS pattern) may be related to the fact that digit ratio is a putative marker of prenatal 
androgen exposure (developmental masculinization), while mid-phalangeal hair count is a 
putative indicator of current androgen action or sensitivity. Thus, as Oinonen (2009) suggested, it 
is possible that extreme 2D:4Ds and hair counts may reflect sensitivity to changes in 
reproductive hormones. The present findings suggest that there may be value in exploring the 
extent to which prenatal androgen exposure and current androgen sensitivity or exposure may 
play a mechanistic role in the PMS and POS patterns. The findings also suggest the possibility 
that women showing a POS pattern may be less likely to experience negative side effects of OC 
use than women with the PMS pattern. The present study appears to be the first to examine 
whether these two variables (2D:4D and MPH) are associated with menstrual cyclicity in 
negative and positive experiences in women.  
Hypothesis 3: Phasic shifts on other scales of the Women’s REP and PARMSS. 
Providing some additional evidence for the validity of the two patterns of NA, PA, and 
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proceptivity, the POS and PMS groups displayed different patterns of phasic change in other 
scales of the Women’s REP and PARMSS. Overall, there were significant interactions between 
phase and group for positive experiences and receptivity (bolded in Tables 3.27 and 3.28). 
Within-group follow-up analyses revealed that, as would be expected, Positive Physical 
Experiences – General and Positive Weight Experiences scores were significantly higher in the 
premenstrual versus periovulatory (a POS pattern) in the POS group. There were also similar 
non-significant trends for Positive Sexual Experiences – Self and Positive Body Image 
Experiences. In the PMS group, Positive Physical Experiences – General, Positive Body Image 
Experiences, Positive Skin Experiences, Positive Breast Experiences, and Positive Appetite 
Experiences scores were significantly higher in the periovulatory phase relative to the 
premenstrual phase (a PMS pattern). Receptivity – ST and Receptivity – LT were also higher in 
the periovulatory phase (a PMS pattern) in the PMS group. Effects sizes, which tended to be 
moderate, appeared somewhat higher for the PMS group. Given the fact that the PMS group 
demonstrated menstrual cycle change in a larger number of scores, the PMS group may have 
stronger psychosexual cyclicity than the POS group. This finding is similar to one found in the 
original PSTS paper (Oinonen, Klemencic, et al., 2008) regarding the restricted 
(unrestrictiveness around ovulation; a PMS pattern) group, who had evidence of greater 
cyclicity, versus the unrestricted (restrictiveness around ovulation; a POS pattern) group.  
General discussion. All three hypotheses in this study were at least partially supported. 
Given the unique and thus, preliminary nature of the present study, the findings need to be 
replicated to assess their robustness. It would be best if replications were conducted in large 
samples of at least 90 (Kiesner & Martin, 2013) because there may be more than two patterns, 
including women who show no change, in affect or sexuality across the menstrual cycle. 
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However, other studies that have identified moderators of the direction of, or groups of women 
with paradoxical, patterns in affective experiences or sociosexuality involve relatively small 
samples of women (e.g., ns = 23 to 38; Oinonen, Klemencic, et al., 2008; Phillips, 2015; 
Scarbrough & Johnston, 2005) and/or used change scores to group women (Reiber, 2009; 
Rivera-Tovar et al., 1992). Daily data across the menstrual is probably beneficial because it 
would (a) result in relatively few women being excluded for being tested outside target phases 
and (b) would allow for the examination of lag effects (similar to Fortenbery et al., 2005). For 
instance, if affect facilitates mating tactics across the cycle, it is possible that phasic changes in 
affect slightly precede changes in mating tactics by a day or two, such as seems to be case for the 
effects of estrogen on women’s ratings of sexual desire (Roney & Simmons, 2013). Moreover, 
different hormonal mechanisms or combinations thereof (i.e., estrogen, progesterone, 
testosterone, LH, follicle-stimulating hormone, and perhaps oxytocin, prolactin, and cortisol) 
may be responsible for not only affective and mating tactic switches (Puts et al., 2005; Roney & 
Simmons, 2013), but also other negative and positive experiences, across the cycle.   
An important factor to consider in evaluating the results of the present study relates to 
social scripts. Although there have been substantial changes over the years, research suggests 
that even in modern society, men and women may be affected by sex/gender roles (O’Sullivan & 
Vannier, 2013). Traditional sexual scripts suggest that men are seen as the initiator or pursuer 
(i.e., more proceptive) and women are seen as restrictors who are either receptive or not (rather 
than proceptive) (O’Sullivan & Byers, 1992). However, while men tend to initiate sexual activity 
more so than women, there may no longer be a sex difference in receptive behaviour (e.g., 
Vannier & O’Sullivan, 2011) or the preference for sexual versus romantic stimuli (Thompson & 
O’Sullivan, 2012). The extent to which a woman enacts a conservative social script may be a 
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psychosocial variable that affects reproductive experiences and mating pursuits (Ussher & Perz, 
2013). For example, self-perceived masculine and non-masculine women have been found to 
pursue different mating strategies, unrestricted (“male-typical”) and restricted (“female-typical”), 
respectively (Clark, 2004). That being said, they also appear to have low (more masculine) and 
high (more feminine) 2D:4Ds, a biological variable (Clark, 2004; Teatero, 2009). In the present 
study, the finding that receptivity, but not proceptivity, shifted across the cycle for all of the 
women may be related to cultural constraint of women’s proceptive sexual behaviour (as also 
suggested by the means in Table 3.20). 
Although some researchers have suggested that changes in symptoms across the cycle 
(namely PMS) or in mating tactics do not exist but rather, are myths or statistical artifacts in 
society (e.g., Romans et al., 2012; Wood et al., 2013), societal biases seem unlikely to fully 
account for the phase and phase x group effects reported here. If they exist, cyclic shifts in 
women’s experiences are “non-intuitive and difficult to explain” without evolutionary theory 
(Gangestad et al., 2015) or biopsychosocial theories such as hormonal sensitivity. For instance, it 
is unclear why the periovulatory and premenstrual phases, the timing of which are arguably 
harder for women themselves to predict or observe than overt menstrual bleeding, have 
otherwise become associated with mild (normal) to severe psychological and physical changes 
by researchers, clinicians, and women alike. That being said, women’s experiences of PMS (and 
potentially POS) are somewhat intersubjective (e.g., dependent on context and life experiences; 
Ussher, Perz, & May, 2013) and use of the terms “symptoms” and “syndrome” may pathologize 
women’s normal cycle-related experiences. However, until new more appropriate wording is 
found and negotiated with women, “PMS pattern” and “POS pattern” seem to be useful terms for 
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describing collections or sets of women’s experiences and are consistent with the extant 
literature. 
Consistent with previous research, the data presented in Study 2 (as well as Study 1) 
indicate that many women experience at least some aversive experiences at reproductive events. 
Positive experiences were also found herein to differ between women of various hormonal and 
reproductive statuses as well as within women across the menstrual cycle. Given bias in the 
relevant health literature towards examining negative changes and the use of medical 
terminology (see Meaden et al., 2005; Chrisler & Caplan, 2002), alternative approaches to 
conceptualizing changes in women’s experiences and functioning at reproductive events are 
clearly needed to avoid pathologization. First, a continuum perspective seems useful in this 
regard (e.g., from reproductive experiences that seem to be a part of life as a woman to hormonal 
sensitivity to pathology; Steiner et al., 2003). Attemps should be made to limit the use of clinical 
terms to samples that have met diagnostic criteria for a reproductive disorder (see O’Brien et al., 
2011 for recommendations regarding the diagnosis of a premenstrual disorder). Second, 
examination of evolutionary accounts of health-related reproductive experiences may reveal 
adaptive or byproduct features of both normal and clinical psychological and physical changes or 
conditions across reproductive events. For example, in this study, the PSTS theory of evolved 
sexual behavior across the menstral cycle was extended to, and support was found for, the 
possibility that mood may modulate sexual proceptivity based on a woman’s overall mating 
strategy.  
It is also important to note that the menstrual cycle is dissimilar from other reproductive 
events in that it appears to be the only one that is cyclic with respect to phases over a woman’s 
lifespan. While research has largely focused on the premenstrual phase (Romans et al., 2012), the 
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menstrual phase may involve relatively more common negative experiences, as suggested by 
Study 1, and the periovulatory phase appears to be equally important in assessing negative and 
positive changes across the cycle. That is, all of the phases of the menstrual cycle may be 
reproductive events in and of themselves. For instance, the present study is one of the first to 
show that not all women exhibit the classic PMS pattern of menstrual cycle experiences and 
some women even experience positive changes in the premenstrual phase combined with 
negative changes in the periovulatory phase. Positive changes across the cycle seem to include 
not only decreased negative experiences but also increased positive experiences and increased 
sexual proceptivity.     
Previous studies that have compared two menstrual cycle phases have not mentioned 
regression to the mean as a possible explanation for findings related to different patterns of 
phasic changes in affect (e.g., Reiber, 2009) or moderators of ovulatory shifts in mating interests 
(e.g., Haselton & Gangestad, 2006). However, it is worth noting that regression to the mean is 
unlikely to account for or negate such results, including those presented here, for at least four 
reasons. First, the three dependent variables (change in NA, PA, proceptivity) were clustered 
simultaneously/together to reveal associations consistent with expectations despite the fact that 
the overall correlations in the full sample between mean NA, PA, and proceptivity, regardless of 
menstrual cycle phase, indicated different relationships. Second, the cluster analysis results were 
different than grouping women based on the median split of each dependent variable (given the 
unequal cluster group sizes). Third, cluster analysis is somewhat more sophisticated perhaps than 
imposing a moderating or grouping variable on the data or by simply grouping women by the 
direction of their menstrual cycle change scores.  
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Fourth, when asked qualitatively, women do report different effects of the premenstrual 
phase on their mood and sexuality (e.g., King & Ussher, 2013). Combined with finding of the 
present study that the PMS and POS groups differed on the previously administered B-REP – 
Premenstrual Phase Ratings, these data suggest that the two types of phasic change, regardless of 
direction/valence, are noticeable enough for some women to identify and thus, are in effect 
“real.” Fifth, there are now at least four studies that directly implicate a woman’s overall 
sociosexual mating strategy, based on a version of the SOI or 2D:4D (Wlodarski & Dunbar, 
2015), to her pattern of menstrual cycle change (present study; Oinonen, Klemencic, et al., 2008; 
Phillips, 2015; Scarbourgh & Johnston, 2009). What have been referred to as alternative patterns 
have been found since the 1930s (see Teatero et al., 2014) yet findings seem to have been limited 
by difficulties in or barriers to statistically testing for individual variability (i.e., random effects) 
compared to average (i.e., fixed) effects in repeated measures data (Moskowitz & Hershberger, 
2002). Paradoxical menstrual cycle patterns have also been found in at least one sample for 
which daily data was analyzed (Kiesner, 2011; Kiesner & Martin, 2013). Overall, when two 
target phases are compared, as is typically the case in menstrual cycle research, regression to the 
mean could account for finding paradoxical patterns in groups of women. While finding 
paradoxical patterns in groups of women may be a result of true hormonal, affective, sexual, or 
physical differences between the two phases, it of course remains a possibility that different 
menstrual cycle findings between and within studies could reflect an overall null or negative 
effect (i.e., type II errors).  
Unfortunately, the validity of researcher assessments of conception probability, hormone 
level estimates, and menstrual cycle phase classifications is unclear and differences in 
methodology are vast (see Gildersleeve et al., 2014). A recent study, however, suggests that the 
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validity of forward count from LMP and backward count from estimated NMP is modest (.40 to 
.55; Gangestad et al., 2015). Backward count from NMP confirmed in follow-up has generally 
been recommended (Brown et al., 2011; Hampson & Young, 2008) with a validity estimate of 
.66 (Gangestad et al., 2015). Thus, a strength of the present study is that 92% of women provided 
their actual NMP at follow-up. Also, given differences within-women between the target phases 
in conception probability estimates, hormone estimates, and assays, one can be reasonably 
confident that the menstrual cycle phase classifications were valid, or at least optimal for 
research in the field. 
Overall, the possibility of different patterns of psychosexual menstrual cycle change 
should not be ignored as they may better represent the lived experiences of women (Bancroft & 
Warner, 1988; King & Ussher, 2013). Analogies can also be drawn to other areas of health and 
well-being. As a clinical example, there is widespread acceptance that there are different mood 
episodes (which may be affected by the menstrual cycle in groups of women; Teatero et al., 
2014) as well as types of depressive and bipolar disorders (APA, 2013). Another example is that 
overall and menstrual cycle-related negative and positive side effects of HCs vary among women 
(Kiesner, 2011; Graham & Bancroft 2013a; see Rapkin, 2003 and Halbreich et al., 2006 for 
reviews regarding, in part, the effects of HCs on PMS). For instance, HCs have been found to 
reduce testosterone levels in women. This hormonal change is associated with three different 
effects in subgroups of women: decreased, increased, and no difference in sexual desire 
(Burrows, Basha, & Goldstein, 2012; Graham et al., 2007; Graham & Bancroft, 2013b; Pastor, 
Holla, & Chmel, 2013). Similar to the conclusions of Graham and Bancroft (2013) regarding the 
effects of HCs on sexual desire, it seems likely that differences between women in their 
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experiences across the menstrual cycle in a given study contribute to differences in findings 
between studies.  
However, given the widespread use of HCs and findings that users may be more 
sociosexually unrestricted than non-users (Bancroft et al., 1991; Oinonen, Jarva, & Mazmanian, 
2008), it should be noted that the women most likely to experience the POS pattern of change 
may be those who opt to use HCs and are thus excluded from most menstrual cycle research. The 
finding that ineligible participants, consisting primarily of HC users, were indeed more 
sociosexually unrestricted than the final free-cycling subsample makes sense in this context. 
Interestingly, there is some evidence that the relationship between affective and sexual 
experiences are dissociated to some extent in HC users and that HCs may not only nullify 
menstrual cycle effects but also disrupt mating adaptations (Greco et al., 2007; Roberts et al., 
2012). Future research should examine the interaction between HC use and menstrual cycle 
phase on affect and sexuality (e.g., see Greco et al., 2007 for opposing patterns of NA and PA 
across the cycle between monophasic and triphasic HC users) as well as the possibility of 
paradoxical patterns of negative and positive affective, sexual, and physical experiences at other 
reproductive events.    
Conclusions 
Part 1 of this study (N = 327) provided some evidence of the internal consistency, test-
retest reliability, and construct validity of the Women’s REP (developed in Study 1) and the 
PARMSS (Phillips, 2015), two measures that were recently developed to address methodological 
issues in the women’s health and evolutionary psychology literature, respectively. In addition, 
findings pertaining to reproductive/hormonal status differences on Women’s REP scores were at 
least partially replicated for five reproductive experience groups (presence/absence): women’s 
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reports of hormonal disorder, HC use, HC side effects, cycle regularity, and PMS. Thus, there is 
considerable support for the concurrent validity of this measure.  
Thus, scales from the Women’s REP and the PARMSS were used in Part 2 to examine 
patterns of NA, PA, and proceptivity across the menstrual cycle in free-cycling women (n = 41). 
Overall, two conclusions can be drawn from this part of the study. First, support was found for 
the existence of two groups of women who have paradoxical patterns of change: a PMS pattern 
in 61% of women (higher NA, lower PA, and lower proceptivity in the premenstrual versus 
periovulatory phase) and a POS pattern in 39% of women (higher NA, lower PA, and lower 
proceptivity in the periovulatory relative to premenstrual phase) (see also Kiesner, 2011 and 
Oinonen, Klemencic, et al., 2008). Second, in line with the PSTS theory, the POS group was 
more sociosexually unrestricted overall, while the PMS group was more restricted. These results 
are also consistent with evolutionary research suggesting that there are two phenotypes of 
sociosexuality within each sex. That is, the menstrual cycle shifts in the PMS and POS groups 
suggest that these two groups of women may experience hormone-calibrated changes that are 
part of the enactment of two different evolved mating strategies.  
While it seems plausible that being in a good mood (e.g., low NA or high PA) facilitates 
sexual behaviour, it is also possible that engaging in certain types of mating strategies, or simply 
even having sex, leads to greater happiness and well-being (e.g., Muise, Schimmack, & Impett, 
2015). However, in the present study (Part 2), change in PA across the menstrual cycle were 
relatively strong (compared to NA and proceptivity), negatively related to change in NA and 
positively related to change in proceptivity. Also, the PMS and POS groups showed opposing 
patterns of change in PA between the periovulatory and premenstrual phases. These two groups, 
while they differed in overall sociosexual orientation (e.g., short-term mating orientation), did 
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not differ in mean levels of affective experiences. These findings seem to provide some evidence 
that being “in the mood” for sexual proceptivity involves being in a relatively good mood, at 
least across the menstrual cycle, given that in the absence of opportunity for behaviour, 
proceptivity is attitudinal. It is arguably non-intuitive that change in proceptivity would predict 
change in mood. The opposite direction, shifts in mood preceding shifts proceptivity across the 
cycle, seems to make sense for understanding how the associations might be adaptive. However, 
further research in this area is needed.  
The present study had some limitations and strengths that should be considered when 
evaluating its results. A strength of the study was that the two main measures used in Part 2, the 
Women’s REP and the PARMSS, were first assessed in Study 1 and Part 1 for evidence of 
reliability in terms of internal consistency as well as temporal stability and valid using both a 
concurrent and multi-trait method. Also, women were recruited from both the Internet 
community and a local community, a strategy that resulted in a large and diverse sample in Study 
1. However, participants in the present study tended to be of young reproductive age in their 
early 20s and thus, the results are likely generalizable to that population but may not be 
generalizable to women in their 30s and early 40s. While many non-clinical studies in the areas 
of women’s health and evolutionary psychology tend to involve university samples, young 
women may have limited reproductive and mating/relationship experiences. Also, the magnitude 
of hormonal shifts across the menstrual cycle peaks in the late 20s to early 30s (see Hampson & 
Young, 2008) and thus, the reproductive/hormonal status group findings in Part 1 and identified 
PMS and POS patterns of phase shifts in Part 2 may be more pronounced in an older sample of 
women.  
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Another limitation was the modest size of the menstrual cycle-related subsample size 
(due to attrition, inclusion criteria, and difficulty accurately predicting women’s menstrual cycle 
phases based on initial self-report information), potentially affecting power to detect overall 
phase effects and cluster analysis pattern groups. Nonetheless, at least partial support was found 
for each of the predictions of both Parts 1 and 2 and guidelines form Gangestad et al. (2014) 
indicate that a sample size of 48 would be needed for 80% power to detect a cyclic shift using 
design of the present study. Also, the study included not only a longitudinal design but also a 
menstrual cycle design that involved careful ongoing follow-up with all participants as well as 
“wet” hormonal measures (i.e., LH testing and saliva collection among a subset of women). In 
menstrual cycle research, these methods are ideal (Brown et al., 2011; Hampson & Young, 2008; 
Gangestad et al., 2015) and are a strength of this study. Thus, the resulting data provided 
confidence that the free-cycling women in the present study were tested in both of the target 
phases. Given that women act as their own controls, repeated measures and within-women 
analyses are more sensitive to menstrual cycle phase shifts than between-women analyses and 
allow for the examination of subgroups of women who may or may not exhibit different 
trajectories of change. Finally, in using cluster analysis, the PMS and POS patterns groups were 
identified in a somewhat more natural way than by imposing a grouping/moderating variable on 
the data; in a more sophisticated manner than by creating groups based on the median split of 
scores; and in a more easily accessed or simple way than HLM. That being said, it is clear that 
further research on patterns of, and relationships between, affect and sexuality across the cycle is 
needed.  
Through further research on the possibility of different patterns of menstrual cycle 
changes in affect and sexuality, society may benefit from the discovery of differences as well as 
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related descriptions and terms that are best representative, respectful, and potentially validating 
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General Discussion 
The primary aim of this two-study dissertation was to contribute to the extant literature 
on women’s affective, sexual, and physical experiences associated with reproductive and 
hormonal events, particularly the menstrual/ovulatory cycle. The overarching theme of this 
dissertation, that seems to also be emerging in women’s health research, was that there are 
differences between women not only in magnitude (e.g., hormonal sensitivity) and valance (i.e., 
direction: negative or positive) but also patterns of responses to the same reproductive events due 
to biological, psychological, and social factors (e.g., Kiesner & Poulin, 2012; King & Ussher, 
2012). For example, there is some evidence of different menstrual cycle patterns in women’s 
well-being between and within studies (e.g., premenstrual syndrome [PMS] and negative 
experiences in the periovulatory phase; Kiesner, 2011), which in part has lead some researchers 
to question the validity of PMS (see Romans, Clarkson, Einstein, Petrovic, & Stewart, 2012).  
This dissertation was also an attempt to integrate research and theories in the areas of 
women’s health and evolutionary psychology. While health research has tended to focus on non-
clinical negative changes and the perimenstrual phase, evolutionary research has tended to 
examine changes in mating tactics and the periovulatory phase. In the latter area, evidence of two 
opposing patterns in women’s sexual behaviour has been reported (e.g., the periovulatory 
sociosexual tactic shift [PSTS]; Oinonen, Klemencic, & Mazmanian, 2008; Phillips, 2015). 
Despite evolutionary models of PMS (e.g., Reiber, 2009) and health research indicative of a link 
between mood and sexual behaviour (see Warner & Bancroft, 1988 for an early study), a 
surprising lack of research has been conducted on changes in negative or positive well-being as 
related to changes in types of sexuality and mating tactics across the cycle. Thus, this dissertation 
seems to have addressed gaps in the existing research by examining: (a) both negative and 
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positive reproductive experiences using a health measure; (b) sexuality using a mating strategies 
measure of both proceptivity and receptivity; and (c) different patterns of affective experiences 
and sexual proceptivity across the menstrual cycle between women.     
Overall, this dissertation consisted of three main parts: a comprehensive general literature 
review (Chapter 1) and two original studies (Chapters 2 and 3). Thus far, the literature review 
has resulted in a manuscript on positive affect across the menstrual cycle (Teatero, Oinonen, 
Mazmanian, & Streutker, 2015) and was the impetus for the publication of a systematic review 
of the research on the effects of the menstrual cycle on bipolar disorder (Teatero, Mazmanian, & 
Sharma, 2014). When designing Study 2, issues in the measurement of women’s reproductive- 
and hormone-related health experiences led to the development of the Women’s Reproductive 
Experiences (REP) Questionnaire in Study 1. As a result, each study has two parts. Study 1 
presented on the initial psychometric properties of this new comprehensive measure that is 
unique in its assessment of both negative and positive experiences associated with reproductive 
events across the lifespan in three domains: affective, sexual, and physical. The initial 
psychometric properties examined were its factor structure and internal consistency (Part 1) as 
well as concurrent validity (i.e., differences in scores between women of various reproductive 
and hormonal statuses; Parts 1 and 2). In Part 1 of Study 2, an attempt was made to replicate 
some of the analyses of Study 1; test-retest reliability as well as convergent and divergent 
validity for the Women’s REP and another newer measure, the Proceptive and Receptive Mating 
Strategies Scale (PARMSS), was assessed; and relationships between these two measures were 
examined (Part 1). Scales of the Women’s REP and PARMSS were then used to examine three 
hypothesizes regarding patterns of change in affect and proceptivity between the periovulatory 
and premenstrual phases (Part 2).  
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Summary of Results 
In Part 1 of Study 1 (overall N = 1934), factor analysis of the 134 items of the Women’s 
REP resulted in seven main scales: Negative Affective Experiences, Negative Physical 
Experiences, Sexual Problems – General, Sexual Problems – Relationship, Positive Affective 
and Physical Experiences, Body Image Quality, and Sleep Quality. Fourteen subscales and 13 
supplementary subscales were also identified (as seen in Figure 2.1 [p. 146] and Table 3.1 [p. 
237]). As demonstrated by comparing Tables 2.2 and 2.3 (pp. 127 and 134), the scales 
corresponded well to the rationally derived content domain scales that were formed in the 
development of the measure. Also, across Studies 1 and 2, the scales and subscales demonstrated 
good internal consistency with an average Cronbach’s alpha for the main scales of .89.  
Concurrent validity of the measure was assessed by examining scale and subscale scores 
as a function of current: hormonal problems; hormonal contraceptive (HC) side effects; and PMS 
(all yes/no; Part 1) as well as reproductive status (i.e., free-cycling, intrauterine device [IUD] 
users, oral contraceptive [OC] users, other HC users, pregnant women, postpartum women, and 
menopausal women); menstrual cycle regularity (amenorrhea, irregularly cycling, and regularly 
cycling among free cycling women); and menstrual cycle phase (free-cycling women in the 
menstrual, periovulatory, versus premenstrual phase) (Part 2). Correlations between Women’s 
REP scores and conception probability/hormone estimates were also examined. Similar analyses 
were also conducted in Part 1 of Study 2 (N = 327) in an attempt to help determine the 
replicability of the findings in Study 1. A detailed summary of the main findings for similar 
analyses between Study 1 and Study 2 can be found in Table 4.1. Overall, women who differed 
in the various hormone- and reproductive-related statuses also tended to differ in expected ways 
on relevant scales. For example, women who reported a current hormonal problem had 
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Summary of Main Findings of Similar Analyses between Study 1 and Study 2 by Area of Analysis 
 
Area  Study 1 
(overall N = 1934) 
Study 2
b 
(overall N = 327) 
Replication 
of Findings 





Scales: .84 to .95  (M = .89) 
Subscales: .67 to .95 (M = .88) 
Supplementary subscales: .62 to .94 (M = .70) 
Scales: .85 to .95 (M = .89) 
Subscales: .69 to .94 (M = .88) 
Supplementary subscales: .61 to .94 (M = .70) 
Yes 




All negative scales and subscale scores > among women 
who reported thinking that they had current hormonal 
problems [.003 to .05] 
 
Most positive scales and subscales < among women with 
a current hormonal problems [.004 to .02], except 
Positive Sexual Experiences – Others and Positive Sexual 
Experiences – Self  
Negative Sexual Experiences – Relationship scores > 
among women who reported being diagnosed with 
current hormonal problems [.06] 
 
Positive Affective Experiences, Positive Physical 
Experiences – General, and Positive Sexual 
Experiences – Relationship scores < among women with 
a current hormonal problem [.01 to .02] 
Partial 
HC status  Negative Affective Experiences, Negative Body Image 
Experiences, and Negative Sleep Experiences scores 
tended to be in the order of other HC users > free-cycling 
women > OC users [all .01] 
 
 
Positive Sexual Experiences – Relationship, Positive 
Affective Experiences and Elation, and Positive Sleep 
Experiences scores tended to be highest among OC users 
compared to free-cycling women and other HC users [.01 
to .03] 
No significant differences in negative scales and 
subscales between free-cycling women, OC users, and 
HC users but means were in directions consistent with 
Study 1 [.01 to .03]; trend for Negative Sexual 
Experiences - Relationships [.03] 
 
Elation scores > in OC users than non-users [.02]; means 
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Area  Study 1 
(overall N = 1934) 
Study 2
b 
(overall N = 327) 
Replication 
of Findings 
Concurrent validity of the Women’s REP 
HC side 
effects  
Most negative scale and subscale scores > among women 
who reported thinking that they had current HC side 
effects [.01 to .03], except Sexual Problems – General and 
related subscales as well as Decreased Appetite and 
General Aches and Pains 
 
 
Many positive scale and subscale scores < among women 
who reported current HC side effects [.01 to .03], except 
Sleep Quality, Positive Sexual Experiences – 
Relationship, and Positive Physical Experiences  
Negative Affective Experiences scores positively related 
to ratings of the negative effects of current HCs on sexual 
functioning and physical health [.18 and .21]; Negative 
Physical Experiences scores positively related to ratings 
of the negative effects of current HCS on emotional 
health and physical health [both .19]; 
   
Body Image Quality scores negatively related to ratings 







Most negative scale and subscale scores tended to in the 
order of women with amenorrhea > irregularly cycling 
women > regularly cycling women [.01 to .05], except 
Negative Sexual Experiences – Self and Negative Sexual 




Most positive scale and subscales scores tended to be in 
order of regularly cycling women > irregularly cycling 
women > women with amenorrhea [.01 to .04], except 
Positive Sexual Experiences (others and self)  
Negative Affective Experiences and Negative Sleep 
Experiences scores as well as Sexual Problems – 
General and related subscale scores > among irregularly 
cycling women than regularly cycling women [.04 to .10]; 
trends for Negative Physical Experiences scale and 
subscale scores [all. 03] and means for Sexual Problems 
– Relationship scores [.04] consistent with Study 1 
 
No significant differences between irregularly and 
regularly cycling women on positive scale and subscale 
scores but most means were in directions consistent with 




Many negative scale and subscale scores > among free-
cycling women in the premenstrual phase who reported 
thinking that they have PMS [.01 to .08], except Sexual 
Problems (both others and relationship), 
 
 
Most negative scale scores were positively related to 
ratings of negative effects of the premenstrual phase on 
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Area  Study 1 
(overall N = 1934) 
Study 2
b 
(overall N = 327) 
Replication 
of Findings 
Concurrent validity of the Women’s REP 
PMS Positive Affective Experiences and related subscale 
scores < among free-cycling women with PMS [.01 to 
.04] 
Sleep Quality scores were positively related to ratings of 
positive effects on the premenstrual phase on emotional, 






Negative Affective Experiences, Negative Physical 
Experiences and some related subscales as well as 
Negative Body Image Experiences and Negative Sleep 
Experiences scale and subscale scores > women in the 
menstrual compared to periovulatory phase [.01 to .09]; 
Latter two scores also > premenstrual than periovulatory 
women [.01 to .03] 
 
Positive scale and subscale scores did not differ between 
phase groups, with the exception of a trend for Positive 
Affective Experiences (periovulatory > menstrual) [.01]; 
No significant differences between periovulatory and 
premenstrual phase groups  
Decreased Appetite scores > in the periovulatory 
compared to premenstrual phase across women’s cycles 
[.21]; Study 1 also found few differences between these 
two phases  
Partial 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. HC = hormonal contraceptive. OC = oral contraceptive. PMS = 
premenstrual syndrome. Values in square brackets represent partial η
2 
effect sizes for significant group differences or correlation coefficients. 
Within, rows, bolded items represent scale or subscale scores that were significant across both studies. 
a 
Part 1 of study: internal consistency, hormonal problems, HC side effects, and PMS. Part 2: HC status, cycle regularity, and menstrual cycle 
phase. 
b
Part 1 of study: all areas except menstrual cycle phase
. c
Women with amenorrhea were not included in these analyses in Study 2 due to low 
subsample size. 
d
However, Negative Affective Experiences scores were also positively related to positive effects on sexual functioning and 
physical health [.40 and .38]. 
e
The menstrual phase was not included in Study 2.  
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significantly higher negative experiences scales (e.g., Negative Sexual Experiences – 
Relationship) and lower positive experiences scores (e.g., Positive Affective Experiences) than 
those who did not.  
The findings in each of the five areas of concurrent validity analyses were at least 
partially replicated. In some cases, methodological differences between Study 1 and Study 2 may 
have contributed to partial replication in findings (i.e., analyses that were only partially 
replicated). For instance, women were asked whether they currently thought that they had 
hormonal problems, HC side effects, and PMS, whereas women in Study 2 were asked whether 
they were currently diagnosed or being treated for such experiences. Only women of 
reproductive age who were not pregnant, postpartum, or menopausal were included in Study 2 
(and thus, findings from Study 1 comparing these specific group could not be replicated). Study 
2 involved a within-subjects menstrual cycle design and included only two instead of three 
menstrual cycle phases. Also, while there were not as many significant findings in the second 
study, the total sample size in Study 1 was 83% larger than that of Study 2. Thus, Study 1 had 
more power to detect any effects. 
Unique to Part 1 of Study 2, the test-retest reliability and construct validity of the 
Women’s REP and the PARMSS were examined. Both measures demonstrated adequate to good 
test-retest reliability as well as evidence of convergent and divergent validity based on patterns 
of relationships with 30 other health and mating strategy variables. As predicted, the scales of the 
two measures tended to be (a) most strongly related to variables measuring similar constructs (in 
terms of area [e.g., health, sexuality, or relationship] and valance [e.g., negative or positive]) and 
(b) weakly or unrelated to dissimilar variables. For instance, negative experiences scores of the 
Women’s REP were positively related to other negatively valenced health- and relationship-
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relevant variables (e.g., neuroticism, hormonal sensitivity, negative affect, and relationship 
jealousy) and negatively related to positively valenced affective, sexual, and physical well-being 
variables as well as sexual satisfaction and relationship quality. Positive experiences scores 
tended to show the opposite relationships. A detailed summary of the main findings specific to 
Study 2 can be found in Table 4.2. 
Relationships between the Women’s REP and PARMSS were also investigated in Part 1 
of Study 2. Contrary to expectations, small positive correlations between proceptivity in the 
context of an imagined short-term relationship (i.e., the Proceptivity – Short-Term [ST] scale) 
and Negative Affective Experiences (NA), Negative Physical Experiences, and Sexual Problems 
– Relationship scores were found. In contrast, the main positive experiences scales were not 
significantly related to receptivity or proceptivity. Some exploratory analyses, however, 
indicated that receptivity and proceptivity was lower in women with a hormonal problem 
compared to other women; higher in women who reported more positive emotional and physical 
health effects associated with their current HCs; and lower in women who reported more 
negative effects of the premenstrual phase on their emotional health. Thus, there was some 
mixed evidence for the hypothesis that being in a good mood is related to being “in the mood” 
for sex in general.  
Patterns of co-variation in NA, Positive Affective Experiences (PA), and proceptivity 
scores based on ratings of photographs of men (Proceptivity – Picture Ratings [PR]) across the 
periovulatory and premenstrual phases of free-cycling women (n = 41) were examined. Three 
hypotheses were made and at least partially supported. Using cluster analyses, support was found 
for the existence of two within-women menstrual cycle patterns differentiated by the phase in 
which NA was higher, PA was lower, and proceptivity was lower: (1) the premenstrual phase 
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Summary of Main Findings Specific to Study 2 by Area of Analysis 
 
Area Reliability of the Women’s REP
a
  
Test-rest reliability Scales: .59 to .71 (M = .66) 
Subscales: .45 to .77 (M = .60) 
Supplementary subscales: .45 to .74 (M = .61) 
 Construct validity of the Women’s REP
a 
Convergent Negative scales and subscales positively related to other negatively valenced health- and relationship-relevant variables 
(e.g., neuroticism, hormonal sensitivity, and negative affect, and relationship jealousy) [.14 to .75]; also, negatively 
related to positively valenced emotional, sexual, and physical health ratings as well as sexual satisfaction, and 
relationship quality [-.17 to -.66] 
 
Positive scales and subscales positively related to other positively valenced health- and relationship-related measures 
(e.g., positive affect, sexual satisfaction, and relationship quality) [.15 to .75]; also negatively related to negatively 
valenced health-relevant variables and relationship jealousy [-.15 to -.46] 
 
Divergent Correlations between affective and sexual scale and subscale scores more strongly correlated with other affective and 
sexual variables, respectively (e.g., Sexual Problems more strongly correlated with sexual health variables [-.32 to -.54] 
than other scales and ratings); however, Negative Physical Experiences scores not strongly correlated with physical 
health ratings (perhaps suggesting the scale measures reproductive symptoms and not general health) 
 
Fewer correlations than the PARMSS with mating strategies variables (e.g., long- and short-term mating orientation)  
 Reliability of the PARMSS
a 
Internal consistency Scales: .92 to .95 (M = .93) 
 
Test-retest reliability Scales: .76 to .83 (M = .79) 
 Construct validity of the PARMSS
a 
Convergent Scales positively related to attraction to men in photographs, unrestrictiveness, short-term mating orientation, relationship 
jealousy, receptive sexual behaviour (with primary partner), and proceptive sexual behaviour (excluding primary partner; 
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 Construct validity of the PARMSS
a
 




Scales not significantly related to most health-relevant variables as well as masturbation frequency 
 Reproductive and hormonal event related findings of the PARMSS 
Reproductive status
a 
Proceptivity – Long Term scores > free-cycling women compared to OC users but not other HC others [.02]; Trend for 




No significant differences between with and without current hormonal problems; Trends for Receptivity – Long Term 








No significant differences between irregularly and regularly cycling women  
PMS
a 
Proceptivity- Short Term and Proceptivity – Picture Ratings scores negatively related to ratings of negative effects of the 







Receptivity – Short-Term and Receptivity – Long-Term scores > in the periovulatory compared to premenstrual phase 
across women’s cycles [.10 and .07] 
 Relationships between the Women’s REP and the PARMSS 
General/overall
a 
Negative Affective Experiences scores positively related to Receptivity – Short Term [.13]; Testosterone-Related 
Experiences and Decreased Appetite, scores positively related to various receptivity and proceptivity scale scores [.12 to 
.15]; Negative Sexual Experiences – Others scores negatively related to various receptivity and proceptivity scale scores 
[-.11 to -.19] 
 
Most positive Women’s REP scale scores not significantly related to the PARMSS scales; Positive Sexual Experiences – 
Others positively related to all PARMSS scales [.25 to .38], while Positive Sexual Experiences – Relationship scores 
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Premenstrual minus periovulatory change scores negatively correlated between Negative Affective Experiences and 
Positive Affective Experience [-.57] and positively correlated between Positive Affective Experiences and Proceptivity – 
Picture Ratings [.39] 
 
Two opposing menstrual cycle pattern groups found that were differentiated by the phase in which they had higher 
Negative Affective Experiences scores as well as lower Positive Affective Experiences and Proceptivity – Picture 
Ratings scores: (1) the premenstrual phase (i.e., a PMS pattern; 61%) and (2) the periovulatory phase (i.e., a 
periovulatory syndrome [POS]; 39%) 
 PMS and POS
b 
Group differences Ratings of positive effects of the premenstrual phase on both sexual functioning and physical health > for POS than PMS 
group [Cohen’s d = 0.65 to 1.15] (evidence of validity of the groups) 
 
 POS group more sociosexually unrestricted (e.g., higher short-term mating orientation scores) overall than PMS group 
[Cohen’s d = 0.68 to 0.91] 
 
Groups not significantly different on demographic, relationship, self-perception, alcohol use, personality/impression 
management (e.g., neuroticism), and body measurement variables  
 
Correlations Higher Negative Affective Experiences scores in the premenstrual versus periovulatory phase positively related to 
relative partner attractiveness [.50] 
 
Higher Positive Affective Experiences scores in the premenstrual versus periovulatory phase positively related to 
sociosexual unrestrictiveness (e.g., short-term mating orientation) [.24 to .40] and middle-phalangeal hair count (high 
androgen activity) [.48 to .51] 
 
Higher Proceptivity – Picture Ratings scores in the premenstrual versus periovulatory phase positively related to 2D:4D 
(low prenatal androgen exposure) [.41 to .54] 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = Proceptive and Receptive Mating Strategies Scale. HC = 
hormonal contraceptive. PMS = premenstrual syndrome. Values in squared brackets represent partial η
2 
effect sizes for significant group 
differences or correlation coefficients, unless otherwise stated. 
a
Part 1 of study. 
b
Part 2 of study.  
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 (a PMS pattern in 61% of women) and (2) the periovulatory phase (what is proposed to be 
periovulatory syndrome [POS] pattern in 31% of women). Supporting the validity of these two 
groups, women in the PMS group reported less positive effects of the premenstrual phase on 
their physical health and sexual functioning than did the POS group – on ratings completed at the 
screening phase of the study before the two prospective cycle-related testing sessions. They also 
displayed opposite patterns of positive physical experiences scores on the Women’s REP and 
other PARMSS scores. In line with the PSTS, support was also found for the hypothesis that 
women who show the POS pattern have a more unrestricted overall mating strategy (e.g., short-
term mating orientation) than those who demonstrate the PMS.  
Limitations and Strengths 
 Specific limitations and strengths of the two individual studies can be found in their 
respective Conclusions sections on pages 198 and 358. However, several general limitations and 
strengths of Studies 1 and 2 warrant mention. The overall sample and subscales sizes across the 
two studies ranged from large, nearly 2,000 women in Study 1, to modest (e.g., n = 41 in Study 2 
Part 2). Based on guidelines from Gangestad et al. (2015), however, both studies had 80% power 
to detect medium-sized menstrual cycle phase effects. Some analyses such as those involving 
pregnant and postpartum women (ns = 24 and 25) and those involving the PMS and POS groups 
(ns = 35 and 16) may have been underpowered. Another limitation may be the reliance on self-
report data. However, use of self-report is appropriate in examining women’s experiences (from 
their perspective), the raw data was thoroughly examined by the author for response sets, and 
there was no indication of significant negative or positive response styles, including on the 
impression management scales of the Personality Assessment Inventory (PAI; Morey, 2007). 
Given the number of analyses across the two studies, some positive findings may be a result of 
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Type I error, yet the results did not substantially change in either study when Bonferroni 
correction was applied to dependent sets of analyses and most positive findings were as 
predicted. That being said, a strength is that both cross-sectional and prospective methods were 
used. Lastly, as demonstrated in Table 4.1, an important strength of this dissertation was that 
some similar or replicated analyses were conducted across Parts 1 and 2 of the first study and 
Part 1 of the second study, which suggests reasonable confidence and robustness in the findings 
pertaining to reliability and concurrent validity of the Women’s REP. Other findings, such as 
those pertaining to the PMS and POS groups were unique and preliminary, and warrant further 
study.  
Practical Implications  
 The Women’s REP seems to be the only measure of both negative and positive 
experiences that can be used at any reproductive event or time point across the lifespan. Thus, 
this newly developed measure could potentially be used to assess women’s reproductive 
experiences in three domains (affective, sexual, and physical) across seven distinct areas (i.e., 
scales) using a common metric for any event or time point. A strength of the Women’s REP is 
that it allows for the measurement of general areas but also specificity in experiences based on its 
13 subscale areas and 14 supplementary subscale areas. It is difficult to compare experiences 
between women of different reproductive/hormonal statuses and across prospective events based 
on separate event-specific measures because they consistent of various sets of experiences 
evaluated using different scales. While some have circumvented this issue by using general 
health measures, these measures were not designed for assessment specific to reproductive 
events and thus, may fail to assess key reproductive or hormonal experiences, and should not be 
used diagnostically. Also, the assessment of positive experiences is consistent with a strength-
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based perspective. It is clear that the presence of negative experiences cannot be assumed to be 
synonymous with the absence of positive experiences.  
 The Women’s REP could be used clinically as a screening measure to obtain a snapshot 
of a woman’s functioning at any given time given that it takes about 20 minutes to complete and 
individual (sub)scales could be used on their own. It appears to be a non-event and non-disorder 
specific measure of hormonal sensitivity. With further research, it may also prove to have utility 
as a diagnostic tool in combination with specific measures. It could be used at individual events 
to assess severity of symptoms (e.g., increased or decreased affective and sexual well-being with 
HC use) and across them over time to assess what has referred to as hormonal sensitivity 
syndrome (HSS; Pope, Oinonen, Mazmanian, & Stone, 2015) or even the effects of treatment 
(pre- and post). That is, the Women’s REP may help to clarify to what extent a woman is 
experiencing symptoms, and which symptoms, at an individual reproductive event but also 
patterns in her experiences across time. While some degree of at least physical experiences 
appear common at certain points in a woman’s life (i.e., seem to come with being a woman), this 
measure involves a comprehensive collection of experiences known to be associated with at least 
one reproductive event, including those that are mood- and sex-related.  
 Another potential implication of the Women’s REP and the present dissertation is 
increasing evidence that all women do not experience a common PMS pattern of mood, sex, and 
physical well-being. In fact, some women seem to show the opposite POS pattern. It remains to 
be well researched whether the POS pattern at its extreme may be a clinical condition, similar to 
premenstrual dysphoric disorder. If so, this would have implications for assessment, diagnosis, 
and treatment. For instance, clinical PMS and POS patterns might have different etiologies and 
differential responses to treatment, such as medications. Women showing these two different 
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menstrual cycle patterns may also have differing experiences at other reproductive events and 
respond differently to possible treatments during those events. This same issue may also apply to 
various patterns at other reproductive events (e.g., women who experience postpartum 
depression versus elation).  
Conclusions 
Conclusions can be drawn from this dissertation in several areas. First, a contribution to 
the existing literature may prove to be the development of the Women’s REP. Studies 1 and 2 are 
the first to use a comprehensive measure of not only negative but also positive affective, sexual, 
and physical experiences associated with all of the major female reproductive events across the 
adult lifespan. The Women’s REP, which is one of the only non-disorder and non-event 
measures of its kind, appears applicable for use with women of all ages. The scales of this 
measure demonstrate evidence of good psychometric properties. These properties include a 
multidimensional scale structure, internal consistency, test-retest reliability, concurrent validity, 
convergent validity, and divergent validity. It is expected that the Women’s REP will have utility 
in research as well as clinical practice related to women’s reproductive health (e.g., HSS; Pope et 
al., 2015). That is, results reported across the two studies herein are important in that they 
provide evidence of the usefulness of such a comprehensive measure as well as of the scales that 
may represent women’s reproductively related or hormonally mediated experiences across the 
adult lifespan. Further study and refinement of the measure is warranted (e.g., confirmatory 
factor analysis).  
Second, Study 2 is one of two studies that have used the newly developed PARMSS 
(Phillips, 2015), distinct in its measurement of both proceptive and receptive mating strategies 
using a common metric. The PARMSS demonstrates good internal consistency, high test-retest 
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reliability, and evidence of construct validity. These psychometric properties of the items of the 
PARMSS appear to be consistent across use with various imaginary vignettes and picture rating 
tasks. These results are similar to those of Phillips (2015). Further study and refinement of this 
measure is also warranted.  
Third, there was mixed evidence for the hypothesis that being in a good mood is related 
to being in the mood for sex. It seems plausible that negative well-being may be related to 
increased sexuality among some women in general (e.g., Lykins, Janssen, & Graham, 2006), 
whereas increases (i.e., changes) in negative and positive reproductive experiences, such as 
across the menstrual cycle, are related to decreased and increased mating behaviour, 
respectively. This possibility should be investigated in the future.   
Fourth, in addition to a PMS pattern in the majority of women, there is evidence for the 
existence of a menstrual cycle pattern in a group of women that involves increased negative 
experiences, such as NA, as well as lower PA and lower proceptivity around ovulation. For 
consistency with past research, this pattern is consistent with a new term: periovulatory 
syndrome (POS). These findings suggest that across the menstrual cycle, being in a good mood 
may facilitate proceptivity or vice versa (i.e., PA and proceptivity seem to be positively related). 
In line with the PSTS theory, women who show a POS pattern may be enacting tactics across the 
cycle of an overall unrestricted mating strategy, while the PMS pattern seems to be consistent 
with a restricted phenotype (Wlodarski & Dunbar, 2015). There are now at least four studies that 
have found a woman’s pattern of menstrual cycle change in mating tactics to be associated with 
her overall sociosexuality (present dissertation; Oinonen, Klemencic, et al., 2008; Phillips, 2015; 
Scarbourgh & Johnston, 2009). This dissertation appears to be the first to extend this finding to 
changes in NA and PA. These results suggest that the possibility of paradoxical or various 
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patterns in women’s experiences across the menstrual cycle should be considered in future 
research.  
Lastly, cluster analysis may have utility in preliminary testing for patterns of women’s 
experiences over time, such as across the menstrual cycle (Study 2, Part 2) and HSS (Pope et al., 
2015). However, the logical next step in this area of research would be to examine the temporal 
order of peaks or troughs in affect and proceptivity across the menstrual cycle, such as by 
examining the effects of previous day affect on current day proceptivity. Mood induction 
procedures might also prove useful in this regard. Future research should also, at least, consider 
the possibility of at least two phenotypes of psychosexual changes across the menstrual cycle, 
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Appendix A 
Forms and Questionnaires for Study 1 
Information and Consent Form  
Dear Potential Participant,  
 
Thank you for your interest in the Women's Health Experiences Study conducted by Ms. Missy 
Teatero and Dr. Kirsten Oinonen with the Health Hormones & Behaviour Laboratory (HHAB 
Lab) in the Department of Psychology at Lakehead University (LU). The main purpose of this 
research is to help develop a questionnaire to assess the physical, emotional, and sexual health 
experiences of women. The data will be used in Ms. Teatero's doctoral dissertation but other 
related research questions in the HHAB Lab will be examined as well. Lakehead University 
students and members of the general public (16 years or older) are eligible to participate.  
 
The study will take about 30 minutes to complete and involves answering questions of a 
personal nature regarding your thoughts, feelings, behaviours, and physical symptoms over 
the past 48 hours. Your participation is voluntary and you may withdraw from, or refuse to 
participate in, any part of the study at any time without explanation or penalty. You may decline 
to answer any question. The information obtained for the study will be securely stored by Dr. 
Oinonen for at least five years after the study is completed. All records of your participation will 
be kept in strict confidence, and there will be absolutely no way to identify you as a participant 
in any subsequent reports. All participants will have the opportunity to enter their name into a 
draw for one of four $50 VISA gift cards. Psychology students at LU may receive 0.5 of a bonus 
point for participation in the study. If you wish to be entered into the draws or to receive 0.5 
bonus points, you will be asked for your name and email address but this information will be 
stored in a separate file from your questionnaire responses and will not be connected to them. 
Thus, all information collected in this questionnaire will remain both anonymous and 
confidential.  
 
There are no known physical or psychological risks associated with participation in this study. 
Some people may experience discomfort when answering personal questions and thus, a list of 
mental health resources is provided at the end of both this letter and the study. The possible 
benefits of participation include: a better understanding of oneself, learning about the research 
process, and contribution to research that will provide a better understanding of women’s 
experiences.  
 
If you would like a summary of the study results, please send a request to Ms. Teatero. If you 
have any questions or concerns regarding this study, please do not hesitate to contact Ms. 
Teatero or Dr. Oinonen. This study has been approved by the Lakehead University Research 
Ethics Board. If you have any questions related to the ethics of the research and would like to 
speak to someone outside of the research team please contact Sue Wright at the Research Ethics 
Board at 807-343-8283 or research@lakeheadu.ca. Please keep this Cover Letter for your 
records. 
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Missy Teatero, M.A. and Kirsten Oinonen, Ph.D., C. Psych.  
hormones@lakeheadu.ca; koinonen@lakeheadu.ca 
807-343-8943; 807-343-8096  
 
Health, Hormones, & Behaviour Lab 
Department of Psychology 
Lakehead University 
955 Oliver Road 
Thunder Bay, ON 
P7B 5E1 
Mental Health Resources 
Your physician, a counselor, a walk-in clinic, or a sexual health clinic  
 
International: http://www.mymentalhealth.ca/ http://www.iasp.info/resources/Crisis_Centres/  
 
Canada: www.crisisline.ca/links.htm  
 
The 24-hour Thunder Bay Crisis Response Service at 807-346-8282  
The Thunder Bay Regional Health Sciences Centre Walk-in Clinic at 807-768-1333  
The Thunder Bay Counseling Centre at 807-684-1880  
The Thunder Bay District Health Unit (sexual health clinic) at 807-625-5900  
The Student Health and Counseling Centre, Lakehead University at 807-343-8361 
*I have read and understood the above information and I agree to participate in this study 
under these conditions. I also understand that I am not obliged to answer questions which I 
am uncomfortable with and that I am free to withdraw from the study at any time without 
penalty or other consequence. 
 
[  ] I understand that my consent to the above is implied if I check this box and choose to 
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Women’s Health Experiences Questionnaire  
 
Note that this questionnaire was administered electronically through a secure Internet database. 
Therefore, the numbering of the items here merely indicates situations in which some items were 
not applicable to certain participants and were automatically not displayed for those individuals. 
This means that some participants were not given all of the items (i.e., different items were 




1. Your biological sex:   [  ] Male [  ] Female [  ] Other  (please specify): _____________ 
 
2. Your age: ________ years and ________ months                     
3. What is your ethnic background? (Chose the option that best describes your ethnicity)  
[  ] Caucasian/White      [  ] Middle Eastern  
[  ] African?Black    [  ] East Indian  
[  ] Native/Aboriginal    [  ] European  
[  ] Hispanic/Latino     [  ] Asian  
[  ] Other (please specify): _____________ 
  
4. Where do you currently live? Province/State: __________ Country: ___________  
 
5. What is your sexual orientation? (Chose the one that best describes you) 
[  ] 0 – Exclusively heterosexual  
[  ] 1 – Predominantly heterosexual, only incidentally homosexual 
[  ] 2 – Predominantly heterosexual, but more than incidentally homosexual 
[  ] 3 – Equally heterosexual and homosexual 
[  ] 4 – Predominantly homosexual, but more than incidentally heterosexual 
[  ] 5 – Predominantly homosexual, only incidentally heterosexual 
[  ] 6 – Exclusively homosexual   
[  ] X Asexual (i.e., lack of attraction to, or desire for, either sex) 
[  ] Other (please describe): _____________ 
6. What is your current relationship status? (Choose the one that best describes you)  
[  ] Married     [  ] Common-law or living together    
[  ] One steady dating partner  [  ] More than one dating partner        
[  ] One regular sexual partner  [  ] More than one sexual partner 
[  ] Single    [  ] Other (please specify): _____________ 
 
7. Sex of your primary partner:   [  ] Male [  ] Female 
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9. Below is a list of sexual experiences that can be positive or negative. Please indicate the extent 
to which you have had each experience in the past 48 hours (i.e., over the past 2 days). If you 
have not engaged in sexual activity in the past 48 hours, please imagine how you would respond 
to the sexual items if you had engaged in sexual activity. 
 










Sexual desire/drive for primary 
partner 
[  ] [  ] [  ] [  ] [  ] 
Disinterest in sexual activity with 
primary partner  
[  ] [  ] [  ] [  ] [  ] 
Difficulty becoming aroused with 
primary partner  
[  ] [  ] [  ] [  ] [  ] 
Easy to become aroused with 
primary partner  
[  ] [  ] [  ] [  ] [  ] 
Difficulty having an orgasm with 
primary partner  
[  ] [  ] [  ] [  ] [  ] 
Easy to have an orgasm with 
primary partner  
[  ] [  ] [  ] [  ] [  ] 
 
Health Background  
 
10. Please indicate whether you think that you have ever had any of the following conditions:  
 
Premenstrual syndrome (PMS; in general and 
not necessarily at the present moment) 
[  ] Never  [  ] Past  [  ] Present     
Hormonal contraceptive side effects  [  ] Never  [  ] Past  [  ] Present     
Mood problems during pregnancy [  ] Never  [  ] Past  [  ] Present     
Mood problems during postpartum period [  ] Never  [  ] Past  [  ] Present     
Hormonal problem or disorder [  ] Never  [  ] Past  [  ] Present     
 
11. Check the statement that best describes your menstrual cycle:   
[  ] I have gone through menopause and do not get a period 
[  ] I am not currently menstruating because I am currently lactating or breast feeding 
[  ] I never have my period 
[  ] I have not had my period in the last three months   
[  ] Some months I get my period and some months I don’t  
[  ] I usually get my period every month, but it is irregular and I cannot predict when it will start  
[  ] I usually get my period within two to three days of when I expect it  
[  ] My period is like clockwork; the same number of days elapse between periods  
 
12. What is the average length of your menstrual cycle (i.e., how many days are there from the 
first day of one period to the day before your next period. Most women range between 25 and 35 
days)?   _______ days  
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13. What is your average length of menstruation (i.e., how many days does your menstrual 
period or bleeding last. Most women range between 2 to 7 days)? ______ days 
14. Using the calendars above, please indicate the first day of your last/most recent menstrual 
period:  
____________________   ____________________   ____________________ 
                 Day                                Month                                  Year 
 
15. How confident are you that your last menstrual period started on the day indicated above?    
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
16. Using the calendars above, please indicate the day that you think your next menstrual period 
will start:  
____________________   ____________________   ____________________ 
                 Day                                Month                                  Year 
 
17. How confident are you that your next menstrual period will start on the day indicated above?    
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
18. Are you menstruating (i.e., on your period) today?   [  ] Yes [  ] No 
 
ITEM 19 WAS FOR WOMEN CURRENTLY MENSTRUATING 
 
19. If yes, for how many days (including today) have you been menstruating?   _____ days 
 
20. Are you currently taking any form of female contraception? If yes, please specific the type:  
[  ] No 
[  ] Oral contraception (the pill)   [  ] Injected contraception (e.g., Depo) 
[  ] Contraceptive patch (e.g., Evra)   [  ] Hormonal Intrauterine Device (e.g., Mirena) 
[  ] Cooper Intrauterine Device (e.g., Flex-T) [  ] Vaginal Ring (e.g., NuvaRing) 
 
ITEMS 21 TO 22 WERE FOR WOMEN CURRENTLY USING AN ORAL 
CONTRACEPTIVE 
 
21. Please indicate the type and specific brand of oral contraceptive you are currently taking or 
using:                   
[  ] Alesse  [  ] Linessa  [  ] Norlevo  [  ] Seasonique  
[  ] Apri  [  ] Lo-Femenal [  ] Ortho 0.5/35 [  ] Select 1/35 
[  ] Aviane  [  ] Loestrin 1.5/30 [  ] Ortho 1/35  [  ] Synphasic                         
[  ] Brevicon 0.5/35  [  ] Marvelon   [  ] Ortho 10/11 [  ] Tri-Cyclen             
[  ] Brevicon 1/35  [  ] Micronor  [  ] Ortho 7/7/7            [  ] Tri-Cyclen Lo            
[  ] Cyclen  [  ] Min-Ovral  [  ] Ortho-Cept [  ] Triquilar                
[  ] Demulen 30  [  ] Minestrin 1/20 [  ] Portia             [  ] Yasmin                         
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[  ] Demulen 50 [  ] Next Choice [  ] Seasonale  [  ] Yaz 
[  ] Other (please specify): _______ 
 
22.  How often do you miss a contraceptive pill (e.g., forget to take at the usual time)?  
 




Every month Every week 
[  ] [  ] [  ] [  ] [  ] 
 
23. What week of your current oral contraceptives pill pack are you in?  
 
Week 1 of active pills Week 2 of active pills Week 3 of active pills Pill-free/inactive or 
sugar pill week  
[  ] [  ] [  ] [  ] 
 
ITEMS 24 TO 27 WERE FOR WOMEN USING CURRENTLY USING ANY HORMONAL 
CONTRACEPTION 
 
24. For how long have you been taking this particular contraceptive?    
________ years and/or _________ months and/or __________ weeks and/or _________ days 
 
25. Do you take the contraceptive continuously without a pill- or hormone-free week? For 
instance, do you skip menstrual/withdrawal bleeding by not taking any time off of the 
contraceptive?   [   ] Yes [   ] No 
 
26. Have you ever used a hormonal contraceptive or non-hormonal intrauterine device in the 
past?   [   ] Yes [   ] No 
 
27. How long has it been since you stopped taking your last (most recent) hormonal 
contraceptive or non-hormonal intrauterine device?  
________ years and/or _________ months and/or __________ weeks and/or _________ days 
 
28. Please indicate whether you are currently . . . 
 
Pregnant? [  ] Yes     [  ] No     [  ] Maybe     
In the postpartum period (within 6 months of 
the birth of a child)?  
[  ] Yes     [  ] No     [  ] Maybe     
Going through of went through natural or 
surgically-induced menopause?  
[  ] Yes     [  ] No     [  ] Maybe     
 
29. To your knowledge, have you ever been pregnant?   [  ] Yes [  ] No  
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31. Below is a list of physical, emotional, and sexual experiences that can be positive or 
negative. Please indicate the extent to which you have experienced each item in the past 48 
hours (i.e., over the past 2 days). If you have not engaged in sexual activity in the past 48 hours, 
please imagine how you would respond to the sexual items if you had engaged in sexual activity.  
 










Anxiety or worry  [  ] [  ] [  ] [  ] [  ] 
Loneliness [  ] [  ] [  ] [  ] [  ] 
Physical health [  ] [  ] [  ] [  ] [  ] 
Energized/active  [  ] [  ] [  ] [  ] [  ] 
Feeling down, sad, or depressed  [  ] [  ] [  ] [  ] [  ] 
Difficulty becoming aroused with 
others or the thought of others 
(excluding primary partner) 
[  ] [  ] [  ] [  ] [  ] 
Sleeping less than usual [  ] [  ] [  ] [  ] [  ] 
Unhappy with food preferences [  ] [  ] [  ] [  ] [  ] 
Leg cramps [  ] [  ] [  ] [  ] [  ] 
Feeling great or special  [  ] [  ] [  ] [  ] [  ] 
Regular bowel movements [  ] [  ] [  ] [  ] [  ] 
Less breakthrough bleeding/spotting [  ] [  ] [  ] [  ] [  ] 
Breast size decrease [  ] [  ] [  ] [  ] [  ] 
Physical pleasure/comfort during 
sexual activity  
[  ] [  ] [  ] [  ] [  ] 
Achievement/productivity in work or 
school 
[  ] [  ] [  ] [  ] [  ] 
Not feeling like self  [  ] [  ] [  ] [  ] [  ] 
Connectedness/support [  ] [  ] [  ] [  ] [  ] 
Abdominal cramps or discomfort [  ] [  ] [  ] [  ] [  ] 
Lack of interest or enjoyment in 
usual activities 
[  ] [  ] [  ] [  ] [  ] 
Unhappy with weight   [  ] [  ] [  ] [  ] [  ] 
Affectionate/intimate with others  [  ] [  ] [  ] [  ] [  ] 
Joint or muscle agility (i.e., ease of 
movement)  
[  ] [  ] [  ] [  ] [  ] 
Focused [  ] [  ] [  ] [  ] [  ] 
Easy to have an orgasm with others 
or the thought of others (excluding 
primary partner)  
[  ] [  ] [  ] [  ] [  ] 
Feeling happy, elated, or euphoric [  ] [  ] [  ] [  ] [  ] 
Emotional calmness/stability [  ] [  ] [  ] [  ] [  ] 
Vaginal dryness [  ] [  ] [  ] [  ] [  ] 
High self-esteem  [  ] [  ] [  ] [  ] [  ] 
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Difficulty having an orgasm through 
masturbation (alone) 
[  ] [  ] [  ] [  ] [  ] 
Content with weight [  ] [  ] [  ] [  ] [  ] 
Mental relaxation/calm [  ] [  ] [  ] [  ] [  ] 
Sexual desire/drive for others 
(excluding primary partner) 
[  ] [  ] [  ] [  ] [  ] 
General physical comfort [  ] [  ] [  ] [  ] [  ] 
Not enough sleep [  ] [  ] [  ] [  ] [  ] 
Clumsiness/minor accidents [  ] [  ] [  ] [  ] [  ] 
Increased appetite [  ] [  ] [  ] [  ] [  ] 
Sweating [  ] [  ] [  ] [  ] [  ] 
Uninterrupted (peaceful) sleep [  ] [  ] [  ] [  ] [  ] 
Unhappy with appetite [  ] [  ] [  ] [  ] [  ] 
Unhappy with food intake [  ] [  ] [  ] [  ] [  ] 
Emotional irritability/sensitivity [  ] [  ] [  ] [  ] [  ] 
Sleeping more than usual [  ] [  ] [  ] [  ] [  ] 
Impairment in work or school [  ] [  ] [  ] [  ] [  ] 
Easy to have an orgasm through 
masturbation (alone) 
[  ] [  ] [  ] [  ] [  ] 
Feeling capable/competent [  ] [  ] [  ] [  ] [  ] 
Acne/pimples [  ] [  ] [  ] [  ] [  ] 
Feeling in control [  ] [  ] [  ] [  ] [  ] 
Healthy bowel movements [  ] [  ] [  ] [  ] [  ] 
Thoughtfulness [  ] [  ] [  ] [  ] [  ] 
Self-blame/critical [  ] [  ] [  ] [  ] [  ] 
Feeling unoriginal or plain [  ] [  ] [  ] [  ] [  ] 
Flatulence/gassy [  ] [  ] [  ] [  ] [  ] 
Please with body shape/size [  ] [  ] [  ] [  ] [  ] 
Mood stability (consistent mood) [  ] [  ] [  ] [  ] [  ] 
Disinterest in sexual activity with 
others (excluding primary partner) 
[  ] [  ] [  ] [  ] [  ] 
Hydrated [  ] [  ] [  ] [  ] [  ] 
Breast size increase  [  ] [  ] [  ] [  ] [  ] 
Eating more than usual [  ] [  ] [  ] [  ] [  ] 
Food aversions [  ] [  ] [  ] [  ] [  ] 
Looking forward to a bright future [  ] [  ] [  ] [  ] [  ] 
Easy to become aroused with others 
or the thought of others (excluding 
primary partner) 
[  ] [  ] [  ] [  ] [  ] 
A strong back [  ] [  ] [  ] [  ] [  ] 
Difficulty becoming aroused for 
masturbation (alone) 
[  ] [  ] [  ] [  ] [  ] 
Even facial skin tone [  ] [  ] [  ] [  ] [  ] 
Easy to become aroused for 
masturbation (alone) 
[  ] [  ] [  ] [  ] [  ] 
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Crying [  ] [  ] [  ] [  ] [  ] 
Feeling thinner than usual [  ] [  ] [  ] [  ] [  ] 
Facial hair growth [  ] [  ] [  ] [  ] [  ] 
Negative thoughts about the future 
(pessimism) 
[  ] [  ] [  ] [  ] [  ] 
Headaches/migraines [  ] [  ] [  ] [  ] [  ] 
Decreased appetite [  ] [  ] [  ] [  ] [  ] 
Unhappy with breast size [  ] [  ] [  ] [  ] [  ] 
Clear complexion/skin [  ] [  ] [  ] [  ] [  ] 
Facial skin discolouration (i.e., 
colour blotches on face) 
[  ] [  ] [  ] [  ] [  ] 
Feeling bigger than usual [  ] [  ] [  ] [  ] [  ] 
Pleased with breast size [  ] [  ] [  ] [  ] [  ] 
Pain/discomfort during sexual 
activity 
[  ] [  ] [  ] [  ] [  ] 
Low self-esteem [  ] [  ] [  ] [  ] [  ] 
Stomach comfort [  ] [  ] [  ] [  ] [  ] 
Content with appetite [  ] [  ] [  ] [  ] [  ] 
Fatigue/lack of energy  [  ] [  ] [  ] [  ] [  ] 
Painful or tender breasts [  ] [  ] [  ] [  ] [  ] 
Impulsivity [  ] [  ] [  ] [  ] [  ] 
Interest or enjoyment in usual 
activities 
[  ] [  ] [  ] [  ] [  ] 
Bloating/swelling  [  ] [  ] [  ] [  ] [  ] 
Sense of physical well-being [  ] [  ] [  ] [  ] [  ] 
Avoidant of intimacy/affection [  ] [  ] [  ] [  ] [  ] 
Disinterest in masturbation (alone)  [  ] [  ] [  ] [  ] [  ] 
Disrupted sleep [  ] [  ] [  ] [  ] [  ] 
Content with food intake  [  ] [  ] [  ] [  ] [  ] 
Vaginal lubrication [  ] [  ] [  ] [  ] [  ] 
Sociable (desire to be around others) [  ] [  ] [  ] [  ] [  ] 
Eating less than usual [  ] [  ] [  ] [  ] [  ] 
Concern about body shape/size [  ] [  ] [  ] [  ] [  ] 
Food cravings [  ] [  ] [  ] [  ] [  ] 
Healthy digestion [  ] [  ] [  ] [  ] [  ] 
Joint or muscle stiffness [  ] [  ] [  ] [  ] [  ] 
Difficulty concentrating  [  ] [  ] [  ] [  ] [  ] 
Strong and nimble legs [  ] [  ] [  ] [  ] [  ] 
Mood lability (mood swings)  [  ] [  ] [  ] [  ] [  ] 
Calm intestinal track [  ] [  ] [  ] [  ] [  ] 
Breakthrough bleeding/spotting [  ] [  ] [  ] [  ] [  ] 
Good judgment or rational [  ] [  ] [  ] [  ] [  ] 
Content with amount of sleep  [  ] [  ] [  ] [  ] [  ] 
Jealous of other women [  ] [  ] [  ] [  ] [  ] 
Content with food preferences [  ] [  ] [  ] [  ] [  ] 
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Nausea or vomiting [  ] [  ] [  ] [  ] [  ] 
Excitement and enthusiasm  [  ] [  ] [  ] [  ] [  ] 
Difficulty falling asleep  [  ] [  ] [  ] [  ] [  ] 
Constipation [  ] [  ] [  ] [  ] [  ] 
Please with self compared to other 
women 
[  ] [  ] [  ] [  ] [  ] 
Decrease in facial hair  [  ] [  ] [  ] [  ] [  ] 
Heartburn or indigestion [  ] [  ] [  ] [  ] [  ] 
Feeling out of control [  ] [  ] [  ] [  ] [  ] 
Difficulty having an orgasm with 
others or the thought of others 
(excluding primary partner) 
[  ] [  ] [  ] [  ] [  ] 
Unsociable (desire to be alone) [  ] [  ] [  ] [  ] [  ] 
Smiling [  ] [  ] [  ] [  ] [  ] 
Clear-headedness [  ] [  ] [  ] [  ] [  ] 
Desire/drive for masturbation (alone) [  ] [  ] [  ] [  ] [  ] 
Physical grace/motor coordination [  ] [  ] [  ] [  ] [  ] 
Backache [  ] [  ] [  ] [  ] [  ] 
Easy falling asleep [  ] [  ] [  ] [  ] [  ] 
Poor judgment or irrational [  ] [  ] [  ] [  ] [  ] 
Diarrhea [  ] [  ] [  ] [  ] [  ] 
Feeling like self [  ] [  ] [  ] [  ] [  ] 
Comfort in breast area [  ] [  ] [  ] [  ] [  ] 
General aches and pains [  ] [  ] [  ] [  ] [  ] 
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Debriefing Form  
 
Dear Participant,  
 
Thank you for completing the Women's Health Experiences Study. It will provide us with a 
better understanding of the associations among women's physical, emotional, and sexual health 
experiences. More specifically, the data you provided will be used to help develop a 
questionnaire to assess the experiences of women over a 48-hour period for a doctoral 
dissertation by Ms. Missy Teatero under the supervision of Dr. Kirsten Oinonen. This research 
project was approved by the Lakehead University Research Ethics Board (807-343-8283 or 
research@lakeheadu.ca).  
 
Please be assured that your name and contact information is not associated with data collected 
and there will be no way to identify your responses. All of your responses will remain 
completely anonymous and confidential. Please send a request to Ms. Teatero if you would like 
to receive a summary of the study results once we are finished collecting data.  
 
All participants can be entered in four draws for $50 VISA giftcards. In addition, 
psychology students at Lakehead University (LU) may receive 0.5 bonus points for the 
completion of this study. If you would like to be entered in the draws or are an LU student 
in a Psychology course and would like to receive 0.5 bonus points, please click here 
 
For your interest, here are two references for articles in this research area:  
 
Haywood, A., Slade, P., & King, H. (2002). Assessing the assessment measures for menstrual 
cycle symptoms: A guide for researchers and clinicians. Journal of Psychosomatic 
Research, 52, 223-237.  
 
O’Brien, P. M. S., Bäckström, T., Brown, C., Dennerstein, L., Endicott, J., Epperson, C. N., . . . 
Yonkers, K. (2011). Towards consensus on diagnostic criteria, measurement and trial 
design of the premenstrual disorders: The ISPMD Montreal consensus. Archives of 




Missy Teatero, M.A. and Kirsten Oinonen, Ph.D., C. Psych. 
hormones@lakeheadu.ca; koinonen@lakeheadu.ca  
807-343-8943; 807-343-8096  
 
Health, Hormones, & Behaviour Lab  
Department of Psychology  
Lakehead University  
955 Oliver Road  
Thunder Bay, ON  
P7B 5E1 
 
WOMEN’S REPRODUCTIVE EXPERIENCES 
   
419 
Mental Health Resources  
 
Your physician, a counselor, a walk-in clinic, or a sexual health clinic  
International: http://www.mymentalhealth.ca/ http://www.iasp.info/resources/Crisis_Centres/  
Canada: www.crisisline.ca/links.htm  
 
The 24-hour Thunder Bay Crisis Response Service at 807-346-8282  
The Thunder Bay Regional Health Sciences Centre Walk-in Clinic at 807-768-1333  
The Thunder Bay Counseling Centre at 807-684-1880  
The Thunder Bay District Health Unit (sexual health clinic) at 807-625-5900  
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Forms and Questionnaires for Study 2 
 
Cover Letter  
 
Dear Potential Participant,  
 
Thank you for your interest in the Hormones & Sociosexuality Study conducted by Ms. Missy 
Teatero and Dr. Kirsten Oinonen with the Health, Hormones, & Behaviour Lab in the 
Department of Psychology at Lakehead University. Dr. Dwight Mazmanian is also a collaborator 
of this study. The main purpose of this research is to examine the effects of hormones (e.g., 
cortisol and progesterone) on patterns of physical, emotional, and sexual well-being. The 
majority of this project will constitute Ms. Teatero’s doctoral dissertation but other related 
research questions will be examined as well. Lakehead University students (16 years or older) 
and members of the general public (18 years or older) are eligible to participate. 
 
This study takes place in 3 main stages. Stage 1 involves an online Screening Questionnaire that 
takes about 40 to 60 minutes to complete. This questionnaire will be used to select participants 
who will be contacted by the researchers in the next few weeks. If selected to participate in 
Stages 2 and 3, you will be asked to complete two Phase Questionnaires and a 2- to 5-minute 
Daily Questionnaire across approximately 1 month, all sent via e-mail unless you would prefer 
hard copies. The two Phase Questionnaires will be separated by about 10 to 14 days and take 
approximately 40 to 60 minutes to complete. Overall, you will be asked to respond to questions 
of a personal and sexual nature that include, but are not limited to, the following: health, 
reproductive experiences like puberty, mood, personality, sexual attitudes and behaviours, and 
romantic relationships.  
 
Thunder Bay residents may be asked to complete the Phase Questionnaires during two separate 
lab sessions (each about 1 hour in total) at Lakehead. During these sessions, a few body 
measurements (e.g., finger length and weight) will be taken by a female researcher and some 
participants will be asked to provide saliva samples for hormone analysis. Some volunteers will 
also be provided with a kit of urine hormone testing strips to use at home, as instructed by the 
researchers. The hormone testing strips will take less than 5 minutes a day for about 5 days. 
 
Your participation is voluntary and you may withdraw from, or refuse to participate in any part 
of, the study at any time without explanation or penalty. You may decline to answer any 
question. The information obtained for the study will be securely stored by Dr. Oinonen for 5 
years. All records of your participation will be kept in strict confidence, and there will be 
absolutely no way to identify you as a participant in any subsequent reports. Once you have 
completed the study, your contact information will be removed from your questionnaires and 
your information will remain both anonymous and confidential.  
 
There are no known physical or psychological risks associated with participation in this study. 
Some people may experience discomfort when answering personal questions and thus, a list of 
mental health resources is provided at the end of this letter. The possible benefits of participation 
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include: a better understanding of oneself, learning about the research process, and contribution 
to research that will provide a better understanding of health and sexual relationships. 
 
Psychology students at Lakehead University may be eligible to receive up to 4 bonus points: 1 
point for Stage 1 (i.e., the Online Screening Questionnaire) and 1 for each of two Online Phase 
Questionnaires OR 1.5 for each of two Lab Sessions. Other Thunder Bay residents (i.e., those not 
eligible for bonus points) who complete lab sessions will be offered nominal remuneration of up 
to $15 (i.e., $5 for Stage 2 and $10 for Stage 3). All participants will be entered into a separate 
draw for a $50 VISA gift card for each of Stages 1, 2, and 3 (the Screening Questionnaire and 
two Phase Questionnaires), whether completed online or in the lab. All participants who 
complete 80% or more of the Daily Questionnaires will be entered into a draw for a $50 VISA 
gift card. Draws will be held periodically until the end of data collection (approximately January 
2014). Funding is provided by the Canadian Institute of Health Research (CIHR). 
 
If you would a summary of the research results, please send a request to Ms. Teatero at the end 
of the study. If you have any questions or concerns regarding this study, please do not hesitate to 
contact Ms. Teatero or Dr. Oinonen. This study has been approved by Lakehead University’s 
Research Ethics Board (807-776-7289). Please keep the Cover Letter for your records.  
 




Missy Teatero, M.A. and Kirsten Oinonen, Ph.D., C. Psych.  
hormones@lakeheadu.ca; koinonen@lakeheadu.ca 
807-343-8943; 807-343-8096  
 
Health, Hormones, and Behaviour Lab 
Department of Psychology 
Lakehead University 
955 Oliver Road 
Thunder Bay, ON 
P7B 5E1 
 
Mental Health Resources  
 
Your physician, a counselor, a walk-in clinic, or a sexual health clinic  
International: http://www.mymentalhealth.ca/ http://www.iasp.info/resources/Crisis_Centres/  
Canada: www.crisisline.ca/links.htm  
 
The 24-hour Thunder Bay Crisis Response Service at 807-346-8282  
The Thunder Bay Regional Health Sciences Centre Walk-in Clinic at 807-768-1333  
The Thunder Bay Counseling Centre at 807-684-1880  
The Thunder Bay District Health Unit (sexual health clinic) at 807-625-5900  
The Student Health and Counseling Centre, Lakehead University at 807-343-8361
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Consent Form A 
 
I have read and understood the Cover Letter for the Hormones & Sociosexuality Study 
conducted by Ms. Teatero and Dr. Oinonen with the Health, Hormones, & Behaviour Lab in the 
Department of Psychology at Lakehead University. I agree to participate in this research and 
understand the following:  
 
1. I am a volunteer, can withdraw at any time from this study, and may choose not to answer any 
question.  
2. There are no known serious risks associated with participation in this study.  
3. Benefits of participation may include: (a) an appreciation of research on hormones, health, and 
sexual attitudes and behaviours, (b) an opportunity to contribute to science, (c) up to 3 bonus 
points for psychology students at Lakehead University or nominal remuneration of up to $15 for 
lab sessions, and (d) entry in up to 4 draws for $50 VISA gift cards.  
4. I will remain anonymous in any publications or presentations of the research findings. All data 
will remain confidential and will only be accessed by researchers who have been trained in 
research ethics. At the end of the study, the data I have provided will be associated with a 
participant number, and not my contact information or any other identifying information.  
5. The data will be securely stored for at least 5 years by Dr. Oinonen at Lakehead.  
6. I may contact the researchers if I would like to receive a summary of the findings.  
7. For the duration of the study, the researchers and I will have ongoing communication via the 
e-mail address(es) and telephone number(s) that I have provided below. This information will 
not be used for any other reason.  
 
*By providing any information below, I agree to the above. 
 
E-mail address(es): ____________________________________________________________ 
 
Phone number(s): _____________________________________________________________ 
 




Psychology professor: ______________________ 
 
Psychology course: _________________________ 
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Note that this Screening Questionnaire and the Daily Questionnaire below were administered 
electronically through a secure Internet database. Therefore, the numbering of the items here 
merely indicates situations in which some items were not applicable to certain participants and 
were automatically not displayed for those individuals. This means that many participants were 




1. Your biological sex:   [  ] Male [  ] Female [  ] Other  (please specify): _____________ 
 
2. You’re age:   ________ years and ________ months         
             
3. What is your ethnic background? (Chose the option that best describes your ethnicity)  
[  ] Caucasian/White      [  ] Middle Eastern  
[  ] African/Black    [  ] East Indian  
[  ] Native/Aboriginal    [  ] European  
[  ] Hispanic/Latino     [  ] Asian  
[  ] Other (please specify): ___________________ 
 
4. Do you currently live in Thunder Bay, Ontario, Canada?    [  ] Yes [  ] No 
 
ITEM 5 WAS FOR PARTICIPANTS WHO DID LIVE IN THUNDER BAY 
 
5. Where do you currently live? Province/State: ___________ Country: ____________ 
 
6. What is your highest level of education?  
[  ] Some elementary school [  ] Completed high school [  ] Some university  
[  ] Completed grade 8 [  ] Some college  [  ] Completed a university degree     
[  ] Some high school  [  ] Completed college [  ] Completed a graduate degree 
 
7. Are you currently a full-time college or university student?    [  ] Yes [  ] No 
 
8. Please choose the option that best describes your handedness: 
[  ] Left-handed [  ] Ambidextrous (use both hands equally)       [  ] Right-handed 
 
9. Please choose the option that best describes you:  
[  ] I feel happiest and most productive in the morning hours of the day 
[  ] I feel happiest and most productive in the evening hours of the day 
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Health Background  
 
10. Please choose the option that best describes your smoking status: 
[  ] Current occasional/social smoker  [  ] Current smoker 
[  ] Previous occasional/social smoker [  ] Previous smoker 
[  ] Non-smoker 
 
11. Are you current taking any over-the-counter or prescribed medications (other than birth 
control)? [  ] Yes [  ] No 
 
ITEMS 12 AND 13 WERE FOR PARTICIPANTS CURRENTLY TAKING MEDICATIONS 
 
12. How many over-the-counter or prescribed medications (other than birth control) are you 
currently taking? _______ 
 
13. What types of over-the-counter or prescribed medications are you currently taking? (Select 
all that apply)   
 
[  ] Anti-anxiety medication (e.g., Celexa, Ativan) [  ] Asthma medication   
[  ] Anti-depressants (e.g., Paxil, Zyban)  [  ] Hormone replacement therapy 
[  ] Anti-psychotics (e.g., Abiligy, Clozaril)   [  ] Pain medication (e.g., Aspirin) 
[  ] Allergy medication     [  ] Thyroid medication 
[  ] Other (please list): ________________________  
 
14. Stress can be experienced as a result of both positive and negative life events and can be 
defined as physical or emotional strain/tension. Compared to other people your age and sex, to 























Stressful negative life 
events between birth 
and 10 years of age?  
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Stressful positive life 
events between birth 
and 10 years of age? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Stressful negative life 
events in the past year?  
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Stressful positive life 
events in the past year? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
15. How aware are you of the health problems of your biological relatives (i.e., your 
grandparents, aunts/uncles, parents, siblings, and children)?  
 
Unaware     Very Aware 
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1 2 3 4 5 6 
[  ] [  ] [  ] [  ] [  ] [  ] 
 
16. Please indicate whether you think that any of your biological relatives (i.e., your 
grandparents, aunts/uncles, parents, siblings, and children) may have ever been diagnosed with 
or treated for any of the following physical/medical or emotional/psychological conditions. If 
applicable, please list the exact condition(s): 
 
  
Cancer:__________________________________________ [  ] Yes    [  ] No   [  ] Maybe 
Heart disease [  ] Yes    [  ] No   [  ] Maybe 
Fertility problem: __________________________________ [  ] Yes    [  ] No   [  ] Maybe 
Hormonal disorder:_________________________________ [  ] Yes    [  ] No   [  ] Maybe 
Menstrual cycle problem: ____________________________ [  ] Yes    [  ] No   [  ] Maybe 
Hormonal contraceptive side effects: ___________________ [  ] Yes    [  ] No   [  ] Maybe 
Depression  [  ] Yes    [  ] No   [  ] Maybe 
Seasonal affective disorder [  ] Yes    [  ] No   [  ] Maybe 
Bipolar disorder (e.g., manic-depression) [  ] Yes    [  ] No   [  ] Maybe 
Mood disorder during pregnancy: _____________________ [  ] Yes    [  ] No   [  ] Maybe 
Post-partum mood disorder: __________________________ [  ] Yes    [  ] No   [  ] Maybe 
Substance abuse:___________________________________ [  ] Yes    [  ] No   [  ] Maybe 
17. Use the following scale to indicate how often, on average, you tend to . . .   
 




















Eat “healthy” (unprocessed) foods [  ] [  ] [  ] [  ] [  ] 
Eat “unhealthy” (processed) foods  [  ] [  ] [  ] [  ] [  ] 
Try to lose weight/diet  [  ] [  ] [  ] [  ] [  ] 
Physically exercise (to the point of 
sweating or elevated heart rate) 
[  ] [  ] [  ] [  ] [  ] 
Drink caffeinated beverages (i.e., 
pop, coffee, and energy drinks) 
[  ] [  ] [  ] [  ] [  ] 
Drink alcohol  [  ] [  ] [  ] [  ] [  ] 
Use recreational drugs [  ] [  ] [  ] [  ] [  ] 
 
18. Compared to other people my age and sex, I believe that I am sensitive to (i.e., susceptible to 
or more likely to experience) the effects of . . .  
 
 Very slightly or 
















[  ] [  ] [  ] [  ] [  ] 
Seasonal changes   [  ] [  ] [  ] [  ] [  ] 
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Smell [  ] [  ] [  ] [  ] [  ] 
Caffeine [  ] [  ] [  ] [  ] [  ] 
Alcohol [  ] [  ] [  ] [  ] [  ] 
Positive mood changes 
following exercise 
[  ] [  ] [  ] [  ] [  ] 
 





























Physical  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Emotional  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Sexual (i.e.,  
desire, arousal, 
and ability to 
orgasm) 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
21. Please answer each question by indicating “yes” or “no” following the question. There are no 
right or wrong answers, and no trick questions. Work quickly and do not think too long about the 
exact meaning of the question. Please remember to answer each question.  
 
 Yes No 
Does your mood often go up and down? [  ] [  ] 
Do you ever feel “just miserable” for no reason? [  ] [  ] 
Are you an irritable person?  [  ] [  ] 
Are your feelings hurt easily? [  ] [  ] 
Do you often feel “fed-up”? [  ] [  ] 
Would you call yourself a nervous person? [  ] [  ] 
Are you a worrier? [  ] [  ] 
Would you call yourself a tense or ‘highly-strung’? [  ] [  ] 
Do you worry too long after an embarrassing experience? [  ] [  ] 
Do you suffer from ‘nerves’ [  ] [  ] 
Do you often feel lonely? [  ] [  ] 
Are you often troubled about feelings of guilt? [  ] [  ] 
 
22. How many tattoos do you have in total? (Please estimate) ________ tattoos 
ITEM 23 WAS FOR PARTICIPANTS WITH TATTOOS 
 
23. If you have at least one tattoo, please indicate the location(s) on your body: (All that apply) 
[  ] Upper back [  ] Lower back  [  ] Arm [  ] Legs  
[  ] Ankle  [  ] Feet   [  ] Chest [  ] Stomach   
[  ] Neck   [  ] Other (please list): ___________ 
 
24. How many piercings (including ear piercings) do you have it total? ________ piercings 
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ITEM 25 WAS FOR PARTICIPANTS WITH PIERCINGS  
 
25. If you have at least one piercing, please indicate the location(s) on your body: (All that 
apply) 
[  ] Ear lobe (regular) [  ] Ear lobe (plug) [  ] Ear cartilage [  ] Navel/belly button 
[  ] Eyebrow  [  ] Nose   [  ] Septum  [  ] Lip   
[  ] Nipple  [  ] Genital  [  ] Surface (please specify): ___________  
[  ] Other (please specify): ___________ 
 
26. Your height (best estimate): ________ (feet and inches) or ________ (cm)     
 
27. Your weight (best estimate): ________ (pounds) or ________ (kg) 
  
Relationships and Sexuality  
 
28. What is your sexual orientation? (Chose the option that best describes you) 
[  ] 0 – Exclusively heterosexual  
[  ] 1 – Predominantly heterosexual, only incidentally homosexual 
[  ] 2 – Predominantly heterosexual, but more than incidentally homosexual 
[  ] 3 – Equally heterosexual and homosexual 
[  ] 4 – Predominantly homosexual, but more than incidentally heterosexual 
[  ] 5 – Predominantly homosexual, only incidentally heterosexual 
[  ] 6 – Exclusively homosexual   
[  ] X Asexual (i.e., lack of attraction to, or desire for, either sex) 
[  ] Other (please describe): _______________ 
 
29. With how many different partners have you . . .  
 
 0 1 2 3 4 5-6 7-9 10-19 20 or 
more 
Deep/French kissed or “made 
out” with in your lifetime? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Had sexual contact (i.e., hands 
to genital or oral sex) that did 
NOT include intercourse in 
your lifetime? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Had sexual intercourse (sex) in 
your lifetime? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Had sex in the past 12 months? [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Had sex on one and only one 
occasion? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Had sex without having an 
interest in a long-term 
committed relationship with the 
person? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
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30. At what age did you first have . . . (Please type “0” [zero] if you have never engaged in the 
activity)  
Sexual contact (i.e., hands to genital or oral 
sex) that did NOT include intercourse? 
_____ years  
Sexual intercourse   _____ years  
 






























 1 2 3 4 5 6 7 8 9 
For me, sex without love is OK [  ] [  ] [  ] [  ] [] [  ] [  ] [  ] [  ] 
I can imagine myself being comfortable and 
enjoying “casual” sex with different partners 
[  ] [  ] [  ] [  ] [] [  ] [  ] [  ] [  ] 
I do not want to have sex with a person until 
I am sure that we will have a long-term 
serious relationship 
[  ] [  ] [  ] [  ] [] [  ] [  ] [  ] [  ] 
 


































































 1 2 3 4 5 6 7 8 9 
Have fantasies about having sex with 
someone you are not in a committed 
romantic relationship with 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Experience sexual arousal when you are in 
contact with someone you are not in a 
committed romantic relationship with 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Have spontaneous fantasies about having 
sex with someone you just met 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Masturbate (alone) [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
33. Considering your past and future behaviour, what is the likelihood (percentage chance) that 
you would have sex with someone for the first time without using a condom? 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
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34. In total, how many months of dating do you consider to be a “long-term relationship”? 
 _____ months 
 
35. How many romantic long-term relationships (more than just casual sex) that were longer 
than 8 months have you been in? _________ 
 
36. What is the longest romantic relationship that you have been in?  
________ years and/or _________ months and/or __________ weeks and/or _________ days 
 
37. How many romantic relationships (more than just casual sex) that lasted less than 8 months 
have you been in? ________ 
 
38. What is your current relationship status? (Choose the one that best describes you)  
[  ] Married     [  ] Common-law or living together    
[  ] One steady dating partner  [  ] More than one dating partner        
[  ] One regular sexual partner  [  ] More than one sexual partner 
[  ] Single    [  ] Other (please specify): __________________    
 
39. Do you currently have a primary romantic partner?    [  ] Yes [  ] No 
 
ITEMS 40 TO 45 WERE FOR WOMEN IN A ROMANTIC RELATIONSHIP  
 
40. Sex of your primary partner:   [  ] Male [  ] Female 
 
41. Age of your primary partner: ________ years  
 
42. How long have you and your primary current partner been together?  
________ years and/or _________ months and/or __________ weeks and/or _________ days 
 
43. Is your relationship long distance?   [  ] Yes [  ] No 
 
44. With how many different people have you “cheated” on your current primary partner with 
someone else in the following ways?   
 
 0 1 2 3 4 5-6 7-9 10-19 20 or 
more 
Sexual contact (i.e., hands to 
genitals or oral sex) that did 
NOT include intercourse  
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Sexual intercourse [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Developing an emotional 
connection  
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
45. With how many different people has your current primary partner “cheated” on you with 
someone else in the following ways?  
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 0 1 2 3 4 5-6 7-9 10-19 20 or 
more 
Sexual contact (i.e., hands to 
genitals or oral sex) that did 
NOT include intercourse 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Sexual intercourse  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Developing an emotional 
connection  
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
Health Background  
 
46. Read each statement and decide if it is an accurate statement about you. Give your own 
opinion of yourself.  
 
 False, not 






My favourite poet is Robert Kertezc [  ] [  ] [  ] [  ] 
Sometimes I get ads in the mail I don’t 
really want 
[  ] [  ] [  ] [  ] 
My favourite sports event on television is 
the high jump 
[  ] [  ] [  ] [  ] 
Most people would rather win than lose [  ] [  ] [  ] [  ] 
My favourite hobbies are archery and 
stamp collecting 
[  ] [  ] [  ] [  ] 
I don’t like to buy things that are 
overpriced  
[  ] [  ] [  ] [  ] 
Most people look forward to a trip to the 
dentist 
[  ] [  ] [  ] [  ] 
In my free time I might read, watch TV, or 
just relax 
[  ] [  ] [  ] [  ] 
Sometimes I cannot remember who I am [  ] [  ] [  ] [  ] 
I have visions in which I see myself forced 
to commit crimes 
[  ] [  ] [  ] [  ] 
Since the day I was born, I was destined to 
be unhappy 
[  ] [  ] [  ] [  ] 
I think I have three or four completely 
different personalities inside of me 
[  ] [  ] [  ] [  ] 
People don’t understand how much I suffer [  ] [  ] [  ] [  ] 
Every once and a while I totally lose my 
memory 
[  ] [  ] [  ] [  ] 
Sometimes my vision is only in black and 
white 
[  ] [  ] [  ] [  ] 
I don’t have any good memories from 
childhood 
[  ] [  ] [  ] [  ] 
I have severe psychological problems that [  ] [  ] [  ] [  ] 
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began very suddenly 
Sometimes I let little things bother me too 
much 
[  ] [  ] [  ] [  ] 
Sometimes I’ll avoid someone I really 
don’t like 
[  ] [  ] [  ] [  ] 
I sometimes complain too much [  ] [  ] [  ] [  ] 
Sometimes I’m too impatient [  ] [  ] [  ] [  ] 
I don’t take criticism very well [  ] [  ] [  ] [  ] 
Sometimes I put things off until the last 
minute 
[  ] [  ] [  ] [  ] 
I sometimes make promises I can’t keep [  ] [  ] [  ] [  ] 
There have been times when  could have 
been more thoughtful than I was 
[  ] [  ] [  ] [  ] 
I rarely get in a bad mood [  ] [  ] [  ] [  ] 
 
47. The questions that follow are different for men and women. For this reason, please specific 
your sex (again):   [  ] Male [  ] Female    
 
48. Please indicate whether you have been, or are presently, diagnosed with or treated for any of 
the following conditions. If applicable, please list the exact condition(s): 
 
Overweight or obesity  [  ] Never  [  ] Past  [  ] Present     
Underweight [  ] Never  [  ] Past  [  ] Present     
Heart disease:_______________ [  ] Never  [  ] Past  [  ] Present     
Fertility problem:____________ [  ] Never  [  ] Past  [  ] Present     
Hormonal disorder:___________ [  ] Never  [  ] Past  [  ] Present     
Balding/thinning of hair [  ] Never  [  ] Past  [  ] Present     
Sexual dysfunction:__________ [  ] Never  [  ] Past  [  ] Present     
Sexually transmitted disease/infection (STD/I): 
_____ 
[  ] Never  [  ] Past  [  ] Present     
Depression  [  ] Never  [  ] Past  [  ] Present     
Seasonal affective disorder  [  ] Never  [  ] Past  [  ] Present     
Bipolar disorder (e.g., manic-depression) [  ] Never  [  ] Past  [  ] Present     
Autism spectrum disorder  [  ] Never  [  ] Past  [  ] Present     
Eating or body image disorder (e.g., 
Anorexia):_____________ 
[  ] Never  [  ] Past  [  ] Present     
Substance abuse: ____________ [  ] Never  [  ] Past  [  ] Present     
Breast cancer [  ] Never  [  ] Past  [  ] Present     
Cervical cancer [  ] Never  [  ] Past  [  ] Present     
Ovarian cancer [  ] Never  [  ] Past  [  ] Present     
Uterine cancer [  ] Never  [  ] Past  [  ] Present     
Other cancer: _______________  [  ] Never  [  ] Past  [  ] Present     
Endometriosis [  ] Never  [  ] Past  [  ] Present     
Anovulation (lack of ovulation) [  ] Never  [  ] Past  [  ] Present     
Amenorrhea (lack of menstruation) [  ] Never  [  ] Past  [  ] Present     
Dysmenorrhea (pain during menstruation) [  ] Never  [  ] Past  [  ] Present     
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Polycystic ovary syndrome (PCOS) [  ] Never  [  ] Past  [  ] Present     
Premenstrual syndrome (PMS) [  ] Never  [  ] Past  [  ] Present     
Premenstrual dysphoric disorder (PMDD)  [  ] Never  [  ] Past  [  ] Present     
Other menstrual cycle problem:___________ [  ] Never  [  ] Past  [  ] Present     
 
49. Please list any other physical or medical conditions with which you have been diagnosed or 
treated: _______________________________________________________________________ 
 
50. Please list any other emotional or psychological conditions (including developmental and 
learning disorders) with which you have been diagnosed or treated: _______________________ 
 
51. On average, is one of your breasts larger than the other? [  ] Yes [  ] No 
 
ITEM 52 WAS FOR WOMEN WITH ONE BREAST THAT WAS LARGER THAN THE 
OTHER 
 
52. Please indicate which breast is larger:  [  ] Left [  ] Right 
 
53. What is your typical bra size (e.g., 32 back, D cup)? Back/band: ______ Cup:_______ 
Other (please specify): __________ 
 
54. Between the ages of 16 and 40, have (did) you ever noticed a milky discharge from your 
nipples (NOT including during pregnancy or recent childbirth)? [  ] Yes [  ] No 
 
55. During your menstruation years (NOT including during pregnancy), did you have a tendency 
to grow dark, course hair on your . . .  
Upper lip   [  ] Yes [  ] No  Back       [  ] Yes [  ] No 
Chin    [  ] Yes [  ] No  Belly       [  ] Yes [  ] No 
Breasts   [  ] Yes [  ] No  Upper arms  [  ] Yes [  ] No  
Chest between the breasts [  ] Yes [  ] No   Upper thighs [  ] Yes [  ] No 
 
56. What is the average length of your menstrual cycle (i.e., how many days are there from the 
first day of one period to the day before your next period)?   _______ days 
 
57. What is your average length of menstruation (i.e., how many days does your menstrual 
period or bleeding last)? ______ days 
 
59. How painful is your menstrual period?  
 








[  ] [  ] [  ] [  ] 
 
60. Check the statement that best describes your menstrual cycle:   
[  ] I have not had my period in the last three months   
[  ] Some months I get my period and some months I don’t  
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[  ] I usually get my period every month, but it is irregular and I cannot predict when it will start  
[  ] I usually get my period within two to three days of when I expect it  
[  ] My period is like clockwork; the same number of days elapse between periods  
 
61. In general, I think that the week before I get my menstrual bleeding is associated with . . .  
 










Negative effects on my physical 
health 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my physical 
health 
[  ] [  ] [  ] [  ] [  ] 
Negative effects on my 
emotional health 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my 
emotional health 
[  ] [  ] [  ] [  ] [  ] 
Negative effects on my sexual 
functioning (i.e., desire, arousal, 
and ability to orgasm) 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my sexual 
functioning (i.e., desire, arousal, 
and ability to orgasm) 
[  ] [  ] [  ] [  ] [  ] 
Increased  interest in short-term 
(sexual) relationships  
[  ] [  ] [  ] [  ] [  ] 
Decreased interest in short-term 
(sexual) relationships 
[  ] [  ] [  ] [  ] [  ] 
Increased interest in long-term 
(romantic) relationships 
[  ] [  ] [  ] [  ] [  ] 
Decreased interest in long-term 
(romantic) relationships  
[  ] [  ] [  ] [  ] [  ] 
 
62. Using the calendars above, please indicate the first day of your last/most recent menstrual 
period:  
____________________   ____________________   ____________________ 
                 Day                                Month                                  Year 
 
63. How confident are you that your last menstrual period started on the day indicated above?    
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
64. Using the calendars above, please indicate the day that you believe your next menstrual 
period will start:  
____________________   ____________________   ____________________ 
                 Day                                Month                                  Year 
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65. How confident are you that your next menstrual period will start on the day indicated above? 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
66. Are you menstruating (i.e., on your period) today?   [  ] Yes [  ] No 
 
ITEM 67 WAS FOR WOMEN CURRENTLY MENSTRUATING 
 
67. For how many days (including today) have you been menstruating? ______ days 
 
68. Are you currently taking any form of hormonal contraception (i.e., birth control pill, patch, 
injection, or hormonal intrauterine device) or non-hormonal (i.e., copper) intrauterine device?  
[  ] Yes [  ] No 
 
ITEMS 69 TO 74 WERE FOR WOMEN CURRENTLY USING CONTRACEPTION 
 
69. Please indicate the type and specific brand of contraceptive you are currently taking or using: 
 
[  ] Oral Contraceptive:                    
[  ] Alesse  [  ] Linessa  [  ] Norlevo  [  ] Seasonique  
[  ] Apri  [  ] Lo-Femenal [  ] Ortho 0.5/35 [  ] Select 1/35 
[  ] Aviane  [  ] Loestrin 1.5/30 [  ] Ortho 1/35  [  ] Synphasic                         
[  ] Brevicon 0.5/35  [  ] Marvelon   [  ] Ortho 10/11 [  ] Tri-Cyclen             
[  ] Brevicon 1/35  [  ] Micronor  [  ] Ortho 7/7/7 [  ] Tri-Cyclen Lo            
[  ] Cyclen  [  ] Min-Ovral  [  ] Ortho-Cept [  ] Triquilar                
[  ] Demulen 30  [  ] Minestrin 1/20 [  ] Portia             [  ] Yasmin                         
[  ] Demulen 50 [  ] Next Choice [  ] Seasonale  [  ] Yaz 
[  ] Other (please specify): _______ 
 
[  ] Injected Contraceptive:    [  ] Contraceptive Patch: 
[  ] Depo-Provera     [  ] Evra 
[  ] Lunelle         ] Other (Please specify): _______ 
[  ] Other (Please specify): _______  
 
  [ ] Intrauterine Device (IUD):   [  ] Vaginal Ring:  
[  ] Mirena (hormonal)     [  ] NuvaRing       
[  ] Nova-T (non-hormonal; copper)   [  ] Other (Please specify): _______ 
[  ] Flexi-T (non-hormonal; copper) 
[  ] Other (Please specify): _______ 
 
70. For how long have you been taking this particular contraceptive?    
________ years and/or _________ months and/or __________ weeks and/or _________ days 
 
71. Do you still experience a menstrual period (i.e., withdrawal bleeding during a hormone-free 
week)?   [  ] Yes [  ] No 
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72. Do you take the contraceptive continuously without a pill- or hormone-free week? For 
instance, do you skip menstrual/withdrawal bleeding by not taking any time off of the 
contraceptive?   [  ] Yes [  ] No 
 
73. On average, how frequently do you experience menstrual/withdrawal bleeding? 
Every _______ days  
 
74. In general, I believe that my current contraceptive has been associated with . . .  
 










Negative effects on my physical 
health 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my physical 
health 
[  ] [  ] [  ] [  ] [  ] 
Negative effects on my 
emotional health 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my 
emotional health 
[  ] [  ] [  ] [  ] [  ] 
Negative effects on my sexual 
functioning (i.e., desire, arousal, 
and ability to orgasm) 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my sexual 
functioning (i.e., desire, arousal, 
and ability to orgasm) 
[  ] [  ] [  ] [  ] [  ] 
Increased interest in short-term 
(sexual) relationships  
[  ] [  ] [  ] [  ] [  ] 
Decreased interest in short-term 
(sexual) relationships 
[  ] [  ] [  ] [  ] [  ] 
Increased interest in long-term 
(romantic) relationships 
[  ] [  ] [  ] [  ] [  ] 
Decreased interest in long-term 
(romantic) relationships  
[  ] [  ] [  ] [  ] [  ] 
 
ITEMS 75 AND 76 WERE FOR WOMEN USING ORAL CONTRACEPTIVES  
 
75. How often do you miss a contraceptive pill (e.g., forget to take at the usual time)?  
 




Every month Every week 
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76. What week of your current oral contraceptives pill pack are you in?  
 
Week 1 of active pills Week 2 of active pills Week 3 of active pills Pill-free/inactive or 
sugar pill week  
[  ] [  ] [  ] [  ] 
 
77. Have you ever used a (different) hormonal contraceptive or non-hormonal intrauterine device 
in the past?   [  ] Yes [  ] No 
 
ITEMS 78 to 84 WERE FOR WOMEN WHO HAD EVER USED (DIFFERENT) 
CONTRACEPTION 
 
78. Please check all types of contraceptives and specific brands that you have ever used: 
[  ] Oral Contraceptive:                    
[  ] Alesse  [  ] Linessa  [  ] Norlevo  [  ] Seasonique  
[  ] Apri  [  ] Lo-Femenal [  ] Ortho 0.5/35 [  ] Select 1/35 
[  ] Aviane  [  ] Loestrin 1.5/30 [  ] Ortho 1/35  [  ] Synphasic                         
[  ] Brevicon 0.5/35  [  ] Marvelon   [  ] Ortho 10/11 [  ] Tri-Cyclen             
[  ] Brevicon 1/35  [  ] Micronor  [  ] Ortho 7/7/7            [  ] Tri-Cyclen Lo            
[  ] Cyclen  [  ] Min-Ovral  [  ] Ortho-Cept [  ] Triquilar                
[  ] Demulen 30  [  ] Minestrin 1/20 [  ] Portia             [  ] Yasmin                         
[  ] Demulen 50 [  ] Next Choice [  ] Seasonale  [  ] Yaz 
[  ] Other (please specify): _______ 
 
[  ] Injected Contraceptive:    [  ] Contraceptive Patch: 
[  ] Depo-Provera     [  ] Evra 
[  ] Lunelle      [  ] Other (Please specify): _______ 
   ] Other (Please specify): _______  
 
[  ] Intrauterine Device (IUD):   [  ] Vaginal Ring:  
[  ] Mirena (hormonal)     [  ] NuvaRing       
[  ] Nova-T (non-hormonal; copper)   [  ] Other (Please specify): _______ 
[  ] Flexi-T (non-hormonal; copper)  
 
79. How old were you when you first started using hormonal contraception?   _______ years 
 
80. In total, how many times have you switched hormonal contraceptives (i.e., was on a 
contraceptive than went off and/or started a new contraceptive?) _______ times 
 
81. In general, I believe that my past hormonal contraceptive use has been associated with . . .  
 










Negative effects on my physical 
health 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my physical [  ] [  ] [  ] [  ] [  ] 
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health 
Negative effects on my 
emotional health 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my 
emotional health 
[  ] [  ] [  ] [  ] [  ] 
Negative effects on my sexual 
functioning (i.e., desire, arousal, 
and ability to orgasm) 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my sexual 
functioning (i.e., desire, arousal, 
and ability to orgasm) 
[  ] [  ] [  ] [  ] [  ] 
Increased interest in short-term 
(sexual) relationships  
[  ] [  ] [  ] [  ] [  ] 
Decreased interest in short-term 
(sexual) relationships 
[  ] [  ] [  ] [  ] [  ] 
Increased interest in long-term 
(romantic) relationships 
[  ] [  ] [  ] [  ] [  ] 
Decreased interest in long-term 
(romantic) relationships  
[  ] [  ] [  ] [  ] [  ] 
 
82. In general, why did you discontinue taking past hormonal contraceptives? (All that apply)  
[  ] Increase in negative mood   [  ] Decrease in negative mood 
[  ] Increase in positive mood   [  ] Decrease in positive mood  
[  ] Increase in sexual functioning  [  ] Decrease in sexual functioning 
[  ] PMS symptoms    [  ] Medical condition 
[  ] Too hard to use    [  ] Too expensive 
[  ] Desire to become pregnant   [  ] Conflict with another medication 
[  ] Short-term/sexual relationship ended [  ] Long-term/dating relationship ended 
[  ] Concerned about hormones  [  ] Other (please specify): ___________________ 
 
83. Please think about all of the different types of hormonal contraception that you have used. 
What is the total (combined) amount of time that you have taken any “continuous” hormonal 
contraception (e.g., Seasonale or other hormonal contraceptives where you skipped menstrual 
periods)?  
_____ years and/or _____ months and/or ______weeks and/or ______days 
 
84. How long has it been since you stopped taking your last (most recent) hormonal 
contraceptive? ________ years and/or _________ months and/or __________ weeks and/or 
_________ days 
 
85. Have you ever taken emergency hormonal contraception (e.g., Plan B)?    [  ] Yes [  ] No 
 
ITEMS 86 and 87 WERE FOR WOMEN WHO HAD EVER USED EMERGENCY 
CONTRACEPTION 
 
WOMEN’S REPRODUCTIVE EXPERIENCES 
   
438 
86. How many different times have you taken emergency hormonal contraception (e.g., Plan B)? 
________ times 
 
87. How long has it been since you last took emergency hormonal contraception (e.g., Plan B)?  
________ years and/or _________ months and/or __________ weeks and/or _________ days 
 
88. How old were you when you first starting menstruating (i.e., got your first menstrual period)?  
_______ years and ______ months 
 
89. Compared to other people of your sex and age, how old were you when you showed most of 




A Little Younger 
2 
About the Same Age 
3 




[  ] [  ] [  ] [  ] [  ] 
  
90. As a teenager and young adult, how did your acne/pimples compare to others your age?  

















[  ] [  ] [  ]    ] [  ] 
 
91. I believe that puberty was associated with . . .  
 










Negative effects on my physical 
health 
[  ] [  ]   [  ] [  ] [  ] 
Positive effects on my physical 
health 
[  ] [  ]   [  ] [  ] [  ] 
Negative effects on my 
emotional health 
[  ] [  ]   [  ] [  ] [  ] 
Positive effects on my 
emotional health 
[  ] [  ]   [  ] [  ] [  ] 
 
92. From birth to the age when you got your first menstrual period, were there ever any males 
living in your home(s) that were NOT biologically related to you (by blood)?   [  ] Yes [  ] No  
  
93. Are you currently pregnant?   [  ] Yes    [  ] No [  ] Maybe  
 
94. Are you currently lactating or breast feeding?   [  ] Yes  [  ] No  [  ] Maybe 
 
95. To your knowledge, have you ever been pregnant?   [  ] Yes  [  ] No  [  ] Maybe 
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ITEMS 96 to 99 WERE FOR WOMEN WHO HAD EVER BEEN PREGNANT 
 
96. How many times have you been pregnant in your lifetime?   _________ times 
 
97. How mahy ectopic (tubal) pregnancie have you had in your lifetime? ________ 
 
98. In total, how many months of your life have spent pregnant? ________ months 
 
99. In general, I believe that pregnancy (i.e., the months during which I was pregnant) was 
associated with. . .  
 










Negative effects on my physical 
health 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my physical 
health 
[  ] [  ] [  ] [  ] [  ] 
Negative effects on my 
emotional health 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my 
emotional health  
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my sexual 
functioning (i.e., desire, arousal, 
and ability to orgasm) 
[  ] [  ] [  ] [  ] [  ] 
Negative effects on my sexual 
functioning (i.e., desire, arousal, 
and ability to orgasm) 
[  ] [  ] [  ] [  ] [  ] 
Increased interest in short-term 
(sexual) relationships  
[  ] [  ] [  ] [  ] [  ] 
Decreased interest in short-term 
(sexual) relationships 
[  ] [  ] [  ] [  ] [  ] 
Increased interest in long-term 
(romantic) relationships 
[  ] [  ] [  ] [  ] [  ] 
Decreased interest in long-term 
(romantic) relationships  
[  ] [  ] [  ] [  ] [  ] 
 
100. Have you ever donated eggs/ova?   [  ] Yes [  ] No 
 
101. Have you personally ever received treatment for infertility?    
[  ] Yes (please explain): __________     [  ] No 
 
102. Have you ever given birth?   [  ] Yes [  ] No 
 
ITEMS 103 TO 109 WERE FOR WOMEN WHO HAD EVER GIVEN BIRTH 
 
104. How many times have you given birth in your lifetime?   ____________ 
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105. How many stillbirths have you had in your lifetime?   _____________ 
 
106. How many Cesarean or C- sections have you had in your lifetime?   _____________ 
 
107. In total, how many months of your life have spent breastfeeding (or lactating)? _____ 
months 
 
108. How long has it been since you last gave birth? ________ years and/or _________ months 
and/or __________ weeks and/or _________ days 
 
109. In general, I believe that postpartum period (i.e., the 6 months after the birth of each of my 
children) was associated with  . . .  
 










Negatives effects on my 
physical health 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my physical 
health 
[  ] [  ] [  ] [  ] [  ] 
Negative effects on my 
emotional health 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my 
emotional health 
[  ] [  ] [  ] [  ] [  ] 
Positive effects on my sexual 
functioning (i.e., desire, arousal, 
and ability to orgasm) 
[  ] [  ] [  ] [  ] [  ] 
Negative effects on my sexual 
functioning (i.e., desire, arousal, 
and ability to orgasm) 
[  ] [  ] [  ] [  ] [  ] 
Increased interest in short-term 
(sexual) relationships  
[  ] [  ] [  ] [  ] [  ] 
Decreased interest in short-term 
(sexual) relationships 
[  ] [  ] [  ] [  ] [  ] 
Increased interest in long-term 
(romantic) relationships 
[  ] [  ] [  ] [  ] [  ] 
Decreased interest in long-term 
(romantic) relationships  
[  ] [  ] [  ] [  ] [  ] 
 
100. Have you ever had an induced abortion?    [  ] Yes [  ] No 
 
ITEMS 111 and 12 WERE FOR WOMEN WHO HAD EVER HAD AN ABORTION 
 
111. How many induced abortions have you had? ______ 
 
112. How long has it been since you last had an induced abortion?  
________ years and/or _________ months and/or __________ weeks and/or _________ days 
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113. Have you ever had a spontaneous miscarriage?   [  ] Yes [  ] No 
 
ITEMS 114 and 115 WERE FOR WOMEN WHO HAD EVER HAD A MISCARRIAGE 
 
114. How many spontaneous abortions have you had? ______ 
 
115. How long has it been since you last had a spontaneous abortion?  
________ years and/or _________ months and/or __________ weeks and/or _________ days 
 
116. Have you started to go through natural or surgically-induced menopause?  
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Debriefing Form A 
 
Thank you for participating in Stage 1 of the Hormones & Sociosexuality Study: the Screening 
Questionnaire. You will be entered into a draw for one $50 VISA gift certificate. If applicable, 
Lakehead University students will receive 1 bonus point towards a psychology course for 
completing this stage of the study.  
 
If you are selected to participate in Stages 2 and 3 of the study, you will be contacted via e-mail 
or telephone by a research assistant in the next few weeks. If applicable, Lakehead University 
students can receive up to 2 more bonus points for completing these stages during lab sessions. 
Other Thunder Bay residents who complete Stages 2 and 3 during lab sessions at Lakehead 
University will be offered nominal compensation of up to $10 ($5 for Stage 2 and $10 for Stage 
3). All participants, including those who complete the entire study through the Internet, have the 
opportunity to be entered into a separate draw for a $50 VISA gift card for each of Stages 2 and 
3. Also, everyone who completes at least 80% of the 2- to 5-minute Daily Questionnaires across 
approximately 1 month will be entered into a draw for a $50 VISA gift card.   
 
Please be assured that your name and contact information will be removed from the Screening 
Questionnaire at the end of the study and there will be no way to identify your responses. All of 
your responses will remain completely anonymous and confidential. If you have any questions or 
concerns regarding this study, please contact Ms. Teatero or Dr. Oinonen. You may also contact 
Lakehead University’s Research Ethics Board, which has approved this study, at 807-776-7289. 




Missy Teatero, M.A. and Kirsten Oinonen, Ph.D., C. Psych.        
hormones@lakeheadu.ca; koinonen@lakeheadu.ca   
807-343-894; 807-343-8096 
 
Health, Hormones, and Behaviour Lab 
Department of Psychology 
Lakehead University 
955 Oliver Road 
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Consent Form B 
 
I have previously read and understood the Cover Letter for the Hormones & Sociosexuality 
Study conducted by Ms. Teatero and Dr. Oinonen with the Health, Hormones, & Behaviour Lab 
in the Department of Psychology at Lakehead University. I agree to participate in this research 
and understand the following:  
 
1. I have been selected to participate in Stages 2 and 3 of this study. This involves online Daily 
Questionnaires (sent via e-mail; 2- to 5-minutes each) as well as two Phase Questionnaires (sent 
via e-mail or, if possible, completed during separate lab sessions; about 1 hour each) across 
approximately 1 month.  
2. If I am selected and able to attend lab sessions, body measurements will be taken by a female 
researcher and I may be asked to provide saliva samples for hormone analysis. Also, I may be 
invited to use urine hormone detection strips (5 minutes each) for about 5 consecutive days, as 
specified by the researchers.  
3. I will be asked to respond to questions of a personal nature that include, but are not limited to, 
the following: health, reproductive experiences like puberty, mood, personality, sexual attitudes 
and behaviours, and romantic relationships.  
4. I am a volunteer, can withdraw at any time from this study, and may choose not to complete 
question in the study.  
5. There are no known serious risks in involved in participating in this study.  
6. Benefits of participation may include: (a) an appreciation of research on hormones, health, and 
sexual attitudes and behaviours, (b) an opportunity to contribute to science, (c) up to 3 more 
bonus points for psychology students at Lakehead University or nominal remuneration of up to 
$15 for lab sessions, and (d) entry in up to 3 more draws for $50 VISA gift cards.  
7. I will remain anonymous in any publications or presentations of research findings. All data 
will remain confidential and will only be accessed by researchers who have been trained in 
research ethics. At the end of the study, the data I have provided will be associated with a 
participant number, and not my contact information or any other identifying information.  
8. The data will be securely stored for at least 5 years by Dr. Oinonen at Lakehead.  
9. I may contact the researchers if I would like to receive a summary of the findings at the end of 
the study.  
 
By providing any information in the following questionnaire, I agree to the above. 
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Phase Questionnaire  
 
Throughout this entire questionnaire, please respond based on your current experiences, feelings, 




1. What time did you wake up today? _______ 
 
2. Below is a list of physical, emotional, and sexual experiences that can be positive or negative. 
Please indicate the extent to which you have experienced each item in the past 48 hours (i.e., 
over the past 2 days). If you have not engaged in sexual activity in the past 48 hours, please 
imagine how you would respond to the sexual items if you had engaged in sexual activity.  










Anxiety or worry  [  ] [  ] [  ] [  ] [  ] 
Loneliness [  ] [  ] [  ] [  ] [  ] 
Physical health [  ] [  ] [  ] [  ] [  ] 
Energized/active  [  ] [  ] [  ] [  ] [  ] 
Feeling down, sad, or depressed  [  ] [  ] [  ] [  ] [  ] 
Difficulty becoming aroused with 
others or the thought of others 
(excluding primary partner) 
[  ] [  ] [  ] [  ] [  ] 
Sleeping less than usual [  ] [  ] [  ] [  ] [  ] 
Unhappy with food preferences [  ] [  ] [  ] [  ] [  ] 
Leg cramps [  ] [  ] [  ] [  ] [  ] 
Feeling great or special  [  ] [  ] [  ] [  ] [  ] 
Regular bowel movements [  ] [  ] [  ] [  ] [  ] 
Less breakthrough bleeding/spotting [  ] [  ] [  ] [  ] [  ] 
Breast size decrease [  ] [  ] [  ] [  ] [  ] 
Physical pleasure/comfort during 
sexual activity  
[  ] [  ] [  ] [  ] [  ] 
Achievement/productivity in work or 
school 
[  ] [  ] [  ] [  ] [  ] 
Not feeling like self  [  ] [  ] [  ] [  ] [  ] 
Connectedness/support [  ] [  ] [  ] [  ] [  ] 
Abdominal cramps or discomfort [  ] [  ] [  ] [  ] [  ] 
Lack of interest or enjoyment in 
usual activities 
[  ] [  ] [  ] [  ] [  ] 
Unhappy with weight   [  ] [  ] [  ] [  ] [  ] 
Affectionate/intimate with others  [  ] [  ] [  ] [  ] [  ] 
Joint or muscle agility (i.e., ease of 
movement)  
[  ] [  ] [  ] [  ] [  ] 
Focused [  ] [  ] [  ] [  ] [  ] 
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Easy to have an orgasm with others 
or the thought of others (excluding 
primary partner)  
[  ] [  ] [  ] [  ] [  ] 
Feeling happy, elated, or euphoric [  ] [  ] [  ] [  ] [  ] 
Emotional calmness/stability [  ] [  ] [  ] [  ] [  ] 
Vaginal dryness [  ] [  ] [  ] [  ] [  ] 
High self-esteem  [  ] [  ] [  ] [  ] [  ] 
Difficulty having an orgasm through 
masturbation (alone) 
[  ] [  ] [  ] [  ] [  ] 
Content with weight [  ] [  ] [  ] [  ] [  ] 
Mental relaxation/calm [  ] [  ] [  ] [  ] [  ] 
Sexual desire/drive for others 
(excluding primary partner) 
[  ] [  ] [  ] [  ] [  ] 
General physical comfort [  ] [  ] [  ] [  ] [  ] 
Not enough sleep [  ] [  ] [  ] [  ] [  ] 
Clumsiness/minor accidents [  ] [  ] [  ] [  ] [  ] 
Increased appetite [  ] [  ] [  ] [  ] [  ] 
Sweating [  ] [  ] [  ] [  ] [  ] 
Uninterrupted (peaceful) sleep [  ] [  ] [  ] [  ] [  ] 
Unhappy with appetite [  ] [  ] [  ] [  ] [  ] 
Unhappy with food intake [  ] [  ] [  ] [  ] [  ] 
Emotional irritability/sensitivity [  ] [  ] [  ] [  ] [  ] 
Sleeping more than usual [  ] [  ] [  ] [  ] [  ] 
Impairment in work or school [  ] [  ] [  ] [  ] [  ] 
Easy to have an orgasm through 
masturbation (alone) 
[  ] [  ] [  ] [  ] [  ] 
Feeling capable/competent [  ] [  ] [  ] [  ] [  ] 
Acne/pimples [  ] [  ] [  ] [  ] [  ] 
Feeling in control [  ] [  ] [  ] [  ] [  ] 
Healthy bowel movements [  ] [  ] [  ] [  ] [  ] 
Thoughtfulness [  ] [  ] [  ] [  ] [  ] 
Self-blame/critical [  ] [  ] [  ] [  ] [  ] 
Feeling unoriginal or plain [  ] [  ] [  ] [  ] [  ] 
Flatulence/gassy [  ] [  ] [  ] [  ] [  ] 
Please with body shape/size [  ] [  ] [  ] [  ] [  ] 
Mood stability (consistent mood) [  ] [  ] [  ] [  ] [  ] 
Disinterest in sexual activity with 
others (excluding primary partner) 
[  ] [  ] [  ] [  ] [  ] 
Hydrated [  ] [  ] [  ] [  ] [  ] 
Breast size increase  [  ] [  ] [  ] [  ] [  ] 
Eating more than usual [  ] [  ] [  ] [  ] [  ] 
Food aversions [  ] [  ] [  ] [  ] [  ] 
Looking forward to a bright future [  ] [  ] [  ] [  ] [  ] 
Easy to become aroused with others 
or the thought of others (excluding 
primary partner) 
[  ] [  ] [  ] [  ] [  ] 
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A strong back [  ] [  ] [  ] [  ] [  ] 
Difficulty becoming aroused for 
masturbation (alone) 
[  ] [  ] [  ] [  ] [  ] 
Even facial skin tone [  ] [  ] [  ] [  ] [  ] 
Easy to become aroused for 
masturbation (alone) 
[  ] [  ] [  ] [  ] [  ] 
Crying [  ] [  ] [  ] [  ] [  ] 
Feeling thinner than usual [  ] [  ] [  ] [  ] [  ] 
Facial hair growth [  ] [  ] [  ] [  ] [  ] 
Negative thoughts about the future 
(pessimism) 
[  ] [  ] [  ] [  ] [  ] 
Headaches/migraines [  ] [  ] [  ] [  ] [  ] 
Decreased appetite [  ] [  ] [  ] [  ] [  ] 
Unhappy with breast size [  ] [  ] [  ] [  ] [  ] 
Clear complexion/skin [  ] [  ] [  ] [  ] [  ] 
Facial skin discolouration (i.e., 
colour blotches on face) 
[  ] [  ] [  ] [  ] [  ] 
Feeling bigger than usual [  ] [  ] [  ] [  ] [  ] 
Pleased with breast size [  ] [  ] [  ] [  ] [  ] 
Pain/discomfort during sexual 
activity 
[  ] [  ] [  ] [  ] [  ] 
Low self-esteem [  ] [  ] [  ] [  ] [  ] 
Stomach comfort [  ] [  ] [  ] [  ] [  ] 
Content with appetite [  ] [  ] [  ] [  ] [  ] 
Fatigue/lack of energy  [  ] [  ] [  ] [  ] [  ] 
Painful or tender breasts [  ] [  ] [  ] [  ] [  ] 
Impulsivity [  ] [  ] [  ] [  ] [  ] 
Interest or enjoyment in usual 
activities 
[  ] [  ] [  ] [  ] [  ] 
Bloating/swelling  [  ] [  ] [  ] [  ] [  ] 
Sense of physical well-being [  ] [  ] [  ] [  ] [  ] 
Avoidant of intimacy/affection [  ] [  ] [  ] [  ] [  ] 
Disinterest in masturbation (alone)  [  ] [  ] [  ] [  ] [  ] 
Disrupted sleep [  ] [  ] [  ] [  ] [  ] 
Content with food intake  [  ] [  ] [  ] [  ] [  ] 
Vaginal lubrication [  ] [  ] [  ] [  ] [  ] 
Sociable (desire to be around others) [  ] [  ] [  ] [  ] [  ] 
Eating less than usual [  ] [  ] [  ] [  ] [  ] 
Concern about body shape/size [  ] [  ] [  ] [  ] [  ] 
Food cravings [  ] [  ] [  ] [  ] [  ] 
Healthy digestion [  ] [  ] [  ] [  ] [  ] 
Joint or muscle stiffness [  ] [  ] [  ] [  ] [  ] 
Difficulty concentrating  [  ] [  ] [  ] [  ] [  ] 
Strong and nimble legs [  ] [  ] [  ] [  ] [  ] 
Mood lability (mood swings)  [  ] [  ] [  ] [  ] [  ] 
Calm intestinal track [  ] [  ] [  ] [  ] [  ] 
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Breakthrough bleeding/spotting [  ] [  ] [  ] [  ] [  ] 
Good judgment or rational [  ] [  ] [  ] [  ] [  ] 
Content with amount of sleep  [  ] [  ] [  ] [  ] [  ] 
Jealous of other women [  ] [  ] [  ] [  ] [  ] 
Content with food preferences [  ] [  ] [  ] [  ] [  ] 
Nausea or vomiting [  ] [  ] [  ] [  ] [  ] 
Excitement and enthusiasm  [  ] [  ] [  ] [  ] [  ] 
Difficulty falling asleep  [  ] [  ] [  ] [  ] [  ] 
Constipation [  ] [  ] [  ] [  ] [  ] 
Please with self compared to other 
women 
[  ] [  ] [  ] [  ] [  ] 
Decrease in facial hair  [  ] [  ] [  ] [  ] [  ] 
Heartburn or indigestion [  ] [  ] [  ] [  ] [  ] 
Feeling out of control [  ] [  ] [  ] [  ] [  ] 
Difficulty having an orgasm with 
others or the thought of others 
(excluding primary partner) 
[  ] [  ] [  ] [  ] [  ] 
Unsociable (desire to be alone) [  ] [  ] [  ] [  ] [  ] 
Smiling [  ] [  ] [  ] [  ] [  ] 
Clear-headedness [  ] [  ] [  ] [  ] [  ] 
Desire/drive for masturbation (alone) [  ] [  ] [  ] [  ] [  ] 
Physical grace/motor coordination [  ] [  ] [  ] [  ] [  ] 
Backache [  ] [  ] [  ] [  ] [  ] 
Easy falling asleep [  ] [  ] [  ] [  ] [  ] 
Poor judgment or irrational [  ] [  ] [  ] [  ] [  ] 
Diarrhea [  ] [  ] [  ] [  ] [  ] 
Feeling like self [  ] [  ] [  ] [  ] [  ] 
Comfort in breast area [  ] [  ] [  ] [  ] [  ] 
General aches and pains [  ] [  ] [  ] [  ] [  ] 
Restlessness [  ] [  ] [  ] [  ] [  ] 
 
3. This scale consists of a number of words that describe different feelings and emotions. Read 
each item and then mark the appropriate answer. Indicate to what extent you have felt this way in 
the past 48 hours (i.e., over the past 2 days), including how you feel now.   
 
 Very slightly  














Interested [  ] [  ] [  ] [  ] [  ] 
Distressed [  ] [  ] [  ] [  ] [  ] 
Excited [  ] [  ] [  ] [  ] [  ] 
Upset [  ] [  ] [  ] [  ] [  ] 
Strong [  ] [  ] [  ] [  ] [  ] 
Guilty [  ] [  ] [  ] [  ] [  ] 
Scared [  ] [  ] [  ] [  ] [  ] 
Enthusiastic [  ] [  ] [  ] [  ] [  ] 
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Proud [  ] [  ] [  ] [  ] [  ] 
Irritable [  ] [  ] [  ] [  ] [  ] 
Alert [  ] [  ] [  ] [  ] [  ] 
Ashamed [  ] [  ] [  ] [  ] [  ] 
Inspired [  ] [  ] [  ] [  ] [  ] 
Nervous [  ] [  ] [  ] [  ] [  ] 
Attentive [  ] [  ] [  ] [  ] [  ] 
Jittery [  ] [  ] [  ] [  ] [  ] 
Active [  ] [  ] [  ] [  ] [  ] 
Afraid [  ] [  ] [  ] [  ] [  ] 
Hostile [  ] [  ] [  ] [  ] [  ] 
Determined [  ] [  ] [  ] [  ] [  ] 
 























Compared to how 
you normally feel? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Compared to others 
your age and sex? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
5. Read each statement and indicate the extent to which it describes how you feel now as well as 
your feelings and experiences in the past 48 days (i.e., over the past 2 days).  
 
 False, 




















Does your mood often go up 
and down? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Do you ever feel “just 
miserable “for no reason? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Are you an irritable person?  [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Are your feelings hurt easily? [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Do you often feel “fed-up”? [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Would you call yourself a 
nervous person? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Are you a worrier? [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Would you call yourself a 
tense or ‘highly-strung’? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Do you worry too long after 
an embarrassing experience? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Do you suffer from ‘nerves’ [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Do you often feel lonely? [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Are you often troubled about [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
WOMEN’S REPRODUCTIVE EXPERIENCES 
   
449 
feelings of guilt? 
 
6. To what extent to which do you wish to avoid pregnancy or having a baby at the present time?  
 










[  ] [  ] [  ] [  ] [  ] 
 
7. Are you currently taking an oral contraceptive (i.e., the birth control pill)? [  ] Yes [  ] No  
 
ITEM 8 AND 9 WERE FOR WOMEN USING ORAL CONTRACEPTION 
 
8. What week of your current pill pack are you in?  
 
Week 1 of active pills Week 2 of active pills Week 3 of active pills Pill-free/inactive or 
sugar pill week  
[  ] [  ] [  ] [  ] 
 
9. How many pills have you missed (e.g., forgot to take at the usual time) in the current week of 
your pill pack? _______ pills  
 
ITEM 10 WAS FOR WOMEN NOT USING ORAL CONTRACEPTION 
 
10. Are you currently using any other form of hormonal contraception (e.g., patch, injection, 
vaginal ring) or non-hormonal (copper) intrauterine device?   [  ] Yes [  ] No 
 
11. Has there been a change in your use/type of hormonal contraception or non-hormonal 
(copper) intrauterine device since the last questionnaire? That is, did you stop using, begin using, 
or switch to a different contraceptive?   [  ] Yes [  ] No 
 
ITEMS 12 FOR PARTICIPANTS WHO STARTED USING A NEW CONTRACEPTIVE 
SINCE THE LAST QUESTIONNAIRE THEY COMPLETED FOR THE STUDY 
 
12. Please select the specific type and brand of your new contraceptive:  
 
[  ] Oral Contraceptive:                    
[  ] Alesse  [  ] Linessa  [  ] Norlevo  [  ] Seasonique  
[  ] Apri  [  ] Lo-Femenal [  ] Ortho 0.5/35 [  ] Select 1/35 
[  ] Aviane  [  ] Loestrin 1.5/30 [  ] Ortho 1/35  [  ] Synphasic                         
[  ] Brevicon 0.5/35  [  ] Marvelon   [  ] Ortho 10/11 [  ] Tri-Cyclen             
[  ] Brevicon 1/35  [  ] Micronor  [  ] Ortho 7/7/7            [  ] Tri-Cyclen Lo            
[  ] Cyclen  [  ] Min-Ovral   [  ] Ortho-Cept [  ] Triquilar                
[  ] Demulen 30  [  ] Minestrin 1/20 [  ] Portia             [  ] Yasmin                         
[  ] Demulen 50 [  ] Next Choice [  ] Seasonale  [  ] Yaz 
[  ] Other (please specify): _______ 
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[  ] Injected Contraceptive:    [  ] Contraceptive Patch: 
[  ] Depo-Provera     [  ] Evra 
[  ] Lunelle      [  ] Other (Please specify): _______ 
[  ] Other (Please specify): _______  
 
[  ] Intrauterine Device (IUD):   [  ] Vaginal Ring:  
[  ] Mirena (hormonal)     [  ] NuvaRing       
[  ] Nova-T (non-hormonal; copper)   [  ] Other (Please specify): _______ 
[  ] Flexi-T (non-hormonal; copper)  
 
ITEM 13 WAS FOR WOMEN CURRENTLY USING HORMONAL CONTRACEPTION 
 
13. Are you currently taking your hormonal contraceptive continuously? For instance, do you 
skip menstrual periods by not taking any time off of the contraceptive?   [  ] Yes  [  ] No 
 
ITEM 14 WAS FOR WOMEN WHO STOPPED TAKING A CONTRACEPTIVE OR 
SWITCHED FROM ONE CONTRACEPTIVE TO ANOTHER  
 
14. Why did you stop taking your contraceptive? (All that apply)  
[  ] Increase in negative mood   [  ] Decrease in negative mood 
[  ] Increase in positive mood   [  ] Decrease in positive mood  
[  ] Increase in sexual functioning  [  ] Decrease in sexual functioning 
[  ] PMS symptoms    [  ] Medical condition 
[  ] Too hard to use    [  ] Too expensive 
[  ] Desire to become pregnant   [  ] Conflict with another medication 
[  ] Short-term/sexual relationship ended [  ] Long-term/dating relationship ended 
[  ] Concerned about hormones   [  ] Other (please specify): ___________________ 
 
ITEM 15 WAS FOR WOMEN WHOSE CONTRACEPTIVE STATUS CHANGED SINCE 
THE LAST QUESTIONNAIRE THEY COMPLETED FOR THE STUDY 
 
15. Using the calendars above, when did this change occur?  
____________________   ____________________   ____________________ 
                 Day                                Month                                  Year 
 
16. Are you menstruating (i.e., on your period) today?    [  ] Yes            [  ] No 
 
ITEM 17 WAS FOR WOMEN CURRENTLY MENSTRUATING 
 
17. For how many days (including today) have you been menstruating? ________ days 
 
18. In the past 48 hours (i.e., over the past 2 days), how many drinks of alcohol have you had? 
_______drinks  
 
19. In the past 48 hours (i.e., over the past 2 days), how many times have you used recreational 
drugs? ______ times  
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20. Has there been any change to your relationship status since the last questionnaire?  
[  ] Yes [  ] No  
 
ITEM 21 WAS FOR WOMEN WHOSE RELATIONSHIP STATUS CHANGED SINCE THE 
LAST QUESTIONNAIRE THEY COMPLETED FOR THE STUDY 
 
21. Please check all that apply: 
[  ] Long-term relationship ended  [  ] Short-term or sexual relationship ended 
[  ] Potential long-term relationship began [  ] Short-term or sexual relationship began 
[  ] Other (please specify): _______________________ 
 
22. Are you currently pregnant?    [ ] Yes  [ ] No  [ ] Maybe  
 
Relationships and Sociosexuality 
 
23. Do you currently have a primary partner?   [  ] Yes [  ] No 
 
ITEMS 24 TO 31 WERE FOR WOMEN IN A RELATIONSHIP 
 
24. Based on the past 48 hours (i.e., the past 2 days), I think that my partner has shown the 
following traits . .  .   
                  


















Attractiveness [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Masculinity [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Femininity [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Naturally smells 
good 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Healthiness  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Social status [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Parenting qualities [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Intelligence [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
25. Please respond based on how feel now as well as your feelings and behaviours in the past 48 
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26. Please respond to the following questions about your current primary partner based on how 

























How satisfied are you with your relationship? [  ] [  ] [  ] [  ]    ] [  ] [  ] 
How content are you with your relationship? [  ] [  ] [  ] [  ]    ] [  ] [  ] 
How happy are you with your relationship? [  ] [  ] [  ] [  ]    ] [  ] [  ] 
How committed are you to your relationship? [  ] [  ] [  ] [  ]    ] [  ] [  ] 
How dedicated are you to your relationship? [  ] [  ] [  ] [  ]    ] [  ] [  ] 
How devoted are you to your relationship? [  ] [  ] [  ] [  ]    ] [  ] [  ] 
How intimate is your relationship? [  ] [  ] [  ] [  ]    ] [  ] [  ] 
How close is your relationship? [  ] [  ] [  ] [  ]    ] [  ] [  ] 
How connected are you to your partner [  ] [  ] [  ] [  ]    ] [  ] [  ] 
How much do you trust your partner? [  ] [  ] [  ] [  ]    ] [  ] [  ] 
How much can you count on your partner? [  ] [  ] [  ] [  ]    ] [  ] [  ] 
How dependable is your partner? [  ] [  ] [  ] [  ]    ] [  ] [  ] 
 
27. Please respond to the following questions about your current primary partner based on how 
you feel now as well as your feelings and behaviours in the past 48 hours (i.e., over the past 2 
days). If you have not had sexual intercourse with your partner, please respond based on sexual 























I wish my partner was more 
sensitive to my physical needs 
when we make love 
[   ] [   ] [   ] [   ] [   ] [   ] [   ] 
I wish my partner initiated sex more 
often 
[   ] [   ] [   ] [   ] [   ] [   ] [   ] 
I wish my partner was more 
affectionate during foreplay 
[   ] [   ] [   ] [   ] [   ] [   ] [   ] 
I wish my partner was a better lover [   ] [   ] [   ] [   ] [   ] [   ] [   ] 
I wish my partner could 
communicate more openly about 
what he wants in our sexual 
encounters 
[   ] [   ] [   ] [   ] [   ] [   ] [   ] 
I wish my partner would make me 
feel more attractive 
[   ] [   ] [   ] [   ] [   ] [   ] [   ] 
I wish I were less inhibited when I 
make love 
[   ] [   ] [   ] [   ] [   ] [   ] [   ] 
I wish my partner was more loving 
and caring when we make love 
[   ] [   ] [   ] [   ] [   ] [   ] [   ] 
I wish my partner was more patient [   ] [   ] [   ] [   ] [   ] [   ] [   ] 
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when we make love 
I wish my partner was more 
romantic when we make love 
[   ] [   ] [   ] [   ] [   ] [   ] [   ] 
 
28. Below is a list of sexual experiences that can be positive or negative. Please indicate the 
extent to which you have had each experience in the past 48 hours (i.e., over the past 2 days). If 
you have not engaged in sexual activity in the past 48 hours, please imagine how you would 
respond to the sexual items if you had engaged in sexual activity. 
 










Sexual desire/drive for primary 
partner 
[  ] [  ] [  ] [  ] [  ] 
Disinterest in sexual activity with 
primary partner  
[  ] [  ] [  ] [  ] [  ] 
Difficulty becoming aroused with 
primary partner  
[  ] [  ] [  ] [  ] [  ] 
Easy to become aroused with 
primary partner  
[  ] [  ] [  ] [  ] [  ] 
Difficulty having an orgasm with 
primary partner  
[  ] [  ] [  ] [  ] [  ] 
Easy to have an orgasm with 
primary partner  
[  ] [  ] [  ] [  ] [  ] 
 
29. In the past 48 hours (i.e., over the past 2 days), I have . . .  
 






A few times 
 
2 
More than a 
few times 
3 
Felt strong sexual attraction 
toward my partner 
[  ] [  ]    ] [  ] 
Fantasized about sex with my 
partner 
[  ] [  ]    ] [  ] 
Engaged in sexual activity with 
my partner 
[  ] [  ]    ] [  ] 
 
30. If you have engaged in sexual activity in the past 48 hours (i.e., over the past 2 days) with 
your partner at least once, please indicate how many times the activity was initiated by:   
You only:   _______  
Your partner only:  _______  
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31. In the past 48 hours (i.e., over the past 2 days), how much has your partner . . .  
 



























Given you attention [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Expressed 
commitment to you 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Expressed feelings 
of love to you 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Expressed sexual 
attraction to you 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 




[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Monopolized your 
time 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Acted possessive of 
you 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
32. Based on how you are feeling now as well as your feelings and behaviours in the past 48 
hours (i.e., over the past 2 days), how jealous would you be if your primary partner cheated on 
you with a . . . (If you do not have a primary partner, please imagine how jealous you would be) 
 


































[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
33. Read each statement and decide if it is an accurate statement about you. Give your own 
opinion of yourself. 
 False, Not 






My favourite poet is Robert Kertezc [  ] [  ] [  ] [  ] 
Sometimes I get ads in the mail I don’t 
really want 
[  ] [  ] [  ] [  ] 
My favourite sports event on television is 
the high jump 
[  ] [  ] [  ] [  ] 
Most people would rather win than lose [  ] [  ] [  ] [  ] 
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34. Based on the past 48 hours (i.e., the past 2 days), I think that I have shown the following 
traits in the past 48 hours (i.e., the past 2 days) . . .   
 


















Attractiveness [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Masculinity [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Femininity [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Naturally 
smell good 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Healthiness  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Social status [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Parenting 
qualities 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Intelligence [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
35. Based on how you are feeling now as well as your feelings and experiences in the past 48 























I am sexually attracted 
to 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am interested in 
sexual behaviour with 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
36. Based on how you feel now as well as your feelings and behaviours in the past 48 hours (i.e.., 













I really enjoy caring for other people [  ] [  ] [  ] [  ] 
It is hard for me to see why some things upset 
people so much 
[  ] [  ] [  ] [  ] 
I find it easy to put myself in somebody else’s 
shoes 
[  ] [  ] [  ] [  ] 
If anyone asked me if I liked their haircut, I would 
reply truthfully, even if I did not like it 
[  ] [  ] [  ] [  ] 
Other people tell me I am good at understanding 
how they are feeling and what they are thinking 
[  ] [  ] [  ] [  ] 
I am able to make decisions without being 
influenced by people’s feelings 
[  ] [  ] [  ] [  ] 
Other people tell me I am good at understanding 
how they are feeling and what they are thinking 
[  ] [  ] [  ] [  ] 
I usually stay emotionally detached when watching [  ] [  ] [  ] [  ] 
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a film 
I can tell if someone is masking their true emotion [  ] [  ] [  ] [  ] 
I tend to get emotionally involved with a friend’s 
problems 
[  ] [  ] [  ] [  ] 
I find it difficult to read and understand things [  ] [  ] [  ] [  ] 
I find it difficult to learn how to programme video 
recorders 
[  ] [  ] [  ] [  ] 
I find it easy to grasp exactly how offs work in 
betting 
[  ] [  ] [  ] [  ] 
I do not enjoy gamed that involve a high degree of 
strategy (e.g., chess, Risk, Games Workshop) 
[  ] [  ] [  ] [  ] 
I can remember large amounts of information 
about a topic that interests me (e.g., flags of the 
world, airline logos) 
[  ] [  ] [  ] [  ] 
I am fascinated by how machines work [  ] [  ] [  ] [  ] 
I know very little about the different stages of the 
legislation process in my country 
[  ] [  ] [  ] [  ] 
I can easily visualize how the motorways in my 
region link up 
[  ] [  ] [  ] [  ] 
I do not enjoy in-depth political discussions [  ] [  ] [  ] [  ] 
If I were buying a stereo, I would want to know 
about its precise technical features 
[  ] [  ] [  ] [  ] 
 
37. In the past 48 hours (i.e., over the past 2 days), I have. . .  
 









More than a 
few times 
3 
Felt strong feelings of sexual desire in 
general 
[  ] [  ] [  ] [  ] 
Fantasized about sex with a stranger or 
acquaintance 
[  ] [  ] [  ] [  ] 
Fantasized about sex with a past partner [  ] [  ] [  ] [  ] 
Felt strong sexual attraction toward 
someone (other than my primary 
partner) 
[  ] [  ] [  ] [  ] 
Felt sexually aroused by the sight of 
someone very physically attractive 
(other than my primary partner) 
 
[  ] [  ] [  ] [  ] 
Felt sexually aroused by the scent of 
someone (other than my primary 
partner) 
[  ] [  ] [  ] [  ] 
Flirted with someone (other than my 
primary partner) 
[  ] [  ] [  ] [  ] 
Engaged in sexual activity with [  ] [  ] [  ] [  ] 
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someone (other than my primary 
partner) 
Had fantasies about having sex with 
someone you are not in a committed 
romantic relationship with 
[  ] [  ] [  ] [  ] 
Experienced sexual arousal when you 
were in contact with someone you are 
not in a committed romantic 
relationship with 
[  ] [  ] [  ] [  ] 
Had spontaneous fantasies about 
having sex with someone you just met 
[  ] [  ] [  ] [  ] 
Masturbated (alone) [  ] [  ] [  ] [  ] 
 
38. If you have engaged in sexual activity with someone (other than a current primary partner) in 
the past 48 hours (i.e., over the past 2 days), please indicate how many times the activity was 
initiated by:   
You only:   _______  
A partner only:  _______  
Both equally:   _______  
 
39. Please respond to the following questions:  
 
 0 1 2 3 4 5-6 7-9 10-19 20 or 
more 
During your entire life, with 
how many partners have 
you had sexual intercourse 
(sex)? 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
With how many different 
partners have you had sex 
within the past 12 months 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
With how many differ 
partners have you had sex 
on one and only one 
occasion?  
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
With how many different 
partners have you had sex 
without having an interest in 
a long-term committed 
relationship with this 
person?  
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40. Please respond honestly to the following general questions based on how you feel now as 






























 1 2 3 4 5 6 7 8 9 
I would like to have a romantic relationship 
that lasts forever 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I would never consider having a brief sexual 
relationship with someone 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I would have to be closely attached to 
someone (both emotionally and 
psychologically) before I could feel 
comfortable and fully enjoy having sex with 
him or her 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
For me, sex without love is OK [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I can see myself settling down romantically 
with one special person 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I would consider having sex with a stranger 
if I could be assured that it was safe and he 
was attractive to me 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I can imagine myself being comfortable and 
enjoying “casual” sex with different partners 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Sometimes I would rather have sex with 
someone I did not care about 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I can imagine myself enjoying a brief sexual 
encounter with someone I find very 
attractive 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I believe in taking sexual opportunities 
when I find them 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am interested in maintaining a long-term 
relationship with someone special. 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I could easily imagine myself enjoying one 
night of sex with someone I would never see 
again. 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I can easily see myself engaging in a long-
term relationship with someone special. 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Long-term romantic relationships are not for 
me. 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Finding a long-term romantic partner is not 
important for me. 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I could enjoy sex with someone I find highly 
desirable even if that person does not have 
long-term potential. 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
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I hope to have a romantic relationship that 
lasts the rest of my life. 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I do not want to have sex with a person until 
I am sure that we will have a long-term 
serious relationship 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
41. Please respond to the following statements based on you feel now as well as your feelings 
and experiences in the past 48 hours (i.e., over the past 2 days). If you have not engaged in 
sexual activity in the past 48 hours, please imagine how you would respond to the sexual items if 























I am satisfied with the frequency with which I 
have sexual intercourse 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am satisfied that my personal needs are 
completely met during lovemaking 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am satisfied with the amount of time that my 
partner and I spend together when we make 
love 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am satisfied with the spontaneity of my 
lovemaking. 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am satisfied with my ability to make my 
physical needs known to my partner(s) 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am satisfied with the frequency with which I 
have orgasms 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am satisfied with the amount of time my 
partner and I spend together immediately after 
intercourse 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am satisfied with the quality of the time my 
partner(s) and I spend together immediately 
after intercourse 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am satisfied with the amount of foreplay 
involved in my lovemaking 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am satisfied with the importance my partner 
(s) places on lovemaking in the relationship 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am satisfied with the times of day and night 
when my partner(s) and I usually make love 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I feel that nothing is lacking in my sex life [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am satisfied with my capacity for enjoying sex [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Generally, I am satisfied with my sex life [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
42. To what extent do you find members of the opposite sex with tattoos to be attractive based 
on how you feel now and how you have been feeling in the past 48 hours (i.e., the past 2 days)?  
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[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
43. To what extent do you find members of the opposite sex with piercings based on how you 
feel now and how you have been feeling in the past 48 hours (i.e., the past 2 days)? 
 



























[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
44. Consider the following hypothetical situation:  
Your life is exactly as it is right now. Imagine that you just met someone new that you think 
would be ideal or attractive for a short-term relationship. A short-term relationship is primarily 
sexual in nature and tends not to last very long. Examples of this type of relationship include 
someone you may have a sexual affair with and someone you may have a one-night stand with. 
Based on how you feel now as well as your feelings and behaviour in the past 48 hours (i.e., over 
the past 2 days), how likely are you to . . .  
 





























 1 2 3 4 5 6 7 9 
Give this person your phone number if asked  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Ask this person for their number [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Return a smile or eye contact from this person [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Smile, or initiate eye contact with, this person  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Dance with this person if asked  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Ask this person to dance with you [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Allow this person to buy you a drink [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Buy this person a drink or ask this person to buy 
you a drink 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Allow this person to kiss you [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Initiate kissing with this person [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Accept a ride home from this person if offered [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Offer this person a ride home or ask this person 
for a ride home 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Allow this person to initiate any sexual activity [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Initiate any sexual activity with this person [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Allow this person to initiate sex [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Initiate sex with this person [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
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45. Based on how you feel now as well as your feeling and behaviours in the past 48 hours (i.e., 
over the past 2 days), how interested in a short-term (sexual) relationship are you?    
 



























[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
46. Consider the following hypothetical situation:   
Your life is as it is now. Imagine that you just met someone new that you would think would be 
ideal or attractive for a long-term relationship. A long-term relationship involves commitment 
as well as an emotional connection. Examples of this type of relationship would include someone 
you may want to move in with, someone you may consider leaving a current partner to be with, 
and someone you may wish to marry at some point. Based on how you feel now as well as your 
feelings and behaviour in the past 48 hours (i.e., over the past 2 days), how likely are you to . . . 
 




























 1 2 3 4 5 6 7 9 
Give this person your phone number if asked  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Ask this person for their number? [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Return a smile or eye contact from this person [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Smile  at, or initiate eye contact with, this person  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Dance with this person if asked  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Ask this person to dance with you [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Allow this person to buy you a drink [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Buy this person a drink or ask this person to buy 
you a drink 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Allow such a person to kiss you [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Initiate kissing with this person [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Accept a ride home from this person if offered [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Offer this person a ride home or ask this person 
for a ride home 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Allow this person to initiate any sexual activity [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Initiate any sexual activity with this person [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Allow this person to initiate sex [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
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47. Based on how you feel now as well as your feelings and behaviours in the past 48 hours (i.e., 
over the past 2 days), how interested are you in a long-term (romantic) relationship? 
 




















[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
48. Read each statement and decide if it is an accurate statement about you. Give your own 
opinion of yourself. 
 False, not 






My favourite hobbies are archery and 
stamp collecting 
[  ] [  ] [  ] [  ] 
I don’t like to buy things that are 
overpriced  
[  ] [  ] [  ] [  ] 
Most people look forward to a trip to the 
dentist 
[  ] [  ] [  ] [  ] 
In my free time I might read, watch TV, or 
just relax 
[  ] [  ] [  ] [  ] 
 
 
For each of the following four images, please imagine that the person pictured is now around 
your age and complete the ratings that follow based on how you feel now as well as your feelings 
and behaviours in the past 48 hours (i.e., over the past 2 days).  
 
Note that in the electronic questionnaire items 49 to 51 were presented four times, once for each 
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49.  How likely would you be to . . .  
 




















[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
 1 2 3 4 5 6 7 9 
Give this person your phone number if asked  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Ask such this person for their number? [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Return a smile or eye contact from this person [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Smile at, or make eye contact with, this person  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Dance with such this person if asked  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Ask this person to dance with you [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Allow this person to buy you a drink [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Buy this person a drink or ask this person to buy 
you a drink 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Allow such a person to kiss you [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Initiate kissing with this person [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Accept a ride home from such a person if offered [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Offer this person a ride home or ask this person 
for a ride home 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Allow this person to initiate any sexual activity [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Initiate any sexual activity with this person [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Allow this person to initiate sex [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Initiate sex with this person [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
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50. If you met this person right now or in the past 48 hours (i.e., the past 2 days), indicate the 
extent to which you would be attracted to this person as . . .  
 
 1 2 3 4 5 6 7 9 
A long-term (romantic) partner   [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
A short-term (sexual) partner [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
51. Indicate the extent to which you think the person has the following characteristics:  
 1 2 3 4 5 6 7 9 
Attractiveness  [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Healthiness [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Parenting qualities [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Social status [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Promiscuity [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Intelligence [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
Think of a person with whom you are having a strong romantic relationship. If you do not have a 
current primary partner, please imagine what your responses would be if you did. This person 
will be referred to as X in the following questions.  
 
52. Based on how you feel now as well as well as your feelings and experiences in the past 48 























I suspect that X is secretly seeing 
someone of the opposite sex 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am worried that some member of the 
opposite sex may be chasing after X.  
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I suspect that X may be attracted to 
someone else 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I suspect X may be physically intimate 
with another member of the opposite 
sex behind my back 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I think that some members of the 
opposite sex may be romantically 
interested in X 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I am worried that someone of the 
opposite sex is trying to seduce X 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I think that X is secretly developing an 
intimate relationship with someone of 
the opposite sex 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I suspect that X is crazy about 
members of the opposite sex 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
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53. Based on how you feel now as well as your feelings and experiences in the past 48 hours 
(i.e., over the past 2 days), how would you emotionally react to the following situations?  
 





















X comments to you on how great 
looking a particular member of the 
opposite sex is 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
X shows a great deal of interest or 
excitement in talking to someone of 
the opposite sex 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
X smiles in a very friendly manner 
to someone of the opposite sex 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
A member of the opposite sex is 
trying to get close to X all the time 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
X is flirting with someone of the 
opposite sex 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
Someone of the opposite sex is 
dating X 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
X hugs and kisses someone of the 
opposite sex 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
X works very closely with a 
member of the opposite sex (in 
school or office 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
54. Based on how you feel now as well as your feelings and experiences in the past 48 hours 























I look through X’s drawers, 
handbag, or pockets 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I call X unexpectedly, just to see if 
he or she is there 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I question X about previous or 
present romantic relationships. 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I say something nasty about 
someone of the opposite sex if X 
shows an interest in that person 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I question X about his or her 
telephone calls 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I question X about his or her 
whereabouts 
[  ] [  ] [  ] [  ] [  ] [  ] [  ] 
I join in whenever I see X talking to [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
WOMEN’S REPRODUCTIVE EXPERIENCES 
   
467 
a member of the opposite sex 
I pay X a surprise visit just to see 
who is with him or her 
 
















I can tell when a man is being genuine and 
sincere in his affection toward me 
[  ] [  ] [  ] [  ] [  ] 
I doubt I could ever pull off cheating  [  ] [  ] [  ] [  ] [  ] 
I look younger than most women my age [  ] [  ] [  ] [  ] [  ] 
When a man doesn’t seem interested in 
me, I take it personally and assume 
something is wrong with me 
[  ] [  ] [  ] [  ] [  ] 
I have a sense of style and wear clothes 
that make me look sexy 
[  ] [  ] [  ] [  ] [  ] 
Honestly, I don’t think I understand men 
at all! 
[  ] [  ] [  ] [  ] [  ] 
With me, a man gets what he sees – no 
pretenses here 
[  ] [  ] [  ] [  ] [  ] 
If I wanted to make my current partner 
jealous, I could easily get the attention of 
other people 
[  ] [  ] [  ] [  ] [  ] 
Men don’t tend to be interested in my 
mind 
[  ] [  ] [  ] [  ] [  ] 
I’m definitely more creative than most 
people 
[  ] [  ] [  ] [  ] [  ] 
I hardly know when a man likes me 
romantically 
[  ] [  ] [  ] [  ] [  ] 
I laugh a lot at men’s jokes [  ] [  ] [  ] [  ] [  ] 
If a man doesn’t want to date me, I figure 
he doesn’t know what he’s missing! 
[  ] [  ] [  ] [  ] [  ] 
I’m not very artistic [  ] [  ] [  ] [  ] [  ] 
I’m usually right on the money about a 
man’s intentions toward me 
[  ] [  ] [  ] [  ] [  ] 
I really don’t have a great body compared 
to other women I know 
[  ] [  ] [  ] [  ] [  ] 
I believe that most men are actually more 
interested in long-term relationships than 
they’re given credit for 
[  ] [  ] [  ] [  ] [  ] 
Most men who are nice to me are just 
trying to get in my pants 
[  ] [  ] [  ] [  ] [  ] 
When it comes down to it, I think most 
men want to get married and have children 
[  ] [  ] [  ] [  ] [  ] 
If I have sex with a man too soon, I know 
he will leave me 
[  ] [  ] [  ] [  ] [  ] 
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1. Today’s Date:   ____________________   ____________________   ____________________ 
         Day                                    Month                                  Year  
 
2. This questionnaire is based on: (Please do not complete a daily questionnaire more than 1 day 
late) [  ] Today [  ] Yesterday 
 
3. Are you menstruating (i.e., on your menstrual period) today?  [  ] Yes [  ] No  
 
4. This scale consists of a number of words that describe different feelings and emotions.  Read 
each item and then mark the appropriate answer. Indicate to what extent you have felt this way 
TODAY.  
 Very slightly  














Interested [  ] [  ] [  ] [  ] [  ] 
Distressed [  ] [  ] [  ] [  ] [  ] 
Excited [  ] [  ] [  ] [  ] [  ] 
Upset [  ] [  ] [  ] [  ] [  ] 
Strong [  ] [  ] [  ] [  ] [  ] 
Guilty [  ] [  ] [  ] [  ] [  ] 
Scared [  ] [  ] [  ] [  ] [  ] 
Enthusiastic [  ] [  ] [  ] [  ] [  ] 
Proud [  ] [  ] [  ] [  ] [  ] 
Irritable [  ] [  ] [  ] [  ] [  ] 
Alert [  ] [  ] [  ] [  ] [  ] 
Ashamed [  ] [  ] [  ] [  ] [  ] 
Inspired [  ] [  ] [  ] [  ] [  ] 
Nervous [  ] [  ] [  ] [  ] [  ] 
Attentive [  ] [  ] [  ] [  ] [  ] 
Jittery [  ] [  ] [  ] [  ] [  ] 
Active [  ] [  ] [  ] [  ] [  ] 
Afraid [  ] [  ] [  ] [  ] [  ] 
Hostile [  ] [  ] [  ] [  ] [  ] 
Determined [  ] [  ] [  ] [  ] [  ] 
 
5. Did you experience any medical illnesses today (e.g., the cold or flu)?  [  ] Yes    [  ] No 
 

















Physical  health (i.e., experience 
of physical symptoms) 
[  ] [  ] [  ] [  ] [  ] 
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Emotional health (e.g., mood) [  ] [  ] [  ] [  ] [  ] 
Sexual functioning (desire, 
arousal, and ability to orgasm) 
[  ] [  ] [  ] [  ] [  ] 
Interest in a short-term (sexual) 
relationship 
[  ] [  ] [  ] [  ] [  ] 
Interest in a long-term 
(romantic) relationship 
[  ] [  ] [  ] [  ] [  ] 
 
7. Please indicate how many times sexual activity was initiated by . . . in the past 48 hours  
You only:   _______  
A partner only:  _______  
Both equally:   _______  
 
8. Who have you engaged in sexual activity with in the past 24 hours? (All that apply) 
[  ] Long-term/committed partner [  ] Regular sexual/uncommitted partner    
[  ] Dating partner   [  ] One-night stand/new sexual partner 
[  ] I have not engaged in sexual activity with anyone in the past 24 hours 
[  ] Others (please specify): ________________ 
 
9. Were you scheduled to use a urine hormone testing strip today?   [  ] Yes    [  ] No 
 
ITEM 10 WAS FOR WOMEN WHO WERE SCHEDULED TO USE A URINE HORMONE 
TESTING STRIP 
 
10. If yes, what was the result of your hormone detection test today?  
[  ] Positive (two [2] coloured bands present) 
[  ] Negative (one [1] coloured band present 
[  ] Unclear (was unable to interpret the results  
[  ] Unavailable (was unable to use a testing strip today) 
 
If the result was negative or unavailable, please continue the daily testing. If the result was 
unclear, please contact the researchers at hormones@lakeheadu.ca to let them know that you 
have an unclear result and continue the daily testing.  
 
ITEM 11 WAS FOR WOMEN WHO WERE SCHEDULED TO USE A URINE HORMOME 
TESTING STRIP AND INDICATED A POSITIVE RESULT 
 





















[  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] [  ] 
 
Please contact the researchers at hormones@lakeheadu.ca to let them know that you have had a 
positive test result. Discontinue use of the hormone detection strips.  
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Debriefing Form B 
 
Thank you for completing the Hormones & Sociosexuality Study. It will provide us with a better 
understanding of the associations among physical, emotional, and sexual health and wellbeing. 
For example, we will examine how changes in emotions influence changes in sexual attitudes 
and behaviours, and how these changes may be affected by reproductive events and hormones. 
 
The dates of the Phase Questionnaires were scheduled to coincide with phases of the menstrual 
cycle. Female participants were scheduled for a high fertility (ovulatory) or mid-cycle phase and 
a low fertility (premenstrual) phase. Otherwise, questionnaire dates were scheduled to be about 
10 to 14 days apart (e.g., for women who do not experience menstrual bleeding or who have 
irregular cycles and men). The results for women will be compared to those for men, and the 
results for women not using hormonal contraception, such as the birth control pill, will be 
compared to those of women using hormonal contraception. To help determine the accuracy of 
the phases, we kindly ask that all female participants please email Ms. Teatero with the start of 
their next menstrual period. This information is important for the data analyses.  
 
The saliva samples that were collected from some female participants during lab sessions will be 
used to determine levels of sex and stress hormones like estrogen, progesterone, and cortisol. 
This information will be used to assess the accuracy of the menstrual cycle phases as well as the 
effects of hormones on the study results. 
 
The body measurements that were taken at the laboratory sessions will be used as health-
indicators, including body mass index (BMI), waist-to-hip ratio (WHR), second-to-fourth finger 
ratio (2D:4D), and mid-phalangeal hair count. Your hands were scanned to obtain the reliability 
of 2D:4D measurements. 
 
Please be assured that your name and contact information will be removed from the data 
collected and there will be no way to identify your responses. All of your responses will remain 
completely anonymous and confidential. Please send a request to Ms. Teatero if you would like 
to receive a summary of the study results once we are finished collecting data. 
 
If applicable, psychology students at Lakehead University have received up to 4 bonus points for 
the completion of the study. Other Thunder Bay residents (i.e., those not eligible for bonus 
points) who completed lab sessions were offered nominal remuneration of up to $15 (i.e., $5 for 
Stage 1 and $10 for Stage 2). All participants will be entered into up to 4 draws $50 VISA gift 
cards (one draw entry for each of Stages 1, 2, and 3; i.e., the Screening Questionnaire and two 
Phase Questionnaires). All participants who completed 80% or more of the Daily Questionnaires 
will be entered into a draw for one $50 Visa gift cards. Draws will be held periodically until the 
end of data collection (approximately January 2014). Only participants who have won the draws 
will be contacted. 
 
For your interest, here are two references for articles in this research area: 
 
Kiesner, J. (2011). One woman’s low is another women’s high: Paradoxical effects of the 
menstrual cycle. Psychoneuroendocrinology, 36, 69-76. 
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Oinonen, K. A. (2009). Putting a finger on potential predictors of oral contraceptive side effects: 




Missy Teatero, M.A. and Kirsten Oinonen, Ph.D., C. Psych.                   
hormones@lakeheadu.ca; koinonen@lakeheadu.ca                              
807-343-8943; 807-343-8096 
 
Health, Hormones, and Behaviour Lab 
Department of Psychology 
Lakehead University 
955 Oliver Road 
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Summary of Means, Frequencies, and Comparisons on Screening Questionnaire (SQ) Variables between 




t  df p 





   
Age (years) 22.73 (5.26) 21.98 (4.93) 1.54 500 .125 
Education level 6.56 (1.28) 6.25 (1.37) 2.55 336.98 .013* 
Sexual orientation 1.43 (0.89) 1.47 (1.09) -0.49 498 .624 
Hormonal sensitivity 2.57 (1.17) 2.47 (1.21) 0.85 500 .394 
Emotional health 5.75 (1.87) 5.54 (1.98) 1.18 500 .237 
Physical health 5.82 (1.72) 5.92 (1.60) -0.70 500 .488 
Sexual functioning 6.31 (1.98) 6.19 (2.02) 0.61 497 .544 
Negative impression 
management 
2.17 (2.80) 2.53 (3.35) -1.27 487 .203 
Positive impression 
management 
13.93 (4.65) 14.51 (4.97) -1.29 493 .199 
Neuroticism 7.62 (3.40) 7.45 (3.42) 0.54 482 .343 
Sociosexuality 9.72 (4.66) 9.30 (4.61) 0.95 500 .201 
Frequency of 
masturbation  





) 24.61 (5.90) 24.01 (6.56) 1.04 499 .297 
Age at menarche (years) 12.70 (1.49) 12.03 (4.07) -.2.39 497 .017* 
Average menstrual cycle 
length (days) 
30.22 (17.49) 28.24 (8.39) 1.38 485 .170 
Menstrual cycle regularity 3.85 (1.03) 3.74 (1.10) 1.15 497 .250 
 n (%) X
2
 df p 
Local community 
     Yes 













     Yes 














     HC use 














     Single 














ns ranged from 319 to 327 due to missing data. 
b
ns ranged from 165 to 175 due to missing data. 
c
Based 
on self-reported height and weight.  
*p < .05.  
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Summary of Means, Frequencies, and Comparisons on Screening Questionnaire (SQ) Variables between 
the Time 1-Time 2 Subsample (n = 277) and Non-Completers (n = 50)  
 
Variable M (SD) t  df p 







   
Age (years) 22.80 (5.29) 22.30 (5.09) 0.63 325 .530 
Education level 5.60 (1.29) 6.38 (1.23) 1.11 324 .270 
Sexual orientation 1.42 (0.89) 1.50 (0.91) -0.58 324 .563 
Hormonal sensitivity 2.58 (1.17) 2.48 (1.15) 0.58 325 .560 
Physical health 5.77 (1.730 6.1 (1.63) -1.27 325 .206 
Emotional health 5.73 (1.82) 5.86 (1.95) -0.48 325 .635 
Sexual functioning 6.24 (1.98) 6.66 (1.92) -1.38 325 .169 
Negative impression 
management 
2.14 (2.85) 2.33 (2.49) -0.44 316 .661 
Positive impression 
management 
13.77 (4.60) 14.88 (4.86) -1.54 322 .124 
Neuroticism 7.71 (3.35) 7.12 (3.65) 1.13 321 .259 
Sociosexuality 9.63 (4.65) 10.21 (4.74) -0.79 317 .432 
Frequency of 
masturbation (alone) 







24.69 (5.90) 24.20 (5.96) 0.53 324 .597 
Age at menarche (years) 12.66 (1.41) 12.95 (1.84) -1.25 324 .211 
Average menstrual 
cycle length (days) 
30.55 (18.83) 28.29 (4.99) 0.83 320 409 
Menstrual cycle 
regularity 
3.83 (1.07) 4.00 (0.81) -1.09 319 .829 
 n (%) X
2
 df p 
Local community 
     Yes 














     Yes 














     HC use 
















     Single 














ns ranged from 270 to 277 due to missing data. 
b
ns ranged from 48 to 50 due to missing data. 
c
Based on 
self-reported height and weight. 
†
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Summary of Means and Comparisons between the Time 1-Time 2 Subsample (n = 277) and Non-
Completers (n = 50) of the Main Time 1 Phase Questionnaire (PQ) Variables  
 
Variable M (SD) t  df p 







   
Main Scales of the Women’s REP 
Negative Affective 
Experiences 
2.09 (0.74) 2.14 (0.82) -0.47 325 .643 
Negative Physical 
Experiences 
1.73 (0.41) 1.74 (0.42) -0.25 325 .804 
Sexual Problems – 
General 
2.72 (0.70) 2.63 (0.71) 0.91 325 .366 




2.19 (0.91) 2.13 (1.04) 0.34 192 .736 
Positive Affective and 
Physical Experiences 
2.84 (0.56) 2.84 (0.59) 0.04 325 .970 
Body Image Quality 3.20 (0.71) 3.22 (0.74) -0.19 325 .852 
Sleep Quality 3.19 (0.81) 3.31 (0.71) -1.00 325 .324 
Receptivity Scales of the PARMSS 
Short-Term 3.97 (2.13) 4.04 (2.10) -0.23 317 .819 
Long-Term  4.93 (2.54) 4.86 (2.30) 0.16 317 .873 
Picture Ratings 3.72 (1.98) 3.72 (1.74) 0.01 317 .991 
Proceptivity Scales of the PARMSS 
Short-Term 2.78 (1.75) 2.83 (1.85) -0.21 317 .835 
Long-Term  3.83 (2.39) 3.81 (2.35) 0.04 317 .965 
Picture Ratings 2.67 (1.68) 2.73 (1.58) -0.19 317 .852 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = 
Proceptivity and Receptivity Mating Strategies Scale.  
a
n = 271 for the PARMSS. 
b
n = 48 for the PARMSS 
c
n = 165 for the Time 1-Time 2 subsample 
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Correlations between the Main Subscales of the Women’s REP in the Full Time 1 Sample (n = 327) 
 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. Hormonal 
Symptoms 
1              
2. Decreased 
Appetite 
.35*** 1             
3. General Aches and 
Pains 
.53*** .31*** 1            
4. Negative Sexual 
Experiences – 
General 
.38*** .21*** .29*** 1           
5. Negative Sexual 
Experiences – Rshipa 
.29*** .01 .19* .40*** 1          
6. Negative Body 
Image Experiences 
.59*** .09 .43*** .33*** .31*** 1         
7. Negative Sleep 
Experiences 
.45*** .34*** .45*** .34*** .27*** .39*** 1        
8. Positive Sexual 
Experiences – Others 
.13* .09 .05 -.36*** .06 .06 -.02 1       
9. Positive Sexual 
Experiences – Self 
-.03 -.07 -.09 -.47*** -.11 -.06 -.17** .54*** 1      
10. Positive Sexual 
Experiences – Rshipa 
-.24** .02 -.17* -.29*** -.73*** -.22** -.20** .001 .19** 1     
11. Positive Affective 
Experiences 
-.19** -.11* -.26*** -.24*** -.38*** -.24*** -.33*** .16** .32*** .45*** 1    
12. Positive Physical 
Experiences 
-.17** -.09 -.24*** -.18** -.25*** -.19*** -.20*** .22*** .40*** .31*** .73*** 1   
13. Positive Body 
Image Experiences 
-.21*** -.11† -.22*** -.20*** -.26*** -.63*** -.23*** .09 .17** .26*** .46*** .47*** 1  
14. Positive Sleep 
Experiences 
-.21* -.15** -.21*** -.17** -.13† -.09† -.60*** .14* .24*** .11 .48** .45*** .25*** 1 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. Rship = Relationship.  
an = 194 women in a relationship.  
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Correlations between the Supplementary Subscales of the Women’s REP in the Full Time 1 Sample (n = 327) 
 




1             
2. Progesterone-Related 
Experiences 
.56*** 1            
3. Negative Sexual 
Experiences – Others 
.38*** .27*** 1           
6. Negative Sexual 
Experiences – Self 
.29*** .20*** .58*** 1          
7. Negative Weight 
Experiences 
.32*** .30*** .25*** .18** 1         
8. Positive Affect 
 





 .01 -.17** -.11* -.16** .75*** 1       




 -.14* -.27*** .71*** .59*** 1      
11. Positive Skin Experiences 
 
-.21*** -.05 -.02 -.01 -.13* .36*** .26*** .35*** 1     
12. Positive Digestion 
Experiences 
-.05 -.08 -.25*** -.18** -.18** .47*** .35*** .52*** .20*** 1    
13. Positive Breast 
Experiences 
-.23*** -.15** -.05 -.17** -.06 .40*** .30*** .40*** .30*** .19** 1   
14. Positive Weight 
Experiences 
-.03 .02 -.07 -.05 -.68*** .46*** .34*** .44*** .21*** .28*** .19** 1  
15. Positive Appetite 
Experiences 
-.19*** -.14* -.21*** -.18** -.48*** .50*** .31*** .50*** .21*** .36*** .31*** .50*** 1 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire.  
†
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Tables of Correlations between the Main and Supplementary Subscales of the Women’s Reproductive Experiences (REP) Questionnaire with the Women’s Brief 














































.19* .18* .04 .08 .08 .08 -.05 .18* .17* .13 
Decreased 
Appetite 





















.25** .33*** .12 .05 .01 .01 -.09 .16* .12 .09 
Negative Sleep 
Experiences 













Variable Negative Negative Negative Positive Positive Positive Increased Decreased Increased Decreased 
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.06 -.10 .004 -.14 -.17
†




.03 -.09 -.04 .11 .13
†








.03 -.21** .01 .04 .10 .11 .23** .05 -.001 .11 
Positive Sleep 
Experiences 
.03 .08 .10 .05 .001 -.01 .09 .12 .07 -.05 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. HC = Hormonal contraceptive. LTRs = long-term relationships. STRs = short-term 
relationships. The B-REP measures current HC users ratings of the negative and positive or increased and decreased side effects of their HCs on their emotional 
health, physical health, and sexual functioning (one item for each valance for a total of 10 ratings) from 1 (not at all) to 5 (extremely). High ratings reflect greater 
side effects, negative or positive.   
a
Actual ns = 155 to 157 due to missing data. 
b
ns = 110 to 111 women in a relationship.  
†
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.06 .25** .04 .001 -.06 -.05 -.18* .02 -.08 .04 
Positive Affect .02 -.08 -.04 .11 .14
†
 .10 .27** .07 .03 .07 
Elation -.03 -.10 -.05 .09 .10 .15
†





.06 -.06 .01 .08 .14
†















Variable Negative Negative Negative Positive Positive Positive Increased Decreased Increased Decreased 
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-.02 -.10 .03 .12 .09 .17* .27** -.02 .01 .07 
Positive Weight 
Experiences 








-.01 -.16* .01 .03 .04 .11 .17* .01 -.08 .01 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. HC = Hormonal contraceptive. LTRs = long-term relationships. STRs = short-term 
relationships. The B-REP measures current HC users ratings of the negative and positive or increased and decreased side effects of their HCs on their emotional 
health, physical health, and sexual functioning (one item for each valance for a total of 10 ratings) from 1 (not at all) to 5 (extremely). High ratings reflect greater 
side effects, negative or positive.   
a
 Actual ns = 155 to 157 due to missing data.  
†
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Tables of Correlations between the Main and Supplementary Subscales of the Women’s Reproductive Experiences (REP) Questionnaire with the Women’s Brief 





















































 -.17 -.09 -.15 -.12 -.30 .25 -.15 -.18 .36* 
General Aches 
and Pains 





.55** .41* .47** -.16 .004 .16 .04 .35
†









 .61* -.21 .18 .20 -.16 .45
†




.49** .23 .03 .17 .36
†
 .43* -.002 -.02 .19 -.04 
Negative Sleep 
Experiences 










.12 -.04 -.12 .32
†





Variable Negative Negative Negative Positive Positive Positive Increased Decrease Increased Decreased 
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 .17 .21 .03 -.47
†





















 .01 .47** .43* .64*** .31
†
 .15 .56** -.11 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. LTRs = long-term relationships. STRs = short-term relationships. The B-REP 
measures women’s reports of the negative and positive or increased and decreased effects of the premenstrual phase (in general) on their emotional health, 
physical health, and sexual functioning (one item for each valance for a total of 10 ratings) from 1 (not at all) to 5 (extremely). High ratings reflect greater side 
effects, negative or positive.   
a
Actual ns = 29 to 30 due to missing data. 
b
n = 15 women in a relationship.  
†
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.01 .02 -.21 -.01 .05 .13 -.04 -.31 -.13 -.21 
Positive Affect -.39* -.27 -.26 .02 -.15 .11 .07 -.12 .003 -.24 
















Variable Negative Negative Negative Positive Positive Positive Increased Decreased Increased Decreased 
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.04 .21 -.18 .26 -.15 .26 .23 .14 .26 .03 
Positive Breast 
Experiences 
.07 -.05 -.03 .29 .37* .44* .13 .02 .42* -.18 
Positive Weight 
Experiences 






-.02 .10 .22 .05 -.09 -.22 -.14 .40* -.25 .36
†
 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. LTRs = long-term relationships. STRs = short-term relationships. The B-REP 
measures women’s reports of the negative and positive or increased and decreased effects of the premenstrual phase (in general) on their emotional health, 
physical health, and sexual functioning (one item for each valance for a total of 10 ratings) from 1 (not at all) to 5 (extremely). High ratings reflect greater side 
effects, negative or positive.   
a
 Actual ns = 29 to 30 due to missing data.  
†
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Varaible NIM PIM N HS NA PA EH PH SF 
Main Subscales 
Hormonal Symptoms .32*** -.29*** .33*** .21*** .47*** -.18** -.25*** -.10† -.10† 
Decreased Appetite .22*** -.07 .13* .07 .25*** -.11† -.08 .01 .05 
General Aches and Pains .30*** -.28*** .25*** .22*** .38*** -.20*** -.30*** -.11* -.08 
Negative Sexual Experiences – General .26*** -.20*** .23*** .05 .29*** -.21*** -.26*** -.06 -.34*** 
Negative Sexual Experiences – Relationshipb .23** -.20** .26*** .15* .36*** -.28*** -.20** -.16* -.51*** 
Negative Body Image Experiences .19*** -.28*** .35*** .19*** .44*** -.20*** -.24*** -.09† -.16** 
Negative Sleep Experiences .27*** -.27*** .30*** .05 .51*** -.34*** -.27*** -.17** -.21*** 
Positive Sexual Experiences – Others -.04 -.01 .02 .01 .07 .11† -.001 .02 .15** 
Positive Sexual Experiences – Self -.05 .12* -.10 -.02 -.10† .20*** .09 .01 .29*** 
Positive Sexual Experiences – Relationshipb -.24** .16* -.16* -.12† -.32*** .39*** .15* .16* .48*** 
Positive Affective Experiences -.26*** .16** -.34*** -.06 -.45*** .79*** .40** .29*** .31*** 
Positive Physical Experiences -.18** .17** -.27*** -.04 -.23*** .54*** .31** .33*** .24*** 
Positive Body Image Experiences -.12* .20*** -.26*** -.07 -.25*** .36*** .28** .29*** .15** 
Positive Sleep Experiences -.16** .13* -.25*** .02 -.21*** .28*** .20** .26*** .18** 
Supplementary Subscales 
Testosterone-Related Experiences .34*** -.31*** .35*** .21*** .49*** -.22*** -.28*** -.13* -.15** 
Progesterone-Related Experiences .18** -.19** .21*** .16** .31*** -.08 -.l4* -.03 .000 
Negative Sexual Experiences – Others .24*** -.16** .21*** .05 .28*** -.21*** -.25*** -.10† -.33*** 
Negative Sexual Experiences – Self .22*** -.18** .20*** .03 .22*** -.17** -.21*** .002 -.27*** 
Negative Weight Experiences .14* -.22*** .26*** .09 .28*** -.24*** -.26*** -.20*** -.15** 
Positive Affect -.27*** .19** -.27*** -.07 -.46*** .79*** .42*** .30*** .28*** 
Elation -.20*** .06 -.20*** -.03 -.30*** .65*** .27*** .22*** .33*** 
Positive General Physical Experiences -.16** .14** -.27*** -.04 -.19** .57*** .30*** .33*** .25*** 
Positive Skin Experiences -.10† .09† -.13* -.02 -.13* .19** .13* .20*** .07 
Positive Digestion Experiences -.06 .13* -.13* .02 -.18** .34*** .23*** .20*** .16** 
Positive Breast Experiences -.20*** .15** -.17** -.02 -.16** .23*** .14* .15** .11* 
Positive Weight Experiences -.05 .14* -.18** -.02 -.15** .33*** .30*** .23*** .11* 
Positive Appetite Experiences -.10† .16** -.24*** .09 -.21*** .37*** .23** .24*** .11* 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. NIM = Negative Impression Management. PIM = Positive Impression Management. 
N = Neuroticism. HS = Hormonal Sensitivity Rating. NA = Negative Affect. PA = Positive Affect. EH = Emotional Health Rating. PH = Physical Health Rating. 
SF = Sexual Functioning Rating.
 
a
Actual ns = 318 to 327 due to missing data. 
b
ns = 180 to 194 women in a relationship.  
†
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Table of Correlations of the Main Subscales and Supplementary Subscales of the Women’s Reproductive Experiences (REP) with Other Sexuality-Relevant 




Variable SO PSSI MF A – LT A – ST SOI LTMO STMO PSB R P 
Main Subscales 
Hormonal Symptoms .09 -.20*** .08 .13* .13* .04 -.10
†
 .06 -.01 -.02 -.02 
Decreased Appetite .04 -.11** .04 .10
†
 .14* .07 -.19*** .09 .01 -.01 .01 
General Aches and Pains .11* -.10
†
 .04 .03 .04 .02 -.10 .05 .02 -.03 .03 
Negative Sexual Experiences – 
General 
.01 -.18** -.12* -.04 -.07 -.17** -.06 .03 -.08 -.04 -.13* 




.20** -.56*** .15* .03 .14* .20** -.08 .25** .16** -.06 -.13
†
 
Negative Body Image Experiences -.02 -.18** -.01 .12* .06 .03 -.04 .11* .06 -.02 -.10
†
 
Negative Sleep Experiences .07 -.21*** -.02 .12* .07 -.09 -.09 .03 -.06 -.05 -.05 
Positive Sexual Experiences – Others .13* .01 .26*** .20*** .28*** .34*** -.13* -.04 .07 -.04 .05 
Positive Sexual Experiences – Self .10
†
 .20*** .51*** -.03 .15** .24*** -.04 .34** .15** .10
†
 .15* 






 .66*** -.09 -.11 -.15* -.16* .14* -.19** -.10 .10 .10 
Positive Affective Experiences -.18** .30*** .08 .02 .05 -.003 .22*** .22** -.04 -.03 -.04 
Positive Physical Experiences -.14* .40*** -.03 .03 .03 -.06 .15** -.01 -.08 .02 -.02 
Positive Body Image Experiences -.07 .21*** .01 -.01 .04 -.07 .05 -.09 -.12* .002 .06 
Positive Sleep Experiences -.08 .23*** .06 -.01 .06 .12* .09 .07 .01 -.01 .02 
Supplementary Subscales 
Testosterone-Related Experiences .13* -.24*** .09 .12* .15** .10
†
 -.12* .14* .04 -.02 -.04 
Progesterone-Related Experiences .000 -.09 .04 .10
†
 .08 -.06 -.05 -.01 -.07 -.01 .01 
Negative Sexual Experiences – Others -.004 -.14* -.03 -.09 -.11 -.17** -.03 -.13* -.03 -.02 -.10
†
 
Negative Sexual Experiences – Self .02 -.18** .19*** .02 .02 -.13* -.08 -.07 -.12* -.06 -.12* 
Negative Weight Experiences .01 -.17** -.01 .07 .03 .04 -.02 .03 .05 -.01 -.06 
Positive Affect -.17** .38*** -.03 .04 .02 -.07 .19*** -.09 -.09 -.02 -.05 
Elation -.16** .40*** -.03 .001 .05 -.03 .23*** -.06 -.02 .11
†
 .07 







Variable SO PSSI MF A – LT A – ST SOI LTMO STMO PSB R P 
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Supplementary Subscales 




 -.01 .01 .02 -.05 .001 -.07 -.02 -.03 -.004 
Positive Digestion Experiences -.03 .22*** .04 .04 .06 .04 .10
†
 .06 -.04 -.09 -.08 
Positive Breast Experiences -.05 .22*** .13* -.05 -.06 -.01 .05 -.04 -.03 -.03 -.05 
Positive Weight Experiences -.08 .15** .01 .04 .07 -.10
†
 .06 -.04 -.14* .02 .04 
Positive Appetite Experiences -.09
†
 .21*** -.01 -.001 .06 -.02 .04 .02 -.12* -.04 .03 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = Proceptive and Receptive Mating Strategies Scales. SO = Sexual 
Orientation rating. PSSI = Pinney Sexual Satisfaction Inventory – General (total score). MF = Masturbation Frequency Rating. A – LT = Attraction for a Long-
Term Relationship – Picture Ratings. ST = Attraction for a Short-Term Relationship – Picture Ratings. SOI = Sociosexual Orientation Inventory – Revised (total 
score). LTMO = Long-Term Mating Orientation. STMO = Short-Term Mating Orientation. PSB = Past Sexual Behaviour. R = Number of Times Receptive to 
Sexual Activity with Others (excluding primary partner) in the past two days (48 hours). P (Proceptive) = Number of Times Sexual Activity with Others Initiated 
by Self or Both Self and Partner (excluding primary partner) in the past two days (48 hours). 
a
ns = 319 to 327 due to missing data. 
b
ns = 189 to 194 women in a relationship.  
†
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Table of Correlations of the Main and Supplementary Subscales of the Women’s Reproductive Experiences (REP) with Other Relationship-Relevant Variables 




Variable PSSI S C I T CJ EJ BJ R P 
Main Subscales 
Hormonal Symptoms -.25** -.18* -.11 -.14
†
 -.21** .20** .14
†
 .20** .04 -.06 
Decreased Appetite -.03 -.20** -.15* -.17* -.25*** .18* .004 .18* .08 .03 
General Aches and Pains -.02 -.22** -.16* -.22** -.18* .17* .14
†
 .17* .11 -.04 




 .10 -.17* -.17* .09 .06 .05 .01 -.16* 
Negative Sexual Experiences – 
Relationship 
-.39*** -.35*** -.08 -.40*** -.24** .12 -.04 .05 -.08 -.20** 
Negative Body Image 
Experiences 
-.20** -.20** -.01 -.19** -.20** .24** .23** .24** .08 -.07 
Negative Sleep Experiences -.13
†
 -.24** -.05 -.17* -.18* .16* .07 .13 .02 -.12 
Positive Sexual Experiences – 
Others 
-.07 -.15* -.27*** -.04 -.03 .11 -.06 .05 -.07 -.002 




 .01 .09 .20** .01 .11 -.02 .09 .22** 
Positive Sexual Experiences – 
Relationship 
.38*** .40*** .17* .48*** .23** -.11 .14 -.02 .14
†
 .35*** 
Positive Affective Experiences .18* .30*** .11 .28*** .28*** -.13 .02 -.08 -.07 .10 
Positive Physical Experiences .30*** .41*** .17* .42*** .34*** -.17 -.05 -.10 .001 .18* 
Positive Body Image Experiences .07 .22** .03 .17* .10 -.11 -.01 -.11 .08 .09 
Positive Sleep Experiences .04 .10 -.07 .06 .07 -.01 .002 .001 -.03 -.06 
Supplementary Subscales 
Testosterone-Related Experiences -.27*** -.23** -.14
†





 -.05 -.05 .02 -.08 .09 .09 .12
†
 .04 .01 
Negative Sexual Experiences – 
Others 
-.08 -.12 .07 -.18* -.12
†
 .10 .11 .10 .03 -.12 
Negative Sexual Experiences – 
Self 
-.03 -.11 .11 -.12 -.19* .05 -.01 -.02 -.02 -.17* 
Negative Weight Experiences -.06 -.22** -.06 -.15* -.10 .17* .05 .13 .08 -.08 
Positive Affect .28*** .40*** .15* .39** .35*** -.19* -.08 -.02 -.03 .15* 
 
 
Variable PSSI S C I T CJ EJ BJ R P 
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   Supplementary Subscales 
Elation .31*** .38*** .17* .44** .26*** -.11 .04 .02 .08 .22** 
Positive General Physical 
Experiences 
.14* .32*** .09 .30** .26*** -.12
†
 .05 -.07 -.05 .13
†
 
Positive Skin Experiences .11 .03 .05 .05 .11 -.07 -.07 -.05 -.08 .03 
Positive Digestion Experiences .10 .26*** .09 .21** .24** -.07 .03 -.02 -.07 .03 
Positive Breast Experiences -.16* .11 .06 .11 .15* -.09 .01 -.07 -.01 .03 
Positive Weight Experiences -.08 .17* .05 .15* .05 -.08 .02 -.03 -.03 .07 
Positive Appetite Experiences -.04 .16* -.06 .13
†
 .10 -.03 .004 -.12 -.09 .08 
Note. Women’s REP = Women’s Reproductive Experiences Questionnaire. PARMSS = Proceptive and Receptive Mating Strategies Scales. PSSI = Pinney 
Sexual Satisfaction Inventory – Partner (total score). S = Relationship Satisfaction. C = Commitment to Partner. I = Intimacy with Partner. T = Trust in Partner. 
CJ = Cognitive Jealousy. EJ = Emotional Jealousy. BJ = Behavioural Jealousy. R = Number of Times Receptive to Sexual Activity with Partner in the past two 
days (48 hours). P (Proceptive) = Number of Times Sexual Activity with Partner Initiated by Self or Both Self and Partner in the past two days (48 hours).  
a
ns = 188 to 194 due to missing data.  
†






















WOMEN’S REPRODUCTIVE EXPERIENCES 
 
   
490 
 
Tables of Correlations between Average as well as Premenstrual Minus (-) Periovulatory Phase Change Scores for Conception 




Correlations between Average as well as Premenstrual Minus (-) Periovulatory Phase Change Scores for Conception Probability 





























CP 1 .07 -.26* .40*** .27* .31** .13 -.34† .14 
E Estimate .29** 1 .37*** .56*** .45** .10 .31 .32 .17 
P Estimate -.15 .37*** 1 .07 -.21*- -.51*** .37† .48* -.08 
T Estimate .43*** .31** -.02 1 .63*** .48*** .41* .05 .15 
LH Estimate .21* .36** -.29** .53** 1 .89*** -.10 -.25 -.08 
FSH Estimate .03 -.10 -.49*** .40** .85*** 1 -.17 -.41* .01 
E Assay
a
 -.07 .12 .40* .08 -.01 -.01 1 .36† .39† 
P Assay
a
 -.24 .28 .48** -.01 .16 .05 .69*** 1 .44* 
T Assay
a
 -.08 .31† .24 -.04 .12 -.07 .64*** .34† 1 
Note. Correlations for average estimates and assays are above the diagonal. Correlations for change scores are below the diagonal. 
Change scores were calculated as lowest fertility phase score minus highest fertility phase score and thus, higher scores change scores 
represent higher scores in the lowest fertility phase. CP = conception probability. E = estradiol. P = progesterone. T = testosterone. LH 
= luteinizing hormone. FSH = follicle stimulating hormone.  
a
n = 31 (27 for change scores) for E and P Assays. n = 30 (26 for change scores) for T Assay.  
†
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Correlations between Average as well as Premenstrual Minus (-) Periovulatory Phase Change Scores for Conception Probability 





























CP 1 -.08 -.14 .11 .06 .12 -.07 -.20 .22 
E Estimate -.07 1 .42** .15 .37* .22 .41 .63** .34 
P Estimate .15 .54*** 1 .53*** -.10 -.17 .16 .45† -.003 
T Estimate .15 .44** .68*** 1 .56** .47** .25 .39 -.05 
LH Estimate .06 .40** .19 .63*** 1 .98** .63** .56* .22 
FSH Estimate .09 .28 .15 .58*** .97*** 1 .58* .47† .10 
E Assay
a
 .14 .09 .39 .18 -.18 .08 1 .46† .51* 
P Assay
a
 -.23 .29 .40 .19 .01 -.01 .44† 1 .15 
T Assay
a
 -.002 -.02 .02 -.18 -.40 -.36 .52† .69** 1 
Note. Correlations for average estimates and assays are above the diagonal. Correlations for change scores are below the diagonal. 
Change scores were calculated as premenstrual phase score minus (-) periovulatory phase score and thus, higher scores change scores 
represent higher scores in the premenstrual phase. E = estradiol. P = progesterone. T = testosterone. CP = conception probability. LH = 
luteinizing hormone. FSH = follicle stimulating hormone.  
a
n = 15 for E and P Assays. n = 14 for T Assay.  
†
p < .10. *p < .05. **p < .01. ***p < .001.
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Summary of Means and Frequencies for Comparisons on Screening Questionnaire (SQ) Variables 




t  df p 
 Part 2 subsample
 
(n = 42) 
Ineligible participants
a 
(n = 190) 
   
Age (years) 22.92 (5.43) 22.43 (4.82) 0.58 230 .561 
Education level 6.67 (1.22) 6.59 (1.23) 0.36 229 .722 
Sexual orientation 1.24 (0.82) 1.43 (0.88) -1.32 229 .189 
Hormonal sensitivity 2.48 (1.21) 2.58 (1.18) -0.54 230 .593 
Physical health 5.60 (1.56) 5.82 (1.74) -.078 230 .439 
Emotional health 5.50 (1.99) 5.73 (1.81) -.074 230 .462 
Sexual functioning 6.00 (1.70) 6.23 (2.02) -0.86 230 .389 
Negative impression 
management 
2.14 (2.70) 2.05 (2.55) 0.21 223 .832 
Positive impression 
management 
14.19 (4.79) 13.79 (4.49) 0.51 229 .609 
Neuroticism 7.61 (3.60) 7.69 (3.35) -0.14 227 .889 
Sociosexuality 8.02 (4.39) 10.04 (4.77) -2.49 226 .013* 
Frequency of 
masturbation  







25.99 (6.43) 24.43 (5.62) 1.56 230 .120 
Age at menarche (years) 12.64 (1.35) 12.65 (1.44) -0.04 230 .971 
Average menstrual 
cycle length (days) 
29.40 (5.26) 30.95 (22.24) -0.44 227 .658 
Menstrual cycle 
regularity 
3.83 (0.70) 3.85(1.16) -0.10 230 .918 
 n (%) X
2
 df p 
Local community 
     Yes 














     Yes 














     Single 














ns ranged from 187 to 175 due to missing data. 
b
Based on self-reported height and weight.  
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Summary of Means and Frequencies for Comparisons on Screening Questionnaire (SQ) Variables 




t  df p 
 Part 2 subsample
 




(n = 45) 
   
Age (years) 22.92 (5.43) 24.29 (6.77) -1.04 85 .301 
Education level 6.67 (1.22) 6.56 (1.63) 0.36 81.31 .719 
Sexual orientation 1.24 (0.82) 1.53 (0.99) -1.51 85 .135 
Hormonal sensitivity 2.48 (1.21) 2.68 (1.12) -0.85 85 .399 
Physical health 5.60 (1.56) 5.69 (1.88) -0.25 85 .802 
Emotional health 5.50 (1.99) 5.91 (1.12) -1.03 85 .304 
Sexual functioning 6.00 (1.70) 6.27 (2.09) -0.65 85 .517 
Negative impression 
management 
2.14 (2.70) 2.51 (3.96) -0.50 85 .616 
Positive impression 
management 
14.19 (4.79) 13.25 (4.91) 0.90 84 .371 
Neuroticism 7.61 (3.60) 7.89 (3.16) -0.38 83 .707 
Sociosexuality 8.02 (4.39) 9.40 (4.06) -1.50 82 .136 
Frequency of 
masturbation  







25.99 (6.43) 24.55 (5.52) 1.02 84 .309 
Age at menarche (years) 12.64 (1.35) 12.70 (1.40) -0.21 85 .837 
Average menstrual 
cycle length (days) 
29.40 (5.26) 30.02 (8.98) -0.39 85 .699 
Menstrual cycle 
regularity 
3.83 (0.70) 3.71 (0.94) 0.68 85 .496 
 n (%) X
2
 df p 
Local community 
     Yes 














     Yes 














     Single 














ns ranged from 42 to 45 due to missing data. 
b
Based on self-reported height and weight.  
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Table of Means, Frequencies, and Comparisons on Demographic and Hormonal Status Variables 




t  df p 
 POS (n = 16) PMS (n = 25)
 
   
Periovulatory phase day 12.18 (2.07) 11.44 (1.78) 1.23 39 .226 
Premenstrual phase day 23.06 (2.58) 24.20 (2.63) -1.36 39 .181 
Menstrual cycle length (days) 29.50 (6.09) 29.44 (4.88) 0.04 39 .972 
Menstrual cycle regularity  3.75 (0.94) 3.88 (0.53) -0.57 21.20 .616 
Sexual orientation 1.31 (0.87) 1.20 (0.82) 0.42 39 .678 
Mean NA 1.95 (0.56) 2.21 (0.63) -1.35 39 .184 
Mean PA 2.90 (0.61) 2.77 (0.59) 0.65 39 .519 
Mean proceptivity  2.71 (1.00) 2.41 (1.51) 0.70 39 .490 
Conception probability 
 





-32.22 (60.04) -32.72 (64.53) -0.03 39 .980 
Progesterone level estimate
b





-60.43 (36.32) -64.38 (52.25) 0.26 39 .794 
LH level estimate
c
  -10.53 (12.53) -6.85 (10.87) 00.99 39 .326 
FSH level estimate
c
  -4.19 (4.05) -2.93 (3.47) -1.06 39 .295 
Estradiol level assay
ad
 -0.19 (0.60) -0.09 (0.93) -0.21 13 .836 
Progesterone level assay
ad
  49.54 (159.51) 46.72 (93.70) 0.04 13 .966 
Testosterone level assay
ad
  -4.76 (18.38) -15.02 (22.10) 0.82 12 .430 
 n (%) X
2
 df p 
Previous HC use 
     Yes 













Note. POS = periovulatory syndrome. PMS = premenstrual syndrome. NA = Negative Affective 
Experiences. PA = Positive Affective Experiences. Proceptivity = Proceptivity – Picture Ratings. 
HC = hormonal contraceptive. Values for conception probability, hormone estimates, and 








ns = 5 and 10, respectively.  
